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Abstract 
It has been proposed that long-term consumption of diets rich in non-digestible 
carbohydrates (NDCs), such as cereals, fruit and vegetables might protect against 
several chronic diseases, however, it has been difficult to fully establish their impact 
on health in epidemiology studies. The wide range properties of the different NDCs 
may dilution their impact when they are combined in one category for statistical 
comparisons in correlations or multivariate analysis. Several mechanisms have 
been suggested to explain the protective effects of NDCs, including increased stool 
bulk, dilution of carcinogens in the colonic lumen, reduced transit time, lowering pH, 
and bacterial fermentation to short chain fatty acids (SCFA) in the colon. However, 
it is very difficult to measure SCFA in humans in vivo with any accuracy, so 
epidemiological studies on the impact of SCFA are not feasible. Most studies use 
dietary fibre (DF) or Non-Starch Polysaccharides (NSP) intake to estimate the 
levels, but not all fibres or NSP are equally fermentable.   
Epidemiological and intervention studies use traditional dietary analysis methods, 
which depend on food composition databases that may not have been updated to 
include non-digestible oligosaccharides (NDOs), resistant starch (RS), and so do 
not provide accurate data on NDCs intake whether or not it is fermented. Therefore, 
this thesis attempted to develop an index of dietary estimation of fermentable 
carbohydrate (FC) from the amount of carbohydrate in diets that bacteria in the 
colon ferment to produce SCFA.  
The first aim of this thesis (Chapter 3) was the development of the equations used 
to estimate the amount of FC that reaches the human colon and is fermented fully 
to SCFA by the colonic bacteria. Therefore, several studies were examined for 
evidence to determine the different percentages of each type of NDCs that should 
be included in the final model, based on how much NDCs entered the colon intact 
and also to what extent they were fermented to SCFA in vivo. Our model equations 
are  
FC-DF or NSP$ 1: 100 % Soluble + 10 % insoluble + 100 % NDOs¥ + 5 % TS**    
FC-DF or NSP 2: 100 % Soluble + 50 % insoluble + 100 % NDOs + 5 % TS    
FC-DF* or NSP 3: 100 % Soluble + 10 % insoluble + 100 % NDOs + 10 % TS    
FC-DF or NSP 4: 100 % Soluble + 50 % insoluble + 100 % NDOs + 10 % TS    
*DF: Dietary fibre; **TS: Total starch; $NSP: non-starch polysaccharide; ¥NDOs: non-digestible oligosaccharide  
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The second study of this thesis (Chapter 4) aimed to examine all four predicted FC-
DF and FC-NSP equations developed, to estimate FC from dietary records against 
urinary colonic NDCs fermentation biomarkers. The main finding of a cross-sectional 
comparison of habitual diet with urinary excretion of SCFA products, showed weak 
but significant correlation between the 24 h urinary excretion of SCFA and acetate 
with the estimated FC-DF 4 and FC-NSP 4 when considering all of the study 
participants (n = 122). Similar correlations were observed with the data for valid 
participants (n = 78). It was also observed that FC-DF and FC-NSP had positive 
correlations with 24 h urinary acetate and SCFA compared with DF and NSP alone. 
Hence, it could be hypothesised that using the developed index to estimate FC in 
the diet form dietary records, might predict SCFA production in the colon in vivo in 
humans.     
The next study in this thesis (Chapter 5) aimed to validate the FC equations 
developed (chapter 3) using in vitro models of small intestinal digestion and human 
colon fermentation. The main findings in these in vitro studies were that there were 
several strong agreements between the amounts of SCFA produced after actual in 
vitro fermentation of single fibre and different mixtures of NDCs, and those predicted 
by the estimated FC from our developed equation FC-DF 4. These results which 
demonstrated a strong relationship between SCFA production in vitro from a range 
of fermentations of single fibres and mixtures of NDCs and that from the predicted 
FC equation, support the use of the FC equation for estimation of FC from dietary 
records. Therefore, we can conclude that the newly developed predicted equations 
have been deemed a valid and practical tool to assess SCFA productions for in vitro 
fermentation. 
In conclusion, this thesis demonstrated several relationships between estimated 
dietary FC using our equations and SCFA products in vivo and in vitro. These need 
to be further validated, for example by using FC from well-designed interventions 
and comparing these with fermentation in humans in vivo. The most reliable method 
that could be used to measure SCFA in humans’ in vivo is the isotope dilution 
method. Once better validated the FC equations developed in this thesis will be a 
powerful epidemiological tool for future cohort, case control and intervention studies 
investigating the role of fermentation in a range of chronic conditions more clearly 
that using DF alone.  
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 Introduction 
The role of non-digestible carbohydrates (NDCs) in disease prevention has been 
studied for many years, but it has been difficult to fully establish their impact on 
health in epidemiology studies. This is due, in part, to the wide range of properties 
of the different NDCs, where combining them all in one category for statistical 
comparisons may dilute their impact in correlations or multivariate analysis (Jones, 
2014a). In addition, the potential role of short chain fatty acids (SCFA) in promoting 
health has received much attention; this has included recently the role of propionate 
in satiety (Arora et al., 2011) and the role of SCFA in obesity (Schwiertz et al., 2010, 
Rahat-Rozenbloom et al., 2014). Schwiertz et al. (2010) and Rahat-Rozenbloom et 
al. (2014) observed that overweight and obese individuals produce more colonic 
SCFA than lean due to differences in colonic microbiota, which may promote obesity 
through increased colonic energy availability for absorption. However, it is very 
difficult to measure SCFA production in humans in vivo with any accuracy, faecal 
SCFA levels may be misleading as most of those produced are absorbed quickly 
making epidemiological studies of the effects of SCFA on chronic disease very 
difficult. This thesis therefore describes the development and testing of an index for 
the estimation of potential SCFA production from dietary intake records which 
should improve the data available for epidemiological studies.  
Carbohydrates can be classified nutritionally into digestible and NDCs, based on the 
way they are handled by the human small intestine (Figure 1.1). NDCs are those 
that enter the colon, where they become available as substrates for fermentation by 
bacteria in the large intestine; examples include non-digestible oligosaccharides 
(NDOs), resistant starch (RS) and dietary fibre (DF) (Table 1.1) (Grabitske and 
Slavin, 2009, Englyst et al., 2007). Epidemiological, systematic reviews and meta-
analysis studies have reported that long term consumption of diets rich in NDCs, 
such as cereals, fruit and vegetables, may protect against several chronic diseases 
including cardiovascular disease (CVD) (Threapleton et al., 2013a, Dauchet et al., 
2006), colorectal cancer (CRC) (Aune et al., 2011, Park et al., 2005, Wiseman, 
2008), diabetes mellitus (Carter et al., 2010), obesity (Lindström et al., 2006) and 
irritable bowel syndrome (Ford et al., 2008). Similarly, the World Cancer Research 
Fund (WCRF) concluded that NDCs ‘probable’ provide protective effects against 
CRC incidence with high cereal, fruit and vegetable intake using their criteria based 
systematic review of the evidence (WCRF, 2007). The WCRF criteria of judgment 
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that support the probably decrease the risk of CRC was based on: 1) the evidence 
should be at least two independent cohort studies or at least five case-control 
studies. 2) the evidence should show no substantial unexplained heterogeneity 
between or within study types in the presence or absence of an association or 
direction of effect. 3) it should be based on good quality studies that exclude the 
detected relationship results from random or systematic error, including 
confounding, measurement error and selection bias (WCRF, 2007). 
Moreover, several mechanisms have been proposed to explain the protective 
effects of NDCs; including increased stool bulk, dilution of carcinogens in the colonic 
lumen, reduced transit time, increased viscosity and water-binding, lowering colonic 
pH and bacterial fermentation of NDC to SCFA in the colon (den Besten et al., 2013). 
Only some of these physiological effects can be attributed to the fermentation of 
carbohydrates to SCFA by the colonic microbiota. The major products of bacterial 
fermentation of carbohydrates are acetate, propionate and butyrate, and the total 
concentration of SCFA in the colonic content may exceed 100 mmol/l (Cummings 
and Macfarlane, 1991). These SCFAs released in the intestinal lumen are readily 
absorbed and used as an energy source by colonocytes, and also by other tissues 
such as the liver and muscles (approximately 10 % of basal energy requirements) 
(den Besten et al., 2013).  Before considering the role of fermentation in preventing 
disease, the definitions and properties of the different NDCs will be discussed. 
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Figure 1.1: Transit and fate of dietary carbohydrates through the human gastrointestinal 
tract and the digestion of nutrients in the small intestine and fermentation in the colon, ↑ = 
increase, ↓ = decrease (adapted from Eswaran et al. 2013; Cummings, 1997). 
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Table 1.1: Nutritional classification of dietary carbohydrates (adapted from Englyst et al., 2007a). 
 
Main categories Chemical 
components 
Nutritional grouping Physiology and health 
Digestible 
carbohydrate  
 
Sugars Lactose Malabsorbed by those with lactase deficiency. 
Fructose (including from sucrose) Largely metabolized by liver. Possible detrimental effect on lipid metabolism. 
Starch Rapidly and slowly digestible starch 
maltodextrins  
RAG and SAG reflect the rate of glucose release from food, which is a main 
determinant of the GI. Evidence suggests that the metabolic response associated 
with slow release carbohydrates are most conducive to optimal health. 
Non-digestible 
carbohydrate  
Resistant starch RS Varied rate and extent of fermentation. Insufficient knowledge of effect on health. 
Non-Starch 
Polysaccharides 
)NSP( 
Dietary fibre (intrinsic plant cell wall 
polysaccharides) 
Marker for minimally refined plant foods that are rich in micronutrients and shown 
to be beneficial to health. 
Added NSP Varied rate and extent of fermentation. Some have specific functional properties. 
Oligosaccharides  Present naturally and added Varied rate and extent of fermentation. Some have specific functional properties. 
Sugar alcohols Present naturally and added Partly absorbed and metabolized, and partly fermented. 
Abbreviations: GI, glycaemic index; NSP, non-starch polysaccharides; RAG, rapidly available glucose; RS, resistant starch; SAG, slowly available glucose. 
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 Dietary fibre (DF) definitions 
In the 1970s Burkitt and Trowell hypothesised that DF intake was a protective factor 
against a number of Western diseases (Trowell, 1976, Burkitt, 1971). They observed 
that diseases common in the West were rare in rural Africa, possibly because of the 
unrefined carbohydrates consumed by Africans. Trowell (1972) defined DF as “The 
residue derived from plant cell walls that are resistant to hydrolysis by human 
alimentary enzymes”. DF is a general term that includes a number of substances 
which escape digestion and absorption in the small intestine. All types of DF are 
fermented to some extent in the colon by microbiota and produce SCFA, but this 
varies considerably between carbohydrates and their sources (Bach Knudsen, 
2001).   
Since the 1970s, there has been no international agreement to produce a DF 
definition that is recognised worldwide, and the wording of the definition has 
changed over time after much debate (de Menezes et al., 2013). There has been 
disagreement over which carbohydrate substances should be included in the 
definition, and which analytical method should be used to derive fibre values 
(Buttriss and Stokes, 2008). Several definitions have been published based on 
different analytical methodologies and physiological properties (e.g. digestion, 
absorption and effects on health). These methods include the enzymic gravimetric 
method approved by the Association of Official Analytical Chemists (AOAC method 
985.29), which is used globally, and the Englyst method which was used mostly in 
the UK (Agostoni et al., 2010). The AOAC method aims to isolate gravimetrically the 
part of the diet which resists breakdown by digestive enzymes; this method includes 
some, but not all, starch made resistant to amylase hydrolysis by food processing. 
The Englyst method measures non-starch polysaccharide (NSP) using gas liquid 
chromatography (GLC) of aldol esters, which provides values for the individual 
monosaccharides and does not include any starch, even that made resistant by 
processing as this is removed by dimethyl sulfoxide (DMSO) (Englyst, 1989).  
In the UK 2015, Scientific Advisory Committee on Nutrition (SACN) recommended 
that dietary fibre should be defined as all carbohydrates that are neither digested 
nor absorbed in the small intestine and have a degree of polymerisation of three or 
more monomeric units, plus lignin. The regular authorities agreed to determine DF 
chemically using AOAC method (SACN, 2015). Several different definitions for DF 
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have been used around the world (Table 1.2). Almost all these definitions 
considered that some carbohydrates escapes digestion and absorption in the small 
intestine and enters the colon, but differ in their acceptance of which carbohydrates 
should be included and whether physiological effects should be required (Jones, 
2014a). For example, the American Association of Cereal Chemists (AACC 2001) 
defined DF as consisting of NDCs, which include polysaccharides, oligosaccharides 
and lignin, that provide beneficial physiological effects including laxation, reduced 
blood cholesterol attenuation and reduced blood glucose (Buttriss and Stokes, 
2008, Committee, 2001).  
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Table 1.2: Current definitions for dietary fibre (DF) from around the world (adapted from Jones, 2014) 
Organisation  Definition  
Non-Starch Polysaccharides (NSP) (UK Department of 
Health 1991) 
The skeletal remains of plant cells that are resistant to digestion by enzymes of man, measured as non α-glucan 
polymers by the Englyst method. It includes NSP, which is comprised of cellulose, hemicelluloses, pectin, 
arabinoxlyans, beta-glucan, glucomannans, plant gums and mucilages and hydrocolloids, all of which are principally 
found in the plant cell wall. 
Does not include oligosaccharides, resistant starch and resistant maltodextrins. 
 
American Association of Cereal Chemists (AACC) 2001  
 
The edible parts of plants or analogous carbohydrates that are resistant to digestion and absorption in the human 
small intestine, with complete or partial fermentation in the large intestine. Dietary fibre includes polysaccharides, 
oligosaccharides, lignin, and associated plant substances. Dietary fibres promote beneficial physiological effects 
including laxation, and or blood cholesterol attenuation, and/or blood glucose attenuation. 
Includes resistant oligosaccharides, resistant starch and resistant maltodextrins. 
 
Institute of Medicine (IOM) 2001 
 
Dietary fibre consists of non-digestible carbohydrates and lignin that are intrinsic and intact in plants. Functional fibre 
consists of isolated, non-digestible carbohydrates with physiological effects in humans. Total fibre is the sum of dietary 
fibre and functional fibre. 
Includes resistant oligosaccharides, resistant starch and resistant maltodextrins. 
 
Food Standards Australia and New Zealand (FSANZ) 2001 
 
Dietary fibre means that fraction of the edible part of plants or their extracts, or synthetic analogues that: Are resistant 
to digestion and absorption, usually with complete or partial fermentation, in the large intestine; and promote one or 
more of the following beneficial physiological effects: 
 Laxation 
 Reduction in blood cholesterol 
 Modulation of blood glucose 
Includes resistant polysaccharides, oligosaccharides (DP >2) and lignin and resistant starches. 
 
European Food Safety Authority (EFSA) 2009 
 
Non-digestible carbohydrates plus lignin, including all carbohydrate components occurring in foods that are non-
digestible in the human small intestine and pass into the large intestine 
Includes non-starch polysaccharides, resistant starch, resistant-oligosaccharides. 
 
Health Canada (HC) 2010 
 
Dietary fibre consists of naturally occurring edible carbohydrates (DP > 2) of plant origin that are not digested and 
absorbed by the small intestine and includes accepted novel dietary fibres. Novel dietary fibre is an ingredient 
manufactured to be a source of dietary fibre. It consists of carbohydrates (DP > 2) extracted from natural sources or 
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synthetically produced that are not digested by the small intestine. It has demonstrated beneficial physiological effects 
in humans and it belongs to the following categories: 
 Has not traditionally been used for human consumption to any significant extent, or 
 Has been processed so as to modify the properties of the fibre, or has been highly concentrated from a 
plant source. Includes resistant oligosaccharides, resistant starch and resistant maltodextrins. 
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In addition, a definition that could be applied worldwide has been debated for 15 
years by the international CODEX Alimentarius Commission; eight stages were 
developed by CODEX to define DF. The CODEX and Foods for Special Dietary 
Uses (CCNFSDU) accepted the following definition in 2008 (Phillips and Cui, 2011) 
(Codex Alimentarius, 2010):   
Dietary fibre means carbohydrate polymers with ten or more monomeric units which 
are not hydrolysed by the endogenous enzymes in the small intestine of humans 
and belong to the following categories: 
 Edible carbohydrate polymers naturally occurring in the food as consumed, 
 carbohydrate polymers, which have been obtained from food raw material by 
physiological, enzymic or chemical means, and which have been shown to 
have a physiological effect of benefit to health as demonstrated by generally 
accepted scientific evidence to competent authorities, 
 Synthetic carbohydrate polymers which have been shown to have a 
physiological effect of benefit to health as demonstrated by generally accepted 
scientific evidence to competent authorities. 
Footnote 1 states, “when derived from a plant origin, dietary fibre may include fractions of lignin 
and/or other compounds associated with polysaccharides in the plant cell walls. These compounds 
also may be measured by certain analytical method(s) for dietary fibre. 
Footnote 2 states that, “Decision on whether to include carbohydrates of 3 to 9 monomeric units 
should be left up to national authorities.” 
National authorities are allowed to decide themselves whether to include NDCs with 
a degree of polymerization (DP), between 3 - 9 according to footnote 2. However, 
this potential variability will prevent international coordination on food labelling, food 
composition tables, and interpretation of research. For example, findings of studies 
including DP 3 - 9 might differ from those excluding them. DF values for foods, such 
as wheat and onions, that contain NDCs with DP 3 - 9 or RS might differ on food 
labels and in food composition tables (Jones, 2014b). Therefore, epidemiological 
and interventional studies using food composition tables might also differ if some 
countries include these materials and others do not. NDCs with DP 3 - 9 should be 
DF because they fit with the definition for many reasons: 1) they are neither digested 
nor absorbed by the enzymes in the small intestine, 2) they are fermentable in the 
large intestine, 3) they aid laxation in the large bowel, and 4) they may increase 
mineral absorption (de Menezes et al., 2013).  
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In 2007, in light of the Codex Alimentarius definition, the European Food Safety 
Agency (EFSA) Panel agreed that DF should be defined based on digestibility in the 
small intestine of carbohydrates with 3 to 9 monomeric residues, and the 
physiological effects of NDCs in human health, such as promoting the growth of 
colonic microflora and SCFA production in the colon (Wong and Jenkins, 2007). 
Therefore, EFSA defines DF as NDCs plus lignin that consists of: 
• NSP – cellulose, hemicelluloses, pectins, hydrocolloids (gums, mucilages, 
beta-glucans) 
• NDOs, fructo-oligosaccharides (FOS), galacto-oligosaccharides (GOS), other 
oligosaccharides that resist digestion (with three or more monomeric units) 
• RS – physically enclosed starch, some types of raw starch granules, 
retrograded amylose, chemically and/or physically modified starches 
• Lignin naturally associated with dietary fibre polysaccharides (Agostoni et al., 
2010). 
Therefore, in the absence of a single analytical method the global confusion has 
continued. Different analytical methods may mislead consumers, for example, the 
food table values that are derive from the Englyst method (used in the UK) may be 
different from  those calculated by the AOAC method (used globally), especially for 
foods rich in starch such as, potato, bread, beans and breakfast cereals such as 
cornflakes (Buttriss and Stokes, 2008). 
1.2.1 Considering colonic fermentation in definitions 
In healthy humans, the fermentation processes are primarily controlled by the 
amount and type of substrates available to bacteria in the colonic ecosystem (Floch, 
2011). The fate of carbohydrates in the colon largely depends on the colonic 
microbiota and the physiochemical properties of the carbohydrate itself (Lupton, 
2004). Oat bran, pectin, and guar are highly fermented; while cellulose and wheat 
bran may be poorly fermented (Muir et al., 2004). On the other hand, the type of 
carbohydrate can also affect the colon microbiota composition. for example, inulin, 
a polymer of fructose monomers present in onions, garlic and asparagus (Bosscher 
et al., 2009) stimulates the growth of specific bacteria. Forty healthy volunteers (18 
males, 22 females) were involved in a study carried out by Bouhnik et al. (2006) to 
evaluate the dose-response effect of short chain fructo-oligosaccharide 
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supplementation in stimulating bifidobacteria growth in the human colon. 
Participants were divided into five groups of 8 and each received a dose of fructo-
oligosaccharide of 2.5, 5.0, 7.5, 10 g/d or a placebo for 7 days, added to their 
habitual diet. The researchers observed that the bifidobacteria count was 
significantly increased with a dose of 2.5 g/d (9.15 ± 0.59 to 9.39 ± 0.70; p = 0.02), 
5 g/d (10.21 ± 0.21 to 10.67 ± 0.22; p = 0.03), 7.5 g/d (9.28 ± 0.49 to 9.85 ± 0.35; p 
= 0.01) and 10 g/d (9.00 ± 0.81 to 10.18 ± 0.60; p = 0.003), when compared to 
placebo (Bouhnik et al., 2006).  
Measuring SCFA production in humans in vivo has become very important because 
of the increasing interest in the link between fermentable carbohydrates (FC), 
specific SCFA, and diseases (den Besten et al., 2013). There is also significant 
interest in the relation between carbohydrate fermentation and SCFA production in 
relation to lipid and cholesterol metabolism, and their potential impact on CVD and 
colon cancer. Threapleton et al. (2013b) conducted a systematic review and dose 
response meta-analysis of 22 cohort studies to examine the relationship between 
DF intake and any potential dose response correlation with coronary heart disease 
(CHD) and CVD. They found that dietary fibre intake was inversely correlated with 
the risk of CVD, with a risk ratio (RR) of 0.91 per 7 g/day (95 % confidence intervals 
(CI): 0.88-0.94).  
Recently, SCFAs have been identified as signals for specific orphaned G-coupled 
protein receptors (GPRs), which might be involved in the regulation of lipid and 
glucose metabolism (Frost et al., 2014a, Kimura et al., 2014). These receptors, for 
example GPR41 and GPR43, also known as free fatty acid receptors (FFAR3 and 
FFAR2 respectively), and have now been identified as SCFA receptors (Brown et 
al., 2003, Tazoe et al., 2008). Several studies have suggested that FFA2 and FFA3 
mediate the beneficial effects associated with a high FC diet, and might be of interest 
as targets for the treatment of inflammatory and metabolic diseases (Lin et al., 2012, 
Thangaraju et al., 2009). FFA2 is also highly recognized in immune cells which might 
play a role in a dysfunctional neutrophil response, such as in inflammatory bowel 
diseases (IBD) (Kovatcheva-Datchary and Arora, 2013).  
However, the impact of FC on colonic health has been rather neglected because of 
the paucity of methods available to study fermentation in humans in vivo. Currently 
there is no validated method to measure the extent of colonic fermentation in 
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humans in vivo, and in addition, 95 % of the SCFA produced is rapidly absorbed by 
the colonocytes, while only 5% is excreted in the faeces (Topping and Clifton, 2001), 
making the often measured faecal SCFA a poor index of colonic production of 
SCFA. Colonic fermentation is an important process, not only for the health of the 
colon, but the metabolites produced may have a beneficial impact on systemic 
metabolism (den Besten et al., 2013). The relationship between FC intake and 
colonic fermentation on health and disease can only be investigated if there is a 
straightforward way to quantify colonic fermentation in both dietary intervention and 
epidemiological studies. 
Most studies use DF or NSP intake but not all fibres or NSP are equally fermentable. 
Another major obstacle to epidemiological studies on diet and the risk of chronic 
disease, is the relative inaccuracy of methods with which individuals' habitual long 
term intake of food or nutrients can be measured by structured dietary 
questionnaires (Westenbrink et al., 2013b). These methods could cause estimates 
of relative risk or other measures of diet disease associations to be weakened (an 
effect usually referred to as attenuation bias), and reduce the statistical power of 
epidemiologic studies (Kaaks, 1997). The diet disease association may be over- or 
underestimated due to the effect of relatively large measurement errors inherent in 
the traditional dietary assessment methods used in epidemiological studies 
(Marklund et al., 2010). Moreover, dietary intake tools often fail to accurately 
characterize habitual diets or food preparation effects (Westenbrink et al., 2013a), 
which will be particularly important for the estimation of RS as the content will vary 
due to the cooking method and whether the food is eaten hot or cold (Sharma et al., 
2008). The traditional analysis method of epidemiological data depends on food 
composition databases, which might not have been updated to include 
oligosaccharide and RS, or to have accurate data on NDCs added to 
food (Westenbrink et al., 2013a, Hollmann et al., 2013). Moreover, it is quite likely 
that each of us would handle the food differently in our gut, meaning that the actual 
amount of FC entering the large intestine is impossible to determine. 
Before developing an index of FC that can be determined from food diaries, it is 
important to consider the types of carbohydrate that escape digestion and 
absorption and enter the colon where they are available for fermentation. 
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 Composition and types of dietary fibre  
The main component of DF is the plant cell wall (Table 1.3), a major structure that 
is comprised of cellulose, hemicellulose and pectin. In addition fibre includes other 
polysaccharides of plant or algal origin, such as gums and mucilage, and these are 
included as NSP (Theuwissen and Mensink, 2008a). DF pass through the small 
intestine unchanged but are fermented in the large intestine.  
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Table 1.3: Description and sources of the main dietary fibre fractions captured by current definitions (adapted from Buttriss and Stokes, 2008; Paeschke, T. 
M. & Aimutis, W. R. 2011). 
Fermentable carbohydrate  Structure Classification  Food sources  
Cellulose β-(1→4)-D-Glcp Insoluble, poorly fermentable  Whole grains  
Fruits, vegetables  
Hemicelluloses β-(1→4)-linked backbones Insoluble, soluble, fermentable vegetables, fruits, 
cereals and legumes 
and nuts 
β-Glucan  β-(1→3 and 1→4)-D-Glcp (backbone); β-(1→6)-D-Glcp 
(branches; only on some types) 
Soluble, viscous, highly fermentable  Oat bran, barley flour  
Chitin β-(1→4)-D-GlcNAc Insoluble, poorly fermentable Shellfish  
Chitosan β-(1→4)-D-GlcNAc and GLcN Soluble, viscous/gel-forming in acidic solution; 
insoluble in neutral pH 
Alkali-treated chitin  
Arabinoxylan  β-(1→3 or 1→4)-D-Xylp (backbone); complex branches of 
Area, Xyl, GlcA and Gal; branches can be esterified with 
phenolic compounds; backbone can be acetylated; polymers 
often cross-linked through oxidative di- and trimerisation of 
phenolic compounds  
Insoluble or soluble and poorly to highly 
fermentable depending on fine structure and 
processing condition; soluble forms can be 
(cereal arabinoxylan) or high viscosity/gel-
forming (psyllium)   
Whole grains, cereal 
bran, psyllium seed 
and husk  
Arabinogalactan β-(1→3 and 1→4)-D-Glap (backbone); side groups of Ara, Gal, 
GlcA, Rha 
Soluble, fermentable Fruits and vegetables 
Acacia Senegal (gum 
arabic) 
Pectin  α-(1→4)-D-GalA with varying degree of methyl esterification 
(backbone) and side groups containing Rha, Gal  
Soluble, viscous, highly fermentable  Fruits and vegetables  
Guar gum  β-(1→4)-D-Manp (backbone); side groups of Gal Soluble, viscous, highly fermentable Cyamopsis 
tetragonolobus seeds 
Xanthan gum β-(1→4)-D-Glcp (backbone); side chain of Man, GlcA, pyruvate Soluble, viscous Xanthamanas 
campetris cultures  
Gellan  Tetrasaccharide repeat of 3  
β-(1→4)-D-Glcp interrupted with 1  
α-(1→3)-L-Rhaf; some acetylation   
Soluble, viscous, gel forming  Pseudomonas elodea 
cultures   
Alginate  Backbone of β-D-ManA and α-L-GulA Soluble at neutral pH; insoluble at acidic pH; 
viscous; gel forming 
Algae  
Carrageenan  
 
 
 
α (1→3 and 1→4)-D-Glap with varying degrees of sulphate 
esters and presence of 3,6-anhydro-Galp 
Soluble, viscous, gel forming Seaweed  
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Gle, glucose; Gal, galactose; Xyl, xylose; Ara, arabinose; Rha, Rhamnose; GlcA, D-glucuronic acid; GlaA, galacturonic acid; GlcN, D-glucosamine; GleNAc, N-acetyl-glucosamine  
Polydextrose  Random polymer of Glc, sorbitol and citric acid  Soluble, low viscosity, partially fermentable   Chemically 
synthesised  
Inulin/fructooligosaccharides  Fructose oligo- or polymer linked β (2→1) with Glc at the non-
reducing end  
Inulin insoluble; FOS soluble and low viscosity, 
highly fermentable  
Onion, Jerusalem 
artichoke, 
enzymatically 
synthesised  
Galactooligosaccahrides  Oligomers of galactose  Soluble, low viscosity, high fermentable β-galactosidase 
treatment of lactose  
Lactulose  D-Galp-β-(1→4)-D-Fru Soluble, low viscosity, high fermentable  Glucose isomerase 
treatment of lactose  
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 Non starch polysaccharide (NSP)  
NSPs are complex polysaccharides, other than starch, which are comprised of 
several hundred thousand monosaccharides units, joined through glycosidic 
linkages (Kumar et al., 2011). There are numerous types of NSP which vary 
according to the sequence and composition of monosaccharides, the types of 
linkages present, the number of monosaccharides with an acidic group (e.g., uronic 
acid), and the presence of branches from the polymer backbone joined 
predominantly by β-glycosidic bonds (Gurr and Asp, 1994). In plants, NSP are 
predominantly structural polysaccharides in the cell wall and other associated 
polysaccharides, proteins, and phenolic compounds (Cummings and Stephen, 
2007). NSP comprises up to 90 % of the cell wall of plants, and is usually less than 
10 % by weight of the grain. The most abundant forms of NSP include cellulose, 
hemicellulose, and pectin (Kumar et al., 2011). Fructans, glucomannan, and 
galactomannan are also included in NSP and they are storage polysaccharides. 
Other constituents of NSP are modified polysaccharides such as, mucilage, 
alginate, exudate gum and β-glucan (Asp and Björck, 1992, Cummings and 
Stephen, 2007). NSP can be classified into various groups based on their 
physicochemical properties, for example, viscosity, water-holding capacity, 
fermentation, and the capacity to bind organic and inorganic molecules. Moreover, 
NSP is classified as either soluble or insoluble based on its reaction with water; 
soluble NSPs are dispersed when mixed with water and have the ability to increase 
the viscosity of digesta, whereas insoluble NSP may not enhance digesta viscosity, 
but could be characterized by their faecal bulking capacity (Kumar et al., 2011).  
1.3.1.1 Cellulose  
Cellulose is a water insoluble fibre that is not digested and absorbed in the small 
intestine, and has a linear chain of β (1→4) linked glucose monomers (Mudgil and 
Barak, 2013). Cellulose chains are formed of long flat linear ribbons of glucose units 
with molecular weights of over 10,000, as the β-(1–4) linkage between the glucose 
units grips the chain in a flat conformation the cellulose chains may align next to 
each other and form numerous hydrogen bonds between the sugar hydroxyl groups. 
The long chains make cellulose highly insoluble in water, but could allow swelling in 
concentrated sodium hydroxide solutions (Mutwil et al., 2008). Moreover, cellulose 
could be used as a dietary fibre supplement; cellulose-rich maize bran could be 
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converted to a cellulosic gel through thermal and shear treatments, followed by 
alkaline peroxidation and shearing (Stone and Fincher, 2004). Cellulose quantity in 
whole grains may be different between species and is largely a consequence of the 
thickness of the husk and seed coat, higher concentrations of cellulose form a 
thicker and a stronger cell wall. Seed endosperm cells contain only thin cell walls, 
and in a well-filled grain the proportion of cellulose to starch, or other reserve 
polysaccharides, should be low. Cellulose is also the structural component of cell 
walls in green plants and vegetables and comprises of about 33 % of all vegetable 
materials. Cellulose can also found in whole grains, fruits and vegetables (Kumar et 
al., 2011).  
Behaviour in the human gut 
In the human large intestine, cellulose is fermented by microbiota in the colon to a 
certain degree, in turn producing SCFA (Wolin and Miller, 1983). In an in vitro study 
of fermentation of different types of DF, Barry et al. (1995) showed that only 6-7 % 
of Solka-floc cellulose was degraded after 24 h incubation.  
1.3.1.2 Hemicelluloses 
Hemicelluloses are a heterogeneous group of polysaccharides, and the term was 
coined by Schulze in 1891 to include substances extractable from agricultural 
biomass with aqueous alkaline solution. Hemicelluloses are polysaccharides in plant 
cell walls that have β-(1→4)-linked backbones with an equatorial configuration, and 
includes xyloglucans, xylans, mannans and glucomannans, and β-(1→3, 1→4)-
glucans (Jensen et al., 2008). These types of hemicelluloses are present in the cell 
walls of all terrestrial plants, except for β-(1→3,1→4)-glucans, which are restricted 
to Poales and a few other groups. Hemicelluloses are a complexes of 
polysaccharides made up of a variety of pentose and hexoses, which include 
arabinose, fructose, galactose, glucose, mannose and uronic acides (Scheller and 
Ulvskov, 2010). The main two types of hemicelluloses that are usually found in the 
foods are xylans and galactans, and sometimes β-glucan and mannans are also 
included in this group. The structure of hemicelluloses and their abundance vary 
widely between different species and cell types, and the most important biological 
role of hemicelluloses is their contribution to strengthening the cell wall by the 
interaction with cellulose and, in some walls, with lignin (Ebringerová et al., 2005). 
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Behaviour in the human gut 
Hemicelluloses can be either completely or poorly fermented based on their diverse 
structures; native hemicelluloses are an insoluble fibre and may contribute to the 
digestive process in the small intestine (Cummings, 1984). In the human colon, 
hemicelluloses which have been solubilized with alkaline are rapidly fermented by 
colonic bacteria (Scheller and Ulvskov, 2010).     
1.3.1.2.1 Arabinoxylan 
Arabinoxylan (AX) is a major component of hemicelluloses, and are comprised of a 
xylose backbone with arabinose side chains (Henry, 1985, Lu et al., 2000). In whole 
grains, AX is considered as the major component of dietary fibre, with considerable 
inclusions in both the endosperm and bran; in wheat it is around 64 to 69 % of the 
NSP in the bran, with ratio of soluble to insoluble NSP of (1:6), and AX is around 88 
% of the endosperm (Ring and Selvendran, 1980, Lu et al., 2000). AX also occurs 
in the endosperm cell walls of barley at a concentration of 20 % (w/w) and rice at 40 
% (w/w). The non-endospermic tissues of wheat (pericarp and testa) comprise a 
very high concentration of AX (64 % (w/w)) (Grootaert et al., 2007).  
AXs are composed of β−(1,4)-linked D-xylopyranosyl residues to which α-L-
arabinofuranose units are linked as side chains (Izydorczyk and Biliaderis, 1995). 
Some arabinoses can be substituted with ferulic acid, and the degree of substitution 
refers to the arabinose (A) moieties on the xylose (X) backbone and is further also 
described as A/X ratio (Kumar et al., 2011). The degree of substitution and 
distribution of the side chains are important factors in the physicochemical 
properties of AX. The degree of substitution of AX from wheat, rye, and barley is 
relatively low, they have higher proportions of unsubstituted xylose residues, and 
lower levels of mono-substituted xylose residues, when compared to the more highly 
branched AX from rice and sorghum. The highest levels of double substituted 
xyloses have been reported for wheat pericarp AX (Maes and Delcour, 2002). 
Behaviour in the human gut 
AX is a soluble fibre, as it is rapidly fermented by the microflora of the colon. 
Fermentation of AX by the human large intestinal (Amrein et al., 2003, Gråsten et 
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al., 2003) and in in vivo rats (Lopez et al., 1999) showed a greater impact on 
propionic acid production, which may result in a cholesterol lowering effect. 
1.3.1.3 β-glucan  
β-glucan is a water-soluble fibre and highly viscous at low concentrations, which 
contains linear polysaccharides of glucose monomers with β (1→4) and β (1→3) 
linkages, and is found in the endosperm of cereal grains, primarily barley and oats 
(Doublier and Wood, 1995). The β-glucan in barley contains approximately 70 % 
(1→4) linkages and 30 % (1→3) linkages, which correlates to segments of two or 
three (1→4) linkages separated by a single (1→3) linkage (Kumar et al., 2011). The 
β-glucans in cereal are made up of 58 %–72 % of β-(1→3) linked units and 20 %–
34 % of β-(1→4) linkaged units (Brennan and Cleary, 2005). β-glucan is an 
important constituent of the walls of the starchy endosperm and aleurone cells of 
most cereal grains, and may account for up to 70 % by weight of the walls. β-glucan 
is found in barley, oat, and rye grains (Cui et al., 2000, Henry, 1987).  
Behaviour in the human gut 
In the human gut, β-glucan is extensively fermented by the microflora of the colon. 
It has a marked effect on increasing the viscosity of the digesta in the small intestine, 
affecting gastric emptying, absorption of nutrients and small intestinal motility 
(Wood, 2007).   
1.3.1.4 Pectin  
Pectin is a gum found in many plants but mainly in citrus fruits (oranges, lemons, 
grapefruits) and apples, and during grumbling, pectin may be changed from an 
insoluble substance to a much more water-soluble component. Pectin is a linear 
polysaccharide of about 300 to 1000 monosaccharide units, mainly D-galacturonic 
acid plus some polysaccharides, and the D-galacturonic acid molecules are joined 
together by α-(1→4) glycosidic bonds (Mohnen, 2008). Citrus fruit contain anywhere 
from 0.5 % to 3.5 % pectin, with a large concentration located in the peel. 
Commercially extracted pectin is widely used in food applications as gelling or 
thickening agent (Thakur et al., 1997).  
Behaviour in the human gut 
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In the human small intestine, pectin had been shown to increase the viscosity of the 
digesta. It is a water soluble polysaccharide that bypasses enzymatic digestion of 
the small intestine, and is easily degraded by the microflora of the colon (Dongowski 
et al., 2002). 
1.3.1.5 Psyllium 
Psyllium is a mucilage from the Plantago ovata plant with high viscosity and water 
holding capacity. The term psyllium has been used interchangeably for the seed 
husk, the seed, and the entire plant (Fischer et al., 2004). It is also known as 
ispaghula. Psyllium has been cultivated because it has a rich source of water soluble 
fibre present in the seed husk, which can be known as psyllium hydrophilic mucilloid, 
psyllium hydrocolloid, and psyllium seed gum (Marlett and Fischer, 2003). The 
bioactive fraction in psyllium is a fibre which has been formed of a highly branched 
AX. The xylose units are the backbone of psyllium, whereas arabinose and xylose 
make up the side chains. The gel-forming of the husk represents 55-60 % of the dry 
weight, and the neutral AX comprises of β-(1 → 4)-linked d-xylopyranosyl residues, 
some carrying single xylopyranosyl side chains at position 2, others bearing, at 
position 3, trisaccharide branches having the sequence l-Araf-α-(1 → 3)-d-Xylp-β-
(1 → 3)-l-Araf (Fischer et al., 2004). Psyllium can be added to foods, such as ready 
to eat cereals, due to its cholesterol lowering properties (Theuwissen and Mensink, 
2008b).  
Behaviour in the human gut 
Psyllium is not digested and absorbed in the human small intestine, and it is 
fermented by microbiota in the colon (Marlett and Fischer, 2003). It is only partially 
fermented and retains its water-holding capacity sufficiently to be an effective stool 
bulker (Marlett et al., 2000, Ruepert et al., 2011).  
 Resistant starch (RS) 
Until the early 1980’s, it was believed that starches were completely digested and 
absorbed in the small intestine. In 1982, Englyst and colleagues, in the process of 
developing an in vitro assay to measure NSP, observed that some starch remained 
after enzymatic hydrolysis (Englyst et al., 1992). Based on this finding, Englyst and 
colleagues agreed to define all the starches that escape digestion in the small 
 
 
37 
 
intestine as resistant starch (RS). In 1992, a concerted action of European 
researchers defined RS as "the sum of starch and products of starch digestion not 
absorbed in the small intestine of healthy individuals" (Asp et al., 1996). Therefore, 
RS is the fraction of starch which is not degraded by digestive enzymes in the small 
intestine within 120 minutes of being consumed, and which then enters the colon for 
fermentation (Englyst et al., 1992).  
There are four important mechanisms that may explain the non-digestibility of RS; 
first, a compact molecular structure limits the accessibility of digestive enzymes, and 
various amylases, in raw starch granules (Haralampu, 2000). This means the starch 
might not be physically bio-accessible to digestive enzymes, for example in grains, 
seeds or tubers. Second, the starch granules may have been formed in a way which 
prevents the digestive enzymes from breaking them down (e.g. raw potatoes, unripe 
bananas and high amylose maize starch) (Nugent, 2005). Third, although 
gelatinization of starch granules makes the molecules fully accessible to digestive 
enzymes, if these starch gels are then cooled, starch crystals are formed which are 
also resistant to the digestive enzymes. This form of ‘retrograded’ starch is found in 
small quantities (approximately 5 %) in foods such as ‘‘corn-flakes” or cooked and 
cooled potatoes, as used in a potato salad (Haralampu, 2000). Fourth, the chemical 
modified of starches by etherisation, esterisation or cross-bonding makes them 
resistant to digestive enzymes (Lunn and Buttriss, 2007).  
 Classification of resistant starch  
RS has been classified into four types (Table 1.4); physically inaccessible starch 
(RS1), resistant starch granules (RS2), retrograded starch (RS3) and chemically 
modified starch (RS4).  
1.4.1.1 Physically inaccessible starch (RS1) 
This type of resistant starch is physically inaccessible and protected from the action 
of α-amylase in the human small intestine (Topping and Clifton, 2001). The 
presence of plant cell walls can entrap the starch to make the RS1 inaccessible for 
digestion in the small intestine, for example, in legume seeds, partially milled and 
whole grains (Champ et al., 2003). RS1 can also be found in highly compact 
processed food like pasta. The preparation and cooking processes are of great 
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importance for the RS1 content of food when consumed, as these procedures may 
contribute to a disruption of the cell walls (Champ et al., 2003, Englyst et al., 1992). 
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Table 1.4: Classification of types of resistant starch (RS), food sources and factors affecting their resistance to digestion in the colon (adapted from 
Nugent, 2005). 
 
RS, resistant starch
Type of RS Description Food sources Resistance reduced by 
RS1 Physically protected Whole or partly milled grains and seeds, legumes, 
pasta 
Milling, chewing 
RS 2 Un-gelatinised B type resistant granules  Raw potatoes, green bananas, some legumes, high 
amylose starches 
Food processing and cooking 
RS 3 Retrograded starch produced during food 
processing  
Cooked and cooled potatoes, bread, cornflakes, 
food products with prolonged and/or repeated  
moist heat treatment e.g. extrusion cooking 
Processing conditions 
RS 4  Chemically modified starches due to cross-bonding 
with chemical reagents, ethers, esters, etc. 
Some fibre rich -drinks, foods in which modified starches 
have been used (e.g. certain breads and cakes) 
Less susceptible to digestibility 
in vitro 
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1.4.1.2 Resistant starch granules (RS2) 
This type of RS refers to B type starches that are found in raw potato and unripe 
banana starch, and are known to be very resistant to enzymic hydrolysis when 
uncooked (Sharma et al., 2008). The B type refers to the X-ray diffraction pattern of 
the starch. Most cooking procedures produce gelatinization of the raw starches, 
which causes a reduction of RS2 in the food (Faisant et al., 1995, Cummings et al., 
1996). The amount of RS2 in bananas depends on the degree of ripening, as during 
this process the banana’s intrinsic enzymes convert the starch into simple sugars 
and sucrose (Champ et al., 2003).  
1.4.1.3 Retrograded starch (RS3) 
RS3 is the most abundant of the resistant starches present in foods which have 
been cooked, then cooled and stored for several hours, up to several months. 
Retrogradation is the recrystallization of starch chains, which happens after 
gelatinisation when the products have not been immediately dried, and single chains 
produce double helixes as mainly the linear fraction of the starch, amylose, is 
retrograded (Sharma et al., 2008). Amylopectin can also be retrograded, although a 
longer time of cooking is required. It has been observed that cooked and cooled 
potatoes contained RS3 in significant amounts (Englyst and Cummings, 1987). 
Reheating of this starch reduced the RS3 content of the potato, showing that the 
retrogradation was partly reversible, however several cycles of heating and cooling 
increased the RS3 levels in the food. RS1, RS2 and/or RS3 can co-exist in the same 
food, and retrograded starch can be found in bread, some brands of corn flakes, 
cooked-cooled potatoes and legumes (Faisant et al., 1995, Champ et al., 2003). 
1.4.1.4 Chemically modified starch (RS4) 
RS4 refers to the amylose-lipid complex and other modified starches which have 
been identified as sources of resistant starch (Sajilata et al., 2006). Amylose-lipid 
complexes occur when fatty acids (12 - 18 carbons) are held within the helical 
structure of amylose (Tufvesson et al., 2003). They are produced naturally during 
starch biosynthesis, and may also be formed during cooking. Lipids might also 
interfere with amylose retrogradation, impairing the formation of retrograded starch 
during processing, but overall they have lower digestibility properties compared with 
cooked starch. Amylase inhibitors occur in raw pulses and may lower the activity of 
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amylase in the human small intestine. However, most of these factors, especially 
enzyme inhibitors, become inactivated during food processing and cooking (Liener, 
1996). Some chemical processes can also alter the bond structure in starches, as 
in pyrodextrinisation, and these would also be classified as RS4 (Higgins, 2004). 
 Fermentability of resistant starch  
It has been suggested that around 80–90 % of the glucose produced by the enzymic 
hydrolysis of standard starch is metabolized in the human body (Sharma et al., 
2008), which means 10 % escapes into the large intestine. Several studies have 
reported that 30–70 % of RS was degraded to SCFA in the colon by bacteria, while 
the balance of the RS escaped even colonic fermentation, and was excreted in the 
faeces (Cummings et al., 1996, Behall and Howe, 1996, Behall and Howe, 1995). 
The overall fermentability of RS is based on its physiological structure and the 
category of RS. Of the total amount of RS3 present in corn and wheat, approximately 
84 % and 65 % are subjected to bacterial fermentation in the colon, respectively. 
Similarly, for RS2 present in raw potatoes and green bananas about 89 % and 96 
%, respectively, are degraded by bacterial fermentation in the colon (Cummings et 
al., 1996). The degradation of RS is also influenced by the different food processing 
conditions under which the RS was produced. On a high RS diet, no more than 10 
% of dietary RS is excreted in the faeces since most RS is fermented and absorbed 
(Cummings et al., 1996, Phillips et al., 1995). 
Estimating daily RS intake at present is very difficult, because there are not enough 
data on the RS content of foods. Moreover, the values obtained from old dietary 
intake data might be misleading, as it may not have been updated to include RS that 
was added to the food (Westenbrink et al., 2013a). Estimates of RS consumption in 
Western developed countries varies in the literature with values ranging from 3-4 to 
15-20 g/d; and for developing countries estimates vary from 9-10 to 30-40 g/d for 
countries with a high starch intake (Stephen et al., 1995). The average RS intake in 
the Chinese population has been estimated as high as 14.9 g/d based on a dietary 
survey (Chen et al., 2010). According to the EURESTA studies, the average daily 
RS intake in European countries ranged from 3·5-6.0 g/d (Dysseler and Hoffem, 
1994). Baghurst et al. (1996) reported that the RS intake represents 5 % of the 
overall starch consumption. Generally it appears that the main categories of foods 
that determine the daily RS intake are cereal-based products (mainly bread, pasta 
 
 
42 
 
and rice), and vegetables (legumes and potatoes); for example in Italy Brighenti et 
al. (1998), reported that the average intake of RS was 8·5 g/d, with regional 
differences (from 7·2 in the North-West to 9·2 g/d in the South), mainly because of 
the different levels of consumption of some typical starchy foods (bread, pasta and 
legumes). In Australia, RS daily intake ranged from 5-7 g/d (Baghurst et al., 2001). 
The RS intake in Australia is higher than in Europe because most top-selling 
commercial breads, baked goods and cereal ingredients are fortified with RS. The 
recommended total daily intake of resistant starch set by Australia’s Commonwealth 
Scientific and Industrial Research Organization (CSIRO) is 20 g/d based on a study 
by Baghurst et al. (2001) for good health. Therefore, this research suggests 
improving breads and other cereal products with ingredients high in RS could make 
a valuable contribution to dietary fibre intake, as slow fermentability of RS in the 
large bowel is tolerated better than other soluble fibres (Lunn and Buttriss, 2007).  
 Resistant starch as a component of dietary fibre  
The awareness of consumers regarding the relationship between food, lifestyle and 
health has increased, and is one of the reasons for the popularity of food rich in 
fibre; therefore, the importance of RS has been  put forward as a new source of 
dietary fibre (Sanz et al., 2008). Generally, the physiological behaviour of RS is 
similar to that of soluble fermentable fibre, such as guar gum, as increased faecal 
bulk and lower colonic pH were the most common findings of RS ingestion (Slavin 
et al., 2010). Overall, since RS acts physiologically as a fibre, it should be included 
in the total dietary fibre definition (Haralampu, 2000). RS is a substrate for the 
colonic microbiota, like soluble fibre, producing metabolites including SCFA (mainly 
acetate, propionate and butyrate) (Topping and Clifton, 2001). Postprandial 
glycaemic and insulinemic responses have been reduced after RS consumption, 
which shows it's consumption might have beneficial implications in the management 
of diabetes (Tharanathan and Mahadevamma, 2003). These findings provide solid 
justification that RS behaves physiologically like soluble fibre (Sajilata et al., 2006). 
Overall RS is nutritionally more similar to NSP than to digestible starch, but it is not 
a cell wall component. Recently there is evidence to suggest that RS has been 
treated as a new ingredient for creating fibre-rich foods (Sharma et al., 2008). 
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 Sources of resistant starch  
RS is naturally found in cereal grains, seeds and in heated starch or starch 
containing foods (Charalampopoulos et al., 2002). Potato starch has been 
considered to have the highest RS concentration and corn starch has the lowest, 
with raw potato starch being comprised of 75 % RS as a percentage of total starch 
(Bednar et al., 2001). Whole grains are rich sources of FCs including DF, RS and 
RO (Slavin, 2004). The RS concentration is generally low for the cereal flour, as it 
has an A-type crystalline pattern, unlike potato starch which is B type, and is more 
readily hydrolysed than raw cereals that are not as highly processed as flours. 
Therefore, cereal flours comprise more RDS and SDS than RS (Asp et al., 1996). 
Grain flour is made up primarily of two components, which are protein and starch. 
In contrast, cereal grains are made of the pericarp, aleurone layers and germ 
portions of the grain which provide lipid and fibre (Higgins, 2004). Cereal grain is 
processed and milled to flour, thereby altering the chemical composition of the flour 
compared with the cereal grain, meaning the RS concentration is five times higher 
in the cereal grain than in the flour (Bednar et al., 2001).  
Legumes are considered to have a high content of both soluble and insoluble dietary 
fibre. Pulse grain has been shown to be high in RS and this retains its functionality 
even after cooking. Legume starches contain higher amylose levels than cereal and 
pseudo-cereal starches (Mikulíková et al., 2008), with the mean RS concentration 
in legumes being 24.7%. Generally, RS concentrations constituted the highest 
proportion of the starch fractions of legumes, and the digestibility of cereal starches 
is much higher than that of legume starches. Leguminous starches have a C-type 
pattern of crystallinity, which are more resistant to hydrolysis than A-type starches, 
which explains why legumes have high amounts of RS (Bednar et al., 2001). Cooked 
legumes are retrograded more quickly, thus lowering the process of digestion, and 
processed legumes contain a significant amount of RS3. The higher RS content 
could be due to the higher content of amylose in legumes, and might account for 
their low digestibility (Tharanathan and Mahadevamma, 2003). There is a very large 
variety in the content of RS in seeds of leguminous plants from 80 % to only a few 
percent (Fuentes-Zaragoza et al., 2010).  
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 Oligosaccharides 
Oligosaccharides are carbohydrate chains with 3 – 10 sugar units. NDOs include 
pyrodextrins produced by heating starch in acid conditions, fructooligosaccharide 
(FOS) from inulin, galactooligosaccharides (GOS) and xylooligosacharides 
(Cummings, 1997). Oligosaccharides are water soluble and typically they are 0.3–
0.6 times as sweet as sucrose (Mussatto and Mancilha, 2007). 
Other oligosaccharides which are not α-glucans include raffinose α-Gal (1- 6) α-Glc 
(1- 2) β-Fru), stachyose (Gal)2 1:6 Glu 1:2 Fru and verbascose (Gal)3 1:6 Glu 1:2 
Fru) (Cummings et al., 2001, Cummings and Stephen, 2007).  
 Sources of oligosaccharide  
Oligosaccharides are naturally found in milk, honey, fruits and vegetables such as, 
onions, Jerusalem artichokes, chicory, leeks, garlic, artichokes, asparagus, sugar 
beet, bananas, rye, barley, yacon and salsify, which are all considered special 
sources of FOS (Sangeetha et al., 2005, Mussatto and Mancilha, 2007). The 
concentration of oligosaccharides in most of these sources is quite low as it ranges 
between 0.3 % and 6 % of fresh weight. Chicory and salsify contain between 5 % 
and 10 % (respectively), while in Jerusalem artichokes and yacon the 
oligosaccharide concentration can reach up to 20 % showing they are much better 
sources of oligosaccharides (Van Loo et al., 1995). The galactosylsucroses 
raffinose and stachyose in soybean and other pulses and leguminous seeds, 
xylooligosaccharides in bamboo shoots and galactose-containing oligosaccharides 
in milk, particularly colostrum either in free form or as glycoconjugates, are other 
examples of naturally occurring oligosaccharides (Voragen, 1998, Vázquez et al., 
2000). Isomaltulose are another example, they occur naturally in honey, sugar cane 
juice, and products derived from these, such as treacles or food-grade molasses 
(Lina et al., 2002). GOS appears naturally in human milk and to a smaller extent in 
cow’s milk (Alander et al., 2001), and cyclodextrins are naturally occurring water-
soluble glucans (Singh et al., 2002). Seeds of legumes, lentils, peas, beans, 
chickpeas, mallow, composite, and mustard are rich in raffinose oligosaccharides 
(Mussatto and Mancilha, 2007). 
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1.5.1.1 Prebiotics 
Prebiotics are carbohydrates and may be oligosaccharides or polysaccharides. 
Gibson and Roberfroid (1995) defined prebiotics as ‘‘non-digestible food ingredients 
that beneficially affect the host by selectively stimulating the growth and/or activity 
of one or a limited number of bacteria in the colon, thus improving host health’’ . This 
definition was later revised by Gibson et al. (2004) as “a selectively fermented 
ingredient that allows specific changes, both in the composition and/or activity in the 
gastrointestinal microflora that confers benefits upon host well-being and health’’. 
All prebiotics are fibres, but not all fibres are prebiotics, therefore, for food 
ingredients to be classified as a prebiotic the following criteria should be fulfilled:  
 Resists gastric acidity, hydrolysis by mammalian enzymes, and absorption in 
the upper gastrointestinal tract  
 Is fermented by the intestinal microflora 
 Selectively stimulates the growth and/or activity of intestinal bacteria 
potentially associated with health and well-being.  
The usual targeted species of microflora for prebiotics are lactobacilli and 
bifidobacteria, and changes in bifidobacteria are more likely to be seen than 
lactobacilli (Gibson and Roberfroid, 1995). This is due to the fact that there are more 
bifidobacteria present in the human colon than lactobacilli, and they exhibit a 
preference for oligosaccharides (Miller et al., 1994). Many different carbohydrates 
are marketed worldwide as prebiotics, but only four have been well supported by 
good quality data from human trials, these are Fructans (inulin and FOS), GOS, and 
the synthetic disaccharide, lactulose (Boehm et al., 2005). 
1.5.1.2 Fructans (Inulin and FOS) 
Inulin and FOS are the two main prebiotics. They are comprised of fructose 
polymers which are generally linked to the moiety of a terminal glucose (Sangeetha 
et al., 2005). In the human small intestine, there is no enzyme able to digest fructans 
and so they pass through the upper gastric intestinal (GI) tract, reach the colon and 
are fermented by colonic microflora producing SCFA (Cummings et al., 2001). 
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Inulin and FOS are composed of a mixture of oligosaccharides (from 2 to more then 
60), with a degree of polymerization (DP) from 2 to 20, and they primarily consist of 
glucose β (2→1) D-fructofuranosyl linkages (Gibson et al., 2004). Onions are a rich 
source of FOS with values in the range from 25 to 40 % of dry matter (Hogarth et 
al., 2000). FOS is produced commercially mainly based on two processing methods, 
which are either a continuous process using immobilized cells in calcium alginate 
gel or an enzyme on an insoluble carrier; or a batch conversion of sucrose by fungal 
fructosyltransferase (Sangeetha et al., 2005). In the human colon, FOS have been 
shown to be completely fermented mostly to lactate, SCFA and gas (Bornet et al., 
2002).  
Inulin is a naturally occurring storage carbohydrate commonly found in leeks, 
onions, wheat, asparagus, garlic, Jerusalem artichokes and chicory (Roberfroid, 
2005). Most of the inulin commercially produced is from chicory roots (Van Loo et 
al., 1995). Native chicory root inulin is produced from fresh roots, which always 
contain glucose, fructose, sucrose and small oligosaccharides. The average daily 
consumption of inulin has been estimated to be between 3 and 11 g in Europe (Van 
Loo et al., 1995) and between 1 and 4 g/d in the USA (Moshfegh et al., 1999). In the 
UK, it was estimated that the mean intake of inulin and oligofructose to be between 
4 and 3.8 g/d (Dunn et al., 2011). Inulin resists hydrolysis by the human small 
intestine enzymes due to the β-conﬁguration of its fructose monomers, which is 
speciﬁc to glycosidic bonds (Roberfroid, 2005). Standard inulin is 10 % more as 
sweet as sucrose, while high performance (HP) inulin (from which the fraction with 
a degree of polymerisation lower than ten has been removed) is not sweet (Seifert 
and Watzl, 2007). Inulin is moderately soluble in water (maximum 10 % at room 
temperature) and has a low viscosity. Inulin is also used in synergy with most gelling 
agents, e.g. gelatine, alginate, gellan gum and maltodextrins, especially as the 
stability of food product foams and emulsions is improved by replacing fat with inulin, 
such as aerated desserts, ice creams, table spreads and sauces. Inulin is often used  
as a stabiliser in different food products (Macfarlane et al., 2008).  
As well as their prebiotic effects, fructans also play a role in decreasing faecal pH, 
increasing SCFA production, decreasing faecal bacterial enzymatic activities, and 
modifying faecal neutral sterols (Boehm et al., 2005, Bornet et al., 2002).  
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 Synthetic carbohydrate compounds 
There are several NDCs which are made by the food industry add they have various 
properties which are useful in food production. These include the pyrodextrins 
mentioned previously (Anderson et al., 2009) and other synthetic carbohydrates, 
such as methylcellulose (MC) and hydroxy-propylmethylcellulose (HPMC) (Gallaher 
et al., 1993). Polydextrose is a non-digestible carbohydrate polymer, with an 
average degree of polymerization of 12. It is produced from glucose and sorbitol, 
using an organic acid (citric acid) as a catalyst. This results in a complex structure 
which is resistant to hydrolysis by human digestive enzymes, and polydextrose is 
partially fermented in the colon and has bulking and prebiotic properties (Craig et 
al., 2000).  
 Physicochemical properties of NDCs 
The physiological effects of NDCs depend on their physicochemical properties, 
which include water holding capacity, viscosity, binding ability, bulking ability, and 
fermentability (Guillon and Champ, 2000a). 
 Solubility 
Based on its solubility in water, DF is divided into soluble (pectin, gums) and 
insoluble (cellulose, lignin) types, and this nature of DF confers their technological 
functionality and also their physiological effects (Jiménez-Escrig and Sánchez-
Muniz, 2000). Soluble fibre may increase luminal viscosity in the stomach and small 
intestine, and reduce postprandial glycaemia (McCarty, 2005) and plasma 
cholesterol (Brown et al., 1999). Insoluble fibres are associated with increased 
faecal bulk, and decreased intestinal transit (Dikeman and Fahey Jr, 2006). In food 
processing, soluble fibres in food products are considered more beneficial as they 
provide viscosity, the ability to form gels and act as emulsifiers, unlike insoluble 
fibres (Mudgil and Barak, 2013). 
 Water holding capacity (WHC)  
The water holding capacity of a fibre is the amount of water retained by a known 
weight of dry fibre under specified conditions of temperature, time soaked, and 
duration and speed of centrifugation. However, WHC can be affected by the portion 
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of the soluble fibres lost during measurement, and the amount of water measured 
by centrifugation could be higher than the amount of water adsorbed (Dikeman and 
Fahey Jr, 2006). In general, the polysaccharide constituent of DF is strongly 
hydrophilic, therefore water is held on the hydrophilic sites of the fibre itself or within 
void spaces in the molecular structure (Mudgil and Barak, 2013).  However, most of 
the WHC of soluble fibres is lost during colonic fermentation. 
 Viscosity or gel formation 
Viscosity is a major physicochemical property associated with DF especially soluble 
forms such as gum, pectin, psyllium, and β-glucan (Dikeman and Fahey Jr, 2006), 
which may change the properties of gut content and affect digestion and absorption 
(Kendall et al., 2010). Viscosity is associated with fibre’s ability to absorb water and 
produce a gelatinous mass. Viscosity makes soluble fibres more like solids than 
liquids in the gastrointestinal tract, and this phenomenon may explain the delayed 
gastric emptying often associated with the ingestion of fibre. Non fermented viscous 
fibres may also provide lubrication to faeces and make it easier to defecate (Gallaher 
et al., 1993). 
 Binding ability 
Bile acids can be trapped by DF in the small intestine. The gel matrix produced by 
soluble fibres that are eventually excreted in the faeces might entrap some of the 
bile acids released from the gallbladder (Mudgil and Barak, 2013). This physical 
property seems to be more pronounced in the terminal ileum where bile acids are 
usually reabsorbed (Elleuch et al., 2011). 
 Bulking ability 
Insoluble fibres, for example cellulose and lignin, are poorly fermented by colonic 
microflora and also increase faecal bulk by their particle formation and water holding 
capacity (Elleuch et al., 2011). Wheat bran is considered the best bulking agent, 
because it is poorly fermented (Lupton and Turner, 1999). Some fermentable 
hemicellulose fibres may increase faecal bulk by increasing faecal flora biomass, 
whereas highly fermentable fibres such as pectin have little effect on faecal bulk 
(Elleuch et al., 2011). However, when bran is fermented by about 50 % stool output 
is increased 2 fold (Chen et al., 1998).   
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 Fermentability 
The extent of DF fermentation is highly variable. It ranges from not at all with lignin 
to almost complete fermentation with pectin. and soluble fibre is almost completely 
fermented by colonic bacteria (Elleuch et al., 2011). Fermentation of soluble fibre 
may also play an important role in some of its physiologic effects. Plants are 
composed of varying proportions of rapidly fermented, slowly fermented, and non-
fermentable dietary fibres. Fruits (such as apples and bananas) and vegetables 
(such as potatoes and beans) are believed to be fermented rapidly and may 
contribute less to faecal bulking than other fibres. RS is proposed to be fermented 
between 80 to 90 % and only 10% are excreted in the faeces (Nugent, 2005). On 
the other hand, psyllium and wheat bran are believed to be fermented slowly and 
help build up the faecal mass through fermentation, which takes place along the 
entire length of the colon (Mudgil and Barak, 2013). 
 Colonic fermentation of carbohydrate 
The colonic fermentation of substrates, in particular RS, NSP and NDOs, is 
determined by several factors, including the chemistry and structure of the 
substrate, the presence of bacterial enzymes, environmental conditions such as pH 
and the transit time through the gut, all of which will be explained in the next section. 
 Colonic bacteria  
The gut microbiota provides two major benefits; firstly, the microbiota influences the 
immune system and increases tolerance of microbial immune-determinants. 
Secondly, the microbiota works as a metabolic organ that can break down 
indigestible food components, degrade potentially toxic food compounds, like 
oxalate, and synthesize certain vitamins and amino acids (Xu and Gordon, 2003). 
The composition of microbiota varies between individuals and is influenced by the 
host genotype and physiology, colonization history, environmental factors, food, and 
drugs such as antibiotics (Zoetendal et al., 2001).    
In humans, the large intestine (approx. 1.5 m long) is comprised of the proximal and 
distal colon, and the rectum (Cummings et al., 1990). Bacteria comprise 40-55 % of 
faecal solid matter (Stephen and Cummings, 1980) and approximately 15 g of faecal 
bacterial biomass is excreted daily in those consuming ‘’Western type’’ diets (Hill, 
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1995). It has been estimated that bacteria present in the colon consist of around 
1000-1150 different species, which can belong to more than different 70 genera 
(Sekirov et al., 2010, Qin et al., 2010). Some studies have shown that the 
numerically predominant bacteria are anaerobes including bacteroides, 
bifidobacteria, eubacteria, streptococci and lactobacilli, with bacteroides constituting 
30 % of the total bacteria in the gut (Gibson and Roberfroid, 1995). The proximal 
colon is the principle site of fermentation as most of the bacterial activities happen 
there where the substrate availability is greatest. Saccharolytic bacteria like 
bacteroides ferment FC specifically in the proximal colon (den Besten et al., 2013). 
Within the colon NSP, RS (Englyst et al., 1992), oligosaccharides and mucins are 
all subject to fermentation processes (Edwards and Rowland, 1992), and it has been 
calculated that the daily amount of carbohydrate needed to sustain the colonic 
microflora is 60-70 g (Wolin, 1981, Cummings et al., 1978). A smaller amount than 
this has been reported to enter the colon for fermentation in studies of ileostomy 
patients (at 25-35 g) (Schweizer et al., 1990). This variation suggested that 
secretions are important substrates for bacterial fermentation in the colon.     
 Substrates  
The degree and rate of SCFA formed during fermentation is dependent on the type 
and amount of FC substrate utilized, the types of bacteria present in the colon, and 
gut transit time (Cook and Sellin, 1998). Not all FC substrates produce an equal 
amount of and type of SCFA (Table 1.5). Pectin in particular is believed to be a good 
source of acetate (80 % of total SCFA), compared to arabinogalactan (54 % of total 
SCFA) and guar (59 % of total SCFA) which are the poorest sources. RS is 
considered a good source of butyrate (23 % of total SCFA), followed by oat and 
wheat bran (20 % of total SCFA), whereas pectin is the poorest source of butyrate 
followed by other non-digestible carbohydrates in corn, soya, sugar beet and peas 
(Cummings and Macfarlane, 1991).  
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Table 1.5: Bacterial fermentation products (molar ratios) formed from different 
carbohydrates (Cummings and Macfarlane, 1997).
Cummings and Macfarlane (1991) estimated that in humans approximately 10-60 g 
of NDCs enter the colon daily for fermentation. Of this, it has been estimated that 8-
40 g/d is RS which is the main fermentable substrate, followed by 8-18 g/d of NSP, 
2-10 g/d non-digestible sugar and 2-8 g/d NDOs. It has been estimated that in 
Europe 4 g/d of RS is ingested (Elmstahl, 2002), and 3-8 g/d of RS in America 
(Murphy et al., 2008). There are other substrates that might produce toxic 
metabolites in the colon derived from microflora fermentation which are harmful to 
health, such as a fraction of dietary protein which includes branched chain fatty acids 
(BCFA), amines, phenols, indoles and reduced sulphurous compounds. These 
products can be irritants to the mucosa (Evenepoel et al., 1999).    
 Transit time 
The transit time of NDCs through the colon is strongly influenced by the activities of 
the gut microflora, as whole gut transit times range from 20 -140 h with a median of 
60 h in normal healthy individuals in the UK (Cummings and Macfarlane, 1991). 
Kaur and Gupta (2002) studied the relationship between transit time and faecal 
SCFA output in humans, and reported that the mean transit time was significantly 
related to the proportion of butyrate in faeces. They showed that rapid transit (30 – 
40 hours) was significantly correlated with higher faecal butyrate concentration than 
a slow transit times (60 – 80 hours). Greater stool weights and excretion of bacterial 
dry matter were correlated with fast transit times, whereas the reverse is true with 
slow gut transits, which are categorized by low stool weights and outputs of bacteria 
(Stephen et al., 1987). The physicochemical properties of NDCs are correlated with 
physiologic effects in both the small and the large intestine, such as solubility, 
 
Substrate  
 
Acetate 
 
Propionate 
 
 
Butyrate 
 
RS  62 15 23 
Pectin  80 12 8 
Bran  64 16 20 
Other NSP 63 22 8 
Mixed diets  63 22 8 
Oligofructose  78 14 8 
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viscosity, and fermentability (Mudgil and Barak, 2013). Several well fermented fibres 
produce viscous solutions in the gut (guar gum and pectin), but lose their WHC on 
fermentation, whereas others which are poorly fermented maintain their moderate 
water-holding capacity (cellulose) and increase stool output. Studies have shown 
that soluble and viscous fibres were correlated with delayed gastric emptying and 
increased small bowel transit time; whereas high-water-holding fibres, which 
escaped fermentation, influenced the volume and the bulk of intestinal contents 
(Tungland and Meyer, 2002). Faecal ammonia concentrations were also affected by 
gut transit time, with higher concentrations found in subjects with slow transit times 
(Cummings et al., 1979). Macfarlane et al. (1989) showed that increasing the 
retention time from 24 to 69 h in an in vitro fermentation system increased the 
amount of protein degraded and consequently, the levels of ammonia and phenols 
generated. 
 Colonic pH 
The diet and the intestinal environment interact in a complex way with the bacterial 
populations in the gut; FC leads to high concentrations of SCFA, and lowers the pH 
in the colon, which in turn influences the composition of the colonic microbiota and 
thereby SCFA production (Duncan et al., 2009). Several studies have observed that 
the concentration of SCFA declined from the proximal to the distal colon, whereas 
pH increased from the cecum to rectum (Cummings et al., 1987, den Besten et al., 
2013). This shows the higher SCFA concentrations lead to a drop in pH from the 
ileum to the cecum, which might cause beneficial effects, such as altered gut 
microbiota composition, and prevention of overgrowth of pH sensitive pathogenic 
bacteria like enterobacteriaceae and clostridia spp (Cherrington et al., 1991, Duncan 
et al., 2009). Studies of human faecal microbial communities observed that at pH 
5.5 the butyrate producing bacteria such as Roseburia spp. and Faecalibacterium 
prausnitzii, both belonging to the Firmicutes phylum, comprised 20 % of the total 
population. In the more distal parts of the large intestine, it has been observed that 
the luminal pH increases to 6.5, and the butyrate producing bacteria almost 
completely disappeared in the absence of FC, and the acetate and propionate 
producing Bacteroides related bacteria became dominant (Walker et al., 2005, 
Duncan et al., 2009). Similarly, Poulsen et al. (2012) examined the relationship in a 
rumen fluid-based in vitro fermentation system between FC (pectin, wheat and corn 
starch and inulin) and pH (ranging from 5.5 to 7.0). At pH 6.0 and 6.5, higher acetate 
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production was observed for pectin, and the lowest for inulin (p < 0.001), and vice 
versa for butyric acid production for pectin and inulin (p < 0.001). High propionate 
production was observed when the pH increased from 5.5 to 6.0, whereas a higher 
butyrate production has been observed when the pH decreased from 7.0 to 5.5 
(p < 0.001) (Poulsen et al., 2012). 
 Colonic fermentation products  
Carbohydrate fermentation starts with hydrolysis of NDCs to their basic sugars, 
which are then fermented and produce SCFA (Savage, 1986). NDCs are the main 
substrate for fermentation; plant cell-wall polysaccharides consist of hexose 
(glucose and galactose), pentose (xylose and arabinose) and uronic acid monomers 
that are fermented by saccarolytic bacteria, primarily in the proximal colon (Miller 
and Wolin, 1979, Cummings, 1981). Hexose is broken down through the Embden-
Myerhoff-Parnas glycolytic pathway to pyruvate, and occasionally, hexose can be 
converted to 6-phosphate-glyconate, and then metabolised by the pentose 
phosphate cycle (Duncan et al., 2004a). Pyruvate is the principle metabolic 
fermentation reaction, hence very little is found in the human gut as it is converted 
into a series of end products, and these are used as energy for microbial growth and 
maintenance and other metabolic products are used by the host (Hamer et al., 
2012). The main end products are SCFAs (acetate > propionate > butyrate) in a 
molar ratio of approximately 60:20:20, together with gases (CO2, CH4 and H2) and 
heat (Figure 1.2). Acetate is formed by the oxidation and decarboxylation of 
pyruvate, whereas butyrate is formed by the reaction of acetoacetate that forms from 
acetate. Propionate is produced by two main pathways; firstly, by fixation of CO2 to 
form succinate, that is subsequently decarboxylated; secondly, through lactate and 
acrylate pathways (Cummings, 1981, Wong et al., 2006).  
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Figure 1.2: Overview of anaerobic bacteria metabolic pathways involved in fermentable 
carbohydrates. Boxes show SCFA products (adapted from Paeschke and Aimutis, 2011). 
  
SCFA produced from NDCs fermentation supplies the human body with 
approximately 10 % of its daily caloric requirements (Musso et al., 2011), with more 
than 95 % of the SCFA formed in the caecum and large intestine being rapidly 
absorbed by the colonocytes, whereas the remaining 5 % is excreted in the faeces 
(Topping and Clifton, 2001). Several studies have reported that faecal excretion 
rates for SCFA were in the range of 10-30 mmol/d for a high fibre diet, compared 
with 5-15 mmol/d for control diets (Cummings et al., 1996, Holt et al., 1996). It is 
important to note that the concentration and production of SCFA in the large 
intestine were not predicted by faecal SCFA concentrations in these studies 
because most of the SCFA was taken up by the host. Therefore, faecal SCFA 
excretion might provide little information about actual levels of intestinal SCFA 
metabolism (den Besten et al., 2013).  
Moreover, SCFA could also be produced by sources other than NDCs fermentation 
in the gut; several studies have reported that cellular metabolism, in particular fatty 
acid oxidation (but also amino acid and glucose metabolism), can also produce 
SCFA (Wolever et al., 1997, Freeland et al., 2010). The major sources of energy in 
metabolic states with decreased glucose metabolism are ketone bodies which are 
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generated via hepatic acetyl-CoA production during fatty acid oxidation (Pouteau et 
al., 2003). Hepatic acetate levels were also increased during fatty acid oxidation, 
and circulating acetate levels increased with the use of acetate as a fuel source in 
fasting states (Layden et al., 2013). A fasting state raises acetate production in the 
liver, but the impacts on other circulating SCFA are still not clear (Sakakibara et al., 
2009). As these different sources can produce the same products, SCFA production 
happening in the gut is often referred to as the exogenous source of SCFA, and 
SCFA generated during cellular metabolism the endogenous source (Pouteau et al., 
2003). 
 Acetate  
Acetate is usually produced by hydrolysis of acetyl-CoA, or from CO2 through the 
Wood-Ljungdahl pathway in which CO2 is reduced to CO and converted with a 
methyl group and CoASH to acetyl-CoA (Ragsdale and Pierce, 2008). Acetate 
becomes the major SCFA produced (50-70 %) from the fermentation of all NDCs 
(Edwards and Rowland, 1992). Pouteau et al. (1998) reported in stable isotope 
study that acetate contributes to 6-10 % of energy expenditure in humans. Duncan 
et al. (2004a) investigated the contribution of exogenous acetate to butyrate 
formation, they found that the proportion of butyrate formed depends on the type of 
butyrate producing-acetate consumingers’ bacteria in the gut and the type of NDCs 
available for fermentation. The important butyrate producing-acetate consuming 
bacteria found in the human colon are Faecalibacterium prausnitzii, Roseburia 
intestinalis and Eubacterium rectale (Pouteau et al., 1998, Duncan et al., 2002). The 
Faecalibacterium prausnitzii and the Roseburia intestinalis produced 85-90 % 
butyrate from exogenous acetate in the presence of 60 mM acetate and 10 mM 
glucose. Duncan et al. (2004a) reported that the amount of butyrate formed from 
exogenous acetate was ranged from 56 % in pectin to 90 % in xylan in continuous 
cultures, and from 72 % to 91 % in the batch cultures.   
Only 70 % of the acetate is metabolised by the liver (Bloemen et al., 2009), where it 
is used as an energy source, a substrate for the synthesis of cholesterol and long-
chain fatty acids, and as a co-substrate for glutamine and glutamate synthesis 
(Soergel, 1994, Wolever et al., 1995). The remaining acetate is used by other 
tissues such as the heart, adipose tissue, kidneys and muscle (Knowles et al., 
1974).    
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 Propionate  
Propionate is the second most abundant SCFA product; its formation has been 
studied by Reichardt et al. (2014) using a combination of genomic analysis and 
microbial physiology to investigate three different pathways of microbial propionate 
formation in the colon. They reported that the succinate pathway was the most 
abundant route for propionate formation, followed by acrylate and propanediol. 
Propionate was formed by the conversion of hexose sugars to propionate in the 
presence of the abundant phylum Bacteroidetes and several Negativicutes bacteria, 
as specified by the expression of the mmdA gene encoding methylmalonyl-CoA 
decarboxylase. The acrylate pathway was restricted to only a few spieces of 
Lachnospiraceae and Negativicutes to produce propionate from lactate by 
Coprococcus catus (as specified by the lcdA gene encoding lactoyl-CoA 
dehydratase). The propanediol pathway was used by Ruminococcus obeum and 
Roseburia inulinivorans members of the Lachnospiraceae to convert deoxysugars, 
such as fucose and rhamnose, to propionate (as shown by the presence of 
the pduP gene encoding propionaldehyde dehydrogenase) (Reichardt et al., 2014).  
 Propionate is metabolised primarily by the liver, where it acts as a precursor for 
gluconeogenesis. In humans, there is a lack of data on the true production rates of 
propionate which means the extent to which propionate contributes to energy 
metabolism is unknown (Hosseini et al., 2011). Concentrations of propionate in 
portal blood and hepatic venous blood suggest that around 30 % of propionate 
produced is absorbed by the liver (Cummings et al., 1987). Studies have suggested 
that the peripheral tissues absorb the remainder of propionate as the peripheral 
venous blood levels were 23 % lower than the hepatic venous blood levels. 
Generally, it is thought that the liver clears a large fraction of propionate from the 
portal circulation but absolute values are still unknown (Cummings et al., 1987). 
 Butyrate 
Butyrate is the main, and preferred, metabolic substrate for colonocytes, providing 
at least 60–70 % of the energy requirements they require for proliferation and 
differentiation (Suzuki et al., 2008). Butyrate is formed from the condensation of two 
molecules of acetyl-CoA, and subsequent reduction to butyryl-CoA, and lactate-
utilizing bacteria might also produce butyrate by first producing acetyl-CoA from 
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lactate (Duncan et al., 2004b). In the so-called classical pathway, the enzymes 
phosphor-transbutyrylase and butyrate kinase convert butyryl-CoA to butyrate and 
CoASH, with the concomitant formation of adenosine triphosphate (ATP) (Louis and 
Flint, 2009). Duncan et al. (2002) showed an alternative pathway, in which butyryl-
CoA could be converted by butyryl-CoA:acetate CoA transferase to butyrate, and 
this conversion utilizes exogenously derived acetate to generate butyrate and 
acetyl-CoA. This finding was confirmed by labelling studies, which observed that 
there was cross feeding between acetate-producing and butyrate-producing 
bacteria (Venema, 2010).  
Like other SCFA, butyrate is absorbed from the colonic lumen. Butyrate that enters 
the portal circulation is metabolised in the liver to produce ketone bodies (Roediger, 
1980). Approximately 95 % of butyrate produced by colonic bacteria is transported 
across the epithelium, but the concentration in portal blood is usually undetectable 
as a result of rapid utilisation (Csordas, 1996). The supply of butyrate to the colonic 
epithelium is dependent largely on the NDC components that escape digestion in 
the small intestine, and studies show that faecal concentrations do not reflect 
production rates of SCFA as a very high proportion of the SCFA is utilized by the 
colonic mucosa. However, there is substantial evidence that indicates that different 
dietary polysaccharides affect the amounts and relative molar proportions of SCFA 
in the gut of pigs, rodents and humans (Hamer et al., 2008). In vitro studies with 
mixed human faecal bacteria have proposed that RS and FOS fermentation yields 
a higher molar proportion of butyric acid amongst the SCFA products, when 
compared to pectin fermentation, therefore RS and FOS are considered butyro-
genic (Topping and Clifton, 2001). 
Ulcerative colitis has been linked with a lack of luminal SCFA and impaired mucosal 
metabolism of butyrate and healing of colitis has been observed after treatment with 
butyrate enemas (Scheppach et al., 1992). It is not clear which bacteria in the colon 
produce the butyrate however, cultural and molecular studies have reported that 
most of these bacteria are strict anaerobes, some of which are previously 
undescribed species related to Eubacterium, Roseburia, Faecalibacterium and 
Coprococcus (Pryde et al., 2002). 
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 Physiological roles of SCFA in affecting host 
metabolism 
The gut microbiota has become recognised as an important factor in the 
development of obesity and metabolic disorders, through its SCFA produced by 
anaerobic fermentation of NDCs and also genetic factors (Kasubuchi et al., 2015). 
Several human and animal studies have shown that alterations in intestinal 
microbiota composition, and shifts in the gut microbiome towards increased energy 
harvest, are associated with metabolic syndrome, bowel disorders, obesity and 
certain types of cancer (Kovatcheva-Datchary and Arora, 2013, Rahat-Rozenbloom 
et al., 2014, Schwiertz et al., 2010, Frost et al., 2014). Moreover, SCFA 
concentrations are recognized by GPRs, also known as FFAR, to potentially be 
involved in the regulation of lipids, obesity and glucose metabolism (Figure 1.3) 
(Brown et al., 2003, Tazoe et al., 2008, Kimura et al., 2014).  
Figure 1.3: The physiological effects of the major SCFAs produced from NDCs fermentation 
by colonic microflora in the gut on energy metabolism, ↑ = increase, ↓ = decrease (adapted 
from Kimura et al., 2014, Hosseini et al., 2011, Kasubuchi et al., 2015). 
 
 
 The impact of SCFA production on obesity  
The development of obesity is a multifactorial process involving genetic 
susceptibility and environmental factors, such as lifestyle and inappropriate diet, and 
the aetiological root of obesity is an imbalance between food intake and energy 
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expenditure (Seidell, 2005). Recently, the gut microbiota has been suggested as a 
dynamic force in the pathogenesis of obesity (Kovatcheva-Datchary and Arora, 
2013). Schwiertz et al. (2010) examined 98 volunteers to evaluate differences in 
intestinal microbiota and faecal SCFA concentrations between lean and obese 
subjects. This study showed that the total amount of SCFA was higher in the obese 
subject group (p = 0.02) than in the lean subject group, and the proportion of 
individual SCFAs changed in favour of propionate in overweight (p = 0.01) and 
obese subjects (p = 0.02). Thus the authors observed that SCFA metabolism might 
play an important role in the development of obesity. These results have been 
supported by a study involving eleven lean (LN) and eleven overweight and obese 
(OWO) subjects carried out by Rahat-Rozenbloom et al. (2014), who showed that 
OWO had higher faecal SCFA than LN subjects. The differences in SCFA may be 
related to OWO subjects having higher Firmicutes abundance (83.1 ± 4.1 vs 69.5 ± 
5.8%, respectively, p = 0.008) and a higher Firmicutes:Bacteriodetes ratio (p = 
0.023) than LN subjects and not just because of difference in diet. Overall these 
studies supported the hypothesis that OWO individuals produce more colonic SCFA 
than LN individuals because of differences in colonic microbiota.  
There are some conflicting results in this area as Layden et al. (2011) observed a 
negative association between serum acetate levels and visceral adipose tissue and 
insulin levels, in a cohort of young obese women (n =18). Moreover, Fernandes et 
al. (2013) assessed the relationship between body mass index (BMI), number of 
faecal Archaea anaerobic microbiota, and faecal SCFA among 95 healthy subjects, 
and their results showed no association between colonic Archaea and obesity in 
healthy humans. Conversely, a study by Frost et al. (2014b) proposed direct effect 
of acetate in appetite regulation. They observed that acetate produced from NDCs 
fermentation in the colon induced an anorectic signal in the hypothalamic arcuate 
nucleus by supporting the glutamate–glutamine transcellular cycle, and leading to 
an increase in lactate and GABA production, which lead to appetite suppression.  
Lin et al. (2012) studied the effects of SCFA supplementation in wild type (WT) and 
FFAR3 knockout mice, and observed that butyrate, propionate, and acetate all 
protected against diet induced obesity and insulin resistance. They also found that 
butyrate and propionate, but not acetate, induced gut hormones and reduced food 
intake. This study also examined the relationship between obesity, insulin resistance 
and FFAR3, and showed that normal body weight and glucose homeostasis was 
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observed among FFAR3 deficient mice. In addition, FFAR2 deficient Knockout mice 
(FFAR2-KO) were fed a high fat diet (HFD) or chow diet, and the results showed 
FFAR2-KO mice had lower body fat mass and increased lean body mass with HFD 
(Bjursell et al., 2011).   
Another possible method the SCFAs have an effect is through Peptide YY (PYY), 
which is a hormone released by the cells in the ileum and the colon and is known to 
decrease appetite, as studies suggest that high NDCs diets are associated with 
increased levels of PYY (Karra and Batterham, 2010). Further evidence comes from 
the fact that PYY (3-36) peripheral injection in rats inhibited food intake and reduces 
weight gain, and the normal postprandial concentrations of PYY (3-36) injection 
significantly decreased appetite and reduced food intake by 33 % over 24 h in 
humans (Batterham et al., 2002). Moreover, Chelikani et al. (2005) assessed the 
dose dependent effects of 3-h IV infusions of PYY (3–36) and PYY (1–36) (0.5-50 
pmol·kg−1·min−1) in non-food deprived rats. They observed significant reductions in 
food intake and gastric emptying following peripheral administration of physiological 
levels of PYY (3-36) with minimal effective dose was 5 pmol·kg−1·min−1 and maximal 
effective was 15 pmol·kg−1·min−1. Overall these results suggest that SCFA 
production in the colon through microflora fermentation of NDCs may induce 
obesity, decrease appetite and insulin resistance.  
 The impact of SCFA production on plasma lipids 
Primary observational studies of dietary modulation of hepatic lipid synthesis have 
shown a strong correlation with NDCs intake (Chen et al., 1984, Venter et al., 
1990a). The SCFA end products of NDCs fermentation, in particular propionate, 
have been proposed to have anti-lipogenic and cholesterol-lowering effects in 
animals (Chen et al., 1984) as well in humans (Venter et al., 1990b, Wolever et al., 
1991). This has been supported by work by Wolever et al. (1989) who showed that 
an infusion of 60 mmol of propionate with 180 mmol of acetate resulted in decreased 
free fatty acids by an additional 10 %, and negated the increase in the serum 
cholesterol observed when acetate was infused alone. In rats, Chen et al. (1984) 
observed that serum and liver cholesterol concentrations were both significantly 
lower in rats fed the cholesterol-propionate diet, than in rats fed the cholesterol diet 
without propionate. This has also been observed in human studies as Venter et al. 
(1990b) reported that a normal diet supplemented with propionate fed to healthy 
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subjects for a period of seven weeks showed a significant increase in high-density 
lipoprotein (HDL) cholesterol with no differences in the glucose tolerance test, 
insulin response or total cholesterol, compared to the control group.  Lin et al. (1995) 
using rat hepatocytes and [14C] acetate, showed that 50 % of cholesterol and 
triglyceride synthesis was inhibited in the presence of a propionate concentration of 
0.1 mmol/l. 
The role of GPR43 in cholesterol and lipid metabolism has been examined in 
adipose tissue; Ge et al. (2008) showed that activation of GPR43 by acetate lead to 
the reduction in plasma free fatty acid levels, without inducing the flushing side effect 
that has been observed after the activation of the nicotinic acid receptor GPR109A. 
This result might show a potential role for GPR43 in regulating plasma lipid profiles. 
Similar findings have been observed by Hong et al. (2005), and Bjursell et al. (2011) 
observed that the liver weight and content of triglycerides, as well as plasma levels 
of cholesterol, were lower in the FFAR2-KO mice fed a HFD compared with FFAR2 
wild-type mice, which supports the role of GPR43 as a regulator of plasma lipid 
profiles.   
 The impact of SCFA production on cancer 
Butyrate is thought to have many potential anticancer properties; it stimulates the 
growth of colonic mucosa and inhibits the growth of cancer cells and induces 
differentiation in colonic cancer lines (Scharlau et al., 2009, Fung et al., 2012). 
Butyrate has been shown to produce growth arrest, differentiation (Augeron and 
Laboisse, 1984, Gamet et al., 1992) and apoptosis (Hague et al., 1995) in cancer 
cells grown in cultures. This is also supported by the results  that showed a lower 
ratio of butyrate and higher ratio of acetate observed in colon polyp and cancer 
patients (Weaver et al., 1988). Lower concentrations of faecal butyrate and 
propionate have also been observed in patients with rectal cancer compared to 
those with more proximal cancers (Pryde et al., 2002).    
The effect of butyrate on cancer cells has been further studied by Kim et al. (2004) 
who examined the potential sensitizing properties of sodium butyrate to TRAIL-
mediated apoptosis in human colon cancer cells. They observed that when HCT116 
cells were incubated with sodium butyrate and TRAIL, TRAIL-mediated apoptosis 
was enhanced, which suggests TRAIL-induced apoptosis can be sensitized by 
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sodium butyrate. The effect has also been investigated by Singh and Lai (2005) who 
examined the effectiveness of a combined treatment of dihydroartemisinin (DHA) 
and butyric acid in killing Molt-4 cells (a human lymphoblastoid leukemia cell line). 
They observed that combination of 20 μM DHA and 1 mM sodium butyrate killed all 
Molt-4 cells at the 24 h time-point and did not significantly affect lymphocytes. 
SCFAs, in particularly butyrate, have also been shown to have anti-tumor 
suppressive functions via the SCFAs receptor GPR43; Tang et al. (2011b) observed 
that GPR43 immunoreactivity was completely lost in most colorectal 
adenocarcinoma tissues (N = 70) and their corresponding lymph node metastatic 
adenocarcinomas (N = 38), compared with normal colon tissues (N = 31). A full 
length GPR43 mRNA was found in only one (HT-29) of nine established human 
colon cancer cell lines after RT-PCR analysis. They restored GPR43 expression in 
tumor cells using propionate/butyrate treatment, which induced G0/G1 cell cycle 
arrest, activated caspases, upregulated p21, decreased cyclin D3 and cyclin 
dependent kinases 1 and 2, and increased apoptotic cell death. This findings 
suggest that GPR43 can act as a tumor suppressor, and provides a possible 
mechanism for the putative connection between a NDCs diet and lower incidence 
of colon cancer.  
 Physiological effects of NSPs 
Several epidemiological  and  clinical  studies have suggested that consumption of 
NSP is inversely related to obesity (Tucker and Thomas, 2009), type two diabetes 
(Meyer et al., 2000), cancer (Park et al., 2009) and cardiovascular disease (Streppel 
et al., 2008). 
 Effect of NSPs on colorectal cancer (CRC)  
Colorectal cancer has become the third most common type of cancer, with 1.2 
million new cases diagnosed in 2008 worldwide, and accounting for about 9.7 % of 
all cases of cancer (Ferlay et al., 2010). Burkitt (1971) hypothesised that dietary fibre 
reduces the risk of colorectal cancer, based on the observation of low rates of such 
cancer among rural Africans who ate a diet with high fibre content. Several plausible 
mechanisms have been suggested to support the hypothesis, including increased 
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stool bulk, dilution of carcinogens in the colonic lumen, reduced transit time, and 
bacterial fermentation of fibre to SCFA (Lipkin et al., 1999).  
Therefore, an electronic literature search (using PubMed and ISI Web of Science) 
for articles published from 1 January 1996 to 20th of April 2014 was conducted to 
retrieve relevant studies on dietary fibre intake and incidence of CRC using subject-
specific keywords. Nine studies examining the relationship between total dietary 
fibre, soluble, insoluble, cereal, fruit and vegetable fibre and the CRC incidence and 
mortality were identified (Table 1.6). Dietary fibre intake was calculated in quintiles 
(the lowest median-the highest median), with intake ranging from 5.4-36.7 g/d. The 
study of Mai et al. (2003) from the United States had the lowest median intake of 
dietary fibre, with a range between 5.4-18.2 g/d, followed by Fuchs et al. (1999) from 
the United States (8.5-28.5 g/day). The study from the UK (Sanjoaquin et al., 2004) 
had the highest median intake of dietary fibre, with a range between 17.0-36.7 g/d 
and the EPIC study (Bingham et al., 2003) has fibre intake ranged between 15 – 34 
g/d for participants across Europe. All of these studies provided sufficient 
information for a comparison between the levels of dietary fibre consumed and the 
incidence of CRC.   
 
 
64 
 
Table 1.6: Evidence table of epidemiological studies on dietary fibre intake and CRC.  
Reference Aim Study population Type of fibre  Dietary fibre intake 
(highest median vs. 
lowest median) g/day 
Effect 
(RR 95 % CI) 
Comments  
Michels K B et al. 
(2005) 
(NHS) and 
(HPFS) 
USA 
To investigate the 
association of fibre 
intake and incidence of 
CRC.  
76,947 Female 
registered nurses 
aged 30-55 years and 
47,279 Health 
Professional males 
aged 40-75 years; 
self-administered 
semi-quantitative 
FFQ included 130 
food items. AOAC 
and Englyst (NSP) 
Total dietary fibre 
Cereal fibre 
Fruit fibre 
Vegetable fibre   
30 vs 12 
11.4 vs 2.8 
9.3 vs 1.4 
12.2 vs 3.6  
  0.91 (0.87-0.95) This study fairly 
consistently indicated no 
important association 
between fibre intake and 
risk of CRC, but revealed 
considerable confounding 
by other dietary and 
lifestyle factors. 
0.93 (0.84-1.03) 
0.89 (0.80-1.00) 
1.05 (0.95-1.16) 
 
  
 
 
 
 
Lin J et al. (2005) 
(WHS) 
USA 
To examine the 
association between 
dietary intake of fruit, 
vegetables and fibre 
and CRC risk 
39,876, 75 % nurses, 
11 % physicians and 
other health 
professionals’ 
resident in the USA; 
aged 52.2-55.7 years; 
FFQ includes 131 
food items 
Total dietary fibre 
Cereal fibre 
Fruit fibre 
Vegetable fibre 
Cruciferous fibre 
Legume fibre 
26 vs 12 
6.1 vs 3.1 
6.0 vs 2.5 
8.0 vs 5.9 
1.6 vs 0.7 
1.8 vs 0.4 
0.75 (0.48-1.17) 
1.00 (0.67-1.49) 
1.00 (0.64-1.55) 
0.97 (0.66-1.43) 
0.74 (0.47-1.17) 
0.60 (0.40-0.91) 
This study could not 
confirm an inverse 
association of intake of 
fruit, vegetables and fibre. 
However, data suggest that 
high intake of legume fibre 
and/or other sources 
related to this intake may 
reduce the risk of CRC 
   
Sanjoaquin M A 
et al. (2004) 
UK 
To examine whether 
the risk of CRC is lower 
in vegetarians than in 
non-vegetarians, and 
low in those who ate 
relatively large 
amounts of fruit or 
vegetables and other 
foods high in fibre. 
10,998 (42.3 % 
vegetarians and 57.7 
% non-vegetarians) 
recruited in the UK; 
median age 33 years; 
simple FFQ 
 
 
Total dietary fibre 
 
36.7 vs 17.0 0.82 (0.43-1.56) No association observed 
between fibre and CRC 
risk; however, information 
needed to estimate dietary 
fibre intake was unavailable 
for 32 cases.  
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Bingham S A et 
al. (2003) 
(EPIC) 
Multi-centre 
prospective   
To study the 
relationship between 
dietary fibre and 
colorectal cancer      
519,978 persons 
aged 25-70 years old; 
extensive self-
administered 
quantitative dietary 
questionnaire, 
containing up to 260 
food items, semi-
quantitative FFQ; 
Combined methods 
were used in the UK 
and Malmo in 
Sweden (semi-
quantitative food-
frequency 
questionnaires and a 
7-day record) and 24-
hour dietary recall 
was used as a 
reference method.   
Total dietary fibre 
Cereal fibre 
Fruit fibre 
Vegetable fibre 
Legume fibre 
35 vs 15 0.75 (0.59-0.95)** In a population with low 
average intake of dietary 
fibre, an approximate 
doubling of total fibre intake 
from foods could reduce 
the risk of CRC by 40 %.   
Bingham S A et 
al. (2003) 
(EPIC) 
Multi-centre 
prospective   
To study the 
relationship between 
dietary fibre and 
colorectal cancer      
519,978 persons 
aged 25-70 years old; 
extensive self-
administered 
quantitative dietary 
questionnaire, 
containing up to 260 
food items, semi-
quantitative FFQ; 
Combined methods 
were used in the UK 
and Malmo in 
Sweden (semi-
quantitative food-
frequency 
questionnaires and a 
7-day record) and 24-
hour dietary recall 
was used as a 
reference method.   
Total dietary fibre 
Cereal fibre 
Fruit fibre 
Vegetable fibre 
Legume fibre 
35 vs 15 0.75 (0.59-0.95)** In a population with low 
average intake of dietary 
fibre, an approximate 
doubling of total fibre intake 
from foods could reduce 
the risk of CRC by 40 %.   
12.05 vs 4.72 0.78 (0.62-0.98) 
7.76 vs 2.21 0.88 (0.70-1.11) 
6.48 vs 2.85 1.04 (0.84-1.30) 
1.73 vs 0.45 0.78 (0.64-0.97) 
Total dietary fibre 18.2 vs 5.4 0.94 (0.71-1.23) 
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Mai V et al. 
(2003) 
(BCDDP) 
USA 
To evaluate the 
association between 
total dietary fibre intake 
and incidence of CRC  
61, 429 women aged 
50-65 years; FFQ 
includes 62 food 
items  
Fruit fibre 
Vegetable fibre 
Beans fibre 
Grain fibre 
5.4 vs 0.5 
4.9 vs 1.0 
2.5 vs 0.1 
6.0 vs 1.3 
1.10 (0.83-1.46) 
0.92 (0.69-1.21) 
0.84 (0.63-1.10) 
1.02 (0.76-1.37) 
There was little evidence 
that dietary fibre intake 
lowers the risk of CRC. 
Pietinen P et al. 
(1999) 
(ATBC) 
Finland  
To examine the 
association between 
dietary fibre and the 
CRC during an average 
of 8 years of follow-up 
29,133 male smokers 
aged between 50-69 
years; self- 
administered 
modified diet 
questionnaire 
included 276 food 
items 
 
Total fibre 
Soluble fibre  
Insoluble fibre  
34.0 vs 16.0 
7.3 vs 3.7 
27.1 vs 12.2 
1.0 (0.6-1.5) 
1.1 (0.7-1.6) 
1.0 (0.6-1.5) 
There was no association 
between the risk of CRC 
and intake of total dietary 
fibre. Since these analyses 
were conducted among 
smokers the results may 
not be applicable to non-
smokers. 
Terry P et al. 
(2001) 
Swedish 
 
To assess the 
relationship between 
the risks of CRC in 
individuals who 
consumed the highest 
and the lowest amount 
of fruit, vegetable and 
cereal fibre. 
66,651 women aged 
between 40-74 years; 
self-administered 
FFQ that included 67 
food items commonly 
eaten in Sweden 
Total fibre  
Cereal fibre 
Fruit fibre 
Vegetable fibre 
21.8 vs 12.3 
16.0 vs 4.3 
5.2 vs 0.8 
2.0 vs 0.6 
0.96 (0.70-1.33) 
0.91 (0.69-1.20) 
0.97 (0.69-1.38) 
1.17 (0.85-1.61) 
Individuals who consume a 
very low amount of fruit and 
vegetables have the 
greatest risk of CRC. 
Relatively high 
consumption of cereal fibre 
does not appear to lower 
the risk of CRC. Hence, 
increasing fruit and 
vegetables may reduce the 
risk of CRC among those 
who consume less than 2 
servings/ day of fruit and 
vegetables.   
Fuch C S et al. 
(1999) 
(NHS) 
USA 
To examine the relation 
between fibre intake 
and risk of CRC 
121,700 women aged 
34-59 years; semi-
quantitative FFQ 
including 61 food 
items was used; in 
1984 questionnaire 
was expanded to 121 
and in 1986  
included 136 items 
Total fibre  
Cereal fibre 
Fruit fibre 
Vegetable fibre 
28.5 vs 8.5 
4.8 vs 1.0 
7.2 vs 0.8 
10.0 vs 2.7 
0.95(0.73-1.25) 
1.0 (0.79-1.27) 
0.86 (0.67-1.10) 
1.35 (1.05-1.72)** 
The results do not support 
the existence of an 
important protective effect 
of dietary fibre against 
CRC. 
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Kato I et al. 
(1997) 
USA 
To assess the 
association between 
diet and CRC 
15,785 women aged 
34-65 years; semi-
quantitative 
questionnaire that 
included 70-items of 
typical American 
food. 
Total dietary fibre No specific information on 
dietary fibre classification. 
Dietary fibre was grouped 
into quintiles. 
1.51 (0.85-2.68) There was no relation 
between dietary fibre and 
incidence of CRC among 
women. 
FFQ-Food Frequency Questionnaire; CRC-Colorectal Cancer; RR-Relative Risk; CI-Confidence Intervals; EPIC-European Prospective Investigation into Cancer and Nutrition; NHS-Nurses Health Study; HPFS-
Health Professional’ Follow-up Study; WHS-Women’s Health Study; ATBC-Tocopherol Beta-Carotene Cancer Prevention Study; BCDDP-Breast Cancer Detection Demonstration Project; CVD-Cardiovascular 
Disease 
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The study by Fuchs et al. (1999) found that a greater consumption of vegetable fibre 
was associated with significant increases in the incidence of CRC among women in 
the highest intake group. Only one out of the nine studies investigating the 
relationship between different sources of fibre intake and CRC incidence showed 
protective effects (Bingham et al., 2003). In a population with low average intake of 
dietary fibre Bingham et al. (2003) reported that an approximate doubling of total 
fibre intake from food could reduce the risk of colorectal cancer by 40 %. The other 
results with strong evidence supporting the hypothesis that dietary fibre protects 
against the risk of CRC, were from a meta-analysis of case control studies 
(Friedenreich et al., 1994). However, the categorical evidence from the large pooled 
analysis of prospective cohort studies failed to show a protective effect against CRC 
(Park et al., 2005), but this study by Park et al. (2005) did not include the EPIC study 
in the pooled analysis project, if they had the findings might be changed to a 
significant reduction effect in the multivariate analysis. 
1.10.1.1 Mechanism behind health effects of NSPs on CRC 
The Food and Drug Administration (FDA) currently accepted health claims for DF; 
the first claim was by decreasing the daily fat intake (by < 30 % of calories), and 
increasing the consumption of DF from fruit, vegetables and whole grains, this might 
reduce some types of cancer (Lattimer and Haub, 2010). This is also supported by 
some recent studies as they have shown an inverse relationship between DF 
consumption and the development of several types of cancer, including colorectal 
and small intestine (Schatzkin et al., 2008, Nomura et al., 2007). Although most 
studies have agreed with these findings, the mechanisms responsible are still 
unclear. Several modes of action have been suggested; first, that the DF escaped 
digestion and absorption in the small intestine, thereby allowing it to enter the large 
intestine where it is fermented to produce SCFA, which might have anti-carcinogenic 
properties (Young et al., 2005). For example butyrate is produced by anaerobic 
fermentation of DF and other substrates in the colonic lumen., and this has been 
shown to inhibit cell proliferation, induce differentiation, and enhance apoptosis in 
human colonic tumour cell lines (Medina et al., 1997). In addition, several studies 
have observed that the inclusion of DF and other oligosaccharides, especially FOS, 
as a dietary constituent produces a significant increase in probiotic-like bacteria, and 
these health-promoting bacteria inhibit the growth of pathogenic bacteria, lower the 
activity levels of genotoxic agent-forming enzymes, lower tumour promoters and 
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consequently decrease the production of carcinogenic substances (Hughes and 
Rowland, 2001, Kaur and Gupta, 2002). 
The second action that could explain the anti-cancer properties is related to DF 
increasing faecal bulking and viscosity, which allowed less contact time between 
potential carcinogens and mucosal cells. A third potential mechanism action 
suggests that DF increased the binding between bile acids and carcinogens, which 
would mean they would be degraded target than continue in the intestine. Increased 
intake of DF may also yield an increase in the levels of antioxidants, which would 
have an effect on cancer cells (Fung et al., 2012). DF might also increase the 
amount of oestrogen excreted in the faeces because it can cause inhibition of 
oestrogen absorption in the intestines (Adlercreutz et al., 1987). 
 Effect of NSPs on cardiovascular disease (CVD)    
The incidence of CVD has declined both among some European countries and also 
in north America (Smolina et al., 2012), even though it is considered as the main 
cause of mortality and accounts for almost half (48 %) of all deaths in Europe and a 
third (32.8 %) of all deaths in the USA (Unal et al., 2004). Dietary factors play an 
important role in the development of CVD through their effect on body weight and 
lipid profile (Liu et al., 2000). In 2003 the World Health Organization (WHO) reported 
that unhealthy dietary practices, such as the high intake of saturated fatty acids, salt 
and refined carbohydrates, contributed to increase the incidence and risk of 
mortality from CVD.  
Trowell (1976) hypothesised that high dietary fibre intake is a protective factor 
against a number of western diseases, such as cancer, CVD, diabetes and obesity. 
Epidemiological studies have reported that a high intake of dietary fibre may play a 
major role in reducing the risk of CVD incidence and mortality. In 2011, an initial 
electronic literature search (using PubMed and ISI Web of Science) for articles 
published from 1 January 1996 to 15th of February 2011 was conducted to retrieve 
relevant studies on the dietary fibre intake and incidence or mortality from CVD using 
subject-specific keywords. This search was updated in 2014 using the same key 
search terms. Twenty-one studies that covered the relationship between total 
dietary fibre, soluble and insoluble fibre, and CVD incidence and mortality were 
examined (Table 1.7). A key study was a systematic review and meta-analysis of 
 
 
70 
 
22 cohort studies on dietary fibre intake and CVD risk showed no relationship 
between dietary fibre intake and the risk of CVD. The studies had a minimum follow-
up of three years and published between 1 January 1990 and 6 August 2013 
(Threapleton et al., 2013b). 
The alternative Healthy Eating Index (AHEI) study conducted by Akbaraly et al. 
(2011) was not included in this analysis because no estimate of dietary fibre intake 
was presented. Of the studies selected nineteen out of the 22 examined the 
relationship between total dietary fibre and CVD incidence and mortality (Table 1.7), 
four of the 22 studies examined the association between soluble fibre intake and 
CVD incidence and mortality (Pietinen et al., 1996, Bazzano et al., 2003, Estruch et 
al., 2009, Threapleton et al., 2013a), two studies investigated the relationship 
between insoluble fibre intake and CVD incidence and mortality (Estruch et al., 
2009, Threapleton et al., 2013a), ten studies investigated the relationship between 
cereal fibre intake and CVD incidence and mortality (Rimm et al., 1996, Wolk et al., 
1999, Mozaffarian et al., 2003, Estruch et al., 2009, Baer et al., 2011, Crowe et al., 
2012, Bernstein et al., 2011, Threapleton et al., 2013a, Buyken et al., 2010, Kaushik 
et al., 2009). and seven studies investigated the relationship between fruit and 
vegetable fibre intake and CVD incidence and mortality (Rimm et al., 1996, Wolk et 
al., 1999, Mozaffarian et al., 2003, Estruch et al., 2009, Crowe et al., 2012, 
Threapleton et al., 2013a, Buyken et al., 2010). Based on these twenty-two studies, 
the overall total dietary fibre intake ranged from 5.8-63.0 g/d, soluble fibre intake 
was 0.9-18.9 g/d, the intake was 25.6-5.9 g/d for insoluble fibre, with 1.1-15.7 g/d of 
cereal fibre, 0.4-11.1 g/d of fruit fibre, and 2.0-9.7 g/d of vegetable fibre. There were 
protective effects of dietary fibre intake against the incidence and mortality from CVD 
reported for 84 % of total dietary fibre studies, 75 % of soluble fibre, 50% of insoluble 
fibre, 60 % of cereal fibre and 43 % of fruit and vegetables studies.  
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Table 1.7: Evidence table of epidemiological studies on dietary fibre intake and CVD.  
Reference Aim Study population Type of fibre  Dietary fibre intake 
(highest median vs. 
lowest median) g/day 
Effect 
(RR 95%CI) 
Conclusion 
Pietinen et al. 
(1996)  
(Alpha-
Tocopherol 
Beta-Carotene 
Study)  
 
Finland  
To examine the 
relations between 
intake of dietary fibre 
and risk of CHD 
heart disease in a 
cohort of middle 
aged smoker Finnish 
men 
21, 930 smoking 
men aged 50-69 
years; validated 
FFQ (276) diet over 
previous year, 
quality check 
by nurse; Englyst 
Total dietary fibre 
Soluble fibre 
34.8 vs 16.1 
18.9 vs 5.4 
0.69 (0.54-0.88) *** 
0.74 (0.66-0.94) ** 
Increasing daily intake 
by 10 g/d and 3 g/d of 
total fibre and soluble 
fibre (respectively) 
appeared to lower the 
risk of CVD death by 27 
% 
Rimm et al. 
(1996) 
(Health 
Professionals’ 
Follow-up 
Study 
USA 
To examine 
the relationship 
between dietary fibre 
and risk of CVD 
43,757 males aged 
40-70 years; 
validated FFQ diet 
(131) diet over 
previous year; 
AOAC 
Total dietary fibre 
Cereal fibre  
Fruit fibre 
Vegetable fibre 
28.9 vs 12.4 
7.9 vs 1.2 
11.1 vs 3.2 
9.7 vs 2.2 
0.64 (0.47-0.87) ** 
0.71 (0.54-0.92) ** 
0.81 (0.62-1.06) 
0.83 (0.64-1.08) * 
10 g increase of TDF 
provides protective 
effect against the risk 
CVD and cereal fibre 
was also strongly 
associated with reduced 
risk of CVD  
Wolk et al. 
(1999)  
(Nurses’ 
Health Study) 
cohort  
USA 
To examine the 
association between 
long term intake of 
dietary fibre from 
different sources and 
risk of CVD in 
women 
68,782 women 
aged 37-64 years; 
validated FFQ 
(116), diet 
assessed at least 3 
times; AOAC 
Total dietary fibre 
Cereal fibre  
Fruit fibre 
Vegetable fibre 
22.9 vs 11.1 
7.7 vs 2.2 
9.5 vs 3.6 
6.8 vs 1.3 
0.76 (0.57-.99) * 
0.63 (0.49-0.81) *** 
0.93 (0.74-1.16) 
1.06 (0.84-1.32) 
Increment of 10 g/d and 
5 g/d of dietary fibre and 
cereal (respectively) 
might be effective in 
reducing the incidence 
of CVD 
Todd et al. 
(1999) 
(Scottish Heart 
Health Study) 
 
UK 
To investigate the 
relation between 
fibre intake and the 
incidence of CVD in 
Scottish population 
11,629 men and 
women aged 40-
59; validated semi-
quantitative FFQ 
(60); Englyst and 
Southgate 
Total dietary fibre (M) 
Total dietary fibre (W)  
11 vs 7 
13.5 vs 8.3  
0.48 (0.25-0.90) * 
0.90 (0.82- 0.99) * 
This result might provide 
evidence that intake of 
dietary fibre is protective 
against the risk of CVD 
incidence 
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Appleby et al. 
(1999) (Oxford 
Vegetarian 
Study)  
 
UK 
 
To evaluate the 
relation between 
fibre intake and the 
mortality from CVD 
in the study subjects  
11 140 UK, 
volunteer cohort 
(half vegetarian), 
both sexes, aged 
16-79 years; 
Simple validated 
FFQ; Southgate 
Total dietary fibre  < 18.0 vs ≥ 32.0 2.25 (0.92-5.53) No relationship observed 
between fibre intake and 
CVD mortality 
Liu et al. (2002) 
Women’s 
Health Study  
(WHS) cohort 
 
USA 
 
To assess the 
association between 
higher intake of 
dietary fibre and the 
risk of CVD in US 
women 
39, 876 women 
aged ≥ 45 years; 
validated semi-
quantitative 
FFQ (131); AOAC 
Total dietary fibre 26.3 vs 12.5 0.65 (0.51-0.84) *** Findings support 
recommendation of high 
intake of dietary fibre-
rich whole grains and 
fruits and vegetables as 
a primary preventive 
measure against CVD 
Bazzaro et al. 
(2003) (NHNES 
I) cohort study 
 
USA 
 
 
To examine the 
relationship between 
total and soluble 
dietary fibre intake 
and the risk of CVD 
9776 adults 25-74 
years; 24 h recall 
including portion 
size estimates; 
unclear, likely 
to be AOAC 
Total dietary fibre 
Soluble fibre  
 
20.7 vs 5.9 
5.9 vs 0.9 
0.89 (0.80- 0.99) * 
0.90 (0.82- 0.99) * 
Dietary fibre and 
especially soluble 
showed a protective 
effect against 
development of CVD    
Mozaffarian et 
al. (2003) 
 
Cardiovascular 
Health Study;  
 
USA 
To determine 
whether fibre 
consumption from 
different sources is 
associated with 
incidence of CVD in 
elderly people 
3,588 men and 
women aged ≥ 65 
years; validated 
FFQ (99) diet over 
previous year; 
AOAC 
Total dietary fibre 16.2 0.84 (0.66-1.07) Increasing cereal fibre 
intake late in life is 
invisibly correlated with 
incidence of CVD  
Cereal fibre 6.3 vs 1.7 0.79 (0.62-0.99) ** 
Fruit fibre 7.5 vs 2.8  0.99 (0.78-1.25) 
Vegetable fibre 
 
9.2 vs 4.2  1.08 (0.86-1.36) 
Streppel et al. 
(2008) 
 
Zutphen  
1960-2000 
Cohort study 
Netherland 
 
To study recent and 
long term intake of 
dietary fibre in 
relation to the risk of 
CVD 
1,373 men mean 
age 77 years; diet 
history, several 
times, intake over 
previous 6-12 
months; AOAC 
Total dietary fibre 33 vs 21 0.83 (0.70-0.98) * The incidence of CVD 
reduced with high intake 
of dietary fibre. 
However, the inverse 
effect of dietary fibre 
was seen with increased 
age for long term intake.   
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Kaushik et al.  
(2009) (Blue 
Mountains Eye 
Study) 
Australia  
 
To assess the 
relationship between 
cereal fibre intake 
and mortality from 
CVD  
3654 Australians, 
sampled to 
represent the 
region, both sexes; 
validated FFQ 
(145); AOAC  
Cereal fibre  5.9 vs 8.5 1.22 (0.95-1.58) Negative association 
between cereal fibre 
intake and death from 
CVD 
Eshak et al. 
(2010b)   
 
Collaborative 
Cohort Study 
 
Japan 
 
 
 
 
To investigate the 
association between 
dietary fibre of 
different types and 
the risk of CVD in 
Japanese population 
23,119 men and 
35, 611 women 
aged 40-79 years; 
validated FFQ (40); 
method similar to 
AOAC 
Total dietary fibre (M) 
Insoluble fibre  
Soluble fibre  
Cereal fibre  
Fruit fibre  
14 vs 6.8 
9.2 vs 5.9 
3.2 vs 1.3 
2.1 vs 1.4 
1.7 vs 0.4 
0.81 (0.61-1.09) * Total dietary fibre, 
soluble, insoluble, fruit 
and cereal fibre proved 
the importance of dietary 
fibre intake from different 
food sources in terms of 
protection against the 
risk of mortality from 
CVD   
0.48 (0.27-0.84) ** 
0.71 (0.41-0.97) * 
0.86 (0.64-0.99) * 
0.56 (0.35-0.90) ** 
Total dietary fibre (W) 
Insoluble fibre  
Soluble fibre  
Cereal fibre  
Fruit fibre 
13.8 vs 7.4 
9.1 vs 6.2 
2.4 vs 1.5 
1.7 vs 1.1 
2.2 vs 0.7 
0.80 (0.57-0.97) * 
0.49 (0.27-0.84) ** 
0.72 (0.43-0.99) * 
0.77 (0.59-0.98) * 
0.40 (0.28-0.78) ** 
Kokubo et al. 
(2011) 
 
Public Health 
Centre-Based 
Cohort 
Japan 
 
To examine the 
association between 
dietary fibre and the 
risk of CVD in a 
Japanese population 
40,046 men and 
46,341 women 
aged 45-64 years; 
validated FFQ 
(138); method 
similar to AOAC 
Total dietary fibre (M) 
 
19.9 vs 6.0 
 
 
0.94 (0.74-1.20)  
 
 
Based on Japan dietary 
fibre intake 
recommendation (20-30 
g/d), this study gave 
evidence that high intake 
of dietary fibre intake 
might reduce the risk of 
CVD in the Japanese   
Total dietary fibre (W) 21.6 vs 7.8 0.65 (0.48-0.87) ** 
Buyken et al. 
(2010) (Blue 
Mountains Eye 
Study) 
Australia 
 
 
 
To examine whether 
dietary fibre is 
associated with CVD 
mortality in older 
Australian cohorts 
3654 Australians, 
sampled to 
represent the 
region, both sexes 
validated FFQ 
(145); AOAC;  
Total dietary fibre (M) 
Cereal fibre  
Fruit fibre 
Vegetable fibre 
36.4 vs 18.4  
11.5 vs 3.0 
11.1 vs 2.4 
13.7 vs 6.0 
0.88 (0.53-1.46) 
0.87 (0.55-1.38) 
1.03 (0.61-1.75) 
1.01 (0.64-1.60) 
Increasing cereal fibre 
intake later in life among 
females is invisibly 
correlated with mortality 
from CVD Total dietary fibre (W) 
Cereal fibre  
Fruit fibre 
Vegetable fibre 
36.2 vs 19.7 
10.9 vs 2.9 
11.7 vs 2.8 
13.5 vs 6.5 
0.84 (0.53-1.34) 
1.04 (0.67-1.61) 
0.61 (0.38-0.99) * 
0.88 (0.60-1.30) 
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Baer et al. 
(2011)  
 
(Nurses’ 
Health Study) 
 
USA 
 
To assess the 
associations of 
cereal fibre intake 
with the risk of CVD 
121 700 females, 
occupational 
cohort, Aged 30-55 
years; validated 
FFQ (116) 
administered 3 
times; AOAC 
Cereal fibre  3.4 vs 5.8 0.84 (0.78, 0.91) * Increase of 4 g/d of 
cereal fibre associated 
with lower risk of CVD 
Park et al. 
(2011)  
 
(NIH-AARP 
Diet and Health 
Study) 
 
USA 
To investigate 
dietary fibre intake in 
relation to the risk of 
death from CVD 
3 881 22 
participants 
represent general 
population, aged 
50-71 yeas, FFQ 
(124), intake over 
previous year 
AOAC 
Total dietary fibre (M) 
Total dietary fibre (W) 
29.4 vs 12.6 
25.8 vs 10.8 
0.78 (0.73-0.82) *** 
0.78 (0.73-0.85) *** 
Every 10 g/d increase  
of dietary fibre intake 
appeared to lower risk of 
death from CVD by 24 % 
to 56 % in men and 
34 % to 59 % in women  
Chuang et al. 
(2012)  
 
(EPIC) 
 
Europe  
 
 
 
 
To assess the 
relationship between 
fibre intake and the 
risk of CVD in a large 
European 
prospective study 
518 408 
Europeans, 
sampled to 
represent 
population, both 
sexes, aged 25-70 
years; semi 
quantitative FFQ, 
diet history; AOAC 
and standardised 
values 
Total dietary fibre ≥ 28.5 vs < 16.4 0.90 (0.88-0.92) * Increasing daily intake 
by 10 g/d of total fibre 
appeared to lower the 
mortality from CVD  
Crowe et al. 
(2012) 
(EPIC-Heart) 
Europe 
 
 
 
To assess the 
associations of total 
and food sources of 
dietary fibre with the 
risk of CVD 
306 331 
Europeans; semi-
quantitative FFQ, 
diet history; AOAC 
and standardised 
values 
Total dietary fibre 
Cereal fibre  
Fruit fibre 
Vegetable fibre 
< 17.5 vs ≥ 27.5 
< 5.0 vs ≥ 11.0 
< 2.0 vs ≥ 6.0 
< 2.0 vs ≥ 6.0 
 
0.85 (0.73-0.99) * 
0.91 (0.82-1.01) 
0.94 (0.88-1.01) 
0.92 (0.78-1.09) 
Each intake 10 g/d of 
total fibre associated 
with 15 % lower risk of 
CVD 
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Wallstrom et al. 
(2012) 
(Malmo Diet 
and Cancer 
Cohort) 
Sweden 
 
 
To examine the 
association between 
intake of 
macronutrients and 
dietary fibre and 
incident of CVD in 
men and women  
8,139 male and 
12,535 female 
participants aged 
44-73 years; 
Interview based 
diet history method; 
non-starch 
polysaccharide 
Total Dietary Fibre (M) 
Total Dietary Fibre (W) 
11.4 vs 5.8 (g/1000cal) 
12.9 vs 6.5 (g/1000cal) 
0.54 (0.42–0.68) ** High fibre intake was 
associated with lower 
incidence rates of CVD 
Wallstrom et al. 
(2012) 
(Malmo Diet 
and Cancer 
Cohort) 
Sweden 
 
 
To examine the 
association between 
intake of 
macronutrients and 
dietary fibre and 
incident of CVD in 
men and women  
8,139 male and 
12,535 female 
participants aged 
44-73 years; 
Interview based 
diet history method; 
non-starch 
polysaccharide 
Total Dietary Fibre (M) 
Total Dietary Fibre (W) 
11.4 vs 5.8 (g/1000cal) 
12.9 vs 6.5 (g/1000cal) 
0.54 (0.42–0.68) ** High fibre intake was 
associated with lower 
incidence rates of CVD 
0.76 (0.59–0.97) * 
Ward et al. 
(2012) 
(EPIC-Norfolk) 
UK 
 
 
To compare FFQ 
and 7DD 
measurements of 
fibre intake with the 
incidence of CHD 
25 639 participants 
represent UK 
regions of both 
sexes, aged 40-79 
years FFQ and 
7DD; Englyst 
Total Dietary Fibre 
 
7DD (M) 24.1 vs 9.8 
7DD (W) 20.1 vs 8.4 
FQQ (M)26.2 vs 11.0 
FQQ (W) 27.8 vs 11.8 
0.87 (0.80–0.95) ** 
0.84 (0.73–0.97) * 
0.99 (0.90–1.08) 
0.90 (0.80–1.01) 
Inconsistency in fibre 
intake and CHD 
relationship which could 
be related to dietary 
assessment methods. 
However, dietary fibre 
intake may be better 
measured by 7DD than 
FQQ.  
Bernstein et al. 
(2011) (Nurses’ 
Health Study) 
USA 
 
 
To examine the 
association between 
intake of cereal fibre 
and incidence of 
CHD 
72 266 females, 
aged 30-55 years; 
validated FFQ 
(116) administered 
multiple times; 
AOAC 
Cereal fibre  8.3 vs 2.0 0.65 (0.55-0.76) *** Increment of 5 g/d of 
cereal fibre intake was 
inversely associated 
with risk of CHD 
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M = Men; W = Women; EPIC=European Prospective Investigation into Cancer and Nutrition; Association of Official Analytical Chemist (AOAC); FFQ=food frequency questionnaire; 7DD = 7 days’ diet diaries; 
NIH-AARP=National Institutes of Health-American Association for Retired Persons Diet and Health Study; * (P < 0.05); ** (P < 0.01), *** (P < 0.001).  
 
Threapleton et 
al. (2013a) 
(UK Women’s 
Cohort Study) 
UK 
 
 
To investigate the 
association between 
dietary fibre intake 
and CVD mortality 
35 691 UK 
volunteer females 
(one third 
vegetarian), mean 
age 51.8 years; 
Validated FFQ 
(217); Englyst 
and AOAC 
NSP 
AOAC  
Soluble fibre 
Insoluble fibre 
Cereal fibre  
Fruit fibre 
Vegetable fibre 
38.3 vs 14.1 
63.0 vs 21.0 
16.4 vs 6.4 
25.6 vs 8.4 
15.7 vs 2.8 
9.5 vs 1.4 
9.5 vs 2.3  
 
0.92 (0.80-1.05) 
0.91 (0.76-1.08) 
0.89 (0.75-1.07) 
0.95 (0.84-1.07) 
0.99 (0.89-1.09) 
1.00 (0.90-1.11) 
0.93 (0.84-1.02) 
 
Total dietary fibre 
(NSP/AOAC) and fibre 
from different food 
sources showed no 
relationship with the risk 
of CVD 
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These results showing a protective effect of dietary fibre were also supported by one 
of the most comprehensive studies on dietary fibre and CVD, which included a 
pooled analysis of cohort studies investigating 336,244 people and 2,506,581 
follow-up years (Pereira et al., 2004). This study showed that, per 10 g/d increased 
intake, total dietary fibre was correlated with a 14 % (RR, 0.86; 95 % CI: 0.78-0.96; 
p for trend = 0.005) decrease in risk of all CVD events, and a 27 % (RR, 0.73; 95 % 
CI, 0.61-0.87; p for trend < 0.001) decrease in risk of CVD death. Fruit fibre intake, 
per 10 g/d increase, was correlated with a reduction in all CVD events (RR, 0.84; 95 
% CI: 0.70-0.99; p for trend = 0.04). Per 10 g/d increase of cereal and fruit fibres 
there was a correlated with the reduced risk of CVD death (RR, 0.75; 95 % CI: 0.63-
0.91; p for trend = 0.003, RR, 0.70; 95 % CI: 0.55-0.89; p for trend = 0.004, 
respectively), which shows overall how effective the increase in the different fibre 
types can be for reducing CVD risk. 
Total serum cholesterol is composed of low density lipoprotein (LDL) cholesterol 
(60-70 %) and high density lipoprotein (HDL) cholesterol (20-30 %) (Antonopoulos, 
2002). Prospective studies among Western countries have shown a significant 
association between triglyceride concentration and CVD risk (Sarwar et al., 2007). 
Iso et al. (2001) stated that a 1 mmol/l increase in plasma triglyceride was 
significantly associated with CVD risk in women, with a RR of 1.42 (95 % CI: 1.15-
1.75; p = 0.001), and in men a RR of 1.29 (95 % CI: 1.09-1.53; p = 0.004) (Iso et al., 
2001). The Atherosclerosis Risk in Communities (ARIC) Study among 12,339 
participants free of CVD showed that concentrations of LDL-cholesterol > 100 mg/dl 
was a predictor of CVD incidence (Sharrett et al., 2001).  
Increased consumption of viscous soluble fibre has been recommended a 
therapeutic lifestyle change to reduce the risk of CVD. In 2002 the National 
Cholesterol Education Program Adult Treatment Panel III (ATP III) reported that 
intake of 5-10 g/d of viscous fibre might reduce LDL-C by 5 % (Antonopoulos, 2002). 
Observational and clinical trial studies have also documented that different types 
(total, soluble and insoluble) and sources (cereal, fruit, vegetable, nuts and seeds) 
of dietary fibre are associated with reduction in the risk factors of CVD especially 
LDL, and nine studies have investigated the relationship between dietary fibre and 
changes in serum lipids (Table 1.8). Seven of these nine (78 %) studies showed a 
protective effect of dietary fibre intake against the risk factors of CVD by altering 
serum LDL. Similarly, Brown et al. (1999) conducted a meta-analysis of 67 
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controlled trials to quantify the cholesterol lowering effect of soluble fibre, and 
showed a significant relationship between soluble fibre and reduced cholesterol 
levels and their protective effect against CVD. Overall these results show positive 
relationship between dietary fibre intake and reduce the risk of CVD.   
1.10.2.1 Mechanisms behind health effect of NSPs on CVD 
The exact mechanism by which these NSP components, especially water soluble 
NSP, affect the risk of CVD has been the focus of many investigations and various 
hypotheses have been proposed to explain these effects (Eshak et al., 2010a, 
Behall et al., 2006a). Evidence suggests that water soluble NSP may initiate lipid 
and/or bile acid metabolism, Which would cause a reduction in serum lipid levels 
(Kritchevsky and Story, 1974, Eastwood and Hamilton, 1968). Other research has 
suggested mechanisms which include the inhibition of hepatic cholesterol synthesis 
by SCFA products, and the delayed absorption of macronutrients leading to 
increased insulin sensitivity (Naumann et al., 2006). 
1.10.2.2 Effects from SCFA produced by fermentation in the colon 
Water-soluble NSP escapes absorption in the small intestine and are fermented in 
the large bowel by colonic bacteria. This fermentation results in the production of 
SCFA, such as acetate, propionate, and butyrate, and it has been hypothesized that 
production of SCFA, and in particular changes in the propionate: acetate ratio, may 
influence lipid metabolism. Bridges et al. (1992) examined the effects of oat bran 
and wheat bran on serum SCFA concentrations in 20 hypercholesterolemic men, 
they found that oat bran decreased serum cholesterol concentrations by 12.8 %, 
whereas wheat bran had no effect. Serum acetate values were significantly higher 
in subjects fed the oat bran diet when compared with the wheat bran diets. This 
would suggest that increased colonic SCFA production lowers LDL cholesterol 
concentrations.  
1.10.2.3 Interference with lipid and/or bile acid metabolism 
The Food and Drug Administration (FDA) has accepted that there is sufficient 
evidence to show the rate of bile excretion was increased through soluble NSP 
intake, therefore, reducing serum total and LDL cholesterol (Story et al., 1997). 
Evidence suggested that some water soluble NSPs implement this effect by binding 
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bile acids during formation of micelles in the intestinal lumen (Eastwood and 
Hamilton, 1968, Kritchevsky and Story, 1974). Water soluble NSP may also 
increase the unstirred water layer in the intestinal lumen, which leads to a decrease 
in the absorption of fats, including cholesterol and bile acids, which may lead to an 
increased faecal output of these two components (Theuwissen and Mensink, 
2008b). Following this the hepatic conversion of cholesterol into bile acids 
increases; the hepatic pool of free cholesterol decreases and reaches a new steady 
state endogenous with increased cholesterol synthesis. This leads to increased 
activity of 7-α-hydroxylase and 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) 
reductase to compensate for the loss of bile acids and cholesterol from the liver 
stores; hepatic LDL cholesterol receptors become up-regulated to restore hepatic 
cholesterol stores, which will lead to a decreased serum LDL cholesterol 
concentration (Hosseini et al., 2011, Flint et al., 2012).  
Human studies have examined the effects of water soluble fibres on bile acid 
excretion, for example Kirby et al. (1981) fed eight hypercholesterolemic subjects 
100 g of oat bran in their test diet for 10 days. The results showed that the oat bran 
diets induced reductions in serum total cholesterol concentrations by 13 % (p < 0.01, 
N = 8) and plasma LDL cholesterol concentrations were 14 % lower (p < 0.05); while 
HDL cholesterol concentrations were not changed compared to the control diet. 
Faecal excretion of total bile acids was higher by 54 % (p < 0.001) on an oat-bran 
diet than on a control diet.  
In another study to investigate the effect of soluble fibre on bile acids conducted by 
Lia et al. (1995), nine ileostomy subjects were provided with four diets in a random 
order, with each diet for 2 consecutive days. Four different kinds of bread, mainly 
prepared from oat bran (OB diet, 12.5 g β-glucan /d), oat bran with beta-glucanase 
(OBE diet, 3.8 g β-glucan /day), barley (B diet, 13.0 g β-glucan /d), or wheat flour 
(W diet, 1.2 g β-glucan /d) were added to a basal diet. It was observed that the 24 
h excretion of bile acids was 53 % higher in the OB diet period than in the OBE diet 
period (p < 0.05), and also was significantly higher than in the B and W diet periods 
(p < 0.05). The excretion of cholesterol was significantly higher in the B diet period 
than in the OBE and W diet periods (p < 0.05).  
In related research, Andersson et al. (2002) examined whether consumption of β-
glucan from oat bran increased bile acid synthesis within hours of consumption, as 
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measured by the serum 7α-hydroxy-4-cholesten-3-one (α-HC) concentration, in 
response to the loss of bile acids from the liver. In a randomized single-blind, wheat 
bran controlled study with crossover design, 8 subjects were provided with a 
controlled diet during 2 periods of 3 days each, with an 11-day washout between 
the periods. Breakfast test diets were included with either 75 g of extruded oat bran, 
of which 11 g was β-glucan, or 75 g of wheat bran, of which 1 g was β-glucan. The 
serum α-HC concentrations after 8 and 12 h of the oat bran diet period was higher 
by 84 % (p = 0.012) and by 92 % (p = 0.017) (respectively), than that before 
breakfast. This showed that α-HC in serum could be used as a marker of increased 
bile acid excretion induced by the diet. Also, Naumann et al. (2006) observed 
decreased cholesterol absorption and increased cholesterol synthesis in 
hypercholesterolemic subjects, as measured by the same markers. In ileostomy 
subjects, Ellegård and Andersson (2007) reported that 75 g of oat bran with 11.6 g 
of native β-glucan increased bile acid excretion within 24 h of consumption, 
compared to 4.5 g of hydrolysed β-glucan, and this increase was accompanied by 
a rise in the serum concentrations of α-HC. Overall these results suggest that oat 
bran has an effect on bile acid excretion, and that a-HC is a suitable marker for 
detecting diet induced changes in cholesterol. 
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Table 1.8: Characteristics of interventional studies on Dietary fibre intake and risk of CVD.  
Reference & 
study design 
Study population Dietary intervention Observation and effect Conclusion 
Estruch et al. 
(2009) 
 
RCT 
 
PREDIMED 
study 
 
Spain 
 
772 high risk subjects (348 men 
and 424 women) aged 55-80 
years, followed for 3 months, 
fasting blood sample and urine 
obtained. 
Food-frequency  
Questionnaires (FFQ) 
Include 137 food items.  
Subjects assigned to 
Mediterranean (Med) diet plus 
virgin oil, Med-diet and nuts or 
control (low fat) diet, and dietary 
advice given to subjects based-on 
diet model.   
Total dietary fibre ranged from 16 g/d in 
the lowest quintile to 26 g/d in the 
highest. 
Inverse association in total cholesterol (P 
= 0.04) and positive association in HDL-
C (P = 0.02) observed among those with 
20% increment of dietary fibre intake. 
Mediterranean diet with 
recommended amount of 
dietary fibre might be 
protective against the risk 
CVD through its inverse 
effect on the lipids profile. 
King et al. 
(2007) 
Randomized 
cross-over trial 
USA 
28 women and 7 men (18 lean 
normotensive and 17 obese 
hypertensive), fasting blood 
sample drowned before and 
during study also weekly urine 
collection. 
Cross-over design 2×3 weeks’ 
dietary intervention either high fibre 
(30 g/d) DASH diet or fibre 
supplemented diet (30 g/d of 
psyllium). Calories composition of 
both diets was 50 % CHO, 34 % fat 
and 16 % protein. 
Significant reduction in Creative protein 
(CRP) level among both naturally high 
fibre diet (4.4-3.8 mg/dl; P = 0.046) and 
fibre supplemented diet (4.4-3.6 mg/dl; P 
= 0.003). Lean subjects had significant 
reduction in CRP level than obese. 
This study confirmed the 
recommendation of dietary 
fibre intake (25-35 g/d) that 
might reduce the risk of 
CVD. 
Sola et al. 
(2007b) 
Randomized 
cross-over 
controlled 
single blind trial 
Spain 
 
28 participants with CVD aged < 
75 years, fasting blood sample 
obtained before beginning of the 
study and at the end of each 
period. 
Cross-over design 2×8 weeks’ 
dietary interventional trial either 
10.5 g/d of plantago ovata husk 
(soluble) or plantago ovata seeds 
(insoluble) fibre diets. The two diets 
were isocaloric (30 % of energy 
from fat). 
Beneficial effect of P. ovata husk shown 
through a significant reduction of plasma 
triglyceride (TG) (6.7 %; p < 0.02), the 
ratio of apo B: apo A-I decreased (4.7 %; 
p < 0.02) and apo A-I increased (4.3 %; 
p < 0.01). 
HDL-C significantly increased by (6.7 %; 
p= 0.006), decrease in total cholesterol: 
HDL-C and LDL: HDL cholesterol in 
soluble fibre compared to insoluble one. 
High intake of soluble fibre 
provided a favourable 
reduction effect on the 
lipoprotein profile among 
CVD patients. 
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Chen et al. 
(2005) 
RCT 
USA 
110 subjects aged 30-65 years, 
24-dietary recall and fasting 
blood sample obtained at 
baseline and at the 12-week 
follow-up visit. 
54 subjects received 8 g/d of 
soluble fibre as a supplement and 
56 subjects were assigned as a 
control group. 
After one month of high soluble fibre diet, 
no significant change on serum lipids 
observed. 
Intake of 8 g/d of soluble 
fibre for one month was not 
enough to provide induced 
effect on lipids profile. 
Behall et al. 
(2006a) 
RCT 
USA 
18 moderately 
hypercholesterolemic men aged 
28-62 years, fasting blood 
sample obtained at baseline and 
weekly during each period of 
study. 
Subjects consumed controlled diet 
Step 1 (30 % fat, 55 % CHO and 
15% Pro), followed by one month of 
interventional diet, either low (< 0.4 
g/d) or med (3g/d) or high (6 g/d) of 
soluble fibre. 
The three diets contained the same 
amount of fibre 30 g/d and calories 
2800 cal/d. 
Low, med and high soluble fibre 
significantly associated with reduction of 
total cholesterol by 20 % (225-186.2 
mg/dl), LDL-C by 24 % (153.3-116.1 
mg/dl) and increased HDL-C by 18% 
(38.2-41 mg/dl). 
This study was able to 
provide evidence to support 
the hypothesis that water-
soluble fibre is protective 
against the risk of CVD 
through lowering serum 
lipids. 
Keogh et al. 
(2003) 
Randomized 
controlled 
cross-over trial 
New Zealand 
18 mild hyperlipidaemic 18-65 
years old, fasting blood and 
urine samples were routinely 
collected on day 0, 1, 7, 14, 21, 
28, 29 in both groups. 
 
Cross-over design 2×4 weeks’ 
dietary interventional trial. Subjects 
were assigned to either  β -glucan 
enriched diet (8.1-11.9 g/d) or 
control diet (isoenergetic dose of 
6.5-9.5 g/d of glucose). 
No significant association observed after 
four weeks of high soluble fibre diet. 
High intake of soluble fibre 
for 4 weeks was not enough 
to show beneficial reduction 
effect against CVD risk 
factors. 
Jenkins et al. 
(2002) 
Randomized 
controlled 
cross-over trial 
Canada 
68 hyperlipidaemic (37 men and 
31 postmenopausal women) 
aged 33-82 years; fasting blood 
sample collected at baseline and 
week 2 and 4 of each phase. 
Cross-over design 2×4-week 
dietary interventional trial. Either 4 
servings of high fibre diet (8 g/d) of 
psyllium or  β -glucan as soluble 
fibre or control diet without fibre 
supplement. Both diets were 
isocaloric and almost consist of the 
same amount of total fibre. 
Significant reduction observed in total 
cholesterol (p = 0.003), total: HDL-C 
ratio (p = 0.001) and LDL-C: HDL-C 
among high soluble fibre group. 
This study supports the 
protective effect of soluble 
fibre against CVD risk 
factors. 
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Wu et al. 
(2007) 
EPIC Norfolk 
 
Cross-sectional 
 
Europe 
22,915 men and women aged 
45-75 years, FFQs 
Includes 131 food items 
Non-fasting blood sample 
Average intake of dietary fibre is 
18 g/d. 
Dietary fibre intake inversely associated 
with total cholesterol regression 
coefficient (β) – 0.03 (95 % CI: -0.052--
0.01; P = 0.001), LDL-cholesterol, β – 
0.03 (95 % CI: -0.052- -0.01; P < 0.001), 
triglyceride, β – 0.04 (95 % CI: -0.059- -
0.023; P < 0.001), and positively with 
HDL-cholesterol, β 0.01 (95 % CI: 0.012- 
-0.025; P < 0.001). 
Dietary fibre intake (18 g/d) 
might reduce the incidence 
of CVD through association 
with serum lipids. 
Lairon et al. 
(2005) 
Cross-sectional 
France 
2,532 men and 3429 women 
aged 
35-60 years, 24-hour dietary 
recall, fasting-blood sample 
collected 
For men 
TDF 16-27.3 
Insoluble 12.8-22.1 
Soluble 3.1-5.2 
For women  
TDF 13.4-22 
Insoluble 10.6-17.7 
Soluble 2.7-4.4 
In both sexes, total dietary fibre intake 
inversely associated with total 
cholesterol, OR 0.68 (95 % CI: 0.53-
0.87; P for trend = 0.01) and triglyceride, 
OR 0.68 (95 % CI: 0.48-0.96; P for trend 
= 0.01). 
Insoluble fibre inversely associated with 
triglyceride, OR 0.65 (95 % CI: 0.46-
0.92; P for trend = 0.01). 
High intake of dietary fibre 
and insoluble fibre might be 
protective against 
development of CVD 
through lowering serum 
lipids. 
 
 
 
 
  
 
 
1.10.2.4 Reduced insulin stimulation of hepatic lipogenesis 
DF, especially water soluble fibres, may lower the rate of glucose absorption, 
because they cause an increase in intestinal viscosity in the intestines (Würsch and 
Pi-Sunyer, 1997). The lowered postprandial glucose concentrations lead to lowered 
postprandial insulin concentrations, and decreased insulin-stimulated hepatic HMG-
CoA activity, and hence cholesterol synthesis (Kimura et al., 2014). Changes in 
other hormones may also contribute to the decreased insulin concentrations after 
water-soluble fibre consumption. Whether these hormonal changes result in 
lowered fasting LDL cholesterol concentrations has, however, never been 
demonstrated in humans (Theuwissen and Mensink, 2008b). Therefore, further 
study into the mechanisms involved is required  
 Physiological effect of RS   
Recently, RS has received much attention for both its potential health benefits and 
functional properties (Fuentes-Zaragoza et al., 2010). RS is one of the most 
abundant dietary sources of FC, and could be as important as NSP in promoting 
large bowel health and preventing CRC, but with a smaller effect on lipid and 
glucose metabolism (Fuentes-Zaragoza et al., 2010). The protective mechanism of 
RS could be implemented through butyrate production as a result of colonic 
fermentation (Topping and Clifton, 2001).    
 Effect of RS fermentation on colon cancer diseases  
The incidence of CRC and other large bowel diseases in South African black people 
is less than in white people (Walker et al., 1973). This is despite the fact that the DF 
intake of urban blacks was lower than that in whites and decreased from 25 – 30 
g/day to 15 – 20 g/day. This paradox may be linked to the fact that the starch intake 
of urban black people was higher, 212 and 162 g/d compared with 172 and 118 g/d 
in black and white men and women, respectively, and, for rural black people, the 
intake of starch might be even higher (Ahmed et al., 2000). Many black households 
cook maize porridge, the main provider of starch in the diet, more than once per 
day, and this maize porridge is sometimes consumed reheated or cold, especially 
in rural areas. It is believed that cold maize porridge contains large amounts of RS, 
and this might explain the variation in colon cancer rates, suggesting RS might 
quantitatively be more important as a substrate of fermentation than NSP (Ahmed 
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et al., 2000). In recent studies RS was considered as the major substrate for colonic 
butyrate production, and butyrate also showed a protective effect against colorectal 
cancer (O'Keefe et al., 1999). 
Moreover, in an international survey carried out by Cassidy et al. (1994) that 
compared the intake of starch, NSP, protein and fat with CRC incidence in 12 
populations worldwide, an inverse association between starch consumption and 
large bowel cancer incidence was seen (large bowel r = - 0.70, colon r = - 0.76). The 
association was not significant for NSP alone, whereas the association with large 
bowel cancer incidence was still significant when NSP was combined with RS to 
give an estimate of fermentable carbohydrate (large bowel; r = - 0.52, colon r = - 
0.60). Even after adjusting for confounding factors (fat and protein), the relationships 
between RS with NSP and cancer incidence remained statistically significant. In this 
study the authors assumed that this protective effect of starch may be the result of 
RS consisting of 5 % of all starch consumed. The strong inverse association 
observed suggests an important role for starch or RS in protecting against CRC, 
and corresponds with the hypothesis that fermentation of FC in the colon could be 
the mechanism for preventing CRC.  
In addition, combining RS with an insoluble NSP such as wheat bran, resulted in 
much higher levels of SCFA, particularly butyrate, observed in the faeces (Leu et 
al., 2002). A study that combined RS with psyllium and fed it to rats showed that this 
resulted in the site of RS fermentation being pushed more distally, and as the distal 
colon is known to be the site at which most tumours arise, this may provide 
additional protection from cancer if RS fermentation is actually protective (Morita et 
al., 1999).      
 Effect of RS fermentation on glucose metabolism   
One of the main benefits of RS is that it behaves like soluble fibre without sacrificing 
palatability and mouth feel; RS combines the health benefits of dietary fibre/whole 
grain with the sensory feeling of refined carbohydrates (Higgins, 2004). The glucose 
metabolism of starchy foods may depend upon different factors, such as the 
amylose/amylopectin ratio, the native environment of the starch granule, the 
gelatinization of starch, the water content and also baking temperature of the 
processed foods (Champ et al., 2003). Several human studies involving RS have 
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shown a decrease in postprandial blood glucose and insulin levels, but it is still 
difficult to completely understand these effects due to differences in study design 
and the type of RS used (Lattimer and Haub, 2010). Therefore, further research is 
needed to clarify the effects and their mechanisms of action.  
One of these studies by Behall et al. (2006b) reported that women consuming 0.71 
g, 2.57 g or 5.06 g of RS had significantly lower postprandial glucose and insulin 
levels when compared to the control. However, this study was not able to maintain 
an equal amount of available carbohydrate between the treatments and control, 
therefore it is difficult to determine whether the attenuation of glucose and insulin 
was due to the RS, or the fact that there was less available carbohydrate in the meal 
for the treatment group. Similarly, Reader et al. (2002) showed that 7.25 g of RS 
added to an energy bar lowered blood glucose and insulin levels in healthy adults, 
however the ingredient amounts and nutrient levels were different for each 
treatment, which makes the results difficult to compare. In contrast to this recently 
Al-Tamimi et al. (2009) removed non-starch ingredients and available 
carbohydrates in their study and reported that postprandial blood glucose and 
insulin levels were significantly decreased with the supplementation of 30 g of RS4. 
Studies have suggested that consumption of food high in RS may moderate the rate 
of digestion and control glucose tolerance, as RS metabolism occurs 5 - 7 h after 
consumption, compared to normally cooked starch which is digested almost 
immediately (Reader et al., 1997). This extended period of digestion may reduce 
postprandial glycaemia, and may also have a beneficial effect on increasing the 
period of satiety (Raben et al., 1994, Reader et al., 1997). There have been a 
number of studies on the effects of different forms and doses of RS on glucose and 
insulin responses, but overall the data are contradictory (Sharma et al., 2008). A 
good example of a positive result come from a study of 10 healthy normal-weight 
males that showed consumption of a meal containing high RS (54 %) significantly 
reduced the postprandial concentration of blood glucose, insulin, and epinephrine, 
compared to a meal containing 50 g of starch free of RS (0 % RS) (Raben et al., 
1994). Moreover, another study reported that intake of a meal containing a 
commercial RS3 ingredient reduced the peak glucose response significantly more 
than the other carbohydrates investigated (simple sugars, oligosaccharides, and 
common starch) (Reader et al., 1997). Overall more research needs to be 
conducted to ascertain the action effect of RS on glucose levels.  
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 Effect of RS fermentation on lipid metabolism   
RS has been observed to affect the metabolism of LDL, cholesterol, triglycerides, 
triglyceride-rich lipoproteins and total lipids, and RS intake has been reported to 
lower the serum cholesterol level in animals (Lopez et al., 2001). In rats, RS diets 
(25% raw potato) increased SCFA production, absorption and lowered plasma 
cholesterol and triglycerides (Sajilata et al., 2006). Another feeding trial on rats used 
RS from Adzuki bean starch (AS) and Tebou bean starch (TS) and the results 
suggested that AS and TS have a serum cholesterol-lowering function due to 
enhanced levels of hepatic SR-B1 (scavenger receptor class B1), and cholesterol 
7alpha-hydroxylase mRNA (Han et al., 2003). Other studies have shown that RS 
was not able to lower fasting serum lipid concentrations in healthy subjects (Heijnen 
et al., 1996, Achour et al., 1997). Research has suggested that the effect of RS diets 
in lowering lipid levels in animals may not be applicable to humans (Asp et al., 1996). 
Overall studies suggest the beneficial effects of RS are more similar to those of 
insoluble dietary fibre than to the cholesterol-lowering action of soluble fibres 
(Kritchevsky and Story, 1986, Anderson et al., 1984).  
Further evidence of the benefit of RS comes from several studies that showed the 
longer term consumption of RS might decrease fasting cholesterol and triglyceride 
levels, for example in a five week study, Behall et al. (1989) found that men 
consuming 34 % of their energy from high amylose maize, had significantly reduced 
fasting cholesterol and triglyceride levels, when compared to a high amylopectin 
carbohydrate. Resier et al. (1989) also stated similar findings in an iso-caloric and 
iso-nutrient diet with either high amylose maize or fructose. Porikos and Van Itallie 
(1983) have proposed that an interaction exists between sucrose, and also most 
likely fructose, and saturated fatty acids, which in turn alter serum triglyceride levels; 
but remarkably, the relationship does not seem to exist for polyunsaturated fatty 
acids. The possible mechanism behind the ability of RS to decrease cholesterol 
levels might be an increased intestinal viscosity. Some studies, such as Jenkins et 
al. (1998), have reported conflicting data with RS2 and RS3, showing no effect on 
serum lipid profiles, however, using the same type of RS, subjects were only tested 
for two weeks, and therefore it is possible that the RS required a longer period of 
time to produce an effect.          
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 Effect of RS fermentation on faecal bulking and bowel 
transit time  
Several studies have observed positive effects of RS supplementation on reducing 
transit time and increasing faecal bulk (Cummings et al., 1996, Phillips et al., 1995, 
Jenkins et al., 1998). The faecal bulk is increased in humans eating mixed diets, 
and is believed to be higher than predicted from their NSP content in a 
‘’carbohydrate gap’’, and (Topping and Clifton, 2001).   
Over a period of 15 days Cummings et al. (1996) fed controlled diets, which included 
glycaemic starch, RDS, wheat bran (NSP), RS2 (from native potato and green 
banana) and an RS3 (retrograded high amylose corn starch), to 12 healthy human 
subjects. It was observed that overall RS significantly increased faecal bulk and 
faecal excretion of SCFA, with RS2 (native potato and green banana) having 
increased faecal bulk by 1.6 and 1.7 g/d, respectively (Cummings et al., 1996). A 
similar study by Phillips et al. (1995) fed 11 healthy subjects mixed diets 
(unprocessed wheat seeds, high amylose corn starch and green banana) high in 
RS (5g/d) over a period of 4 days. They observed that the high RS diet increased 
faecal output, lowered pH, and increased the daily excretion of butyrate. Similar 
findings have been observed by Jenkins et al. (1998).; the authors reported that 
faecal output on the wheat bran supplementation (258 ± 22 g/d) was significantly 
higher than the three other substrates (RS2, 187 ± 24 g/d; RS3, 182 ± 23 g/d; low 
fibre control, 163 ± 23 g/d). The faecal output in RS2 (24 ± 9 % g/d) and RS3 (29 ± 
14 % g/d) supplemented diets were also significantly increased compared with the 
low fibre control diet. Overall these results show that RS fermentation significantly 
increased faecal bulk and faecal excretion of SCFA.  
Further evidence of the effect of RS comes from a study by Hylla et al. (1998) who 
fed 12 healthy volunteers over a period of 2 x 4 weeks, a controlled basal diet 
enriched with either amylomaize starch (55.2 ± 3.5 g RS/d; high RS diet) or available 
corn starch (7.7 ± 0.3 g RS/d; low RS diet). Almost 90 % of the RS eaten 
disappeared in the intestinal passage, and they reported that a high RS diet 
significantly increased faecal wet and dry weight by 49 % and 56 %, respectively (p 
≤ 0.005), while stool water content was not changed significantly (Hylla et al., 1998). 
The values for increased faecal bulk by RS were less than that after condition of 
wheat bran fibre (4.9 % g/g of fibre) and represented only 32 % - 55 % of faecal bulk 
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(Cummings et al., 1996). The amount of RS excreted might be greater when 
compared to excretion of standard dietary starch as less RS is metabolised within 
the body compared with digestible starch (Jenkins et al., 1998). In humans, an 
undigested high RS diet was observed to produce as much as 10 % of the faeces 
weight, while the excretion of digestible starch in the faeces is generally insignificant 
(Cummings et al., 1996). 
 Effect of RS fermentation on mineral absorption   
The ileal absorption of a number of minerals in rats and humans has been shown to 
be influenced by RS; for example, Lopez et al. (2001) and Younes et al. (1995) have 
observed an increased absorption of calcium, magnesium, zinc, iron and copper 
when rats were fed RS-rich diets, whereas in humans, these effects might be limited 
to calcium (Trinidad et al., 1996, Coudray et al., 1997). In pigs, Morais et al. (1996) 
compared the apparent intestinal absorption of calcium, phosphorus, iron, and zinc 
in the presence of either resistant or digestible starch, and showed that a meal 
containing 16.4 % RS resulted in a greater apparent absorption of calcium and iron, 
when compared with completely digestible starch. This increase in absorption by 
RS can be offset by the fact that wholemeal bread and bran contain phytate, which 
is a known inhibitor of mineral absorption (calcium, magnesium, zinc and iron) in 
humans (McCance and Widdowson, 1949, Andersson et al., 1983). In the present 
of mucosal phytase and alakaline phosphatase in the human small intestine, almost 
no digestion of phytate happened, while the dietary phytase may be an important 
factor for phytate hydrolysis (Sandberg and Andersson, 1988).  
Most mineral absorption arises in the small intestine and, unlike viscous fibre, RS 
would not be expected to affect small intestinal absorption; but a significant 
proportion of mineral absorption occurs in the large intestine, and fermentation of 
RS may influence mineral absorption here (Lopez et al., 2001). RS fermentation in 
the large intestine could affect mineral absorption through lowering the pH which 
would make the minerals soluble and more absorbable. SCFA production might also 
increase the size and mucosal surface area of the proximal colon resulting in 
increased absorption capacity (Sajilata et al., 2006).  
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 Physiological effect of NDOs    
As discussed in section (1.5), the NDOs have several important physiological effects 
including increasing satiety and modulating lipid metabolism, several of which are 
shared with any fermentable fibre. However they also act as prebiotics act as a 
fermentable substrates within the colon, stimulating the preferential growth and 
activity of a limited number of microbial species that confer health benefits on the 
host (Gibson et al., 2004). FC with established prebiotic properties include inulin-
type fructans (inulin, oligofructose and FOS) and GOS, which are known to improve 
the proliferation of beneficial lactic acid-producing species such as bifidobacteria 
and lactobacilli (Roberfroid et al., 2010).  
 The effect of NDOs on satiety 
Several studies support the relevance of prebiotic fermentation in appetite 
management in humans (Cani et al., 2009, Cani et al., 2005). In a single-blinded, 
crossover, placebo-controlled design study, Cani et al. (2005), examined the effects 
of oligofructose (OFS) on satiety and energy intake in five men and five women aged 
21 – 39 years, ingesting either 16 g of OFS/d or 16 g of dextrin maltose (DM) as a 
placebo for 2 weeks. The authors observed that OFS increased satiety following 
breakfast (p =0.04), dinner (p = 0.04), with a reduced hunger (p = 0.04) and 
prospective food consumption following dinner (p = 0.05). It was noted that total 
energy intake per day was 5 % lower during OFS treatment than in the DM period. 
These results were confirmed by the same researchers in another study, a 
randomized, double-blind, parallel, placebo-controlled trial in healthy volunteers 
(n=10) (Cani et al., 2009). Participants receiving 16 g of soluble fructan/d for 2 weeks 
showed a 3-fold increase in breath-hydrogen (a marker of gut microbiota 
fermentation) and a decrease in hunger rates. Furthermore, plasma glucagon-like 
peptide 1 and breath-hydrogen excretion were significantly correlated (p = 0.007) 
and glucose response was negatively correlated with the breath-hydrogen excretion 
(p = 0.02) (Cani et al., 2009).  
 The effect of NDOs on lipid metabolism  
 Some studied have suggested that NDOs can have an effect on lipid metabolism, 
for example the effect of inulin supplementation on lipid concentrations was 
examined, in a double-blind, randomized, placebo-controlled crossover design 
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study conducted by Letexier et al. (2003). Eight healthy subjects were examined 
twice, receiving a moderately high carbohydrate, low fat diet (55 % of total energy) 
plus an oral placebo or 10 g of high-performance inulin/d for 3 weeks. The authors 
found that plasma triacylglycerol concentrations and hepatic lipogenesis were 
significantly lowered after inulin treatment compared to placebo ingestion (p < 0.05), 
but cholesterol synthesis and plasma cholesterol concentrations were not 
significantly different between the two groups (Letexier et al., 2003).  
In another randomized, double blind, crossover design, participants (n =12) were 
supplemented with either sucrose or inulin (20 g/d) in one pint of vanilla ice cream 
for 3 weeks (Causey et al., 2000). They observed that 20 g/d of inulin significantly 
reduced serum triglycerides by 40 mg/dL (p=0.05) and improved the SCFA profile 
compared to the control (Causey et al., 2000). In addition, a randomized double 
blind cross-over design was used on young healthy males (n = 22), consuming 
either 11 % inulin-enriched or control pasta over a period of 2 weeks. The 
researchers found that HDL-cholesterol concentrations increased by 35.9 %, and 
total cholesterol/HDL-cholesterol ratio, triglycerides, and Apo-lipoprotein 
concentrations decreased by 22.2, 23.4, and 16.5 % in the inulin-enriched group 
compared to control pasta, respectively (Russo et al., 2008). These findings show 
that inulin supplementation improve lipid profiles. Further evidence of the effect of 
this supplementation comes from the study by Vulevic et al. (2013) who conducted 
a double-blind, randomized, placebo (maltodextrin)-controlled, crossover study on 
overweight adults (n = 45)  with ≥3 risk factors associated with metabolic syndrome. 
Participants received either 5.5 g/d of the placebo (maltodextrin) or GOS 
supplementation with a mixture of Bi2muno (B-GOS) powder for 12 weeks. They 
observed that B-GOS supplementation decreased total cholesterol, triglyceride and 
the total cholesterol/HDL-cholesterol ratio. Overall these results suggest that NDOs 
fermentation significantly impact on lipid metabolism. 
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As discussed in this chapter, to evaluate the health benefits of fermentation of NDCs 
in humans in intervention and epidemiological studies. A suitable method to 
determine the portion of NDCs that escape digestion and absorption in the small 
intestine and are fermented in the colon is needed. Determination of SCFA 
production in human in vivo is not feasible or possible directly, and most studies use 
faecal concentrations which do not represent the full production of SCFA, as most 
are absorbed higher up in the colon.  Most studies measure DF or NSP intake to 
correlate with health effects but not all DF or NSP are equally fermentable. 
Epidemiological and intervention studies currently use traditional dietary analysis 
methods, which depend on food composition databases, that may not have been 
updated to include NDOs and RS, and so do not provide accurate data on NDCs 
intake whether or not it is fermented. Moreover, different types of NDCs are 
fermented to varying extents in the human gut, meaning that the actual amount of 
FC entering the large intestine is very difficult at present to predict.  
 Aims and objectives  
The aim of this study was to develop an index of the amount of carbohydrate in diets 
from which bacteria in the colon produce SCFAs. 
The objectives of this study were: 
 To develop an index of FC that can be used to estimate, from food diaries, 
the carbohydrate sources that escape digestion and absorption and are 
fermented fully to SCFA by the colonic bacteria.  
 To test our prediction equations for FC using dietary records from a human 
study in which urinary SCFA was measured. To test our prediction equations 
against the SCFA produced by colonic bacteria in vitro from a range of dietary 
fibres, NDCs mixtures and model diets containing different proportions of 
NDCs. 
 To use an in vitro enzymatic digestion model for the removal of starch and 
other digestible macronutrients prior to the in vitro fermentation of FC samples  
 To use an in vitro human colon fermentation model, to study the metabolic 
capacity of the colonic bacteria when single fibre, mixtures of isolated 
fermentable carbohydrate diets and different amounts of FC in food mixtures 
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based on the habitual diets of subjects were fermented, and to test our 
equations against the SCFA amounts produced from each carbohydrate. 
 To compare the SCFA concentration produced via in vitro fermentation of FC 
against the predictable amounts of SCFA using our prediction equations. 
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 Chapter Two 
General Materials and Methods 
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 Introduction  
This chapter describes the general materials and methods used throughout this 
thesis. The thesis comprises secondary analysis of a previous study conducted at 
the Universities of Glasgow and the Scottish Universities Environmental Research 
Centre (SUERC) which measured dietary intake and urinary SCFA (Chapter 4). This 
was used to help develop an index of dietary FC (Chapter 3); and the equations 
developed to predict fermentation in the colon were then further evaluated and 
validated using a series of in vitro studies (Chapter 5). 
 Secondary analysis data 
 Three day weighed record of habitual diet used in 
secondary analysis  
This study used data obtained from a previous project “Validating in vivo biomarkers 
of colonic carbohydrate and protein fermentation” conducted in 2009 at the 
University of Glasgow and SUERC, which measured dietary intake and urinary 
SCFA. The study involved monitoring the habitual diet and corresponding urinary 
excretion of SCFA for three days in 122 participants from the general population, 
and the results of this were included in this study. Subjects had been asked to weigh 
and record their normal dietary intake for 3 days (one weekend and two week days), 
using the provided food scales and food diaries. The original dietary records were 
reviewed and inspected to ensure that the subjects’ diaries were complete, and 
sufficient detail had been recorded. Initial dietary analysis was carried out using 
Windiets software version 2005 (Robert Gordon University, Aberdeen, UK). Diet 
diaries were analysed for daily energy and macronutrient intake in absolute amounts 
as well as the percentage of energy derived from the main macronutrients. For the 
work in this thesis these diets were reanalysed for fermentable carbohydrate content 
using data from a series of equations (Chapter 3). This also entailed a detailed 
literature review for oligosaccharide content and resistant starch in foods, as well as 
using websites and other data sources to calculate fibre content determined by 
different methods.  
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 Database production 
The database was developed using a Microsoft Excel spreadsheet; the subjects’ 
diet analysis results were transferred from Windiets into Microsoft Excel. Dietary 
fibre AOAC (soluble and insoluble), NSP (soluble and insoluble), inulin and 
oligofructose of different fruits, vegetables and grains obtained from the literature 
search were entered into Microsoft Excel, along with other content information 
obtained from supermarket and manufacturers’ websites. The amount of dietary 
fibre AOAC method (soluble and insoluble), NSP Englyst method (soluble and 
insoluble), inulin and oligofructose present in these products were entered as g/100 
g wet weight against the products in the database. The amount of total starch was 
obtained from Windiets 2005 for each food item in the dietary record.  
 In vitro digestion model  
An in vitro digestion model was used to mimic conditions and luminal reactions of 
the human gastrointestinal tract, which occur in the mouth, stomach, duodenum, 
ileum, according to the method of Aura et al. (1999). This was used to predigest all 
carbohydrate sources used for the in vitro validation of the fermentable carbohydrate 
concept (Chapter 5). The method of Aura et al. (1999) was chosen after 
consideration of the methods available in the published literature (Table 2.1); these 
methods were designed for the measurement of RS (Englyst et al., 1992, Berry, 
1986, Muir and O'Dea, 1992, Champ, 1992, Åkerberg et al., 1998, Goñi et al., 1996, 
McCleary and Monaghan, 2002). 
The studies in this thesis required the residue left after an in vitro digestion model 
to be tested in an in vitro fermentation model, therefore all digestion products need 
to be removed from the residue. Dialysis tubing (Biotech Cellulose Ester Membrane 
cut-off: 500-1000 MWCO; SPECTRUM LABS.COM) was used to remove digested 
products from the mixture. The retained materials (retentates) were subsequently 
freeze-dried prior to use in the in vitro fermentation model.   
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Table 2.1: Comparison between different methods to measure resistant starch (RS) in vitro adapted from Laurentin and Edwards (2005). 
Method  Sample Treatment 
incubation 
Types of RS 
measured a Preparation Pre-treatment Treatment Post-treatment 
Berry (1986) Milling  None  Pancreatic α-amylase 
and 
pullulanase 
KOH b 
Amyloglucosidase 
Shaking for 16 h at 37 
°C, pH 5.2 
Sum of RS2 and 
RS3 
Faisant et al. (1995) Milling None  Pancreatic α-amylase KOH b 
Amyloglucosidase 
Shaking for 16 h at 37 
°C, pH 6.9 
Sum of RS2 and 
RS3 
Goñi et al. (1996) Milling Pepsin  Pancreatic α-amylase KOH 
Amyloglucosidase 
Shaking for 16 h at 37 
°C, pH 6.9 
Sum of RS2 and 
RS3 
Englyst et al. (1992)   Chewing  Pepsin  Pancreatic α-amylase, 
amyloglucosidase, and 
invertase 
KOH b 
Amyloglucosidase 
Shaking for 2 h at 37 
°C, pH 5.2 
RS1, RS2, RS3 
and total RS 
Muir & O’Dea 
(1992)   
Chewing Salivary α-amylase 
then pepsin  
Pancreatic α-amylase, 
amyloglucosidase 
Thermostable α-amylase 
Dimethyl sulfoxided 
Amyloglucosidase and 
pancreatic α-amylase 
Stirring for 15 h at 37 
°C, pH 5.0 
Total RS 
Åkerberg et al. 
(1998) 
 
Chewing Salivary α-amylase 
then pepsin 
Pancreatic α-amylase, 
amyloglucosidase 
KOH b Thermostable α-amylase 
Amyloglucosidase 
Stirring for 16 h at 40 
°C, pH 5.0 
Total RS 
Aura et al. (1999) Milling Salivary α-amylase 
then pepsin 
Bile acid, Pancreatin 
and mucin 
Dialysis tubing  Shaking for 6 h at 37 
°C, pH 6.5-7.5 
Removing 
digested starch  
McCleary and 
Monaghan (2002) 
Milling  None  Pancreatic α-amylase, 
amyloglucosidase 
KOH b 
Amyloglucosidase 
Shaking for 16 h at 37 
°C, pH 6.0 
Sum of RS2 and 
RS3 
a RS, resistant starch; RS1, physically inaccessible starch; RS2, resistant granules; RS3, retrograded starch. b, KOH and dimethyl sulfoxide are used as resistant starch solubilizing agents.
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 Mouth  
All incubation steps were performed at 37 °C, with stirring and shaking in a water-
bath under the same conditions. 1 g of each NDC was weighed into a 100 ml beaker 
containing mixture of 10 ml distilled water and 7 ml sodium chloride solution (0.85 
wt %). In the in vitro digestion model used in this thesis, starch hydrolysis in the 
mouth was simulated in the in vitro model using commercial salivary α-amylase 
(Sigma A-3276) (50 U/50 µl), which was dissolved with sodium phosphate buffer 
(0.02 M, pH 6.9) and added to the sample in the presence of 10 ml of distilled water 
and 7 ml of sodium chloride solution (0.85 wt %) (Table 2.2). The samples were then 
incubated for 5 minutes.     
 Stomach 
In the stomach, gastric glands secrete pepsinogen and hydrochloric acid (HCl) for 
protein digestion. The optimum pH for pepsin (which is activated pepsinogen) is 
between 1.8 and 3.5. In our in vitro digestion model the conditions of the stomach 
were simulated by adding HCl (0.15 M, 4 ml), which decreased the sample pH to 
2.5. A 2 mg of Pepsin (Sigma P-7000) was dissolved in 1 ml of 0.02 M of HCl/ 
solution. Then, 1 ml of 0.02 M of HCl acid was added to the sample and blank and 
then incubated for 2 h. Residence time in the human stomach varies based on the 
particle size (Guyton and Hall, 1996b), but the incubation times used in the different 
in vitro batch models in the literature were fixed, ranging from 30 min to 2 hours 
depending on the method (Åkerberg et al., 1998, Muir and O'Dea, 1992, Lebet et 
al., 1998, Aura et al., 1999). Therefore, 2 h incubation time was selected to mimic 
stomach digestion condition.  
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Table 2.2: Composition and preparation of the solutions used for the in vitro digestion 
model 
 
 
 
 Duodenum and ileum 
The pH between the duodenum and distal ileum changes to 6.2-7.9 (Gee et al., 
1999). The conditions of the duodenum and ileum were simulated in the in vitro 
digestion model, the pH was adjusted to 6.5-7.0 using 6 M sodium hydroxide 
(NaOH). Pancreatin, a mix of amylase, proteases and lipase, was used mimic 
pancreatic enzymes released into the dueodenum. Pancreatin (Sigma P-7545) (75 
mg) was dissolved in 4 ml of 0.15 M of sodium bicarbonate solution and then added 
to the sample (Figure 2.1). A porcine extract bile acid (Sigma B8631) (400-600 
mg/sample) was then dissolved in 4 ml of 0.15 M sodium bicarbonate and added to 
the sample. The residence time of food in the duodenum and ileum is between 3 
and 6 hours, during which time it is digested and absorbed (Guyton and Hall, 1996a). 
Absorption in the duodenum stage was simulated in the in vitro digestion model 
using a dialysis tube with small molecular weight cut off (35 cm with flat width 31mm, 
Dia 20 mm; cut-off 500-1000 MWCO; Biotech Cellulose Ester Membrane MWCO; 
Name  Composition  Preparation   
Sodium 
phosphate buffer 
(PBS) 
0.02 M of KH2HPO4 
0.02 M of Na2HPO4 
0.272 g 
0.283 g 
Distilled water was added to make up 100 
ml and stored at 4°C 
  
0.15 M of 
Hydrochloric acid 
(HCl) solution 
 37% HCl 6 ml Distilled water was added to make up 500 
ml and stored at 37°C 
  
0.02 M of 
Hydrochloric acid 
(HCl) solution 
37% HCl 800 µl Distilled water was added to make up 500 
ml and stored at 37°C 
  
0.150 M of Sodium 
bicarbonate 
solution 
NaHCO3 (MW 84.0) 2.25 g Distilled water was added to make up 200 
ml and stored at 4°C 
  
0.85 wt % Sodium 
chloride solution 
(Normal saline) 
Sodium chloride NaCl 4.25 g Distilled water was added to make up 500 
ml and stored at 37°C 
  
Digestion 
Enzymes 
Salivary α-amylase   
Pepsin 
Pancreatin 
Extract bile acid 
50 U 
2 mg 
75 mg 
0.4-0.6 g 
Dissolved in  50µl of 0.02M of PBS 
Dissolved in  1 ml of 0.02M of HCL 
Dissolved in  4 ml of 0.15M of NaHCO3 
Dissolved in  4 ml of 0.15M of NaHCO3 
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SPECTRUM LABS.COM) in a 2 L beaker and filled with distilled water at pH 6.5 - 7. 
The tubing was incubated for 6 h at 37 °C to remove only digested components from 
the mixture and to retain the non-digestible carbohydrates in the retentates, which 
was then freeze-dried prior to the in vitro fermentation. The dried digested samples 
were weighed and the sample was then subject to RS, fructan and dietary fibre 
measurement and/or the in vitro fermentation model.   
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Figure 2.1: In vitro enzymatic digestion model (Aura et al., 1999). 
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 Measurement of FC fermentation   
The freeze dried digested samples were then incubated in the in vitro fermentation 
model. The in vitro model of colonic fermentation used in this thesis was established 
in our laboratories (Jaganath et al. (2009).  
 Collection of faecal samples 
Fresh faecal samples were obtained from volunteer healthy adults, who had not 
taken antibiotics for at least two months prior to each study. Volunteers were asked 
to pass an entire bowel movement and collect it using the kit provided (plastic bag 
inside a pot, using the support of a paper bedpan on the toilet seat). The pot was 
sealed in a bag with an anaerobic gas kit (Anaerocult® A Merck KGaA 62471 
Darmstadt, Germany), to induce anaerobic conditions. An indicator strip 
(Anaerotest® A Merck KGaA 1151120001 Darmstadt, Germany) was included to 
ensure anaerobic conditions had been achieved. The stool sample was kept at 0 oC 
(in an insulated bag with frozen ice blocks) to slow on going bacterial metabolism, 
and was transferred to the laboratory within two hours of passage. Fresh faecal 
samples were used for in vitro faecal bath culture fermentation. 
 Preparation of fermentation medium 
All chemicals and reagents used in the fermentation model including medium, 
buffers, macromineral, micromineral, and reducing solutions were supplied by 
Fisher Scientific (Leicestershire, UK), Sigma-Aldrich Company Ltd. (Dorset, UK), 
and BDH AnalaR Laboratory (Dorset, UK) (Table 2.3). Sodium phosphate buffer 
(SBP) (1/15 M KH2PO4 (9.078 g/L) and 1/15 M Na2HPO4 (11.876 g/L) mixed in a 
ratio of 1:4) was boiled for 5 minutes and cooled to 37 oC for 30 minutes under an 
oxygen-free nitrogen (OFN) atmosphere to reach an anaerobic environment. The 
basal fermentation medium was prepared according to the method of Jaganath et 
al. (2009) by mixing 2.25 g of tryptone in 450 ml of distilled water with 112.5 µl of 
micromineral solution (13.2 g CaCl2.2H2O, 10 g MnCl2.4H2O, 1 g CoCl2.6H2O, 8 g 
FeCl3.6H2O, and distilled water to 100 ml).  After vortexing, 225 ml buffer solution (2 
g NH4HCO3, 17.5 g NaHCO3 in 500 ml of distilled water), 225 ml macromineral 
solution (2.85 g Na2HPO4.H2O, 3.1 g KH2PO4.H2O, 0.3 g MgSO4.7H2O in 500 ml of 
distilled water) and 1.125 ml of 0.1% resazurin solution, as a redox indicator, were 
added and the medium was boiled for five minutes to remove oxygen and to sterilize 
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it. The pH of the medium was adjusted using a hand-held pH meter (Hanna pH 
instruments, USA) to 7.0 using 6 M HCl before boiling on the hot plate. The medium 
was then purged with oxygen-free nitrogen (OFN) to create an anaerobic condition, 
indicated by a colour change from indigo to colourless (Figure 2.2). At the same time, 
a reducing solution was prepared (312.5 mg of cysteine hydrochloride, 2 ml of 1 M 
NaOH, 312.5 mg Na2S, and 50 ml of distilled water) and the pH was maintained at 
7 by using 6 M HCl.   
Each freshly voided human faecal sample was homogenised with sodium 
phosphate buffer (0.1 M, pH 7.0) in a blender (Braun Multi-quick 3 hand blender, 
MQ 325 Omelette BmbH; Germany) to make a 32 % (w/v) of faecal slurry (16 g 
faecal sample with 50 ml sodium phosphate buffer). The slurry was filtered using 
cotton or nylon mesh to remove large particles. 42 ml of the medium was transferred 
into 100 ml McCartney bottles and purged with OFN for 1 minute. The reducing 
solution was then added to the fermentation medium (0.5 ml/10 ml or 2 ml/42 ml of 
fermentation medium). 1 g of the retentates substrate was then added to the 
McCartney bottle along with 5 ml of fresh slurry. Each bottle was crimped with a self-
sealing rubber cap, and was flushed with OFN for one minute. The samples were 
then incubated horizontally in a shaking water bath at 37 °C and 50 strokes /min for 
24 h. All fermentations were carried out in duplicate apart from the blank, which had 
everything except the substrate. A 3 ml sample was transferred by syringe an into 
bijoux tube at 0 h to measure pH, which then was frozen at -20 °C for later SCFA 
analysis. At 4 h and 24 h, 3 ml of fermented samples were removed and analysed 
for pH and fermentation products. 
 Determination of pH 
pH was measured in the fermentation fluids using an auto calibrated portable digital 
pH meter (Hanna pH20instruments, USA). 3 ml of the fermented medium samples 
were transferred by syringe into bijoux tubes and the pH determined at different time 
points (0, 4, and 24 hours). The samples were then frozen at -20 °C for later SCFA 
analysis after the addition of 1 ml of 1 M NaOH to bring the pH to > 9.0. 
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Table 2.3: Composition and preparation of the solutions used for fermentation studies 
(Jaganath et al., 2009). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Solution Volume Composition  Preparation  
Buffer Solution  
 
500 ml NH4HCO3 
NaHCO3 
Distilled water  
Store at 4 oC 
2 g 
17.5 g 
up to 500 ml 
Macro-mineral 
Solution  
500 ml Na2HPO4 or Na2HPO4.2H2O 
KH2PO4 or KH2PO4.2H2O 
MgSO4.7H2O 
Distilled water  
Store at 4oC 
2.85 g or 3.57 g 
3.1 g or 3.92 g 
0.3 g 
up to 500 ml 
 
Micro-mineral 
Solution  
100 ml CaCl2.2H2O 
MnCl2.4H2O 
CoCl2.6H2O 
FeCl3.6H2O 
 Distilled water  
13.2 g 
10 g 
1 g 
8gm 
up to 100 ml 
Fermentation 
Medium  
1000 ml 
approx. 
Tryptone in 450 ml of distilled 
water  
Micro-mineral solution 
Agitate solution to dissolve the 
chemicals 
Buffer solution 
Macro-mineral solution 
0.1%resazurin solution 
Adjust the medium pH to 7, using 
6M HCl 
Store at 4oC 
2.25 g 
112.5 µl 
 
225 ml 
225 ml  
1.125 ml 
Sodium Phosphate 
Buffer 
200 ml KH2PO4 1/15 M (9.078 g/l): 1.82 
g/200ml 
Na2HPO4 1/15 M (11.876 g/l): 
2.38 g/200mL 
Maintain pH of 7 & at 20oC by 
adding 1M NaOH 
Store at 4oC 
78 ml of (a) to 122 
ml of (b)  
 
Reducing Solution  50 ml Cysteine hydrochloride 
NaOH 1M 
Na2S.9H2O 
 Distilled water  
312.5 mg 
2 mL 
312.5 mg 
up to 50 ml 
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Figure 2.2: Flow chart of in vitro fermentation protocol. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Faeces within 2 h of passage (no antibiotics for 2 months)   
SBP and FM Cooled in OFN to 37
o
C for 30 min and reducing solution prepared, pH for all 7 
16 g (32%) F. slurry homogenized in 50 mL SBP (pH 7) and filtered through nylon mesh 
42 mL fermentation medium added to McCartney fermentation bottles (100 mL) 
2 ml reducing solution added to McCartney bottles 
Bottles sealed with self-sealing rubber top-caps and flushed with OFN for 1 min 
5 mL slurry added to each bottle containing 1-1.5 g of sample meal  
Bottles sealed with crimp top self-sealing rubber caps again 
Purged with OFN for 1 min 
3 ml of samples in Bijoux tubes at 0, 4 and 24 h taken, pH measured and stored at -20
o
C for 
SCFA  
Shaking water bath at 37
o
C - 50 shakes/ min 
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 Short chain fatty acid (SCFA) analysis 
SCFA were measured using GC-FID using a TRACE™ 2000 gas chromatograph 
(Thermo Quest Ltd, Manchester, UK) (Laurentin and Edwards, 2004). All the 
chemicals used in the SCFA extraction (orthophosphoric acid, sodium hydroxide, 
diethyl ether, and external & internal standards) were obtained from Fisher Scientific 
(Leicestershire, UK), Sigma-Aldrich Company Ltd (Dorset, UK). 
The GC has a flame ionisation detector (250 °C) and a Zebron ZB-Wax capillary 
column (15 m x 0.53 mm id x 1 μm film thickness), (catalogue No.7EK-G007 22, 
Phenomenex, Cheshire, UK). The carrier gas was nitrogen (30 ml/min). Samples (1 
ul) were automatically injected (230 °C, splitless) onto the column. The column 
temperature was held at 80 °C for 1 min, increased at 15 °C/min until 210 °C and 
then held for 1 min. Analyses of GC-FID data were performed with Chrom-Card 32-
bit software version 1.07β5 (2000) Thermo Quest (Milan, Italy). Identification of 
SCFAs was achieved by comparison with retention times of authentic standards. 
Quantification was based on the averaged area ratio with the internal standard of 
each external standard (concentrations based on expected values in healthy faecal 
samples) which was run batch-wise, with grouped analysis of samples from the 
same individuals to reduce inter-assay error. A set of five calibrated standards was 
extracted and analysed before and after the samples. A signal standard used as a 
calibrated quality control, was run every 10 samples. Samples were extracted in 
duplicate and their results were averaged, whereas the standards were extracted 
once and injected twice and each run lasted approx. 15 minutes (Figure 2.3).   
 Internal standard  
2-Ethylbutyl acid was supplied from Sigma Chemicals Company Ltd., 
(Loughborough, UK). The internal standard was made up by adding 1.714 g of 2-
Ethylbutyl acid to 200 ml of 2 M of NaOH. The 2 M of NaOH was prepared by adding 
16 g of NaOH (Merck, Loughborough, UK) to 200 ml of distilled water.  
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Figure 2.3: Example of typical run on GC-FID. 
 
 
 
 
 
 
 
 
 External standard 
The external standard was made up of a mixture of acids. These were placed in a 
volumetric flask with 2.9 g NaOH to adjust the pH to 7.0 before making the volume 
up to 100 ml with distilled water. These were used to obtain a standard curve, which 
allowed calculation of each of the SCFAs in the test samples (Table 2.4) and 
included a total of 11 short, medium and branched chain fatty acids, extracted with 
6 dilutions (10 µl, 25 µl, 50 µl, 100 µl, 200 µl and 300 µl). 
 
 
 
 
 
 
 
C3
IC4
C4 IC5
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C6 C7
C8
IC6
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V
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Table 2.4: Constituents of the external standard used for SCFA analysis. 
 
No. Acid Name Molar Mass (g/L) Calculated 
Molarity (mM) 
1 Acetic acid 60.05 183.50 
2 Propionic acid 74.08 134.52 
3 Butyric acid 88.11 111.74 
4 Iso-butyric acid 88.11 104.22 
5 Iso-valeric acid 102.13 85.51 
6 Iso-Caproic acid 116.16 52.41 
7 Valeric acid 102.13 89.92 
8 Caproic acid 116.16 80.12 
9 Enanthic acid 130.18 68.53 
10 Caprylic acid 144.21 57.59 
 
 SCFA extraction procedure     
Distilled water was added to each external standard solution to make a final volume 
of 800 µl. 100 µl of internal standard (2-Ethylbuty) and 100 µl of Orthophosphoric 
acid were then added (Table 2.5). The faecal fermented samples were treated in 
the same way, except that 800 µl of liquid samples were used instead of distilled 
water and external standard. The mixture in all tubes was then extracted using 3 ml 
of diethyl ether. The tubes were mixed well for one minute and the top layer of the 
tubes was extracted. This step was carried out three times for each sample and 
standard. The extracted top layers were pooled and placed in clean tubes. The 
pooled samples were then placed in glass tubes with a crimp-top seal, which were 
placed in the GLC for SCFA analysis. 
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Table 2.5: Solutions used for SCFA extraction. 
 
 Determination of resistant starch (RS) in samples 
The in vitro RS (McCleary and Monaghan, 2002) was quantified in this thesis using 
a RS kit (standard AOAC 2002.02 and AACC 32-40) after removing the digestible 
starch from the samples using an extensive in vitro enzymatic digestion (salivary α-
amylase, pepsin, pancreatin and bile acid) as described by Aura et al. (1999). The 
RS kit was purchased from Megazyme International Ireland Ltd. All chemicals used 
in the RS determination including buffers and solutions (Table 2.6) were supplied by 
Sigma-Aldrich Company Ltd. (Dorset, UK).  
100 ± 5 mg samples were weighed directly into each screw cap tube and gently 
tapped to ensure that the sample falls to the bottom (Figure 2.4). 4.0 ml of pancreatic 
α-amylase (10 mg/ml) containing Amyloglucosidase (AMG) (3 U/ml) was added to 
each tube. The tubes were then tightly capped, mixed on a vortex mixer and placed 
horizontally in a shaking water bath, aligned in the direction of motion. The tube 
samples were incubated at 37°C with continuous shaking 200 strokes /min for 
exactly 16 hours. The tubes were removed from the water bath and any excess 
surface water was removed with a paper towel. The tube contents were treated with 
4.0 ml of ethanol (99% v/v) with vigorous stirring in a vortex mixer. The tube samples 
were then centrifuged at 1,500 g (approx. 3,000 rpm) for 10 min un-capped. The 
supernatants were carefully decanted and the pellets re-suspended in 2 m lof 50 % 
ethanol (v/v) with vigorous stirring in a vortex mixer. A further 6 ml of 50 % ethanol 
was added and the tubes were mixed and centrifuged again at 1,500 g for 10 min. 
External solution extraction 
External 
solution 
10 µl 
25 µl 
50 µl 
100 µl 
200 µl 
300 µl  
 
Faecal 
sample  
 
800 µl 
Distilled 
water 
790 µl 
775 µl 
750 µl     
700 µl 
600 µl 
500 µl 
 
Solution 
 
+ 100 µl of internal 
standard 
+ 100 µl of 
Orthophosphoric 
acid 
 
Solution extraction 
3 ml of diethyl ether added, vortexed for one min 
× 3. The pooled top layer extracted and placed 
on clean tube. The pooled ether placed in 
crimped glass tubes and placed in GLC for 
SCFA analysis 
 
 
 
 
 
Solution extraction 
3 ml of diethyl ether added, vortexed for one min 
× 3. The pooled top layer extracted and placed 
on a clean tube. The pooled ether placed in 
crimped glass tubes and placed in GLC for 
SCFA analysis 
 
Solution 
+ 100 µl of internal standard 
+ 100 µl of Orthophosphoric 
acid 
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The supernatants were carefully decanted and the suspension and centrifugation 
steps repeated once more. The tubes were then inverted on absorbent paper to 
drain excess liquid.   
A magnetic stirrer bar 5 x 15 mm and 2 ml of 2 M KOH were then added to each 
tube and the pellets re-suspended (dissolving the RS) by stirring for approx. 20 min 
in an ice/water bath over a magnetic stirrer. 8 ml of 1.2 M sodium acetate buffer pH 
3.8 was added to each tube by stirring with the magnetic stirrer. Then, immediately 
0.1 ml of AMG solution (1; 3300 U/ml) was added, mixed well and the tubes placed 
in a water bath at 50 °C. The tubes were incubated for 30 min with intermittent mixing 
in a vortex mixer.    
 111 
 
Table 2.6: Solutions and enzymes used for RS determination (from manufacturer’s leaflet). 
Enzymes (Kit) 
Amyloglucosidase solution 
(AMG) 
This solution is viscous and therefore should be dispensed with a positive displacement dispenser e.g. Eppendorf-Multipette. Dilute 2 ml 
of concentrated AMG solution to 22 ml with 0.1 M sodium maleate buffer. Divide into 5 ml aliquots and store frozen in polypropylene 
containers between uses. Stable for 5 years at -20 °C 
Immediately before use 
 Suspend 1 g of the contents of Pancreatic α-amylase in 100 ml of sodium maleate buffer (100 mM, pH 6.0) and stir for 5 min. Add 1.0 
ml of Dilute AMG (300 U/ml) and mix well. Centrifuge at > 1,500 g for 10 min, and carefully decant the supernatant solution. Use this 
solution (Solution 2) on the day of preparation 
GOPOD Reagent Buffer Dilute the contents in 1 L of distilled water. This is solution 3 to be used immediately. 
GOPOD Reagent Enzymes Dissolve the contents in 20 ml of Solution 3 and quantitatively transfer this to the bottle containing the remainder of Solution 3. Cover this 
bottle with aluminium foil to protect the enclosed reagent from light. This is Solution 4 Glucose Determination Reagent (GOPOD 
Reagent). Stable for 3 months at 2-5 °C or > 12 months at -20 °C. 
D-Glucose standard solution 
and Resistant starch control 
Use the contents as supplied. Stable for > 5 years at room temperature. 
Buffers and solutions  
100 mM Sodium maleate 
buffer 
Dissolve 23.2 g of maleic acid in 1600 ml of distilled water. Adjust the pH to 6.0 with 4 M (160 g/litre) sodium hydroxide. Add 0.74 g of 
calcium chloride dihydrate (CaCl2.2H2O). Add 0.4 g of sodium azide. Adjust the volume to 2 L with distilled water. Stable for 12 months 
at 4 °C. 
1.2 M Sodium acetate buffer 
(pH 3.8) 
Add 69.6 ml of glacial acetic acid (1.05 g/ml) to 800 ml of distilled water. Adjust to pH 3.8 using 4 M sodium hydroxide. Adjust the volume 
to 1 litre with distilled water. Stable for 12 months at room temperature 
100 mM Sodium acetate buffer 
(pH 4.5) 
Add 5.8 ml of glacial acetic acid to 900 ml of distilled water. Adjust pH to 4.5 using 4 M sodium hydroxide. Adjust the volume to 1 litre 
with distilled water. Stable for 2 months at 4 °C 
2 M Potassium hydroxide 
solution 
Dissolve 112.2 g KOH in 900 ml of deionised water with stirring. Adjust volume to 1 litre. Store in a sealed container. Stable for 2 years at 
room temperature 
Aqueous ethanol (approx. 50 
% v/v) 
Add 500 ml of ethanol (95 % v/v or 99% v/v) to 500 ml of H2O. Store in a well-sealed bottle.  Stable for > 2 years at room temperature 
 
The reagent blank Mix 0.1 ml of 100 mM of sodium acetate buffer (pH 4.5) and 3.0 ml of GOPOD reagent 
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For samples containing > 10 % RS content 
The contents of the tube were transferred to a 100 ml volumetric flask and washed 
(using a distilled water wash bottle). An external magnet was used to retain the 
stirrer bar in the tube during washing. The volume was adjusted to 100 ml with 
distilled water and mixed well. The mixed solution centrifuged at 1,500 g for 10 min. 
For samples containing < 10 % RS content 
The tubes were centrifuged at 1,500 g for 10 min (no dilution). The final volume in 
the tube was approximately 10.3 ml.  
0.1 ml of aliquots (in duplicate) of the solution (either diluted or undiluted 
supernatants) were transferred into glass test tubes (16 x 100 mm). 3 ml of GOPOD 
reagent was added to each tube and incubated at 50 °C for 20 min. Finally, 
absorbance was measured at 510 nm against the reagent blank to determine the 
resistant starch concentration.  
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Figure 2.4: Flow chart of resistant starch extraction and measurement. 
Weigh 100 mg sample directly into each screw cap tube 
Add 4.0 mL of pancreatic α-amylase containing AMG to each tube 
Tightly cap the tubes, vortex mixer and attach them horizontally in shaking water-bath 
Incubate tubes at 37°C with continuous shaking (200 strokes /min) for exactly 16 h 
Remove the tubes from the water-bath and add 4.0 mL of 99% EtOH with vigorous stirring 
Centrifuge at 1,500 g (approx. 3,000 rpm) for 10 min (non-capped) 
Carefully decant the supernatants and re-suspend the pellets in 2 mL of 50% EtOH, with 
vigorous stirring 
Add 6 mL of 50% EtOH, mix the tubes and centrifuge again at 1,500 g for 10 min 
Decant the supernatants and repeat suspension and centrifugation step once more 
Carefully decant the supernatants and invert the tubes on absorbent paper to drain 
excess liquid 
Add 2 M KOH with stirring over ice/water bath 
Add 8 mL 1.2 M sodium acetate buffers (pH 3.8) 
Immediately add 0.1 mL of AMG (sol 1) mix well 
Place in a water bath at 50°C, 30 min with stirring 
Samples (> 10% RS) 
Transfer to 100 mL volumetric flask with stirrer 
Adjust to100 mL with H2O 
Centrifuge, at 1,500 g for 10 min 
Samples (< 10% RS) 
Centrifuge at 1,500 g for 10 min (no dilution) 
Then for all > 10% RS or < 10% RS 
Transfer 0.1ml in duplicate of both samples into glass test tubes 
Add 3.0 mL of GOPOD reagent (solution 4); incubate at 50°C for 20 min 
Measure the absorbance at 510 nm against the reagent blank for RS 
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 Determination of NDOs (inulin and oligofructose) 
concentration  
NDOs (inulin and oligofructose) were quantified using a fructan kit (Megazyme 
International Ireland Ltd.) (McCleary et al., 2000), after removing the digestible 
starch from the samples using an extensive in vitro enzymatic digestion (salivary α-
amylase, pepsin, pancreatin and bile acid) as described by Aura et al. (1999). All 
chemicals used in the fructan determination including buffers and solutions were 
supplied by Sigma-Aldrich Company Ltd. (Dorset, UK) (Table 2.7).  
Sample containing (12-50 % of w/w fructan) 
1000 ± 10 mg of each sample was weighed directly into a 100 ml beaker and 40 ml 
of hot distilled water added. Beakers were placed on a hot plate with magnetic 
stirring for 15 min until boiled. The beakers were cooled to room temperature, the 
content of each beaker transferred to a 50 ml volumetric flask, and the volume was 
adjusted to 50 ml with distilled water and mixed well (Figure 2.5). 
Sample containing (0-12 % of w/w fructan) 
1000 ± 10 mg of each sample was weighed accurately and directly into a 200 ml 
beaker and 80 ml of hot distilled water was added. The beakers were cooled to room 
temperature, then the content of each beaker was transferred into a 100 ml 
volumetric flask, the volume was adjusted to 100 ml with distilled water and mixed 
well. 
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Table 2.7: Solutions and enzymes used for fructan concentration determination (from manufacturer’s leaflet). 
Enzymes (Kit) 
Sucrase enzyme bottle   Dissolve the contents of bottle in 22 ml of (0.1 M, pH6.5) of sodium maleate, store at -20 °C 
Fructanase enzyme bottle Dissolve the contents of bottle in 22 ml of (0.1 M, pH 4.5) sodium acetate, store at -20 °C 
 PAHBAH Reducing Sugar Reagent 
Sucrose/cellulose control 
powder 
should be analysed with each new lot of reagents 
D-fructose standard 0.2 ml of D-fructose standard solution (1.5 mg/ml) is added to 0.9 ml of Buffer 2; 100 mM sodium acetate (pH 4.5) and mixed thoroughly. 
Aliquots (0.2 ml) of this solution (containing 54.5 mg of D-fructose) are dispensed, in quadruplicate, into glass test tubes (16 x 100 mm). 
Buffer 2 (0.1 ml) is added to each tube plus 5.0 ml PAHBAH Working Reagent (immediately before incubation in the boiling water bath) 
Buffers and solutions  
Sodium maleate buffer 
(100 mM, pH 6.5) 
Dissolve maleic acid (11.6 g, Sigma cat. no. M-0375) in 900 ml of distilled water and adjust the pH to 6.5 with sodium hydroxide solution 
(2 M). Adjust volume to 1 litre. Stable for > 3 months at 4 °C 
Sodium acetate buffer (100 
mM, pH 4.5) 
Add glacial acetic acid (5.8 ml) to 900 ml of distilled water. Adjust to pH 4.5 using 1 M sodium hydroxide. Adjust the volume to 1 litre. 
Stable for > 3 months at 4 °C 
Solution (A) 10 g of p-hydroxybenzoic acid hydrazide dissolved in 60 ml of distilled water in a 250 ml beaker with stirring. During stirring add 10 ml of 
concentrated HCl solution. Adjust the volume to 200 ml using distilled water and store at room temperature 
Solution (B) 24.9 g of tri-sodium citrate dihydrate (Na3C6H5O7 • 2H20) added to 500 ml of distilled water and stir to dissolve. 2.2 g of calcium chloride 
dihydrate (CaCl2•2H2O) added to solution with stirring. 40.0 g of NaOH added to solution. Adjust the volume to 2 litres using distilled 
water 
Important to remember: PAHBAH reagent works by adding 20 ml of Solution A to 180 ml of Solution B and mixing thoroughly immediately before use. The mixed 
solution stored on ice is stable for 4 hours. 
50 mM Sodium hydroxide 2.0 g of NaOH dissolved in 900 ml of distilled water. Adjust the volume to 1 litre and store at room temperature 
Alkaline borohydride 
(NaBH) (10 mg/mL sodium 
borohydride in 50 mM of 
NaOH) 
Weigh 50 mg of sodium borohydride into polypropylene containers (10 ml volume with screw cap). Record the exact weight on the tubes 
(approx. 10 for convenience), seal the tubes and store in a desiccator for future use. Immediately before use, dissolve the sodium 
borohydride (at 10 mg/ml) in 50 mM sodium hydroxide. This solution is stable for 4-5 hours at room temperature 
0.2 M Acetic acid (C2H4O2) 11.6 ml of glacial acetic acid dissolved in 600 ml of distilled water. Adjust the volume to 1 litre and store at room temperature 
The reagent blank 0.3 ml of 100 mM sodium acetate buffer (Buffer 2) + 5.0 ml of PAHBAH Working Reagent. 
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The mixture in the volumetric flask was filtered into a 200 ml beaker using Whatman 
paper No.1. 200 µl of the mixture solution was transferred to a glass tube, 200 µl of 
diluted sucrose/β-amylase solution was added and then incubated at 40 °C for 30 
min. 200 µl of alkaline borohydride solution was then added to the tube stirring 
vigorously, which was then incubated at 40 °C for 30 min to convert the reducing 
sugar to sugar alcohol. 500 µl of 0.2 M of acetic acid was added to the tube stirring 
vigorously to adjust pH to 4.5. 200 µl of the mixture was transferred into three new 
glass tubes where 100 µl of fructanase solution was added to two tubes (sample) 
and 0.1 ml of 0.1 M of sodium acetate buffer was added to a third tube (sample 
blank). The tubes were then sealed with parafilm and incubated at 40 °C for 30 min. 
500 ml of p-hydroxybenzoic acid hydrazide solution (PAHBAH) was added to all 
tubes and incubated in a boiling water bath for 6 min. Immediately after incubation, 
the tubes were placed in cooled water (18-20 °C) for 5 min. The absorbance of the 
tube content was then measured at 410 nm against the reagent blank. The fructan 
content (%, as-is basis) was measured using the reference equation by McCleary 
et al. (2000): 
𝑻𝒐𝒕𝒂𝒍 𝑭𝒓𝒖𝒄𝒕𝒂𝒏, %
= 𝑨 × 𝑭 × 𝟓 × 𝑽 × (𝟏. 𝟏 𝟎. 𝟐⁄ ) × (𝟏𝟎𝟎 𝑾⁄ ) × 𝟏 𝟏𝟎𝟎𝟎⁄ × (𝟏𝟔𝟐 𝟏𝟖𝟎⁄ ) 
A = PAHBAH absorbance of reaction solutions (0.2 ml) read against reagent blank 
F = factor to convert absorbance values to mg fructose (= 54.5 mg fructose/ 
absorbance value for 54.5 mg fructose)  
5 = factor to convert from 0.2 ml as assayed to 1.0 ml  
V = volume (ml) of extractant used (100 or 50 ml) 
1.1/0.2 = 0.2 ml was taken from 1.1 ml enzyme digest for analysis 
W = weight (mg) of sample extracted; 100/W = factor to express fructan as 
percentage of flour weight 
1/1000 = factor to convert from mg to mg 
162/180 = factor to convert from free fructose, as determined, to anhydrofructose 
(and anhydroglucose), as occurs in fructan 
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 Figure 2.5: Flow chart of fructan measurement protocol. 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The mixture reduces with alkaline borohydride + acetic acid and incubated for 30 min at 40 °C 
100 mg of sample  
40 ml of distilled water added to the beaker   
Placed on hot plate with stirring until boiling for 15 min   
Cool the mixture to room temperature, and then transfer the mixture to a 50 ml volumetric flask  
50 ml of water added and mixed well   
Place 200 µl of mixture in glass tube  
200 µl of diluted sucrose/β-amylase solution added and incubated at 40 °C for 30 min   
Aliquots treated with fructanase solution 
Test mixture treated PAHBAH reagent 
Absorbance read at 410 nm against reagent blank 
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 Statistical analysis 
Statistical analysis was performed for all data using Minitab statistical software 
version 16. Normality of the data was tested using the Anderson-Darling test. 
Descriptive statistics are presented as mean and standard deviation (SD), or 
medians and inter quartile range (IQR). Comparisons between groups were carried 
out using the Mann-Whitney test for non-normally distributed data, and a paired test 
and 2 sample t-tests for the normally distributed data. Spearmen correlation 
coefficients were calculated for the excretion of the urinary SCFA products with FC. 
Additionally, in the urinary analysis study (Chapter 4) a regression analysis was 
conducted on the preferred biomarkers to derive an index with confidence and 
prediction intervals to examine the power of a predictive marker of fermentable 
carbohydrate intake from urinary biomarkers. Other specific tests are described in 
each relevant chapter.  
  
 119 
 
 Chapter Three 
Developing an index of dietary estimation of FC 
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 Introduction  
This chapter describes the development of the equations used to estimate the 
amount of FC that reaches the human colon. As it is the development of an index, 
the chapter does not follow a traditional layout of methods and results, but is more 
of a discussion of the evidence for the amount of each type of NDCs that reaches 
the colon and for the extent of its fermentation. 
Different studies have shown that NDCs can have an impact on human health, and 
several physiochemical properties have been suggested to explain these impacts 
including regulation of intestinal transit time and digestive function through faecal 
bulking, dilution of carcinogens in the colonic lumen, lowering of colonic pH, and 
bacterial fermentation of NDCs to SCFAs in the colon (den Besten et al., 2013, Tan 
et al., 2013). Until now, there was no reliable estimate of SCFA production for 
individuals who consume mixed NDCs, as not all insoluble fibre is fermented. In the 
UK, wheat bran intake is > 10 times as much as white rice and oat (Stevenson et 
al., 2012), and wheat bran is considered to be a rich source of DF, and mainly (46 
%) consists of NSPs, including AX, cellulose and β-glucan at 70 %, 24 % and 6 % 
respectively, whereas NSP in wheat endosperm are < 88% AX (Lu et al., 2000, 
Maes and Delcour, 2002). AX and β-glucan in wheat bran are fermented by colonic 
microflora to form SCFA, while cellulose increase faecal bulk and shorten the colonic 
transit time (Wood, 1997, Lu et al., 2000). 
Several studies have reported the impact of wheat bran consumption on increased 
faecal bulk (Muir et al., 2004, Lupton and Turner, 1999), which have agreed with 
other studies that have shown wheat bran is not well fermented by colonic 
microflora, but it increases faecal weight and reduces colonic transit time (Elleuch 
et al., 2011, Stevenson et al., 2012). Chen et al. (1998) examined the impact of 
consuming (30 g/d) of wheat bran with oat bran as control diet in five men. They 
observed that wheat bran fibre mixed with the diet increased the wet stool weight by 
52.4 g/d, which provided a 4.85 g/d increase in stool weight for each additional gram 
of fibre intake, which suggested the increased in faecal weight was due to the non-
digestible components (50 - 60 %) of wheat bran. Similarly, Cummings (2001) 
reported that each gram of wheat bran consumed increased faecal weight by 5.4 g, 
which is similar to the results from  EFSA and the UK Scientific Advisory Committee, 
who stated that each gram of wheat fibre consumed daily increases faecal weight 
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by 5 g, compared to other fibres for example, fruit and vegetables (4.1 g/g), gums 
(4 g/g), soya products (2.5 g/g) and pectin least of all (1.2 g/g) (Agostoni et al., 
2010). This is probably due to the differences in bacterial fermentation of the fibres 
in the colon. 
In Western diets the amount of NDCs that enter the colon may be in the range of 20 
- 40 g/d, whereas in countries where starchy foods are the main part of the diet, 
NDC concentrations could reach 50 g/d (Cummings, 1997). However, it has been 
reported that an individual required approximately 80 g/d of NDCs to sustain the 
bacterial biomass and SCFA production (Stephen, 1991), and only 25 % might be 
provided by NSP (Hill, 1995).  
Protein (amino acids) is also fermented by proteolytic bacteria in the proximal colon, 
and the main products of amino acid fermentation are SCFA, BCFA and ammonia 
(Hamer et al., 2012). Five volunteers were involved in a study to examine the impact 
of high protein diet on colonic metabolism products; after one week they had a 
significantly higher faecal ammonia (p = 0.002), faecal valeric acid (p = 0.02) and 
urinary p-cresol (p = 0.04), which shows the level of fermentation that was occurring 
(Geypens et al., 1997). BCFAs are often used as faecal and urinary biomarker for 
amino acid fermentation (Hamer et al., 2012).  
An additional substrate for fermentation is mucus, which is made of glycoproteins in 
ileal effluent, and also formed by goblet cells in the colonic epithelium to form a 
protective gel that is spread over the mucosal surface (Cummings and Macfarlane, 
1991). Studies have shown that it becomes a substrate for colonic microflora 
fermentation in the absence of NDCs and protein substrates (Miller et al., 1984). 
Stephen et al. (1983) used intubation studies to investigate mucus fermentation, and 
they estimated the amount of mucus that entered the colon to be 3 - 4 g/d, but much 
more may be made in the colon itself, therefore it is difficult to estimate this. 
These results suggest adding RS and NDOs, protein and mucus might overcome 
the NDCs gap. Many of the health benefits of NDCs may be related to fermentation 
and SCFA production, therefore it is important to consider all of these substrates 
when looking at the role of fermentation in preventing disease. Not all of these can 
be measured, but we proposed to develop an index of FC that could be used to 
determine NDCs from food diaries, based on information and evidence in published 
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literatures. This index will consider all NDCs that escape digestion and absorption 
and enter the colon for fermentation by colonic microbiota.  
One reason for the need for such index is that it is very difficult to measure 
fermentation in vivo. To develop such index, it is important to know how much NDCs 
enters the colon, and how much of this is fermented. In the next section different 
methods to estimate colonic fermentation, and also the amount of substrate entering 
the colon, will be discussed. These studies were examined for evidence to 
determine the different percentages of each type of NDCs that should be included 
in the final model, based on how much entered the colon intact, and also to what 
extent they were fermented to SCFA in vivo. 
 Studies which have estimated the amount of NDCs 
which reach the colon 
This chapter discussed in detail the evidence for the digestibility of all ingested 
carbohydrates and for those that are not digested the likely extent of their 
fermentation by colonic bacteria. The search for evidence was carried out using 
PubMed, and the ISI Knowledge databases (Figure 3.1). The MeSH heading 
‘starch’, ‘resistant starch’, ‘RS’, ‘fermentable’, ‘fermentation’, non-digestible’ and 
‘digestible’ were applied either alone or in different combinations to search all 
databases to find literature regarding fermentable RS. The MeSH heading ‘dietary 
fibre’, ‘fibre’, ‘soluble fibre’ ‘insoluble fibre’, ‘cereals’, ‘whole grain’, ‘polysaccharides’, 
‘fermentable’, ‘fermentation’, non-digestible’ and ‘digestible’ were applied either 
alone or in different combinations to search all databases to find literature regarding 
fermentable DF. The MeSH heading ‘prebiotics’, ‘inulin’, ‘oligofructose’, ‘non-
digestible oligosaccharide’, ‘fructooligosaccharide’, ‘galactooligosaccharide’, 
‘fermentable’, ‘fermentation’, non-digestible’ and ‘digestible’ were applied either 
alone or in different combinations to search all databases to find literature regarding 
fermentable NDOs. Most estimates of the amount of carbohydrate reaching the 
colon and their fermentation has been studied using indirect measurement of 
carbohydrate fermentation, for example, breath hydrogen (H2), direct intubation of 
the ileum, and the ileostomy model and faeces. This is because quantifying the 
amount of NDCs that escapes digestion and absorption in the small intestine directly 
is difficult. 
 123 
 
Figure 3.1: Flow chart of estimating fermentable carbohydrate in foods  
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 RS measurement 
RS has been reported as a major substrate for fermentation in the human colon 
(Englyst and Cummings, 1990, Stephen et al., 1983). Several models have been 
used in humans to estimate the amount of starch that resists pancreatic amylase, 
and escapes digestion in the small intestine. These models were direct intubation of 
the ileum, the ileostomy, and breath hydrogen (H2) models (Cummings and Englyst, 
1991).   
3.2.1.1 Intubation model 
This model measured starch malabsorption of normal foods through intubation of 
the ileum of healthy subjects. Stephen et al. (1983) intubated the terminal ileum of 
seven normal volunteers; they found that starch malabsorption from test meals 
containing either 20 g of starch from banana and rice was 6.0% or 60 g from banana, 
rice, and potato was 9.3%. Flourie et al. (1988) evaluated six subjects and fed them 
a diet containing 100 g or 300 g of starch from white bread, potato, and noodles for 
two periods eight days. The 24 hours aspiration test showed that 4.1 % and 3.2 % 
of starch were recovered in the terminal ileum for both low and high starch meals, 
respectively. These studies show that the % of malabsorption depends on the 
concentration of starch used.  
3.2.1.2 Ileostomy model 
This model is considered to be a direct and quantitative method to measure all 
intestine excretion. People with established Ileostomies who were involved in these 
experiments had had their large intestine completely removed, after colectomy 
surgery; and the terminal ileum brought out onto the anterior abdominal wall as a 
fistula. Ileal effluent is collected in a bag, which is changed every 2 h during the day. 
Most ileostomies have a normal life.  This model was considered to be a reliable 
model for studying the small intestine digestion physiology for many reasons; the 
ileostomy effluents provide digestive enzymes, which resemble normal pancreatic 
performance, and the ileal excretion of substrates is believed to be comparable to 
that of a healthy subject. Studies have also shown that gut hormone responses to 
test meals were similar to that of those with an intact gut, and transit time of the 
stomach and small intestine is similar to that of intact gut subjects (Cummings and 
Englyst, 1991).  
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Table 3.1: Resistant starch measured in the ileostomy model adapted from Cummings and 
Englyst, (1991). 
Some studies have used this model to measure RS (Chapman et al., 1985, 
Sandberg et al., 1981). Chapman et al. (1985) recruited six ileostomies subjects and 
fed them three mixed meals in day containing approximately 157 g of starch (Table 
3.1). Only 1.3 - 5.0 %, with mean 2.4 % of a 157 g load of starch appeared in ileal 
effluent of the six ileostomies. Sandberg et al. (1986) fed seven ileostomy subjects 
a low fibre diet supplemented with a mixture of bran gluten starch 54 g/d for (periods 
A), or the corresponding extruded product (period B) for 4 days each period. They 
found only 0.6 - 0.7 % of ingested starch was recovered in ileostomy contents in 
both periods, respectively, which shows that most of the starch was digested in this 
study. O’Donnell et al. (1989) fed nine non-obese ileostomies breakfast (containing 
52.4 g starch) comprised of soda bread scones made from 76 g fine or coarsely 
milled whole meal flour. All subjects had the two breakfasts in a random order for 
seven days. They observed that 0.7-1.1 % of wheat flour escaped digestion in the 
small intestine, which almost was similar to the findings of Sandberg et al. (1986). 
Englyst and Cummings (1985) fed seven ileostomies subjects either 100 g oats, 100 
g cornflakes, or 150 g white bread as breakfast. They reported that less than 0.6 %, 
4 % and 2.5 % of oats, cornflakes and white bread (respectively) escaped digestion 
in the small intestine, which shows the different meals had different rates of 
Food source Starch fed 
(g/d) 
Starch recovered 
(g/d) 
% 
recovery 
Reference 
Rice, bread 98 – 127 0.5 < 1.0 (Sandberg et al., 1981) 
Rice, bread 140 0.7 < 1.0 (Sandberg et al., 1983) 
Bread 107 0.3 < 1.0 (Sandberg et al., 1986) 
Wheat starch     
rice, bran 107 0.5 < 1.0  
Wheat, potato 157 1.9 2.4 (Chapman et al., 1985) 
White bread 100 12.4 13 (Wolever et al., 1986) 
Wholemeal 
bread 100 10 11  
Lentils 100 20 21  
White bread 61.9 1.3 2.5 (Englyst and Macfarlane, 1986) 
Oats 57.8 0.4 2.2  
Cornflakes 74.2 3 5  
Banana 2-21 0.3 75 (Englyst and Cummings, 1985) 
Potato     
Hot 45.4 1.1 3.3 (Englyst and Cummings, 1985) 
Cold 47.2 3.1 12.2  
Wheat     
Fine 52.4 0.4 0.7 (O'Donnell et al., 1989) 
Coarse 52.4 0.6 1.1   
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absorption. On the other hand, Wolever et al. (1986) gave three ileostomies subjects 
starchy meals (either 100 g white bread, 100 g whole meal bread, or 100 g red 
lentils). They observed that 10 % of white bread, 8 % of whole meal bread, and 22 
% of the red lentils meals escaped digestion and absorption in the small intestine, 
which is much higher than the other studies. Englyst and Cummings (1987) showed 
that 3 % of hot potato starch, 12 % of cold potato starch and 75 % of banana starch 
escaped digestion in the small intestine of ileostomy patients. In contrast, the starch 
in oats is well digested, while that in lentils may well be partly resistant (Cummings 
and Englyst, 1991). 
3.2.1.3 Breath hydrogen model 
NDCs fermentation by colonic microflora produces hydrogen as one of its end 
products, and the hydrogen is excreted by the lungs with expired air. It has been 
reported that the hydrogen measured in the colon by a gas perfusion technique, 
correlated with the total hydrogen excreted by the lungs (Champ et al., 2003). Each 
subject was calibrated with a standard dose of fermentable substrate, which was 
lactulose, which was considered to be a good control for the model of NDC 
fermentation (Cummings and Englyst, 1991). Levitt et al. (1987) fed thirty healthy 
subjects with various complex carbohydrates. They reported that 2.8 % of white 
wheat, 13.6 % of whole wheat, 9.0 % of refined oats, 3.2 % of whole oats, 7.6 % of 
whole corn, 10.0 % of potatoes, 1.8 % of rice and 38.0 % of baked beans escaped 
digestion in the small intestine (Table 3.2). Wolever et al. (1986) fed subjects with 
120 g of white bread; 120 g of wholemeal bread and 120 g of lentils. These foods 
produced 10.7 %, 8.3 % and 17.6 % of malabsorbed starch, respectively. Moreover, 
Scheppach et al. (1989) showed that 60 g of potatoes (cooked, cooled and 
reheated) produced 6.6 %, 22.8 % and 5.0 % of resistant starch, respectively. 
Overall, breath hydrogen studies measuring NDCs fermentation in human suffer 
from some problems in their interpretation. One of the problem, it could be that the 
hydrogen generated from NDCs fermentation, such as starch is the same on a 
milliliter of hydrogen formed from gram of other NDCs fermentation such as NSP 
(Cummings and Englyst, 1991). Levitt et al. (1987) stated that this is not so in vitro 
and in vivo. Secondly, it is also assumed that hydrogen gas is the only route for 
disposal of reducing equivalents in fermentation. Therefore, they are probably the 
least reliable way of obtaining quantitative data on starch malabsorption, although 
qualitatively they may confirm results obtained by other techniques. For example, 
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Stephen et al. (1983) and Flourie et al. (1988) examined breath hydrogen in their 
subjects in parallel with their intubation studies. They observed no correlation at all 
in starch malabsorption as determined by the two methods. 
These variations in the digestion of starchy foods might be due to different of 
reasons (Silvester et al., 1995). Firstly, starch enclosed within plant structures may 
be physically inaccessible to pancreatic amylase, such as seeds or grains. 
Secondly, starch granules that categorized by X-ray diffraction which contain either 
a B or C type crystalline pattern for example, potatoes, bananas, and some begums 
are less digestible than those with an A type pattern, such as cereals. Thirdly, starch 
may retrograde on cooling into a less digestible B type crystalline pattern after 
gelatinization (Silvester et al., 1995, Nugent, 2005). Additionally, digestibility of 
starch may be affected be other factors for example intestinal transit time and 
interactions with other food components, such as NSP, lipids and protein (Nugent, 
2005).  
Table 3.2: Resistant starch measured by the hydrogen excretion in breath adopted from 
Cummings and Englyst, (1991), 
Food source starch fed 
(g/d) 
Starch malabsorbed 
(g/d) 
% malabsorbed Reference 
White bread 120 12.6 10.7 (Wolever et al., 1986) 
Wholemeal 
bread 120 9.4 8.3  
Lentils 120 20.2 17.6  
White wheat 50 1.4 2.8 (Levitt et al., 1987) 
Whole wheat 50 6.8 13.6  
Refined oats 50 4.5 9.0  
Whole oats 50 1.6 3.2  
Whole corn 50 3.8 7.6  
Potatoes 50 5 10.0  
Rice 100 0.9 1.8  
Baked beans 100 19 38.0  
Potato   2.2  
Cooked 60 5.7 and 2.3 6.7 
(Scheppach et al., 
1988a) 
Cooled 60 13.0 and 14.4 22.8  
Reheated 60 3 5.0   
 
 Validation of RS measurement in vitro and in vivo  
There have been different studies that have combine measurements in vivo with 
results from in vitro models. Muir and O'Dea (1993) assessed the amount of total 
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starch (TS) that escaped digestion in the small intestine of eight ileostomy subjects 
and used this to validate an in vitro assay. Five different foods (baked beans 22.7 g, 
pearl barley 41.0 g, cornflakes 44.1 g, whole rice 48.9 g and ground rice 46.1 g) 
comprising different amount starch were provided to the subjects. The researchers 
found that the 0.7 % of TS in ground rice and 5.7 % of TS in baked beans was 
recovered in the ileostomy effluent which correlated (r = 0.90, p < 0.05) with NDCs 
of in vitro model after 6 h of incubation.  
Englyst et al. (1996) used a more detailed analytical technique that developed to 
categorize and analyse RS in plant foods in vitro, which might reflect the rate and 
extent of starch digestion in the human small intestine. This technique gave values 
for those types of starchy foods that were rapidly digestible, slowly digestible and 
resistant to digestion. This method was validated against malabsorbed starch from 
these types of foods fed to healthy subjects. Nine subjects with an ileostomy were 
fed with 100 g of biscuits made from wheat, potato or banana flour, or moist-heat 
processed wheat or maize flours. On the day before the experimental day, each 
subject received a polysaccharide free diet, then subjects randomly received one of 
the five biscuits for two days (two subjects) or three days (seven subjects). In the in 
vitro study, TS and RS was determined using the Englyst method (1992). The starch 
that was recovered in the ileostomy subjects’ effluent ranged from 12.5-15.5 g/d, 
and the starch that was recovered in vitro was in the ranged of 8.5-15.0 g/d. This 
finding confirmed that the values of RS obtained in vitro reflected the amount of 
malabsorbed starch in the human small intestine (Englyst et al., 1996). The 
proportion RS in a starchy food is usually less than 5 to10% but can be between 0% 
and 100% (Silvester et al., 1995). Chapman et al. (1985) and Englyst et al. (1996) 
reported that overall in the Western diet approximately 10 % of total starch might be 
RS, which would not be digested in the small intestine.  
 Measurement of NSPs and its fermentability  
3.2.3.1 In vivo 
The fermentability of NSP is highly influenced by a number of physiological and 
biochemical factors. The physiological factors include the extent of lignification of 
the cell wall polymers, water solubility of NSP, and the particle size of foodstuffs. 
The bran cell wall is the most lignified found in human food, and therefore the least 
digestible (Southgate et al., 1976). The more water soluble a material is the more 
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digestible, and the smaller its effect on faecal composition and bowel habit is 
(Stephen and Cummings, 1979). Similarly, breakdown of foodstuffs is affected by 
the particle size; foodstuffs with fine particles are less laxative and more readily 
digested than coarse ones (Brodribb and Groves, 1978, Heller et al., 1980).  
In the early 19th century, a study carried out by Williams & Olmsted (1936), reported 
that at least 50 % of cellulose and 80 % of non-cellulosic polysaccharides 
(hemicellulose) from a variety of sources were fermented by microflora in the human 
gut. Similarly, in vivo in humans, Chen et al. (1998) have reported that the 
fermentability of oat bran was 96 %, compared 56 % of wheat bran, which correlates 
with the results of Cummings (1981) who reported that 40 % of bran fibre was 
fermented in the healthy human gut.  
3.2.3.2 In vitro 
An in vitro study carried out by Bourquin et al. (1992) examined the fermentability of 
three dietary fibre sources (corn wheat bran, corn fibre and oat bran). After 48 h of 
incubation with human colonic bacteria, they observed that 87.8 % of corn fibre, 73.5 
% of wheat bran and 39.8 % of oat bran remained non-fermented. In the same 
manner, the same researcher conducted an in vitro experiment to assess the 
fermentability of 11 dietary fibres incubated with human faeces. This study showed 
that dietary fibre fermentability ranged from high fermentability (83.3 % of citrus, 
76.6 % of gum Arabic, and 70.9 % of guar) to low fermentability (11.2 % of corn 
bran, and 5.8 % of oat fibre) (Bourquin et al., 1996). Moreover, fermentability of five 
dietary fibre sources using a simple in vitro batch system (human faeces and rats 
caecal) were estimated in five European laboratories in a studies carried out by 
Barry et al. (1995). After 24 h of incubation they observed that pectin (97.4 %) and 
soya bean (91.1 %) were highly fermented, compared with the lower fermentability 
of cellulose (7.2 %) and maize bran (6.2 %). An intermediate level of fermentability 
was observed with sugar beet fibre (59.5 %). The findings were similar from both in 
vitro models (inoculated with human faeces and rat caecal bacteria).  
  Measurement of NDOs and its fermentability  
In the human small intestine, the recovery of inulin isolated from Jerusalem artichoke 
was measured in ileostomy subjects by Knudsen and Hessov (1995). The subjects 
were fed a low dietary fibre diet based on white wheat bread and virtually free of 
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inulin, and the same diet with the addition of 10 g and 30 g inulin product, 
respectively. Researchers observed that approximately 86 % and 87 % 
(respectively) of inulin was recovered in the ileal effluents at both ingestion levels. 
Two other studies conducted with ileostomy patients showed the mean excretion of 
inulin and oligofructose at the end of the ileum was about 88 %, and 90 % 
(respectively) of the ingested dose  (Ellegård et al., 1997, Andersson et al., 1999). 
In another study, six healthy individuals were involved in a study over a period of 
eleven days to examine fermentability of FOS by the microflora in the human colon. 
Subjects received three doses of 20.1 g FOS, and the researchers evaluated FOS 
output using intestinal aspiration after each dose. They observed that 89 % of FOS 
entered the colon for fermentation (Molis et al., 1996). Overall these studies 
confirmed that 80 to 90 % of NDOs were not digested and absorbed in the small 
intestine, and entered the colon for fermentation. 
 Development of the models for calculation of FC 
Our model equations for estimating fermentable carbohydrate were based on the 
above evidence, for example that hemicellulose fibre such as pectin is completely 
fermented (100 %) and cellulosic fibre such as wheat bran is less fermented (10-50 
%). Similarly, NDOs were included as 100 % of NDOs is fermented. Finally, the 
amount of RS was estimated as 5 - 10 % of TS, but this is believed to be totally 
fermented. These data were considered in detail and several different equations 
proposed with varying amounts of insoluble fibre, and TS. These were modelled with 
real diets until the final equations to be tested in the in vivo and in vitro studies in 
the following chapters were agreed (Table 3.3; Figure 3.2). 
Table 3.3: The FC equations were developed as follows: 
 
Dietary fibre (AOAC) method 
FC-DF 1 100 % Soluble DF + 10 % insoluble DF + 100 % NDOs + 5 % TS    
FC-DF 2 100 % Soluble DF + 50 % insoluble DF + 100 % NDOs + 5 % TS    
FC-DF 3 100 % Soluble DF + 10 % insoluble DF + 100 % NDOs + 10 % TS    
FC-DF 4 100 % Soluble DF + 50 % insoluble DF + 100 % NDOs + 10 % TS    
Non-starch polysaccharide (NSP) 
FC-NSP 1 100 % Soluble NSP + 10 % insoluble NSP + 100 % NDOs + 5 % TS    
FC-NSP 2 100 % Soluble NSP + 50 % insoluble NSP + 100 % NDOs + 5 % TS    
FC-NSP 3 100 % Soluble NSP + 10 % insoluble NSP + 100 % NDOs + 10 % TS    
FC-NSP 4 100 % Soluble NSP + 50 % insoluble NSP + 100 % NDOs + 10 % TS    
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 Measurement of FC in habitual diet study 
In this study, the aim was to further develop an index of FC, which required 
information from the literature on the degree of fermentation of NDCs. It also 
required information from the literature on the presence of dietary fibre (AOAC) 
method (soluble, insoluble), NSP (soluble, insoluble), NDOs (inulin and 
oligofructose) and TS in various foods. Information from websites of food 
manufactures, information from food products in the local markets and weight 
dietary records of study healthy volunteers, were also needed for the calculations. 
This information helped to create a database with various foods, and to estimate the 
amount of fermentable carbohydrate in the study volunteers’ habitual diet.  
3.3.1.1 NDOs in habitual diet   
The search for evidence from literature on the presence of FOS in natural food was 
conducted using inulin and oligofructose, rather than looking for 
xylooligosaccahride, polydextrose and GOS, as inulin and oligofructose are 
naturally present in the foods and are also used for fortification in various processed 
foods (Van Loo et al., 1995). The search was carried out using PubMed, and the ISI 
Knowledge database. The MeSH heading ‘prebiotics’, ‘inulin’, ‘oligofructose’, 
‘fructooligosaccharide’, ‘content’, ‘concentration’, ‘plants’, ‘foods’, ‘feed’, ‘foodstuff’, 
‘source’, ‘products’, ‘measurement’, ‘determinations’ and ‘methods’ were applied 
either alone or in different combinations to search all databases to find literature 
regarding inulin and oligosaccharide content in the foods.11 studies in total were 
found from electronic databases searching on the amount of inulin and oligofructose 
in various food items using different determination methods. Of these 11 studies, 
only 3 studies were selected as they used approved determination methods by the 
AOAC, which included ion exchange chromatography, enzymatic method with high 
performance liquid chromatography (HPLC), and high performance anion exchange 
chromatography (HPAEC) (Van Loo et al., 1995, Hogarth et al., 2000, Campbell et 
al., 1997). 
The principle of these methods to determine the amount of inulin and oligofructose 
in the foods were dependent on the enzymatic treatment of a food product with an 
inulinase enzyme, followed by determination of the released sugars. The NDOs 
were then extracted from the food products with boiling water. An aliquot of the 
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extract was treated with amyloglucosidase, prior to analysis using ion exchange 
chromatography (Prosky and Hoebregs, 1999).  
The presence of inulin and oligofructose in processed foods that were not obtained 
from electronic search were assessed from local supermarkets such as, ASDA, 
Tesco and Sainsbury. The amount of inulin and oligofructose present in the food 
products were considered as DF. Food product manufacture websites for example, 
Kellogg’s, DANONE and Muller, were also assessed for presence of inulin and 
oligofructose in food products, which were not obtained from the local supermarkets. 
Nineteen food items were obtained from websites and local supermarkets.  
The inulin and oligofructose concentration of each food item containing 
oligosaccharide in the diet diary, was estimated by multiplying the amount of food 
intake in the diet (g) (obtained from Windiets, 2005) by the inulin and oligofructose 
of that food item (obtained from literature), which was then divided by 100 (Van Loo 
et al., 1995, Hogarth et al., 2000, Campbell et al., 1997). The inulin and oligofructose 
values were calculated in this way, for each food item containing oligosaccharide. 
The inulin and oligofructose was summed to give the inulin and oligofructose for 
three days, and this value was then divided by three to give the average daily inulin 
and oligofructose concentration.    
3.3.1.2 Dietary fibre AOAC (soluble and insoluble) and NSP (soluble and 
insoluble) in habitual diet   
The soluble DF content of each food item was obtained by using a DF medical 
calculator provided by the GLOBALRPH website, which calculated Insoluble DF as 
the difference between soluble and total DF. The presence of the soluble DF content 
in food items that were not obtained from the GLOBALRPH website DF calculator 
were assessed from literature searches. Soluble and insoluble DF fractions present 
in food items were determined using an enzymatic-gravimetric procedure method 
(991.43) approved by AOAC (Lee et al., 1992). The principle of this method to 
determine the amount of soluble and insoluble DF in the food sample, foods that 
contained a high level of sugar were extracted with 85 % ethanol before analysis to 
remove most of the sugars (Lee et al., 1992). The residue was suspended in MES-
TRIS buﬀer and digested sequentially with: heat-stable alpha-amylase at 95 – 100 
°C, protease at 60 °C, and Amyloglucosidase at 60 °C. The mixture then was ﬁltered 
through glass crucible, and the crucible containing the insoluble DF was rinsed with 
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four volumes of 95 % ethanol followed by acetone, and dried overnight in at 105 °C 
in an oven. The filtrate plus washes were mixed with 4 volumes of 95 % ethanol to 
precipitate materials that were soluble DF. Total DF was calculated as the sum of 
soluble and insoluble DF. 
The soluble NSP and insoluble NSP fractions present in food items were obtained 
from two studies by Englyst and colleagues using the enzymatic chemical method 
(Englyst et al., 1988, Englyst et al., 1989), which is a development of Southgate 
method. The aim is to determine the amount of cell wall polysaccharide as NSP in 
plant foods, and the principle of the method is to remove starch enzymatically after 
solubilisation. The total NSP is then measured as the sum of the individual 
constituent sugars that are released by acid hydrolysis. Total NSP is precipitated for 
one-hour extraction with phosphate buffer pH 7, at 100 °C instead of ethanol. The 
values that were obtained represent insoluble NSP, and soluble NSP is calculated 
as the difference between total NSP and the insoluble NSP. This method is suitable 
for individual NSP measurements by gas-liquid chromatography or colorimetric 
methods. 
Within this study FC (AOAC) (soluble and insoluble), NSP (soluble and insoluble), 
inulin and oligofructose, and RS were estimated from the subjects’ three day 
weighed intake diaries. Each food item that contained DF and NSP in the diet diary, 
had the soluble DF or NSP estimated by multiplying the amount of food intake in the 
diet (g) (obtained from Windiets, 2005) by the soluble DF or NSP content of that 
food item (obtained from GLOBALRPH website and literature), which was then 
divided by 100. The soluble fibre or NSP were summed to give the soluble (fibre or 
NSP) for three days, and this value was then divided by three to give the average 
daily soluble DF or NSP. The daily insoluble DF or NSP was then calculated as the 
difference between soluble fibre or NSP and total the DF or NSP intake (obtained 
from Windiets 2005).        
3.3.1.3 RS in habitual diet   
Until recently, no in vitro method has been capable of quantifying all RS fractions 
likely to be present in food, even though RS has been reported as the major 
substrate for fermentation in the human colon (Cummings and Macfarlane, 1991). 
Several in vivo human studies have estimated RS from analysis of starch output in 
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ileostomy effluents (Englyst and Cummings, 1990, Stephen et al., 1983, Muir and 
O'Dea, 1992, Silvester et al., 1995, Chapman et al., 1985), and by ileal intubation of 
healthy subjects (Stephen et al., 1983, Faisant et al., 1995). The RS has also been 
measured  indirectly by measurement of breath H2 levels (Levitt et al., 1987, 
Wolever et al., 1986), or blood acetate concentrations (Cummings and Englyst, 
1991, Muir et al., 1995). Several developed in vitro procedures which mimic the 
physiologic conditions in humans have simplified the determination of RS in food 
(McCleary et al., 2002, Åkerberg et al., 1998, Englyst et al., 1992, Goñi et al., 1996). 
However, the amount of RS that enters the colon each day is difficult measure due 
to lack of sufficient data on the RS content of foods. The average daily RS intake 
has been estimated as 4 g across Europe (Elmstahl, 2002) and 3 - 8 g in USA 
(Murphy et al., 2008).  
Therefore, the RS amount of each food item containing starch in the diet diary that 
obtained from Windiets 2005 was estimated as 5 % and 10 % of TS, based on FC 
equations developed (Table 3.3). The RS values were calculated in this way, for 
each food item containing starch, the RS was summed to give the RS for three days, 
and this value was then divided by three to give the mean daily 5 % and 10 % of TS 
intake. 
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Figure 3.2: Flow chart of the fermentable carbohydrate calculation. 
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 Chapter Four 
Predicting SCFA production in the human colon in 
vivo derived from urinary output using developed 
index to estimate fermentable carbohydrate from 
dietary records 
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 Introduction  
This chapter describes a comparison between our predictive equations developed 
to estimate FC from dietary records for a secondary analysis of a previous study 
conducted at the SUERC, which measured urinary excretion of SCFA.    
Epidemiological studies have frequently reported that diets rich in NDCs may reduce 
the risk of chronic diseases including CVD (Crowe et al., 2012), CRC (Aune et al., 
2011b, Bingham et al., 2003), diabetes mellitus (Carter et al., 2010) and obesity 
(Bäckhed et al., 2007). Similar results were also found by the World Cancer 
Research Fund in their major systematic review, they reported that NDCs ‘‘probably’ 
protect against CRC incidence when there is a high cereals, fruits and vegetables 
intake (WCRF, 2007). Cereal fibre was the main component behind these protective 
effects, as NDCs are mainly found in whole grain cereals, pulses, fruit and 
vegetables (Guillon and Champ, 2000b). According to the European Food Safety 
Authority (EFSA) report, the average dietary fibre intake is 15 - 30 g per day with 
the lowest at 6 - 9 g/d and the highest at 39 - 51 g/d in adults across European 
countries (Agostoni et al., 2010). Therefore, this amount of variation allowed the 
differences in intake to be compared to investigate if there are any protective effects.   
The main characteristics of NDCs are their relatively high content of RS, NDOs and 
NSPs; these components were shown in intervention studies to induce and sustain 
improvements to metabolic syndrome risk factors such as, CVD and diabetes 
mellitus (Steffen et al., 2003, Maki et al., 2012). Steffen et al. (2003) showed that 
adolescence who consumed of more than 1½ servings of whole grain foods per day 
were leaner and more insulin sensitive, when compared to those who consumed 
less than ½ serving per day. Other research shows a healthy diet supplemented 
with psyllium fibre at a concentration of 30 g/d improve insulin sensitivity, body 
weight and BMI, when compared with the control (Pal and Radavelli‐Bagatini, 2012). 
There are many other studies that show the benefit of NDCs, for example Maki et 
al. (2012) observed that consumption of 15 - 30 g/d of high-amylose maize resistant 
starch (HAM-RS2) for 4 weeks, enhanced insulin sensitivity in overweight and obese 
men. Additionally, Lipoprotein profiles in patients with CVD improved after intake of 
10.5 g/d of soluble fibre (psyllium ovata husk) for 8 weeks, more than a comparable 
amount of those of insoluble fibre (psyllium ovata seeds) (Sola et al., 2007a). 
Othman et al. (2011) conducted a systematic review to study the relationship 
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between oat β-glucan consumption and blood cholesterol level reduction. They 
found that a daily intake of at least 3 g of oat β-glucan may reduce plasma total and 
LDL cholesterol levels by 5 - 10 % in hypercholesterolemic subjects. In a 
randomized crossover study conducted by Willis et al. (2009) the results showed 
that 8 g of RS intake kept subjects significantly less hungry than the baseline reading 
for 120 minutes, and satisfied for the180 minute test period. This effect was also 
observed by Cani et al. (2006) who found that consumption of either 8 g of 
oligofructose or dextrin maltose twice a day for two weeks at breakfast, significantly 
reduced total energy 5 % per day and increased satiety. It is likely that the effects of 
NSP, NDOs and RS observed in these studies are brought about through the 
fermentation of NDCs in the colon, which results in the production of the SCFAs 
(Kimura et al., 2014).   
The principal components of SCFAs are the end products of luminal microbial 
fermentation of predominantly NDCs (den Besten et al., 2013). SCFAs are produced 
in varying amounts depending on the diet and the composition of the intestinal 
microbiota, with different carbon chain lengths (acetate (C2), propionate (C3), 
butyrate (C4), valerate (C5) and caproate (C6)) creating different end products (van 
Nuenen et al., 2003). Several studies have shown that SCFAs not only exert effects 
in the colonic epithelial cells, but also enter the circulation and have an impact on 
metabolic processes in other tissues and organs, for example acetate and 
propionate have been shown to have an impact on glucose and lipid metabolism in 
the liver (Chen et al., 1984, Wolever et al., 1989, Venter et al., 1990a, Nishina and 
Freedland, 1990). Acetate is used in the liver as substrate for the synthesis of 
cholesterol and fatty acids, whereas it appears propionate inhibits these processes 
(Nishina and Freedland, 1990). The deorphanization of the free fatty acid (FFA) 
receptors FFA2 (GPR43) and FFA3 (GPR41) are activated by SCFAs and this effect 
of SCFA is likely to occur  in adipose tissue metabolism due to the high expression 
of GPR43 in these tissues (Hong et al., 2005). Ge et al. (2008) observed that the 
anti-lipolytic effect is abolished in adipocytes isolated from GPR43 knockout 
animals, and this suggests there is a potential role for acetate and propionate in 
regulating plasma lipid profiles through activation of GPR43. In addition, some 
studies have suggested that FFA2 might play a role in regulation of appetite and 
metabolism (Sleeth et al., 2010, Psaltopoulou et al., 2010). 
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There is evidence to suggest a high fibre diet is associated with weight reduction 
and a lower incidence of diabetes (Psaltopoulou et al., 2010). Several studies have 
shown that SCFAs produced by colonic fermentation of fibre may be responsible for 
this through FFA2 activation (Sleeth et al., 2010, Zhou et al., 2008). Moreover,  a 
high fibre diet has been linked with increased levels of PYY, a hormone known to 
decrease appetite (Karra and Batterham, 2010). Karaki et al. (2008) observed that 
FFA2 is responsible for PYY secretion in entero-endocrine L-cells and these L-cells 
are also responsible for GLP-1 secretion, an effective anorectic incretin hormone, 
which also regulates insulin secretion from pancreatic β-cells and can increase 
insulin sensitivity in target tissues (Tolhurst et al., 2012). Further evidence for the 
importance of these cells comes from the work by Tolhurst et al. (2012) who 
confirmed that FFA2 and FFA3 expression are enriched in L-cells, and FFA2 
mediate SCFAs promoted GLP-1 discharge from mixed colonic cultures in vitro. 
These findings suggest that the FFA2 receptor might have potential to be used as a 
therapeutic for treatment of type 2 diabetes and related metabolic conditions. 
Studies have shown that butyrate provides 70 % of the energy required by the 
colonocytes for cellular respiration,  it influences a wide range of cellular functions 
affecting colonic health; it may also have an anti-carcinogenic and anti-inflammatory 
potential, and can affect the intestinal barrier and play a role in satiety (Hamer et al., 
2008). Further evidence for its anti-cancer properties comes from studies that have 
reported that Butyrate has a protective effect against colon cancer and adenoma 
development (Bornet et al., 2002). Several studies have reported that butyrate 
inhibits proliferation, induces differentiation and apoptosis in CRC cells in vitro, at 
concentrations similar to those found in the large bowel in vivo (Fung et al., 2012, 
Thangaraju et al., 2009). Other studies have shown that high butyrate production 
reduces the incidence of carcinogen-induced colon tumours in rodent models, partly 
through induction of apoptosis (Clarke et al., 2008, Le Leu et al., 2009). 
The primary mechanisms of butyrate anti-inflammatory action are through the 
suppression of nuclear factor κB (NFkB) activation, the inhibition of interferon γ 
production, the upregulation of peroxisome proliferator-activated receptor γ 
(PPARγ), and possibly through the inhibition of histone deacetylase (HDAC) (Hamer 
et al., 2008).  
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The effect of NDCs has been further investigated in intervention studies, for example 
in ulcerative colitis (UC) patients, which proposed that high intake of NDCs stimulate 
luminal butyrate production, and may results in an improvement of the inflammation 
and symptoms (Hallert et al., 2003, Vernia et al., 2003). The study involved twenty 
two quiescent UC patients being advised to add 20 g of NDCs to their daily diet, and 
the results showed a significant increase of faecal butyrate concentration, and 
improvement of abdominal symptoms, after four weeks of NDCs intake (Hallert et 
al., 2003). In a double-blind, placebo-controlled multicenter trial, Vernia et al. (2003) 
observed that patients with active distal UC who were treated with rectal enemas 
containing 5-ASA plus sodium butyrate (80 mM) twice a day, show a significant 
improvement of the disease activity score, compared with those treated with 5-
aminosalicylic acid (5-ASA) alone. These studies suggest butyrate is a useful 
therapy for the treatment of this condition. 
Studies have shown that butyrate and propionate favorably activate FFAR3 more 
than acetate, which leads to suppressing weight gain and stimulating gut hormones 
(Gao et al., 2009, Lin et al., 2012). This has been further studied by Lin et al. (2012) 
who fed FFAR3 knockout mice and wild-type littermates with standard chow diet, 
and for one week with high fat diet (HFD). They observed that the FFAR3 knockout 
mice showed no significant difference in body weight compared to their wild-type 
littermates on standard chow and HFD diets. Then the HFD was supplemented with 
butyrate and propionate and provided to the mice for eight days. The results showed 
that the butyrate and propionate inhibited weight gain and food intake in FFAR3 
knockouts to the same extent as in wild-type mice. Moreover, Gao et al. (2009) 
reported that a HFD supplemented with butyrate (5 % wt/wt) reduced obesity and 
insulin resistance in obese mice; they also observed that the plasma butyrate 
concentration increased and blood lipids decreased, showing that butyrate has an 
effect on lipid profiles as well as suppressing weight gain. The results of these 
studies showed that butyrate and propionate have an impact on reducing body 
weight and lipids profiles.     
Numerous studies have shown that urinary output can be used as functional 
markers of human vitamin C status for individual and population dietary intake 
assessments (Carr et al., 2012, Carr et al., 2013). In randomized cross-over study 
of fifteen male university students for 4 weeks, Carr et al. (2012) examined the effect 
of a high vitamin C containing fruit intake such as kiwifruit on blood plasma and urine 
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vitamin C levels and specifically to determine the dosage required to reach ‘healthy’ 
and ‘optimal’ levels. They observed that one kiwifruit per day was sufficient to 
achieve ‘healthy’ plasma and urine levels of vitamin C (>50 µmol/l) and with 2 or 3 
per day, ‘optimal’ plasma and urine levels of the vitamin were reached. They have 
suggested that plasma and urinary vitamin C may reflects dietary intake. On the 
other hand, most of interventional studies in this area have demonstrated that 
consumption of diets rich in NDCs, such as cereals, fruit and vegetables might be 
protective against CVD, CRC, obesity, satiety and diabetes, and it is believed that 
some of the protective effects of NDCs may be attributed to their fermentation to 
SCFA in the colon by the colonic microbiota (Tan et al., 2013). However, until now 
these interventional studies have relied on many food composition tables’ old 
values, due to the lack of new values (Westenbrink et al., 2013b). Additionally, the 
amount of NDCs that enters the colon is difficult to estimate because we cannot 
measure SCFA production, not all non-digestible fibres are fully fermented, and 
some dietary components normally considered to be fully digested and absorbed in 
the small intestine may actually escape and enter the colon, for example fructose if 
eaten in large amounts (Cummings, 1997). RS intake is difficult to determine 
because any handling of starchy foods in the diet, for example mixing with water, 
heating, homogenization, freezing or cooling, may affect RS content (Sharma et al., 
2008). Overall the importance of FC on colonic health remains unrecognized, mainly 
because there is no validated method to study SCFA production and colonic 
fermentation in vivo, the only way to quantify NDC intake is food tables; however, 
most FC may be hidden in food tables, not defined or unavailable (Westenbrink et 
al., 2013b). Therefore, an index of FC value needs to be developed to determine 
the bioactive fraction and to predict SCFA production in the colon.  
This chapter describes the further development of the equations to predict FC in the 
diet, based on the content of NDCs in foods, their fermentability and an 
approximation of RS content. This was then compared with urinary SCFA 
concentrations measured in human volunteers who had kept 7 day dietary diaries. 
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   Objectives 
The objectives of the study were: 
1. To develop an index to estimate FC in the diet from dietary records to predict 
SCFA production in the colon in vivo in humans  
2. Assessment of the relationship between FC intake and urinary excretion of 
SCFA products for human volunteers based on their habitual diet 
 Methods  
 Study population  
4.3.1.1 Habitual diet study  
The data used in this study was obtained from a previous project “Validating in vivo 
biomarkers of colonic carbohydrate and protein fermentation” conducted in 2009 by 
the Human Nutrition Section, University of Glasgow, and was provided by Professor 
Christine Edwards, Professor Tom Preston, Dr Douglas Morrison, Dr Laura Hanske 
and Alexandra C Small. Of 241 healthy volunteers, 77 subjects withdrew their 
willingness to participate, and 25 subjects met the exclusion criteria, therefore only 
122 subjects completed the study (52 males, 70 females, mean age 34.8 years (19 
– 64 years), mean body mass index (BMI) 25.5 kg/m2 (16.7 – 39.9 kg/m2)) and 
provided urine collection and dietary records that had satisfactory urinary analysis 
conducted. The 122 subjects were also examined for under-reporting of dietary 
intake by using physical activity level (PAL) 1.2 × Basal Metabolic Rate (BMR) 
equation, calculated from weight according to Schofield (1984) as a cut-off to 
determine if calculated caloric intake fell below 1.2 × BMR. Of the 122 included in 
the study, only 78 subjects were considered as valid participants and included in the 
second group (42 females and 36 males).   
 Three day weighed record of habitual diet  
The results from a three day weighed record of habitual diet, and corresponding 
urinary excretion of SCFA products, for 122 participants from the general population 
were included in this study. Diet diaries were analysed for daily energy and 
macronutrient intake in absolute amounts, as well as the percentage of energy 
derived from the main macronutrients. This entailed a literature review for contents 
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of oligosaccharides and resistant starch in foods on websites, as well as other data 
sources for fibre content. Habitual diet was analysed for FC using equations 
developed in chapter 3. 
 Statistical analysis 
Statistical analysis was performed for all data using Minitab statistical software 
version 16.1.2 (Minitab Inc., State College, Pennsylvania, USA). The normality of 
the data was tested using the Anderson-Darling test, which showed the data were 
not-normally distributed. Descriptive statistics are presented as medians and inter 
quartile range (IQR). Mann-Whitney U test was applied to measure the differences 
in independent variables between genders and anthropometrics characteristics, 
genders and FC, genders and the excretion of the urinary SCFA products. 
Spearman Rank correlation was used to determine rank correlations between 
different continuous variables such as, DF (AOAC 991.43 method), FC-DF, NSP, 
FC-NSP, protein and alcohol intake (since alcohol is a potential confounding factor 
in acetate production) and colonic fermentation biomarkers. Additionally, in the 
habitual diet study a regression analysis was conducted on the preferred biomarkers 
to derive an index with confidence, and prediction intervals, to examine the power 
of predictive markers of FC intake from urinary biomarkers. Any p-values of less 
than 0.05 were considered significant.    
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 Results 
 Anthropometric Characteristics  
Dietary records and urine were collected from 241 healthy volunteers who 
responded to the recruitment advert expressing an interest in the study. Of 241 
healthy volunteers, 77 subjects withdrew their willingness to participate and 25 
subjects met the exclusion criteria. Of 139 volunteers who had not taken antibiotics 
for at least three months prior to the study, only 122 subjects completed the study. 
A total of 122 healthy volunteers (52 males, 70 females, mean age 34.8 years (19 – 
64 years), mean BMI is 25.5 kg/m2 (16.7 – 39.9 kg/m2)) completed the 24 h urine 
collection (Table 4.1). 
Table 4.1: Characteristics of all study participants (n = 122); values are the median and 
range.  
 * Mann-Whitney; Statistical significant value (p < 0.05) 
As mentioned previously, the 122 subjects were also examined for under-reporting 
of dietary intake by using physical activity level (PAL) 1.2 × BMR equation from 
weight according to Schofield (1984). Of the 122 in the study, only 78 valid subjects 
were included (42 females and 36 males) (Table 4.2).  
 
 
 
 
 
 
 
 Female 
n = 70 
Male 
n = 52 
 Median Range Median Range 
Age (years) 31 19 - 64 30 19 - 57 
Height (cm) 165 153 - 181 176 154 – 194 * 
Weight (kg) 65.8 46.5 - 109 79.1 58.6 – 112 * 
BMI (Kgm-2) 24.4 16.7 - 39.9 25 20 - 33.4 
Energy (kcal/day) 1770 1073 - 3163 2448 1271 – 4035 * 
Protein (g/d) 70.5 29.8 – 119.1 102.4 48.1 – 230.1* 
Alcohol (g/d) 0.0 0.0 – 29.2 0.0 0.0 – 61.3 
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Table 4.2: Characteristics of the valid participants (n= 78); values are the median and range. 
 Female 
n = 42 
Male 
n = 36 
 Median Range Median Range 
Age (years) 31.5 19 - 64 31 19 - 57 
Height (cm) 165 155 - 176 177 156 – 193 * 
Weight (kg) 64.5 46.5 - 109 76.8 58.6 – 113 * 
BMI (Kgm-2) 23.6 16.8 - 35.2 24 20 - 33.1 
Energy (kcal/day) 2054 1542 - 3163 2579 1912 – 4035 * 
Protein (g/d) 78.9 50.7 – 119.1 103.7 50.3 – 230.1* 
Alcohol (g/d) 2.0 0.0 – 29.2 0.0 0.0 – 61.3 
* Mann-Whitney; Statistical significant value (p < 0.05) 
 
 Characteristics of daily fermentable carbohydrate intake 
The results (Table 4.3) for the daily estimated FC intake of all the healthy volunteers 
(n = 122) in absolute amounts after three days of habitual diet, showed how the 
different markers measured varied between participants. There was no significant 
difference in the daily NSP intake between females and males observed after three 
days of habitual diet intake, whereas DF intake was higher in males compared to 
females (IQR 9.9; p = 0.03). There was a significantly higher intake of estimated FC-
DF 1 (IQR 6.1; p = 0.0001) and FC-NSP 1 (IQR 4.9; p = 0.0001) in males compared 
with females. After the addition of 50 % insoluble fibre to FC equations, males 
continued to have higher intake of estimated FC-DF2 (IQR 9.7; p = 0.0001) and FC-
NSP 2 (IQR 8.1; p = 0.0001) compared to females. Moreover, the estimated FC-DF 
3 (IQR 7.6; p = 0.0001) and FC-DF 4 (IQR 11.7; p = 0.0001) and FC-NSP 3 (IQR 
7.0; p = 0.0001) and FC-NSP 4 (IQR 10.3; p = 0.0001) intakes were also higher in 
males than females. This suggests that the diets differed between the males and 
females in this study. 
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Table 4.3: Characteristics of all the study participants and predicted fermentable 
carbohydrate intake (n = 122); values are the median and range. 
 Female  
n = 70 
Male 
n = 52 
 
 
 Median IQR Median IQR p value* 
DF (AOAC; g/d) 18.5 11.8 22.6 9.9 0.03 
FC-DF 1ӕ (g/d) 12.4 5.5 16.6 6.1 0.0001 
FC-DF 2Ө (g/d) 21.3 9.4 26.4 9.7 0.0001 
FC-DF 3¥ (g/d) 18.7 8.5 25.2 7.6 0.0001 
FC-DF 4§ (g/d) 27.9 12.2 34.5 11.7 0.0001 
NSP (Southgate; g/d) 17.2 8.4 18.7 8.7 0.06 
FC-NSP 1Ӕ (g/d) 12.6 4.4 16.8 4.9 0.0001 
FC-NSP 2ԃ (g/d) 18.8 6.11 24.7 8.1 0.0001 
FC-NSP 3Ж (g/d) 18.7 8.7 25.9 7.0 0.0001 
FC-NSP 4Л (g/d) 25.5 8.9 33.3 10.3 0.0001 
ӕ FC-DF1 = soluble DF + 10% insoluble DF + oligosaccharide + 5% TS; Ӕ FC-NSP1 = soluble NSP + 10% insoluble NSP + 
oligosaccharide + 5% TS; Ө FC-DF2 = soluble DF + 50% insoluble DF + oligosaccharide + 5% TS; ԃ FC-NSP2 = soluble NSP 
+ 50% insoluble NSP + oligosaccharide + 5% TS; ¥ FC-DF3 = soluble DF + 10% insoluble DF + oligosaccharide + 10% TS; Ж 
FC-NSP3 = soluble NSP + 10% insoluble NSP + oligosaccharide + 10% TS; § FC-DF4 = soluble DF + 50% insoluble DF + 
oligosaccharide + 10% TS; Л FC-NSP4 = soluble NSP + 50% insoluble NSP + oligosaccharide + 10% TS; * Mann-Whitney; 
Statistical significant value (p < 0.05) 
The daily estimated FC intake of the valid participants (n = 78), after three days of 
habitual diet showed no significant difference in the daily DF and NSP intake 
between females and males (Table 4.4). It was observed that there was a significant 
difference in the intakes of estimated FC-DF 1 (IQR 5.9; p = 0.0001) and FC-NSP 1 
(IQR 4.3; p = 0.0001) between males and females. After the addition of 50 % 
insoluble fibre to FC equations, males continued to have a higher intake of estimated 
FC-DF2 (IQR 11.9; p = 0.0003) and FC-NSP 2 (IQR 7.1; p = 0.0001) compared to 
females. Similarly, the estimated FC-DF 3 (IQR 7.4; p = 0.0001) and FC-DF 4 (IQR 
12.9; p = 0.0001) and FC-NSP 3 (IQR 5.7; p = 0.0001) and FC-NSP 4 (IQR 8.8; p = 
0.0001), which contained 10 % of total starch, showed that male subjects have 
higher FC intakes than females.  
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Table 4.4: Characteristics of the valid participants and predicted fermentable carbohydrate 
intake (n = 78); values are median and range. 
ӕ FC-DF1 = soluble DF + 10% insoluble DF + oligosaccharide + 5% TS; Ӕ FC-NSP1 = soluble NSP + 10% insoluble NSP + 
oligosaccharide + 5% TS; Ө FC-DF2 = soluble DF + 50% insoluble DF + oligosaccharide + 5% TS; ԃ FC-NSP2 = soluble NSP 
+ 50% insoluble NSP + oligosaccharide + 5% TS; ¥ FC-DF3 = soluble DF + 10% insoluble DF + oligosaccharide + 10% TS; Ж 
FC-NSP3 = soluble NSP + 10% insoluble NSP + oligosaccharide + 10% TS; § FC-DF4 = soluble DF + 50% insoluble DF + 
oligosaccharide + 10% TS; Л FC-NSP4 = soluble NSP + 50% insoluble NSP + oligosaccharide + 10% TS; * Mann-Whitney; 
Statistical significant value (p < 0.05) 
 
 Urinary excretion output of SCFAs 
The 24 h urinary excretion output of SCFA products of all the participants in the 
study of healthy volunteers (n = 122) (Table 4.5), showed that the 24 h urinary 
excretion output acetate was higher (IQR 377.8; p = 0.06) in males. The 24 h urinary 
excretion output SCFA was also higher (IQR 379.1; p = 0.06) in males compared to 
females, but the difference did not reach statistical significance. The 24 h urinary 
excretion of propionate was higher (IQR 5.0; p = 0.008) in males compared to 
females. In addition, the 24 h urinary excretion output BCFA was also higher (IQR 
20.9; p = 0.002) in males than females. On the other hand, the 24 h urinary excretion 
of butyrate did not show any difference between males and females (IQR 1.5; p = 
0.92).  
 
 
 
 
 
 
 
 Female  
n = 42 
Male 
n = 36 
 
 
 Median IQR Median IQR p value* 
DF (AOAC; g/d) 22 8.2 22.9 11.3 0.11 
FC-DF 1ӕ (g/d) 13.6 4.0 16.7 5.9 0.0001 
FC-DF 2Ө (g/d) 21.7 9.0 26.7 11.8 0.0003 
FC-DF 3¥ (g/d) 20.8 6.6 25.5 7.4 0.0001 
FC-DF 4§ (g/d) 29.4 12.2 36.0 12.9 0.0001 
NSP (Southgate; g/d) 18.6 7.4 19.9 11.2 0.12 
FC-NSP 1Ӕ (g/d) 13.6 2.8 17.7 4.3 0.0001 
FC-NSP 2ԃ (g/d) 20.1 6.6 24.9 7.1 0.0001 
FC-NSP 3Ж (g/d) 20.8 4.4 26.4 5.7 0.0001 
FC-NSP 4Л (g/d) 26.5 8.5 33.3 8.8 0.0001 
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Table 4.5: Total daily excretion of 24 h urinary SCFA products (µmol/24 h) of all study 
participants (n=122); values are median and range. 
 
Female  
n = 70 
Male 
n = 52 
 
 
Median  IQR Median  IQR p value* 
Acetate 24h 445.4 292.3 511.9 377.8 0.06 
Propionate 24h 6.4 3.9 8.2 5.0 0.008 
Butyrate 24h 1.0 1.5 1.0 1.4 0.92 
SCFA 24h 451.8 298.0 519.0 379.1 0.06 
BCFA 24 h 21.5 21.5 28.6 20.9 0.002 
SCFA: BCFA 24 h 20.17 20.2 18.6 10.8 0.08 
Acetate: 2mB 24 h 46.0 30.5 41.5 24.5 0.24 
Acetate: 3mB 24 h 82.8 42.0 73.5 34.8 0.12 
* Mann-Whitney; Statistical significant value (p < 0.05) 
However, the 24 h urinary excretion of acetate (Table 4.6) was higher (IQR 395.4; 
p = 0.04) and the 24 h urinary excretion of SCFA was also higher (IQR 397.2; p = 
0.04) in males compared to females, for the valid subjects (n = 78). The 24 h urinary 
excretion of propionate was also higher (IQR 5.4; p = 0.01) in males compared to 
females. Moreover, the 24 h urinary excretion output BCFA was also higher (IQR 
18.8; p = 0.001) in males than females. The 24 h urinary excretion of butyrate was 
higher in males compared to females, but still did not show any significant difference 
(IQR 1.6; p = 0.66).   
Table 4.6: Total daily excretion of 24 h urinary SCFA products (µmol/24 h) of the valid 
participants’ outputs (n = 78); values are median and range 
* Mann-Whitney; Statistical significant value (p < 0.05) 
 
 
 
 
 
 
Female  
n = 42 
Male 
n = 36 
 
 
Median  IQR Median  IQR p value* 
Acetate 24 h 454.9 266.2 527.7 395.4 0.04 
Propionate 24 h 6.4 3.5 8.2 5.4 0.01 
Butyrate 24 h 1.0 1.4 1.0 1.6 0.66 
SCFA 24 h 460.3 270.3 537.1 397.2 0.04 
BCFA 24 h 23.7 20.6 28.5 18.8 0.001 
SCFA: BCFA 24 h 21.5 11.8 18.7 11.4 0.07 
Acetate: 2mB 24 h 46.9 32.3 42.0 24.1 0.18 
Acetate: 3mB 24 h 82.8 46.2 69.9 44.5 0.09 
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 Relationships between fermentable carbohydrate and 
urinary excretion of SCFA products 
The study data were analysed for all healthy volunteers (n = 122) and study valid 
participants (n = 78). The Spearman correlation coefficient (R) was used to 
determine the relationship between FC variables and urinary biomarkers of colonic 
fermentation.  
4.5.4.1 Relationship between DF, FC-DF and urinary biomarkers of colonic 
fermentation (n = 122) 
In all study participants (n = 122) the results (Table 4.7) showed that data analysis 
confirmed the predicted relationships between DF (AOAC 991.43 method), FC-DF, 
NSP, FC-NSP, protein and alcohol intake (since alcohol is a potential confounder in 
acetate production) and colonic fermentation biomarkers. The predicted FC-DF 1 
showed no relationship with the 24 h urinary excretion of colonic fermentation 
biomarkers. In FC-DF 2, the addition of 50 % insoluble fibre improved the 
relationship between FC and the 24 h urinary excretion of acetate (R = 0.22; p = 
0.01; Figure 4.1) and SCFA (R = 0.21; p = 0.01), whereas no relationship with other 
SCFA products was seen.  
Figure 4.1: Scatter-plot showing correlation of FC-DF2 with urinary excretion of acetate 
(µmol/24 h) of all participants.  
 
R; Spearman rank correlation, FC-DF2; fermentable carbohydrate-dietary fibre 2. P-value based on Spearman 
rank correlation.  
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The relationship between the predicted FC-DF 3 and the 24 h urinary excretion of 
colonic fermentation biomarkers was similar to the relationship reported by FC-DF 
1, which could be due to the presence of only 10 % of insoluble fibre in the FC-DF 
3 equation. When 50 % insoluble fibre was combined with 10 % of TS in the 
predicted FC-DF 4 equation (Table 4.7), a significant positive relationship was 
observed between FC and the 24 h urinary excretion of acetate (R = 0.20; p = 0.02; 
Figure 4.2) and SCFA (R = 0.20; p = 0.02; Figure 4.3), whereas there was no 
relationship was observed with the other SCFA products. There was also a 
significant correlation between DF and the 24 h urinary acetate and SCFA.  
Figure 4.2: Scatter-plot showing correlation of FC-DF 4 with urinary excretion of acetate 
(µmol/24 h) of all participants.  
  
R; Spearman rank correlation, FC-DF4; fermentable carbohydrate-dietary fibre 4. P-value based on Spearman 
rank correlation.  
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Figure 4.3: Scatter-plot showing correlation of FC-DF 4 with urinary excretion of SCFA 
(µmol/24 h) of all participants.  
 
R; Spearman rank correlation, FC-DF4; fermentable carbohydrate-dietary fibre 4. SCFA; short chain fatty acid. P-
value based on Spearman rank correlation.  
 
4.5.4.1 Relationship between NSP and FC-NSP and urinary biomarkers of 
colonic fermentation (n = 122) 
Data from all the study participants (n = 122) showed a higher correlation between 
the predicted FC-NSP and the urinary colonic fermentation biomarkers. There was 
a significant positive relationship between FC-NSP 1 and 24 h urinary excretion of 
acetate (R = 0.19; p = 0.03) and SCFA (R = 0.19; p = 0.03). The predicted FC-NSP 
2 also showed a positive correlation with the 24 h urinary excretion of acetate (R = 
0.22; p = 0.01) and SCFA (R = 0.22; p = 0.01); while there was no relationship 
observed between FC-NSP 3 and the 24 h urinary biomarkers when only 10 % of 
insoluble fibre was added to the predicted FC-DF3 equation (Table 4.7). The 
predicted FC-NSP 4 was positively correlated with the 24 h urinary excretion of 
acetate (R = 0.18; p = 0.04) and SCFA (R = 0.18; p = 0.04; Figure 4.4). There was 
a significant positive relationship between the protein intake and BCFA output in the 
urine (R = 0.45; p < 0.01). Moreover, a regression predictive model was developed 
to assess the association between predictive FC equations and urinary biomarker, 
this showed there was a positive significant relationship between FC-DF 4, FC-NSP 
4 and 24 h urinary excretion of acetate.  
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Figure 4.4: Scatter-plot showing correlation of FC-NSP 4 with urinary excretion of acetate 
(µmol/24 h) of all participants.  
 
R; Spearman rank correlation, FC-NSP 4; fermentable carbohydrate-non starch polysaccharide 4. P-value based 
on Spearman rank correlation.  
The data from all the study participants (n = 122) showed a negative relationship 
between protein vs. acetate: 2-methylbutyrate, protein vs. acetate: 3-methylbutyrate 
(Figure 4.5) and protein vs. SCFA: BCFA. On the other hand, an analysis of the data 
by a multivariate regression model of protein intake and iso-butyrate (p < 0.001) and 
2-methylbutyrate (p = 0.003) as protein urinary excretion biomarkers, with FC-DF 
and FC-NSP as covariates, showed no significant effect for FC intake on the 
excretion of biomarkers related to protein intake. However, when the 24 h urinary 
excretion of acetate was added to the multivariate regression model as a urinary 
excretion biomarker of FC, there was a significant effect on iso-butyrate (p = 0.005) 
and intake protein disappeared. This effect of the 24 h urinary excretion of acetate 
(as the predominant SCFA product) might provide evidence that increasing FC 
intake could decrease protein fermentation products.  
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Figure 4.5: Scatter-plot showing correlation between protein intake vs. acetate: 3-
methylbutrate (dotted line) and acetate: 2-methylbutyrate ratios (solid line). 
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Table 4.7: Correlation between dietary fibre (AOAC), NSP, FC and urinary biomarkers of colonic fermentation of all the study participants (n = 122). 
 Correlation* Acetate Propionate Butyrate SCFA BCFA SCFA: BCFA Acetate:2mB Acetate:3mB 
Iso-
butyrate 
2mBψ 3mBφ 
DF R 0.20 0.04 0.02 0.19 0.07 0.21 0.20 0.13 0.03 0.04 0.15 
 p 0.02 NS NS 0.03 NS 0.02 0.02 NS NS NS NS 
             
FC-DF1 R 0.15 0.08 0.00 0.15 0.11 0.03 0.06 -0.04 0.09 0.09 0.20 
5 % TS & 10 % insoluble DF p NS NS NS NS NS NS NS NS NS NS 0.02 
             
FC-DF2  R 0.22 0.11 0.03 0.21 0.11 0.14 0.15 0.07 0.07 0.08 0.21 
5 % TS & 50 % insoluble DF   P 0.01 NS NS 0.01 NS NS NS NS NS NS 0.02 
             
FC-DF3 R 0.14 0.09 0.01 0.14 0.11 0.01 0.04 -0.04 0.08 0.10 0.19 
10 % TS & 10 % insoluble DF p NS NS NS NS NS NS NS NS NS NS NS 
             
FC-DF4  R 0.20 0.12 0.04 0.20 0.12 0.11 0.11 0.04 0.08 0.10 0.21 
10 % TS & 50 % insoluble DF p 0.02 NS NS 0.02 NS NS NS NS NS NS NS 
             
NSP R 0.22 0.04 0.02 0.22 0.08 0.22 0.22 0.15 0.04 0.06 0.17 
 p 0.01 NS NS 0.01 NS 0.01 0.01 NS NS NS NS 
             
FC-NSP1 R 0.19 0.17 -0.03 0.19 0.13 0.05 0.08 0.01 0.15 0.09 0.18 
5 % TS &10 % insoluble NSP p 0.03 NS NS 0.03 NS NS NS NS NS NS 0.04 
             
FC-NSP2  R 0.22 0.15 0.01 0.22 0.10 0.15 0.16 0.09 0.10 0.08 0.17 
5 % TS & 50 % insoluble NSP p 0.01 NS NS 0.01 NS NS NS NS NS NS NS 
             
FC-NSP3 R 0.16 0.15 0.00 0.16 0.13 0.03 0.06 0.00 0.13 0.10 0.17 
10 % TS & 10 % insoluble NSP p NS NS NS NS NS NS NS NS NS NS NS 
             
FC-NSP4  R 0.18 0.13 0.02 0.18 0.10 0.11 0.12 0.06 0.08 0.08 0.17 
10 % TS & 50 % insoluble NSP p 0.04 NS NS 0.04 NS NS NS NS NS NS NS 
             
Protein R 0.30 0.31 0.02 0.31 0.47 -0.20 -0.18 -0.13 0.49 0.39 0.48 
 p 0.00 0.00 NS 0.00 0.00 NS NS NS 0.00 0.00 0.00 
             
Alcohol R 0.23 0.04 0.02 0.23 0.09 0.15 0.12 0.14 0.07 0.10 0.11 
 p 0.01 NS NS 0.01 NS NS NS NS NS NS NS 
BCFA, Branched chain fatty acid; SCFA, Short chain fatty acid; ψ2mB, 2-methylbutyrate; φ3mB, 3-methylbutyrate; *R, Spearman correlation coefficients
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4.5.4.2 Relationship between DF, FC-DF and urinary biomarkers of colonic 
fermentation in the valid participants (n =78) 
The data of valid participants (n = 78) were analysed to determine the relationships 
between DF (AOAC 991.43 method), FC-DF, NSP, FC-NSP, protein intake, alcohol 
intake, and colonic fermentation biomarkers (Table 4.8). Data analysis showed no 
relationship between DF and the 24 h urinary excretion of colonic fermentation. The 
only positive relationship that was observed was between DF and urinary excretion 
of SCFA: BCFA (R = 0.27; p = 0.01). The predicted FC-DF 1 showed a positive 
relationship with 3-methylbutraye (R = 0.31; p < 0.01). FC-DF 2 and FC-DF 3 
showed no relationship with the 24 h urinary excretion of colonic fermentation 
biomarkers of FC, whereas FC-DF 3 showed a significant positive relationship with 
3-methylbutyrate (R = 0.29; p < 0.01). Only FC-DF 4 with the addition of 50 % 
insoluble fibre and 10 % of TS showed a significant positive relationship with the 24 
h urinary excretion of acetate (R = 0.22; p = 0.04; Figure 4.6) and SCFA (R = 0.22; 
p = 0.04; Figure 4.7); whereas no relationship with other SCFA products was seen.  
Figure 4.6: Scatter-plot showing correlation of FC-DF 4 with urinary excretion of acetate 
(µmol/24 h) of valid participants (n = 78).   
 
R; Spearman rank correlation, FC-DF4; fermentable carbohydrate-dietary fibre 4. P-value based on Spearman 
rank correlation.  
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Figure 4.7: Scatter-plot showing correlation of FC-DF 4 with urinary excretion of SCFA 
(µmol/24 h) of valid participants (n = 78).   
 
R; Spearman rank correlation, FC-DF4; fermentable carbohydrate-dietary fibre 4. P-value based on Spearman 
rank correlation.  
 
4.5.4.3 Relationship between NSP and FC-NSP and urinary biomarkers of 
colonic fermentation in the valid participants (n = 78)  
The data of valid participants (n = 78) showed a higher correlation between the 
predicted FC-NSP and urinary colonic fermentation biomarkers than all participants 
(n = 122). There was a significant positive relationship between FC-NSP 1 and the 
24 h urinary excretion of acetate (R = 0.29; p = 0.01), SCFA (R = 0.29; p = 0.01) 
and propionate (R = 0.26; p = 0.02). The predicted FC-NSP 2 also showed a positive 
correlation with 24 h urinary excretion of acetate (R = 0.29; p = 0.01) and SCFA (R 
= 0.29; p = 0.01). There was also a relationship between FC-NSP 3 and the 24 h 
urinary FC biomarker of acetate (R = 0.27; p=0.01), SCFA (R = 0.27; p = 0.01) and 
propionate (R = 0.22; p = 0.05). There was positive relationship between predicted 
FC-NSP 1 and 2-methylbutrate (R = 0.25; p = 0.03); protein fermentation 
metabolites and FC-NSP 3 also correlated with 3-methylbutyrate excretion (R = 
0.25; p = 0.03). The predicted FC-NSP 4 positively correlated with the 24 h urinary 
excretion of acetate (R = 0.26; p = 0.02; Figure 4.8) and SCFA (R = 0.26; p = 0.02). 
There was a significant positive relationship between protein intake and BCFA 
output in the urine (R = 0.45; p < 0.01). A regression predictive model was developed 
to assess the association between the predictive FC equations and urinary 
biomarker, the results showed there was a positive significant relationship between 
FC-DF 4, FC-NSP 4 and the 24 h urinary excretion of acetate. 
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Figure 4.8: Scatter-plot showing correlation of FC-NSP 4 with urinary excretion of acetate 
(µmol/24 h) of valid participants (n = 78).   
 
 
R; Spearman rank correlation, FC-NSP 4; fermentable carbohydrate of non-starch polysaccharide 4. P-value 
based on Spearman rank correlation.  
The data of valid participants (n = 78) showed an inverse relationship between 
protein vs. acetate: 2-methylbutyrate, protein vs. acetate: 3-methylbutyrate and 
protein vs. SCFA: BCFA. On the other hand, an analysis of the data by a multivariate 
regression model of protein intake and iso-butyrate (p = 0.005) and 2-methylbutyrate 
(p = 0.02) as protein urinary excretion biomarkers, with FC-DF and FC-NSP as 
covariates, showed no significant effect of FC intake on excretion of these 
biomarkers of protein intake. Even when the 24 h urinary excretion of acetate was 
added to the multivariate regression model as a urinary excretion biomarker of FC, 
there was still no significant relationship between 2-methylbutyrate (p = 0.085) and 
3-methylbutyrate (p = 1.00) and protein intake. This negative relationship might 
provide evidence that increasing FC intake causes a reduction in the protein 
fermentation metabolite productions. 
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Table 4.8: Correlation between Dietary fibre (AOAC), NSP and FC and urinary biomarkers of colonic fermentation of the valid participants (n = 78). 
 Correlation* Acetate Propionate Butyrate SCFA BCFA SCFA: BCFA Acetate:2mB Acetate:3mB 
Iso-
butyrate 
2mBψ 3mBφ 
DF   R  0.13 0.00 0.06 0.13 -0.04 0.27 0.21 0.20 -0.10 -0.04 0.06 
 p NS NS NS NS NS 0.01 NS NS NS NS NS 
             
FC-DF1 R 0.20 0.09 -0.03 0.20 0.19 0.00 0.03 -0.08 0.11 0.17 0.31 
5 % TS & 10 % insoluble DF p NS NS NS NS NS NS NS NS NS NS 0.00 
             
FC-DF2  R 0.21 0.12 0.06 0.21 0.10 0.17 0.13 0.09 0.01 0.08 0.22 
5 % TS & 50 % insoluble DF p NS NS NS NS NS NS NS NS NS NS NS 
             
FC-DF3 R 0.20 0.10 -0.02 0.20 0.19 0.01 0.03 -0.05 0.09 0.17 0.29 
10 % TS & 10 % insoluble DF p NS NS NS NS NS NS NS NS NS NS 0.00 
             
FC-DF4  R 0.22 0.14 0.08 0.22 0.14 0.13 0.09 0.07 0.04 0.13 0.24 
10 % TS & 50 % insoluble DF p 0.04 NS NS 0.04 NS NS NS NS NS NS 0.03 
             
NSP R 0.14 -0.03 0.06 0.14 0.00 0.23 0.18 0.18 -0.08 0.00 0.06 
 p NS NS NS NS NS 0.03 NS NS NS NS NS 
             
FC-NSP1 R 0.29 0.26 -0.08 0.29 0.20 0.05 0.10 0.02 0.20 0.15 0.25 
5 % TS & 10 % insoluble NSP p 0.01 0.02 NS 0.01 NS NS NS NS NS NS 0.03 
             
FC-NSP2  R 0.29 0.16 0.03 0.29 0.10 0.22 0.19 0.16 0.04 0.08 0.18 
5 % TS & 50 % insoluble NSP p 0.01 NS NS 0.01 NS 0.04 NS NS NS NS NS 
             
FC-NSP3 R 0.27 0.22 -0.04 0.27 0.20 0.05 0.08 0.03 0.17 0.17 0.25 
10 % TS & 10 % insoluble NSP p 0.01 0.05 NS 0.01 NS NS NS NS NS NS 0.03 
             
FC-NSP4  R 0.26 0.16 0.05 0.26 0.12 0.16 0.13 0.12 0.05 0.11 0.19 
10 % TS & 50 % insoluble NSP p 0.02 NS NS 0.02 NS NS NS NS NS NS NS 
             
Protein R 0.33 0.30 0.08 0.33 0.47 -0.16 -0.12 -0.11 0.50 0.38 0.48 
 p 0.00 0.00 NS 0.00 0.00 NS NS NS 0.00 0.00 0.00 
             
Alcohol R 0.26 0.04 0.08 0.26 0.06 0.22 0.16 0.19 0.03 0.09 0.08 
 p 0.02 NS NS 0.02 NS NS NS NS NS NS NS 
BCFA: Branched chain fatty acid; SCFA Short chain fatty acid; ψ2mB, 2-methylbutyrate; φ3mB, 3-methylbutyrate; *R, Spearman correlation coefficients
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 Discussion  
Several studies have demonstrated that long term consumption of diets rich in 
NDCs, such as cereals, fruit and vegetables might be protective against CVD 
(Estruch et al., 2009), CRC (Bingham et al., 2003), obesity (Bazzano et al., 2005) 
and diabetes (Lindström et al., 2006). It is proposed that some of the protective 
effects of NDCs may be attributed to their fermentation to SCFA in the colon by the 
colonic microbiota (Edwards et al., 1996). However, these studies use traditional 
dietary analysis methods which depend on old food composition databases, which 
may not have been updated to include all FC sources and so do not provide accurate 
data on NDCs intake whether or not it is fermented (Westenbrink et al., 2013b). 
Therefore, this study describes a comparison between our predictive equations 
developed to estimate the amount of potential FC from dietary records of secondary 
analysis study combined with urinary excretion of SCFA.  
Our results for both data analyses (n = 122) and (n = 78), showed weak but 
significant correlation between the 24 h urinary excretion of acetate and estimated 
FC-DF 4 and FC-NSP 4. In the same manner, the 24 h urinary excretion of SCFA 
was correlated with estimated FC-DF 4 and FC-NSP 4. It was also observed that 
FC-DF and FC-NSP had positive correlations with 24h urinary acetate and SCFA 
compared with DF and NSP alone. Hence, it could be hypothesised that using 
developed index to estimate FC in the diet form dietary records, might predict SCFA 
production in the colon in vivo in humans. There are a number of potential reasons 
that might explain the weak correlation between predicted FC intake and 24 h 
urinary excretion of colonic metabolites.  
Firstly, this study examined habitual NDCs intake, which possibly represents the 
difficulty in assessing FC from dietary intake data, because participants are likely to 
eat a wide variety of DF, which not all may be readily fermentable, for example wheat 
bran. On the other hand, the supplementation/trial studies clearly added known and 
relatively well controlled amounts of fermentable NDCs, for example a randomized 
crossover block-design study carried out by Muir et al. (2004), fed 12 subjects three 
diets of wheat bran (WB 12 g/d), WBRS combined diet (WB 12 g/d and RS 22 g/d) 
or control for three weeks. They found a higher faecal concentration of acetate 
output (101 %) in the WBRS combined diet compared with WB alone and the 
control. Ahmed et al. (2000) examined colonic SCFA formation in patients with a 
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left-sided colectomy. They found a higher SCFA production, and in particular 
butyrate production after consumption of a specific mixture of high RS diet as 
compared with a low RS diet. Moreover, this is similar to the fermentation found in 
rats fed with various single fibre sources, including wheat barn and high amylose 
cornstarch, or in combinations for 13 days (Henningsson et al., 2002). Henningsson 
et al. (2002) observed that rats fed with known amount of high amylose cornstarch 
with wheat barn produced higher faecal excretion of total SCFA (184 ± 19 μmol/d), 
than rats fed with a single fibre source high amylose cornstarch (77 ± 10 μmol/d) or 
wheat barn (116 ± 12 μmol/d), which also showed the lowest SCFA producer was 
wheat bran which is comprised of > 80 % insoluble DF. Additionally, Le Leu et al. 
(2002) reported that when RS was combined with wheat bran in a rat diet, there was 
a high production total SCFA was observed. These findings further support that 
combined known amount of fermentable NDCs showed predictable higher SCFA 
concentration than habitual diets.       
The second reason that might explain the weak correlation between predicted FC 
intake and 24 h urinary excretion of colonic metabolites, is that approximately 95 % 
of all SCFA (acetate, propionate and butyrate) components are rapidly absorbed by 
the colonocytes, while the remaining 5 % are excreted in the faeces. All the 
metabolites are rapidly absorbed across the colonic epithelium, mediated by the 
specific cellular transport protein mono-carboxylate transporter isoform 1 (MCT-1) 
(Miller and Wolin, 1996). However, once they are transported out of the lumen of 
the colon, each SCFA can have a different fate; acetate and propionate pass 
through almost entirely into the portal circulation, whereas butyrate is considered as 
the major fuel driving energy transduction in colonocytes and therefore an unknown 
quantity reaches the portal circulation (Kimura et al., 2014). Once in the portal 
circulation, the SCFAs will be transported to the liver where only acetate escapes 
the first pass of hepatic metabolism to any significant degree; approximately 40 to 
60 % of acetate may spill over into the general circulation, whereas only a limited 
amount of propionate and a very small amount of butyrate appear systemically 
(Layden et al., 2013). These results suggest that excretion rates are a poor measure 
of dietary intake.   
These results suggest that acetate would to be the ideal systemic marker for NDCs 
fermentation in the colon, but the fate of hepatic splitting of acetate is complex and 
not yet completely understood (den Besten et al., 2013). Research has suggested 
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that approximately 70 % of the acetate production, which is exogenous acetate 
formed by colonic bacterial fermentation of NDCs and endogenous acetate, rather 
than formed in the liver during fatty acid oxidation, is taken up by the liver (Tan et 
al., 2013). The liver uses acetate as an energy source; but also as a substrate for 
the synthesis of cholesterol and long-chain fatty acids, and as a co-substrate for 
glutamine and glutamate synthesis; other tissues, including the heart, adipose 
tissue, kidney and skeletal muscle, metabolize the remainder of the acetate 
(Bloemen et al., 2009, Layden et al., 2013). It would be predicted that endogenous 
levels of acetate would scale with the metabolic rate, which would remain fairly 
constant and independent of NDCs intake, while exogenous acetate would relate to 
NDCs fermentation, and therefore would be variable depending on NDCs intake. 
This also might explain why the urinary excretion of SCFA is not well validated to 
reflect colonic production of SCFA, and the low level of urinary excretion of acetate 
in the study participants’ urine samples.   
Thirdly, under-reporting of food intake is one of the main obstacles that inhibit the 
collection of accurate habitual dietary intake data, which is often used to investigate 
the relationship between diet and health. Macdiarmid and Blundell (1998) stated that 
under-reporting ranged between 18 % and 54 % in the large nutritional surveys 
when considering the whole study group, and it could reach  up to 70 % in some 
subgroups. In particular, women were more likely to under-report their daily dietary 
intake than men, and under-reporting is also more common among overweight and 
obese individuals. In our study from all 122 healthy volunteers (n = 122), 36 % under-
reported their dietary intake. Of the 36 % under-reporting their dietary intake, 57 % 
were female, whereas from the data of valid participants (n = 78) 53.8 % were 
female. This is further supported  by a study conducted by Goran and Poehlman 
(1992), who assessed the relationship between body composition and energy intake 
in six women and seven men aged 56 - 78 years. They observed that women were 
underreporting their intake by 32 % and men were underreporting their intake by 13 
%. Moreover, Conway et al. (2003) recruited forty nine normal weight, overweight 
and obese women aged 21 - 65 years old to assess validity of the US Department 
of Agriculture (USDA) 5-step multiple-pass method for 24 h dietary recall. They 
observed that normal weight and overweight women significantly (p < 0.01) 
overestimated their energy, protein and carbohydrate intake. 
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The analysis of the 24 h urinary excretion outputs of SCFA products of all healthy 
volunteers (n = 122) and those valid participants only (n = 78) were higher in males 
compared to females, this can partly by explained by the frequent daily bowel 
movements in the females compared to the males, as this may account for the lower 
urinary SCFA product excretion in females. As the majority of NDCs are fermented 
in the colon, transit time  can influence changes in the microbiota and SCFA 
absorption, which may impact SCFA availability and metabolism (Lampe et al., 
1993b). There are several studies that have suggested a longer transit time in 
women compared to men (Lampe et al., 1993a, Fisher and Yousef, 1973, Gear et 
al., 1981, Degen and Phillips, 1996). Lampe et al. (1993) stated that men displayed 
faster transit time (p = 0.02) and greater stool bulk (p = 0.005) than women when 
they consumed identical dietary fibre, and men excreted more bile acid in the faeces 
than women (p < 0.05) (Lampe et al., 1993a). Other studies have reported similar 
results even when men and women consumed their habitual diet (Metcalf et al., 
1987, Davies et al., 1986, Kelsay and Clark, 1984, Rao et al., 1987). Faecal output 
was reported to be positively correlated, and transit time negatively correlated, with 
energy intake and food consumption (Eastwood et al., 1984, Kelsay and Clark, 
1984). 
The data from all study participants (n = 122) and valid participants (n = 78) showed 
that formation of SCFA from high FC intake might decrease production of protein 
fermentation products. It is believed that high FC intake might reduce the production 
of toxic metabolites in the large intestinal derived from the fermentation of 
fermentable proteins in humans and animals (Ross et al., 2013, Pieper et al., 2012). 
This has been shown in a study of seventeen healthy adults who participated in 
randomized crossover trial and received either wheat grain or refined grain for two 
weeks. The results showed that wheat grain increased acetate and butyrate 
production and decreased urinary excretion of protein fermentation products (Ross 
et al., 2013). Moreover, Pieper et al. (2012) showed that feeding thirty two weaned 
piglets a high FC diet increased the acetate to propionate ratio toward acetate (p < 
0.05), and reduced ammonia (p < 0.05) production. Overall these studies show that 
formation of SCFA derived from fermentable NDCs play a role in reducing the 
production of toxic metabolites in the large intestinal derived from the fermentation 
of fermentable proteins.       
 163 
 
In conclusion, the data of this study showed a weakly significant correlation between 
the 24 h urinary excretion of acetate and SCFA, and estimated FC-DF and FC-NSP. 
FC-DF and FC-NSP also had positive correlations with 24 h urinary acetate and 
SCFA compared to DF and NSP alone. The weak correlation between the 24 h 
urinary acetate, SCFA and FC estimated intake suggested that using urinary output 
may not be an appropriate index to reflect colonic production of SCFA. This might 
be explained by the high uptake of these substrates; approximately 70 % of the 
exogenous acetate formed by colonic bacterial fermentation of NDCs and 
endogenous acetate formed in the liver during fatty acid oxidation is taken up by the 
liver (Layden et al., 2013). Urinary excretion of SCFA was not validated well as it 
didn’t reflect the colonic production of SCFA as hoped. Therefore, an in vitro 
enzymatic digestion and fermentation study was conducted to investigate the 
relationship between NDCs and SCFA products (Chapter 5).          
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 Chapter Five 
Prediction of SCFA production from a single fibre 
and mixtures of fermentable carbohydrates using 
in vitro small intestinal digestion and human colon 
fermentation models and the equations for 
fermentable carbohydrate 
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 Introduction  
This chapter will examine the validity of the FC equations developed in chapter 3 
and tested on in vivo data in chapter 4, using in vitro models of small intestinal 
digestion and human colon fermentation. These equations were based on the 
content of dietary fibre in foods by using both the AOAC method and the NSP, with 
50 % of insoluble and 100 % of soluble fibre. Ten percent of the total starch was 
chosen to represent the amount of RS, and all NDOs were assumed to enter the 
colon for fermentation in the experiments. In chapter 4, these equations were 
applied to three day weighed dietary records of 122 healthy subjects on their 
habitual diet, and correlated with urinary SCFA production. It was observed weak 
but significant correlations between FC-DF 4, FC-NSP 4 with urinary acetate and 
SCFA. However, it was clear that urinary SCFA may not reflect the colonic 
production of SCFA as efficiently as required. The results of chapter 4 were not 
sufficient to test the robustness of our proposed equations to predict FC; therefore, 
this study was designed to use in vitro digestion models for mimicking the 
physiological actions of the upper intestine and the bacterial fermentation of NDCs 
in the human colon.  
Human colonic bacteria exhibit a range of fermentation activities, as they act on a 
wide variety of diet based fermentable carbohydrate or protein substrates (Tan et 
al., 2013). It has been estimated that there are more than 1000 - 1150 different 
species of bacteria in the colon, which may belong to more than 70 genera (Sekirov 
et al., 2010). The numerically predominant bacteria are anaerobes, including the 
species bacteroides, bifidobacteria, eubacteria, streptococci and lactobacilli. 
Studies have shown that bacteroides can constitute 30 % of the total bacteria in the 
gut (den Besten et al., 2013).  
Colonic anaerobic bacterial degradation of FC produces energy for bacterial growth, 
and SCFAs (acetate, propionate and butyrate) as the major end products of NDCs 
fermentation, with mean ratio of 60:20:20 acetate: propionate: butyrate (Tan et al., 
2013). The proportion of SCFAs may differ between individuals, due to their type of 
diet, gut microflora, gut transit time, and the presence of any gastrointestinal 
diseases, such as inflammatory bowel disease. The amount and proportion of these 
SCFAs may also differ with the type of NDCs available for fermentation (den Besten 
et al., 2013, Flint et al., 2012), as the main components of NDCs that pass the small 
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intestine are NSPs, RS, and NDOs (Roy et al., 2006). In Western societies, the 
mean NDCs intake is approximately 20 - 25 g/d (Bingham et al., 2003), which leads 
to NDCs fermentation in colon to produce 400 - 600 mmol of SCFAs/d, which may 
provide approximately 10 % of the human energy needs (Musso et al., 2011). SCFA 
may play a significant role in many metabolic diseases such as obesity, metabolic 
syndrome, and diabetes, as well as gastrointestinal diseases like CRC and 
inflammatory bowel disease (Sekirov et al., 2010). An increase in SCFA 
concentration can also have beneficial properties, for example propionate has 
potential health promoting properties that include anti-lipogenic, cholesterol 
lowering, anti-inflammatory and anti-carcinogenic action (Hosseini et al., 2011). 
Additionally, propionate has a role in improving satiety through up regulation of the 
gut hormone PYY, and appetite suppression through increased leptin levels (Arora 
et al., 2011). Of the SCFAs produced butyrate has been investigated the most due 
to its potential anti-tumorigenic properties, whereas acetate is the most abundant 
colonic SCFA; butyrate is considered to be the main energy source for large human 
intestine epithelial cells. Studies have shown it inhibits proliferation, induces 
differentiation and apoptosis of CRC cells in vitro at concentrations similar to those 
found in the large bowel in vivo (Hamer et al., 2008). 
Despite the physiological importance of the colonic anaerobic bacteria and their 
degradation of fermentable carbohydrate (chapter 1), the main site of FC is the 
proximal colon, as it has the greatest substrate availability and a higher liquid 
content the other parts of the colon, which means most of the SCFA are produced 
and absorbed here (den Besten et al., 2013). Proximal colonic SCFA cannot be 
measured easily in humans because it is very difficult to take samples from proximal 
colon in healthy subjects (Edwards et al., 1990). The limitations of using faecal 
SCFA to estimate fermentation have been discussed (chapter 4), but there is no 
validated method to measure the extent of colonic fermentation in vivo, especially 
as 95 % of the SCFA produced are rapidly absorbed by the colonocytes, while only 
5 % is excreted in the faeces making faecal SCFA a poor index of colonic production 
of SCFA (Topping and Clifton, 2001).  
Therefore, it may be more useful to use an in vitro fermentation model using a 
human faecal sample as its inoculum to determine SCFA levels. These models are 
cheap and easy to use for measuring the level of  NDCs fermentability and SCFA 
profiles produced (Edwards et al., 1996). Faecal sample collection is easy but 
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unpleasant (Edwards and Rowland, 1992). In terms of mimicking human colonic 
conditions, the sample of faecal bacteria will provide most of the bacteria present in 
the colon and with a medium mimicking the large intestine (buffer, macronutrients 
and micronutrients) however, there are several potential differences with the in vivo 
situation, most importantly the lack of absorption of SCFA and other products 
(Cummings, 1997).  For the purposes of this thesis, it was important to determine 
the fermentation capacity of the different carbohydrate sources and their digestibility 
before fermentation. Therefore, it was important to remove any carbohydrates and 
other macronutrients which would normally be digested and absorbed in the small 
intestine. It is important to perform an in vitro model enzymatic digestion to hydrolyse 
starch and protein before in vitro fermentation, because a high amount of normally 
digestible starch may mask the in vitro fermentation of the dietary fibre (McBurney 
et al., 1988). 
Overall this suggests an in vitro fermentation model using human faeces as 
inoculum is suitable and easy method to measure NDCs fermentability and SCFAs 
product (Edwards et al., 1996). This model would allow testing of the equations to 
predict FC in the diet by allowing direct comparison of SCFA from the carbohydrates 
that escape simulated small intestinal digestion. Therefore, the aim of this study was 
to assess the digestibility of different dietary carbohydrates, to see if the different FC 
produced predictable amounts of SCFA using an in vitro human colon fermentation 
model. 
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 Objectives  
The objectives of the present study were:   
1. To use an in vitro enzymatic digestion model for the removal of starch and 
other digestible macronutrients prior to the in vitro fermentation of FC samples  
2. To use an in vitro human colon fermentation model, to study the metabolic 
capacity of the colonic bacteria when single fibre, mixtures of isolated 
carbohydrates and food mixtures based on the habitual diets of subjects were 
fermented, and to test our equations against the SCFA amounts produced 
from each carbohydrate. 
3. To compare the SCFA concentration produced via in vitro fermentation of FC 
against the predictable amounts of SCFA using our prediction equations. 
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 Methods  
 Substrates used for in vitro upper gastrointestinal digestion 
These substrates were subjected to in vitro upper gastrointestinal digestion (section 
2.3.1).  
5.3.1.1 Single dietary fibre sources (raw potato starch, raftiline, wheat bran, 
psyllium and a mixture of all four) 
Raw potato starch was obtained from Avebe (Foxhol, The Netherlands; samples 
I/P), un-treated non-pre-digested wheat bran was obtained from Infinity foods co. 
(UK). Raftiline Orafti® HP, a long chain inulin fructo-oligosaccharide with a degree 
of polymerization (DP) > 23 which was extracted from chicory root (cichorium 
intybus), which was obtained from Beneo Orafti (Tienen Belgium), and psyllium husk 
seed was obtained from Sat-Isabgol factory (India). The four fibre mixture was 250 
mg of each fibre.   
5.3.1.2 Three different NDCs mixtures (low, medium and high) 
These NDCs mixture were obtained from habitual dietary records in the previous 
study, which was likely to contain varied amounts of DF, RS and NDOs. Three 
different NDCs mixture were selected as low, medium and high NDCs. The fibre 
content in mixtures was reassessed using similar products in a supermarket. For 
each NDCs mixture, all food items in each mixture were weighed on a digital kitchen 
scales (Brabanita, UK) onto a plate and mixed in a blender (Braun™). Some food 
items in each mixture were cooked based on the most commonly eaten form, before 
they were mixed in the blender. After that, each NDCs mixture were freeze-dried 
and milled before use in the in vitro digestion study (Table 5.1). 
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Table 5.1: Dietary composition of the three different mixtures of NDCs from habitual dietary records in the previous study used for in vitro digestion (g/d). 
Low FC Medium FC High FC 
Food item g/d Starch NDO DF Food item g/d Starch NDO DF Food item g/d Starch NDO DF 
Strawberries, raw 66.0 -  1.3 Fresh orange juice 178.0 -  0.2 Bran Flakes 96.0 46.5 2.32 14.4 
Orange juice, freshly 
squeezed 
125.0 -  0.1 Wholemeal bread 181.0 77.3 4.86 13.8 Wholemeal bread 256 100.1 13.79 16.2 
Porridge made with whole 
milk 
130.0 10.1  1.0 Lettuce, raw 9.0 - 0.19 0.1 Fruit jam 20.0 -  0.2 
Satsumas 89.0 -  1.5 Olives 25.0 0.0  1.0 Yeast extract 10.0 0.2  - 
Kiwi fruit 67.0 0.2  - Roasted cashew 
nuts 
46.0 6.1  - Apples, raw 432.0 - 0.03 8.6 
Lettuce, raw 382.0 - 0.13 4.9 Anchovy sauce 156.0 0.2  - Digestive biscuits, 
chocolate 
45.0 17.1  1.4 
Chocolate cake 53.0 11.5  2.0 Plain pasta cooked 179.0 55.0  - White rice, boiled 500.0 148.0  4.0 
Breadcrumbs, homemade 6.0 4.5  0.3      New potatoes, boiled 500.0 83.5  6.0 
New potatoes, boiled 93.0 15.5  1.1      Orange juice 600.0 -  0.6 
Lettuce, raw 257.0 - 0.06 3.3           
Sweet pickle 69.0 1.4  1.0           
Low fat yogurt 175.0 0.5  -           
Oatcakes 25.0 15.0  0.9                
Total 1537 58.7 0.19 17.4  774 138.6 5.05 15.1  2459 395.4 16.14 51.4 
NDCs, non-digestible carbohydrates; DF, dietary fibre; NDO, non-digestible oligosaccharide 
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5.3.1.3 Mixtures of different isolated NDCs (RS, Soluble DF, Insoluble DF 
and NDOs)  
Sample foods were digested in vitro either raw or cooked, based on the most 
commonly form eaten (Table 5.2). For example, apple was in vitro digested raw, 
while red kidney beans were cooked. The food samples were purchased from Tesco 
supermarket. Food samples were categorized into four groups:  
1. RS mixture 
a) 400 mg of banana  
b) 200 mg of red kidney beans  
c) 200 mg of rye bread 
d) 200 mg of apple 
2. Soluble DF mixture 
a) 400 mg of carrot, raw fresh 
b) 200 mg of red kidney beans  
c) 200 mg of new potatoes, boiled 
d) 200 mg of apple 
3. Insoluble DF mixture 
a) 400 mg of all bran 
b) 200 mg of red kidney beans  
c) 200 mg of new potatoes, boiled 
d) 200 mg of apple 
4. NDOs mixture 
a) 400 mg of wheat bread 
b) 200 mg of red kidney beans  
c) 200 mg of new potatoes, boiled 
d) 200 mg of Ryvita, high fibre 
Table 5.2: Dietary composition of isolated NDCs mixtures used for in vitro digestion 
*DF, dietary fibre; NDOs, non-digestible oligosaccharides 
Items 
g/100g 
Red 
Kidney 
Beans 
All 
bran 
Ryvita Carrot 
Wheat 
bread 
Apple Banana    
New 
potatoes, 
boiled  
 
Rye 
bread 
Starch 12.8 28.6 58.0 0.3 39.3 trace  54.2 16.7 44 
DF* 19.1 25.3 18.9 19.5 9.1 9.9 3.2 5.8 13.3 
Soluble DF 9.1 4.2 14.2 11.4 6.0 3.6 2.2 3 6.6 
Insoluble 
DF 
9.9 21.1 4.7 8.1 3.1 6.3 1.0 5.8 6.7 
NDOs 0.01 trace trace 0.02 2.8 0.01 1.0 0.5 1.4 
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 In vitro upper gastrointestinal digestion model 
Three in vitro digestion and fermentation studies are included in this chapter (section 
2.3.1). The in vitro upper gastrointestinal digestion was based on a model previously 
described by Aura et al. (1999). 
Briefly, all NDC samples were freeze-dried and milled before in vitro digestion. All 
incubation steps were performed at 37 °C, with stirring and shaking in a water-bath. 
1 g of each NDC was weighed into a 100 ml beaker containing mixture of 10 ml 
distilled water and 7 ml of a 0.85 wt % sodium chloride solution. Salivary α-amylase 
(50 U/50 µl) was dissolved with sodium phosphate buffer (0.02 M, pH 6.9) and added 
to the mixture. The mixture was then incubated for 5 minutes to mimic the digestive 
actions in the mouth. To mimic events in the stomach hydrochloric acid (0.15 M, 4 
ml) was added to adjust the pH to 2.5. 2 mg of pepsin was dissolved in 1 ml of 0.02 
M of HCL acid/ sample, and added to the sample, which was then incubated for 2 
h. To mimic events in the small intestine porcine extract bile acid (400-600 
mg/sample) was dissolved in 4 ml of 0.15M sodium bicarbonate and added to the 
mixture. 75 mg pancreatin (which contains amylase, proteases and lipase) was 
dissolved in 4 ml of 0.15 M of sodium bicarbonate solution and added to the mixture. 
The pH was adjusted to 6.5 using 6 M NaOH. Each digestion mixture at this stage 
was placed into a dialysis tube (Biotech Cellulose Ester Membrane; 35 cm long with 
flat width 31 mm, Dia 20 mm; cut-off: 500-1000 MWCO), which was placed in a 2 L 
beaker and filled with distilled water and incubated for 6 h at 37 °C with stirring. After 
dialysis, the retentates were freeze-dried and used as substrates for in vitro 
fermentation. 
 Subjects used as donors of faecal inoculum 
Fresh faeces were obtained from five healthy adults (males aged 25-45 years), the 
same subjects were donors of fresh faecal samples for all three in vitro fermentation 
experiments (section 2.4.1).  
 In vitro fermentation model 
After in vitro upper gastrointestinal digestion, the freeze-dried remnants of all four 
different isolated NDCs mixtures (RS, Soluble NSP, Insoluble NSP and NDOs), 
single dietary fibre (raw potato starch, raftiline, wheat bran, psyllium and mixture) 
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and different NDCs mixtures (low FC, medium FC and high FC), were used as a 
source of carbohydrate in these experiments. One control culture without any added 
substrate was used with each set of incubations to calculate the fermentation of the 
indigestible substrates in the original inoculum. Samples were taken from each 
incubation at 0, 4, and 24 hours. A 3 ml sample was transferred by syringe into 
bijoux tubes at 0 h to measure pH and then was frozen at -20°C for later SCFA 
analysis. Then at 4 h and 24 h, a further 3 ml of each fermented sample was 
removed and analysed for pH and fermentation products.  
 Non-digestible fraction measurement 
After in vitro upper gastrointestinal digestion, the freeze-dried substrates of all four 
different isolated NDCs mixtures (RS, Soluble NSP, Insoluble NSP and NDOs), 
single dietary fibres (raw potato starch, raftiline, wheat bran, psyllium and mixture of 
these) and different NDCs mixtures (low FC, medium FC and high FC), were subject 
to content analysis. The RS content was analysed using the Megazyme RS assay 
kit (AOAC Method 2002.02) (McCleary et al., 2002), the fructan content using the 
Megazyme fructans assay kit (AOAC Method 999.03). The non-digestible fractions 
analyses were performed in duplicate. Soluble DF and insoluble DF fractions 
present in NDCs were estimated approximately from the GLOBALRPH website 
dietary fibre calculator, and the studies by Windiets 2005, Lee et al. (1992), and 
Anderson and Bridges (1988) (section 2.6.1).     
 SCFA Analysis  
SCFAs were analysed by gas chromatography (GC) according to Laurentin and 
Edwards (section 2.5).  
 Statistical analysis 
Statistical analysis was performed for all data using Minitab Version 16 (Minitab® V. 
16 Inc. USA). The Anderson-Darnley test of normality was applied to evaluate the 
normal distribution of continuous variables, and all data were expressed as standard 
deviation (SD). Paired test and two sample t-tests for the normally distributed data 
were used to explore the differences between more than two independent variables. 
Pearson correlation coefficients was used to find correlations between different 
continuous variables, NDCs, and predicted FC with SCFA concentration. Linear 
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regression analysis was used to estimate predicted SCFA concentration of FC by 
the respective SCFA concentration produced via in vitro fermentation of FC. The 
agreement between the two methods, was evaluated with Bland-Altman plots using 
MedCalc Version 15.8 (MedCalc V. 15.8 Belgium), by plotting the individual 
differences of a measure, between the two methods, against their mean. The bias 
of the method is equal to the mean difference of the methods. Limits of agreement 
between predicted SCFA concentration of FC and SCFA concentration produced 
via in vitro fermentation were calculated as the mean difference of the two methods 
± 1.96 times the SD of the mean difference (van Stralen et al., 2008). Any p-values 
of 0.05 or below were considered significant. 
  
 Results  
 Residue dry weight of single dietary fibre sources (raw 
potato starch, raftiline, wheat bran, psyllium and a mixture 
of all four) after in vitro digestion vs. predicted fibre  
The amount of the non-digestible fractions of raw potato starch, raftiline, wheat bran, 
psyllium and the four fibre mixture, which remained after removing the digestible 
starch and other macronutrients from the samples using an extensive in vitro 
enzymatic digestion model, vs. the predicted amount of the same fibre measured 
using the developed FC equations was analysed (Figure 5.3). Our model equation 
for predicting FC was: soluble DF was 100 % fermented and insoluble DF was 50 
% fermented, and NDOs were 100 % fermented. Finally, the amount of RS was 
estimated as 10 % of total starch, which is believed to be totally fermented. Where 
a mostly pure source of RS was used this was considered to be 100 % fermented.      
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Table 5.3: FC fractions of raw potato starch, raftiline, wheat bran, psyllium and 4 fibre mixtures vs. predicted (mg/g) 
* The values are reported as mean (standard deviation) for actual (n = 5) vs. predicted (n = 5); ** Predicted FC-DF 4 equation: 100 % Soluble DF + 50 % insoluble DF + 100 % NDOs + 10 % TS    
 
 
 
 
 
 
 
NDCs Raw potato starch 
 
Raftiline 
 
Wheat bran 
 
Psyllium 
 
Mixture 
 
  Actual Predicted Actual Predicted Actual Predicted Actual Predicted Actual Predicted** 
RS  482.17 ± 19.8* 642.95 ± 58.1 0.0 ± 0.0 0.00 ± 0.0 3.83 ± 0.1 4.71 ± 0.2 0.41 ± 0.02 0.32 ± 0.0 13.97 ± 0.8 15.62 ± 0.9 
NDOs  0.00 ± 0.0 0.00 ± 0.0 872 ± 29.9 901 ± 30.9 39.68 ± 1.3 31.61 ± 1.0 0.39 ± 0.02 0.34 ± 0.0 235.03 ± 14.4 239.33 ± 14.6 
Insoluble DF 28.82 ± 1.2 28.54 ±1.2 0.0 ± 0.0 0.0 ± 0.0 142.57 ± 4.6 142.57 ± 4.7 34.48 ± 1.6 34.48 ± 1.6 64.89 ± 3.9 65.9 ± 4.0 
Soluble DF 14.27 ± 0.6 14.41 ±0.6 0.0 ± 0.0 0.0 ± 0.0 24.21 ± 0.8 24.21 ± 0.8 699.35 ± 32.0 699.35 ± 32.2 182.16 ± 11.8 192 ± 11.7 
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 Differences in the production of total and major SCFA after 
24 h of in vitro fermentation of single dietary fibre sources 
(raw potato starch, raftiline, wheat bran, psyllium and a 
mixture of all four).  
Total SCFA produced after 24 h in vitro fermentation were used to characterise the 
fermentation pattern of single dietary fibre sources (raw potato starch, raftiline, 
wheat bran, psyllium and a mixture of all four) (Table 5.4). SCFAs production was 
also used to compare the predictive capacity of the equations for FC against the 
individual NDC dietary models in this experiment.   
The results (Table 5.4) show there was no significant difference in the total SCFA 
concentration in these single fibres, except for in the 4 fibre mixtures culture (4.05 ± 
0.6 µmol/ml) at 0 h of incubation was higher than raw potato starch, raftiline and 
wheat bran. It was observed that the rapidly fermented raftiline had highest total 
SCFA concentration (57.82 ± 6.2 µmol/ml) followed by the 4 fibre mixture fibre 
(53.19 ± 3.7 µmol/ml) at 4 h, whereas the fermentation of wheat bran had lowest 
total SCFA concentration followed by psyllium at this time (Table 5.4). The total 
SCFA concentration in cultures containing raw potato starch, raftiline and psyllium 
were not significantly different from each other at 24 hours. The mixture of dietary 
fibre was ranked as having the highest total SCFA concentration (89.07 ± 2.1 
µmol/ml; Figure 5.1) followed by raw potato starch (84.75 ± 4.9 µmol/ml), and 
raftiline (82.18 ± 1.4 µmol/ml), which was significantly higher when compared with 
that in the cultures of wheat bran and psyllium at 24 hours. At this period of 
incubation, fermentation of wheat bran continued to produce a lower total SCFA 
concentration (49.29 ± 3.2 µmol/ml).  
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Figure 5.1: Mean (±SEM) concentrations of total SCFA (µmol/ml) after 24 h incubation of single 
dietary fibre sources (raw potato starch (RPS), raftiline (RF), wheat bran (W.Bran) and 
psyllium (PSY)) and mixture of all four (MIX) with the faecal inoculum (n= 5). 
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Table 5.4: Concentrations of total and major individual SCFA (µmol/ml) between 0 and 24 h of in vitro fermentation using human faecal samples (n = 5) with 
single dietary fibre substrates.  
 
The values with different letters are significantly different within a row. SCFA was compared with paired t-test between 0, 4 and 24 hours for the same type of culture (P < 0.05). 
 
 
 
 
 
 
 
SCFA   NDC 
Raw potato starch 
Mean ± SEM 
Raftiline 
Mean ± SEM 
Wheat bran 
Mean ± SEM 
Psyllium 
Mean ± SEM 
4 fibre Mixture 
Mean ± SEM 
Acetate       
0 h 2.36 ± 0.4 a 2.29 ± 0.4 a 2.66 ± 0.6 a  3.95 ± 0.8 b 3.27 ± 0.6 b 
4 h 28.16 ± 2.3 c  36.52 ± 5.8 c 15.23 ± 1.7 d 18.06 ± 2.7 d 31.67 ± 3.9 c 
24 h 51.08 ± 6.8 a 49.81 ± 7.0 a  25.44 ± 1.0 b 38.81 ± 3.0 a  45.82 ± 5.7 a 
Propionate       
0 h 0.66 ± 0.1 a 0.61 ± 0.1 a  0.57 ± 0.1 a 0.50 ± 0.2 a 0.66 ± 0.1 a 
4 h 9.21 ± 1.6 a 15.60 ± 1.1 b 6.16 ± 0.5 a 7.53 ± 1.1 a 14.62 ± 1.4 b 
24 h 11.97 ± 1.4 a 20.70 ± 5.3 a, b 11.00 ± 0.8 a 23.46 ± 0.5 b 21.39 ± 1.7 b  
Butyrate       
0 h 0.32 ± 0.09 a 0.28 ± 0.1 a 0.32 ± 0.09 a 0.27 ± 0.1 a 0.31 ± 0.1 a 
4 h 5.20 ± 0.8 a 3.25 ± 0.2 b  2.44 ± 0.5 b 2.11 ± 0.2 b 4.79 ± 0.5 a 
24 h 16.18 ± 2.3 a 4.96 ± 0.3 b  6.32 ± 0.62 b  3.55 ± 0.3 b 13.03 ± 0.6 a 
Total SCFA      
0 h 3.15 ± 0.4 a 3.00 ± 0.0 a 3.36 ± 0.4 a 4.5 ± 0.8 a, b 4.05 ± 0.6 b 
4 h 45.60 ± 1.8 a 57.82 ± 6.2 a, d 27.15 ± 3.9 b 30.67 ± 4.6 c, b 53.19 ± 3.7 d 
24 h 84.75 ± 4.9 a, d    82.18 ± 1.4 a, b 49.29 ± 3.2 c 70.39 ± 4.2 a, b 89.07 ± 2.1d 
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5.5.2.1 Correlation of in vitro total SCFA concentration (µmol/ml) of single 
fibre sources (n = 5; raw potato starch, raftiline, wheat bran, psyllium 
and mixture of all four) after 24 h of incubation vs. predicted FC (n = 
5) using the predictive equation 
The Pearson correlation coefficient was used to determine the relationship between 
in vitro total SCFA concentration of single dietary fibre (raw potato starch, raftiline, 
wheat bran, psyllium) and mixture of all four fibres with the predicted FC (Table 5.5). 
The in vitro fermentation total SCFA concentration of raw potato starch and raftiline 
were compared against the predicted FC, and the result (Figure 5.2) of raftiline 
showed an excellent relationship with predicted FC of total SCFA concentration. The 
bland Altman plot showed that the bias between raftiline SCFA concentration and 
predicted SCFA concentration was small (0.04 µmol/ml; Figure 5.3), with relatively 
wide limits of agreement were 1.80 and -1.72 µmol/ml. Wheat bran also showed a 
strong correlation with total SCFA concentration (R = 0.96; p = 0.009) when 
compared with the predicted FC (R = 0.93; p = 0.02). Similarly, mixture of all 4 fibres 
showed an excellent correlation with total SCFA concentration (R = 0.98; p = 0.002; 
Figure 5.4) compared with predicted FC (R = 0.95; p = 0.01). The bland Altman plot 
showed that the bias between mixture of all four fibres SCFA concentration and 
predicted SCFA concentration of all four fibres was small (0.2 µmol/ml; Figure 5.5), 
although with wide limits of agreement were 1.66 and -1.26 µmol/ml. Moreover, the 
predicted FC had a better correlation with total SCFA concentration (R = 0.94; p = 
0.01) when compared with the psyllium fibre (R = 0.89; p = 0.04). These results 
show a good agreement correlation between single DF and mixture of all 4 fibres 
with total SCFA concentration and with those predicted FC.   
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Figure 5.2: Scatter-plot showing correlation of 24 h total SCFA concentration (µmol/ml) of 
raftiline fermentation (n = 5) vs. predicted raftiline (n = 5). Dotted line indicates predicted 
raftiline; solid line indicates raftiline. 
 
Black circle dot indicates predicted SCFA of raftiline (μmol/ml). Blue circle dot indicates SCFA produced from in 
vitro fermentation of raftiline (μmol/ml). 
 
Figure 5.3: Bland Altman plot of 24 h total SCFA concentration (µmol/ml) of raftiline 
fermentation (n = 5) vs. predicted raftiline. 
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Figure 5.4: Scatter-plot showing correlation of 24 h total SCFA concentration (µmol/ml) of 
mixture of all 4 fibres fermentation (n = 5) vs. predicted mixture of all 4 fibres (n = 5). Dotted 
line indicates predicted mixture of all 4 fibres; solid line indicates mixture of all 4 fibres.  
 
Black circle dot indicates predicted SCFA of mixture of all 4 fibres (μmol/ml). Blue circle dot indicates SCFA 
produced from in vitro fermentation of mixture of all 4 fibres (μmol/ml). 
Figure 5.5: Bland Altman plot of 24 h total SCFA concentration (µmol/ml) of mixture of all 4 
fibres fermentation (n = 5) vs. predicted mixture of all 4 fibres (n = 5). 
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Table 5.5: Correlation between actual single fibre and mixture fermentation (n = 5) with total and major individual SCFA concentration (µmol/ml) after 24 h of 
in vitro fermentation using human faecal microbiota vs. predicted FC (n = 5).  
 
 SCFA Raw potato starch 
 
Raftiline 
 
Wheat bran 
 
Psyllium 
 
Mixture 
 
  Actual Estimated Actual Estimated Actual Estimated Actual Estimated Actual Estimated 
  R * p R p** R p R p R p R p R p R p R p R p 
SCFA 0.96 0.008 0.96 0.008 0.93 0.02 0.97 0.004 0.96 0.009 0.93 0.02 0.89 0.04 0.94 0.01 0.98 0.002 0.95 0.01 
                      
Acetate 0.97 0.004 0.97 0.004 0.87 0.06 0.89 0.04 0.90 0.03 0.95 0.01 0.95 0.01 0.96 0.01 0.88 0.06 0.84 0.07 
                      
Propionate 0.99 0.001 0.99 0.001 0.93 0.02 0.93 0.01 0.86 0.06 0.93 0.02 0.90 0.03 0.96 0.01 0.98 0.002 0.96 0.007 
                      
Butyrate 0.99 0.001 0.99 0.001 0.98 0.002 0.98 0.002 0.94 0.01 0.97 0.005 0.87 0.057 0.86 0.06 0.96 0.009 0.98 0.003 
* R; Pearson correlation coefficient, ** p; value significant (p < 0.05) 
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5.5.2.2 Correlation of acetate concentration (µmol/ml) of single fibre sources 
(n = 5; raw potato starch, raftiline, wheat bran, psyllium and mixture 
of all four) after 24 h of incubation vs. predicted FC (n = 5) using the 
predictive equation. 
At 24 hours, fermentation of wheat bran continued to produce the lowest acetate 
concentration (25.44 ± 1.0 µmol/ml), followed by psyllium (38.81 ± 3.0 µmol/ml) 
compared with the other fibres (Table 5.4). Also at this time point it was observed 
that raw potato starch had the highest acetate concentration (51.08 ± 6.8 µmol/ml) 
followed by raftiline (49.81 ± 7.0 µmol/ml). Wheat bran was significantly lower in 
acetate concentration than other fibres (p< 0.05).   
In the comparison of the acetate concentration of raw potato starch and predicted 
FC (Table 5.5), the results showed an excellent equal relationship in acetate 
concentration with predicted FC. The predicted FC showed better correlation with 
acetate concentration (R = 0.95; p = 0.01) compared with wheat bran fermentation 
(R = 0.90; p = 0.03). On the other hand, the mixture of all four (R = 0.88; p = 0.06) 
and predicted FC (R = 0.84; p = 0.07) were unable to show any correlation with 
acetate concentration. The predicted FC (R = 0.96; p = 0.01) and psyllium (R = 0.95; 
p = 0.01; Figure 5.6) showed a stronger correlation with acetate concentration. 
Additionally, the bias between psyllium acetate concentration and predicted acetate 
concentration of psyllium was fairly small (0.2 µmol/ml; Figure 5.7), but with wide 
limits of agreement (3.4 and -2.9 µmol/ml), which suggest the comparison is not 
acceptable.  
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Figure 5.6: Scatter-plot showing correlation of acetate concentration (µmol/ml) of psyllium 
(n = 5) after 24 h incubation vs. predicted psyllium (n = 5). Dotted line indicates predicted 
psyllium; solid line indicates psyllium. 
 
Blue circle dot indicates predicted SCFA of psyllium (μmol/ml). Black circle dot indicates SCFA produced from 
in vitro fermentation of psyllium (μmol/ml). 
 
Figure 5.7: Bland Altman plot of acetate concentration (µmol/ml) of psyllium fibre after 24 h 
incubation vs. predicted psyllium. 
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5.5.2.3 Correlation of propionate concentration (µmol/ml) of single fibre 
sources (raw potato starch, raftiline, wheat bran, psyllium and 
mixture of all four) after 24 h incubation vs. predicted FC using the 
predictive equation 
There was no significant difference in the propionate concentration in raw potato 
starch, wheat bran and psyllium at 4 hours. However, psyllium had the highest 
propionate concentration (23.46 ± 0.5 µmol/ml), followed by the mixture of fibres 
(21.39 ± 1.7 µmol/ml), and raftiline (20.70 ± 5.3 µmol/ml), which had a significantly 
higher concentration compared with that in the cultures of wheat barn and raw potato 
starch at 24 hours.     
Similar to the SCFA and acetate concentrations, raw potato starch and raftiline have 
an excellent relationship with in vitro propionate concentration (Table 5.5) and that 
of predicted FC. No correlation was observed between wheat bran fermentation and 
propionate concentration (R = 0.86; p = 0.06), while predicted FC had a good 
relationship with propionate concentration (R = 0.93; p = 0.02). The mixture of all 4 
fibres fermentation showed an excellent correlation with propionate concentration 
(R = 0.98; p = 0.002) compared with the predicted FC (R = 0.96; p = 0.007), and the 
predicted FC (R = 0.96; p = 0.01) also had a good relationship with propionate 
concentration when compared with the psyllium fermentation (R = 0.90; p = 0.03). 
These results show a good agreement correlation between psyllium with propionate 
concentration and with those predicted FC.    
5.5.2.4 Correlation of butyrate concentration (µmol/ml) of single fibre 
sources (raw potato starch, raftiline, wheat bran, psyllium and 
mixture of all four) after 24 h incubation vs. estimated FC using the 
predictive equation 
At 24 h, fermentation of raw potato starch generated the highest concentrations of 
butyrate (16.18 ± 2.3 µmol/ml), followed by the mixture of fibres (13.03 ± 0.6 
µmol/ml) and was significantly higher than raftiline, wheat bran and psyllium.  
The analysis of the correlation of the single fibres and predicted results (Table 5.5) 
showed that the raw potato starch and raftiline fermentation have an excellent 
relationship with butyrate concentration, which is similar to that of predicted FC. The 
predicted FC showed a strong relationship with butyrate concentration (R = 0.96; p 
= 0.007) compared with wheat barn fermentation (R = 0.94; p = 0.01). The psyllium 
fermentation and predicted FC were showed no correlation with butyrate 
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concentration, whereas the mixture of all 4 fibres fermentation (R = 0.96; p = 0.009) 
and predicted FC (R = 0.98; p = 0.003) showed an excellent correlation with butyrate 
concentration.   
5.5.2.5 In vitro fermentation of single fibres and 4 mixture DF pH changes  
At 0 h, as expected no pH differences were observed between all cultures (Table 
5.6). The pH then dropped rapidly during the fermentation of raw potato starch, 
raftiline, wheat bran, psyllium and 4 fibre mixture up to 4 hours, but then did not 
change appreciably for the cultures of wheat bran during the prolonged incubation. 
A progressive fall in pH from 0 hour to 24 hours of fermentation was seen in cultures 
containing raw potato starch, raftiline, psyllium and mixture, and the raw potato 
starch and raftiline consistently produced lower pH valued compared to wheat bran, 
psyllium and mixture fibres cultures (Table 5.6). 
Table 5.6: Changes in pH (mean ± SEM) of human faecal cultures containing raw potatoes 
starch, raftiline, wheat bran, psyllium and 4 mixture DF over 24 h (n = 5) after in vitro anaerobic 
incubation. 
Values with different letters within a column are significantly (P < 0.05) different. There are significant (P < 0.05) 
differences between time points within a row except Raftiline (4 h vs 24 h).  
 
 
 
 
 Residue dry weight of different mixtures (low, medium and 
high FC) NDCs after in vitro digestion vs. predicted fibre  
The amount of the different mixtures (low FC, medium FC and high FC) NDCs after 
removing the digestible starch from the samples using an extensive in vitro 
enzymatic digestion model, was compared to the predicted amount of the same fibre 
measured using developed FC equations (Table 5.7).  
 
 
 
 
 
  pH at 0 h pH at 4 h pH at 24 h 
Raw potato starch 7.00 ± 0.08 a 5.8 ± 0.02 a 4.60 ± 0.01 a 
Raftiline 6.98 ± 0.07 a 4.80 ± 0.08 a 4.27 ± 0.18 a 
Wheat bran 7.01 ± 0.07 a 6.66 ± 0.10 b 6.40 ± 0.07 c 
Psyllium 6.98 ± 0.07 a 6.51 ± 0.09 b, 2 5.40 ± 0.12 b 
MIX 7.03 ± 0.08 a 5.54 ± 0.15 a 4.9 ± 0.10 b 
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Table 5.7: Non-digestible fractions of different mixture NDCs (low, medium and high FC) vs. predicted (mg/g) 
 
* The values are reported as mean (standard deviation) for actual (n = 5) vs. predicted (n = 5); ** Predicted FC-DF 4 equation: 100 % Soluble DF + 50 % insoluble DF + 100 % NDOs + 10 
% TS    
 
 
 
 
 
 
 
 
 
NDC Low-FC 
 
Medium-FC 
 
High-FC 
 
  Actual  Predicted**  Actual  Predicted  Actual  Predicted  
Resistant starch  12.66 ± 0.5* 11.99 ± 0.5 14.80 ± 0.5 16.94 ± 0.6 27.58 ± 1.3 30.05 ± 1.4 
NDOs  3.74 ± 0.2 3.52 ± 0.1 5.86 ± 0.2 6.13 ± 0.2 9.65 ± 0.4 9.43 ± 0.4 
Insoluble DF 8.79 ± 0.4 8.81 ± 0.4 11.85 ± 0.4 10.85 ± 0.4 12.86 ± 0.6 12.86 ± 0.6 
Soluble DF 5.83 ± 0.2 5.83 ± 0.2 10.82 ± 0.3 11.22 ± 0.4 12.87 ± 0.6 12.87 ± 0.6 
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 In vitro fermentation of different NDCs (low, medium and 
high FC) mixtures 
Total SCFA concentrations during in vitro fermentation were used to characterise 
the individual different mixed fermentable diets in this experiment. It was also used 
to compare the equation for FC against the individual NDC dietary models in this 
experiment (Table 5.8). At 4 h of fermentation, it was observed that the high FC 
samples had the highest total SCFA concentration (63.48 ± 2.1 µmol/ml), compared 
to the low and medium FC mixture of NDCs (Table 5.8). At 24 hours, fermentation 
of high FC mixture of NDCs continued to generate a higher total SCFA concentration 
(142.53 ± 5.7 µmol/ml), followed by the medium (107.50 ± 4.5 µmol/ml) and low FC 
mixtures (85.81 ± 5.0 µmol/ml) (Figure 5.8). The total SCFA concentration in the low 
FC mixture of NDCs culture at 24 h was lower than other NDCs mixture cultures.  
Figure 5.8: Mean (±SEM) concentrations of total SCFA (µmol/ml) produced after 24 h 
incubation of different mixed (low, medium and high FC) NDCs with the faecal inoculum (n= 
5). 
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Table 5.8: Concentration of total and major individual SCFA (µmol/ml) between 0 and 24 h of in vitro fermentation using human faecal samples (n = 5) with 
NDC substrates.  
The values are reported as mean (standard error) of two duplicate. Values with different letters are significantly different within a row. SCFA was compared with paired t-test between 0, 4 
and 24 hours for the same type of culture (P < 0.05). 
 
 
SCFA NDC 
   Low-FC Medium-FC High-FC Blank 
Acetate      
0 h 3.78 ± 0.2 a 3.41 ± 0.15 a 3.49 ± 0.2 b 2.67 ± 0.2 c 
4 h 19.96 ± 0.8 a 28.96 ± 2.6 b 51.92 ± 2.3 c 11.36 ± 1.1 d 
24 h 50.89 ± 2.2 a  67.05 ± 2.4 b  97.13 ± 2.0 c 15.73 ± 1.5 d  
Propionate      
0 h 0.87 ± 0.1 a 0.95 ± 0.1 a, b 0.91 ± 0.1 b 0.86 ± 0.1 a, c 
4 h 8.75 ± 2.2 a 7.84 ± 2.4 a, b 10.13 ± 2.7 a, b 3.26 ± 0.6 b 
24 h 26.00 ± 3.3 a 31.37 ± 4.0 a  36.61 ± 5.1 a 5.98 ± 1.4 b 
Butyrate      
0 h 0.48 ± 0.05 a 0.47 ± 0.09 a 0.50 ± 0.06 a 0.22 ± 0.01 b 
4 h 0.83 ± 0.3 a 1.41 ± 0.2 a 2.50 ± 0.3 b  0.63 ± 0.1 a 
24 h 5.38 ± 1.5 a 6.13 ± 1.2 a  7.07 ± 0.9 a 4.05 ± 0.6 a 
Total SCFA     
0 h 4.93 ± 0.2 b 4.84 ± 0.3 a, b 5.17 ± 0.2 a 3.97 ± 0.3 c 
4 h 29.58 ± 2.4 a 37.49 ± 1.8 b 63.48 ± 2.1 c 17.86 ± 2.3 d 
24 h 85.81 ± 5.0 a 107.50 ± 4.5 b 142.53 ± 5.7 c 31.47 ± 3.5 d 
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Table 5.9: Correlation of different mixtures NDC (n = 5) fermentation of total and major 
individual SCFA concentration (µmol/ml) after 24 h of in vitro fermentation using human faecal 
microbiota vs. predicted FC (n = 5). 
* R; Pearson correlation coefficient, ** p value significant (P < 0.05) 
 
5.5.4.1 Correlation of total SCFA concentration (µmol/ml) of different mixture 
NDCs (low, medium and high FC) after 24 h incubation vs. predicted 
FC using the predictive equation 
The results (Table 5.9) showed that total SCFA concentration was strongly 
correlated with low-FC mixture NDCs fermentation (R = 0.98; p = 0.003) when 
compared with the predicted FC (R = 0.94; p = 0.01; Figure 5.9). Whereas, predicted 
FC had a better correlation with total SCFA concentration (R = 0.94; p = 0.01) when 
compared with medium-FC mixture NDCs (R = 0.90; p = 0.03; Figure 5.10). The 
bland Altman plot showed that the bias between medium mixture NDCs total SCFA 
concentration and predicted total SCFA concentration was fairly small (1.0 µmol/ml; 
Figure 5.11), with wide limits of agreement (6.3 and -4.4 µmol/ml). Moreover, high-
FC mixture NDCs fermentation (R = 0.94; p = 0.01) and predicted FC (R = 0.90; p 
= 0.03) showed a good relationship with total SCFA concentration. Overall these 
results show a good correlation between different mixture of NDCs (low, medium 
and high FC) with total SCFA concentration and with those predicted FC. Therefore, 
we can conclude that the newly developed predicted equations deemed a valid and 
practical tool to assess SCFA production in in vitro fermentation.       
 
 
 
 
 
 SCFA Low-FC 
 
Medium-FC 
 
High-FC 
 
  Actual Estimated Actual Estimated Actual Estimated 
  R * p** R p R p R p R p R p 
SCFA 0.98 0.003 0.94 0.01 0.90 0.03 0.94 0.01 0.94 0.01 0.90 0.03 
              
Acetate 0.87 0.07 0.81 0.09 0.98 0.004 0.90 0.03 0.94 0.008 0.96 0.009 
              
Propionate 0.83 0.08 0.85 0.06 0.90 0.03 0.94 0.01 0.93 0.02 0.87 0.06 
              
Butyrate 0.65 0.23 0.62 0.25 0.97 0.004 0.90 0.03 0.92 0.02 0.86 0.06 
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Figure 5.9: Scatter-plot showing correlation of total SCFA concentration (µmol/ml) of mixture 
low-FC (n = 5) after 24 h incubation vs. predicted mixture low-FC (n = 5). Dotted line indicates 
mixture low-FC; solid line indicates predicted mixture low-FC. 
 
Blue circle dot indicates predicted SCFA of mixture low-FC (μmol/ml). Red circle dot indicates SCFA produced 
from in vitro fermentation of mixture low-FC (μmol/ml). 
 
Figure 5.10: Scatter-plot showing correlation of total SCFA concentration (µmol/ml) of 
mixture Medium-FC (n = 5) after 24 h incubation vs. predicted mixture Medium-FC (n = 5). 
Solid line indicates medium mixture of FC; Dotted line indicates predicted mixture Medium-
FC. 
 
Blue circle dot indicates predicted SCFA of mixture Medium-FC (μmol/ml). Red circle dot indicates SCFA 
produced from in vitro fermentation of mixture Medium-FC (μmol/ml). 
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Figure 5.11: Bland Altman plot of total SCFA concentration (µmol/ml) of mixture Medium-FC 
(n = 5) after 24 h incubation vs. predicted mixture Medium-FC (n = 5). 
 
 
5.5.4.2 Correlation of acetate concentration (µmol/ml) of different NDCs 
mixture (low, medium and high FC) after 24 h incubation vs. 
predicted FC using the predictive equation 
At 24 hours, fermentation of the high FC mixture induced the highest acetate 
concentration (97.13 ± 2.0 µmol/ml), followed by the medium mixture (67.05 ± 2.4 
µmol/ml). At 4 and 24 hours, there was significant difference in the acetate 
concentration between high, medium and low FC mixture of NDCs respectively 
(p<0.05). The results (Table 5.9) show there was no relationship observed between 
the acetate concentration and low-FC mixture of NDCs fermentation, and the 
predicted FC, whereas the medium-FC mixture of NDCs had an excellent correlation 
with the acetate concentration (R = 0.98; p = 0.004) compared with predicted FC (R 
= 0.93; p = 0.02). The high-FC mixture of NDCs fermentation and predicted FC, 
showed significant relationship with acetate concentration (Figure 5.12). 
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Figure 5.12: Scatter-plot showing correlation of acetate concentration (µmol/ml) of High-FC 
mixture (n = 5) after 24 h incubation vs. predicted High-FC mixture (n = 5). Dotted line indicates 
High-FC mixture; solid line indicates predicted High-FC mixture. 
 
Black circle dot indicates predicted SCFA of High-FC mixture (μmol/ml). Red circle dot indicates SCFA produced 
from in vitro fermentation of High-FC mixture (μmol/ml). 
 
5.5.4.3 Correlation of propionate concentration (µmol/ml) of different NDCs 
(low, medium and high FC) mixtures after 24 h incubation vs. 
predicted FC using the predictive equation  
The results showed there was no significant difference in the propionate 
concentration between any of the NDCs mixtures after 4 h of incubation. After 24 
hours of fermentation, all the NDCs fermentable mixtures had a higher propionate 
concentration than at 4 hours, but there were still no significant differences observed 
between the different fermentable NDCs mixtures.  
By comparing the different FC mixtures and predicted values, the results (Table 5.9) 
show only the medium-FC mixture of NDCs (R = 0.90; p = 0.03) and the predicted 
FC (R = 0.94; p = 0.01) had significant relationship with the propionate 
concentration. The high FC mixtures of NDCs (R = 0.93; p = 0.02) showed a good 
correlation with propionate concentration, but the predicted FC did not have a good 
relationship with the propionate concentration. Overall these results show a good 
agreement correlation between different mixture of NDCs (low, medium and high 
FC) with propionate concentration and with those predicted FC.      
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5.5.4.4 Correlation of butyrate concentration (µmol/ml) of different NDCs 
(low, medium and high FC) mixtures after 24 h incubation vs. 
predicted FC using the predictive equation 
At 4 h, the high-FC mixture of NDCs showed a significantly higher butyrate 
concentration (2.50 ± 0.3 µmol/ml) than low and medium FC mixtures. At 24 h of 
fermentation, there was also no significant differences observed in butyrate 
concentration between all the FC mixtures of NDCs. 
In term of the relationship between the FC mixtures of NDCs and the predicted FC 
with butyrate concentration, the butyrate concentration was strongly correlated with 
the medium FC mixture NDCs fermentation (R = 0.97; p = 0.004) compared with the 
predicted FC (R = 0.90; p = 0.03; Table 5.9).  
5.5.4.5 In vitro fermentation of different NDCs (low, medium and high FC) 
mixtures pH changes  
The analysis of the pH of the cultures (Table 5.10) showed that the pH dropped 
rapidly during the fermentation of low, medium and high FC mixtures of NDCs up to 
4 hours. The pH in culture of medium FC then only showed relatively small 
decreases in pH during prolonged incubation, whereas there was a progressive fall 
in pH from 0 hour to 24 hours of fermentation for the cultures containing high FC. 
Overall, the high FC consistently produced a lower pH compared to the low and 
medium FC cultures.  
Table 5.10: Changes in pH (mean ± SEM) of human faecal cultures containing low, medium 
and high FC mixtures of NDCs over 24 h (n=5) after in vitro anaerobic incubation with human 
faeces. 
 
Values with different letters within a column are significantly (P < 0.05) different. There are significant (P < 0.05) differences 
between time points within a row except Blank (0h vs. 4h and 4h vs 24h). 
 
 
 
 
  pH at 0 h pH at 4 h pH at 24 h 
Low-FC 7.22 ± 0.02 a 6.43 ± 0.11 a 5.93 ± 0.12 a 
Medium-FC 7.20 ± 0.05 a, c 6.45 ± 0.08 a, e 6.13 ± 0.09   a, d   
High-FC 7.18 ± 0.03 c 6.42 ± 0.11 a, d 5.41 ± 0.14 b, e 
Blank 7.22 ± 0.07   a, c  7.32 ± 0.05    b 7.33 ± 0.04   c 
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 Residue dry weight of isolated FC mixtures of (RS, soluble 
DF, insoluble DF and oligosaccharide) after in vitro 
digestion vs. predicted fibre  
The results (Table 5.11) for the amount of isolated RS, soluble DF, insoluble DF and 
NDOs after removing the digestible starch from the samples using an extensive in 
vitro enzymatic digestion model, vs. the predicted amount of the same fibre 
measured using developed FC equations showed the differences between the 
isolated mixtures and predicted values produced. 
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Table 5.11: Non-digestible fractions of isolated FC mixtures of (RS, soluble DF, insoluble DF and oligosaccharide) vs. predicted (mg/g). 
* The values are reported as mean (standard deviation) for actual (n = 5) vs. predicted (n = 5); ** Predicted FC-DF 4 equation: 100 % Soluble DF + 50 % insoluble DF + 100 % NDOs + 10 % TS.    
 
 
 
 
 
  
 
 
 
 
 
 
 
NDC Isolated mixture of RS 
 
Isolated mixture of soluble DF 
 
Isolated mixture of insoluble DF 
 
Isolated mixture of oligosaccharide 
 Actual Predicted** Actual Predicted Actual Predicted Actual Predicted 
Resistant Starch 336.47 ± 16.9 378.56 ± 19.0 14.18 ± 0.7 5.02 ± 0.2 10.53 ± 0.5 27.95 ± 1.4 44.72 ± 2.0 46.01 ± 2.3 
Fructan 5.27 ± 0.2* 5.95 ± 0.3 2.43 ± 0.1 5.95 ± 0.3 2.1 ± 0.1 0.84 ± 0.4 9.36 ± 0.4 21.24 ± 1.0 
Soluble DF 12.37 ± 0.6 12.37 ± 0.6 108.54 ± 5.5 108.54 ± 5.5 56.05 ± 2.8 56.05 ± 2.8 86.35 ± 4.3 86.35 ± 4.3 
Insoluble DF 25.84 ± 1.3 25.84 ± 1.3 23.67 ± 1.1 23.67 ± 1.2 47.36 ± 2.4 47.36 ± 2.39 13.91 ± 0.7 13.91 ± 0.7 
197 
197 
 
 In vitro fermentation of mixtures of different isolated FC (RS, 
Soluble DF, Insoluble DF and NDOs)  
Total SCFA concentrations during in vitro fermentation were used to compare the 
equations for FC against the individual FC dietary models in this experiment (Table 
5.12). The results show there was no significant difference in the total SCFA 
concentration in these models at 4 h (Figure 5.13), whereas at 24 h, it was observed 
that insoluble DF isolated mixture had lower SCFA concentration (61.19 ± 3.0 
µmol/ml) compared with RS, soluble and oligosaccharide isolated mixtures (Table 
5.12).    
Figure 5.13: Mean (±SEM) concentrations of total SCFA (µmol/ml) produced after 24 h 
incubation of mixtures of different isolated FC (RS, Soluble DF (Sol), Insoluble DF (Insol) and 
NDOs (Oligo)) with the faecal inoculum (n= 5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.5.6.1 Correlation of total SCFA concentration (µmol/ml) of mixtures of 
different isolated FC (n = 5; RS, Soluble DF, Insoluble DF and NDOs) 
after 24 h incubation vs. predicted FC (n = 5) using the predictive 
equation 
The results (Table 5.13) show the isolated RS mixture fermentation was strongly 
correlated with total SCFA concentration (R = 0.99; p = 0.001), when compared with 
predicted FC (R = 0.97; p = 0.005). No correlation was observed for the isolated 
mixture of soluble DF and predicted FC with total SCFA concentration. The isolated 
mixture of insoluble DF showed a higher correlation with total SCFA concentration 
(R = 0.96; p = 0.007) than the predicted FC (R = 0.93; p = 0.01), whereas the isolated 
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NDOs mixture showed a strong correlation with total SCFA concentration (R = 0.96; 
p = 0.007), when compared with predicted FC (R = 0.94; p = 0.01) (Table 5.13).  
Table 5.12: Concentration of total and major individual SCFA (µmol/ml) between 0 and 24 h of 
in vitro fermentation using human faecal samples (n = 5) with NDC substrates.  
 
SCFA NDC 
Isolated 
mixture of RS 
Isolated mixture 
of soluble DF 
 
Isolated mixture of 
insoluble DF 
 
Isolated mixture 
of NDOs 
 
Acetate      
0 h 3.49 ± 0.3 a 3.64 ± 0.2 a 3.40 ± 0.3 a 3.00 ± 0.2 b** 
4 h 30.48 ± 2.2 a 32.91 ± 3.0 a 31.73 ± 2.6 a 29.48 ± 3.2 a 
24 h 50.70 ± 4.6 a 61.77 ± 3.1 b 42.77 ± 1.4 c 56.04 ± 3.9 c, d 
Propionate      
0 h 0.53 ± 0.2 a* 0.48 ± 0.2 a 0.56 ± 0.2 a 0.30 ± 0.1 a 
4 h 16.02 ± 5.6 a, b 17.88 ± 3.7 a, b 9.00 ± 3.4 a 25.38 ± 2.8 b 
24 h 36.59 ± 4.3 a 36.45 ± 2.0 a 37.52 ± 3.8 a, b 48.46 ± 4.7 b 
Butyrate      
0 h 0.36 ± 0.1 a 0.41 ± 0.1 a 0.41 ± 0.1 a 0.22 ± 0.1 a 
4 h 1.77 ± 0.6 a 1.36 ± 0.4 a 1.1 ± 0.1 a 0.88 ± 0.2 a 
24 h 7.96 ± 0.9 a 5.55 ± 1.0 a 3.04 ± 0.4 b 5.25 ± 1.0 a 
Total 
SCFA 
    
0 h 4.42 ± 0.5 a 12.96 ± 1.5 b 4.40 ± 0.5 a 3.94 ± 0.6 c 
4 h 48.40 ± 5.4 a 48.94 ± 3.6 a 48.52 ± 7.0 a 47.38 ± 3.9 a 
24 h 101.30 ± 0.9 a 105.58 ± 2.9 a 61.19 ± 3.0 b 104.91 ± 6.8 a 
*Values with different letters are significantly different within a row. **SCFA was compared with paired t-test 
between 0, 4 and 24 hours for the same type of culture (P < 0.05). 
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Table 5.13 Correlation of actual NDC fermentation of total and major individual SCFA concentrations (µmol/ml) after 24 h of incubation using human faecal 
microbiota vs. predicted FC (n = 5). 
 SCFA Isolated mixture of RS 
 
Isolated mixture of soluble DF 
 
Isolated mixture of insoluble DF 
 
Isolated mixture of oligosaccharide 
 
  Actual Predicted Actual Predicted Actual Predicted Actual Predicted 
  R p R p R P R p R p R p R p R p 
SCFA 0.99 0.001 0.97 0.005 0.78 0.13 0.77 0.12 0.96 0.007 0.93 0.01 0.96 0.007 0.94 0.01 
                  
Acetate 0.78 0.11 0.75 0.14 0.82 0.09 0.82 0.09 0.94 0.01 0.96 0.009 0.94 0.01 0.94 0.01 
                  
Propionate 0.81 0.09 0.80 0.10 0.72 0.16 0.74 0.15 0.99 0.00 0.99 0.00 0.93 0.02 0.92 0.02 
                  
Butyrate 0.97 0.006 0.94 0.01 0.77 0.12 0.78 0.11 0.95 0.01 0.92 0.02 0.97 0.004 0.93 0.02 
* R; Pearson correlation coefficient, ** p value significant (P < 0.05) 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.5.6.2 Correlation of acetate concentration (µmol/ml) of mixtures of 
different isolated FC (RS, Soluble DF, Insoluble DF and NDOs) after 
24 h incubation vs. predicted FC using the predictive equation 
The results (Table 5.12) show there was no significant difference in the acetate 
concentration at 4 h of fermentation in all these models. After 24 h there was a 
consistent but small increase in acetate in the isolated mixture containing RS (50.70 
± 4.6 µmol/ml), soluble DF (61.77 ± 3.1 µmol/ml) and NDOs (56.04 ± 3.9 µmol/ml), 
with a significantly higher acetate concentration compared with insoluble DF (Table 
5.12).  
The isolated RS (Table 5.13), soluble DF mixtures and predicted FC showed no 
relationship with the acetate concentration, whereas the predicted FC showed an 
excellent correlation with acetate concentration (R = 0.96; p = 0.009), which was 
better than the isolated mixture of insoluble DF (R = 0.94; p = 0.01; Figure 5.14). 
The isolated NDOs mixture and predicted FC showed a similar correlation with the 
acetate concentration (R = 0.94; p = 0.01) (Table 5.13).   
Figure 5.14: Scatter-plot showing correlation of acetate concentration (µmol/ml) of isolated 
FC mixture of insoluble DF (n = 5) after 24 h incubation vs. predicted isolated FC mixture of 
insoluble DF (n = 5). Solid line indicates isolated FC mixture of insoluble DF; Dotted line 
indicates predicted isolated FC mixture of insoluble DF. 
 
Blue circle dot indicates predicted SCFA of isolated FC mixture of insoluble DF (μmol/ml). Black circle dot 
indicates SCFA produced from in vitro fermentation of isolated FC mixture of insoluble DF (μmol/ml). 
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5.5.6.3 Correlation of propionate concentration (µmol/ml) of mixtures of 
different isolated FC (n = 5; RS, Soluble DF, Insoluble DF and NDOs) 
after 24 h incubation vs. predicted FC (n = 5) using the predictive 
equation 
The results (Table 5.13) show there was a significant difference in the propionate 
concentration between the isolated FC mixture of insoluble DF and RS, soluble DF 
and NDOs FC mixtures at 4 hours. At 24 h, the isolated FC mixture of NDOs 
continued to have a higher propionate concentration (48.46 ± 4.7 µmol/ml) than the 
other mixtures. RS and soluble DF isolated mixtures had almost similar propionate 
concentrations at 24 hours of fermentation.    
The isolated RS (Table 5.13), soluble DF mixtures and predicted FC showed no 
relationship with the propionate concentration, whereas the predicted FC showed 
an excellent correlation with the propionate concentration (R = 0.99; p = 0.0001), 
and the isolated mixture of insoluble DF (R = 0.99; p = 0.0001). The predicted FC 
(R = 0.92; p = 0.02) and isolated NDOs mixture (R = 0.93; p = 0.02) showed a similar 
correlation with the propionate concentration (Table 5.13).  
5.5.6.4 Correlation of butyrate concentration (µmol/ml) of mixtures of 
different isolated FC (n= 5; RS, Soluble DF, Insoluble DF and NDCs) 
after 24 h incubation vs. predicted FC (n =5) using the predictive 
equation 
The results (Table 5.13) showed there was no significant difference in the 
concentration of butyrate between the carbohydrate models at 0 hours of 
fermentation, but there was a substantial butyrate concentration with the increasing 
incubation time observed at 4 h the for FC mixture of RS, compared with other 
mixtures. At 24 h, the fermentation of the RS mixture had the highest concentration 
of butyrate (7.96 ± 0.9 µmol/ml), followed by the soluble DF and the NDOs mixtures 
and were significantly higher than the insoluble DF mixture.    
The isolated FC mixture of RS (Table 5.13) showed an excellent relationship with 
the butyrate concentration (R = 0.97; p = 0.006), which was better than the predicted 
FC (R = 0.94; p = 0.01). Soluble DF mixtures showed no relationship with butyrate 
concentration. The isolated mixture of insoluble DF (R = 0.95; p = 0.01) and the 
isolated oligosaccharide mixture (R = 0.97; p = 0.004) showed a higher correlation 
with the butyrate concentration than predicted FC (Table 5.13).   
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5.5.6.5 In vitro isolated FC mixtures fermentation pH changes  
The results for the changes in pH over time (Table 5.14) showed that at 0 h, there 
were no pH differences observed between all the mixture cultures, and then the pH 
decreased rapidly up to 4 h during the fermentation of RS, soluble DF, insoluble DF 
and NDOs mixtures. The pH in culture of insoluble DF mixture did not change 
appreciably during prolonged incubation, whereas a progressive fall in pH from 0 to 
24 hours of fermentation was seen only in cultures containing RS, soluble DF and 
NDOs mixtures. The final pH (24 hours) was significantly lower in NDOs than 
insoluble DF mixtures (Table 5.14).  
Table 5.14: Changes in pH (mean ± SEM) of human faecal cultures containing, Soluble DF, 
Insoluble DF and NDOs isolated FC mixtures over 24 h (n=5) after in vitro anaerobic 
incubation 
Values with different letters within a column are significantly (P < 0.05) different. There are significant (P < 0.05) 
differences between time points within a row except high insoluble NSP model (4 h vs 24 h).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  pH at 0 h pH at 4 h pH at 24 h 
Isolated mixture of RS 7.14 ± 0.03 a 6.05 ± 0.10 a 5.95 ± 0.09 a, b 
Isolated mixture of soluble DF 7.15 ± 0.05 a 6.03 ± 0.17 a, b 5.93 ± 0.13 a, b 
Isolated mixture of insoluble DF 7.15 ± 0.04 a 6.08 ± 0.09 a 6.07 ± 0.07 b 
Isolated mixture of NDOs 7.14 ± 0.03 a 5.88 ± 0.12 b 5.80 ± 0.12 a 
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 Discussion  
These in vitro digestion and fermentation experiments were conducted to validate 
the relationship between FC and the 24 h urinary excretion of acetate and SCFA, 
observed in the previous habitual dietary intake and 24 h urinary excretion SCFA 
study (chapter 4). The results in chapter 4 showed the equations for FC-DF 4 and 
FC-NSP 4 had a good correlation with 24 h urinary excretion of acetate and SCFA 
compared to either DF or NSP alone. To the best of our knowledge, this is the first 
in vitro study to estimate FC from single and mixtures of different NDCs with the use 
of developed equations to predict the amount of SCFA produced in an in vitro 
fermentation of NDC after digestion in an in vitro enzymatic digestion model.  
Therefore, it is important to perform an in vitro model of enzymatic digestion to 
hydrolyse starch and protein before undergoing in vitro fermentation (Aura et al., 
1999, Nordlund et al., 2012). In this study an enzymatic in vitro digestion was 
performed to remove digestible starch from the samples and to produce NDCs 
fractions prior to the in vitro colon model. The fructan content of raftiline decreased 
from 90 to 87 %, which shows the change in the fructan content by the digestion 
step was small, whereas the content of RS in raw potato starch decreased from 72 
to 50 % in this step which is as expected.   
In the current study, measurements of SCFA concentration carried out by the two 
different methods were highly correlated. The SCFA concentration in estimated FC 
using our developed equations is predicted by mathematical models (Fievez et al., 
2005). The agreement of the SCFA concentration measurement methods was 
assessed using Bland Altman plots. Bland and Altman measures agreement 
between two quantitative methods by constructing limits of agreement, which 
calculated by using the mean and the standard deviation of the differences between 
two methods. This will allow to check the assumptions of normality of differences 
(Giavarina, 2015). Whereas, Pearson correlation coefficient measures the degree 
to which two variables are related. However, a high correlation does not mean that 
there is good agreement between the two methods. The correlation coefficient and 
regression technique are sometimes inadequate and misleading when assessing 
agreement, because they evaluate only the linear association of two methods (van 
Stralen et al., 2008).  
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The overall bias of SCFA concentration was relatively small and the limits of 
agreement were wide for all the SCFA concentrations of FC. The most interesting 
findings of our in vitro experiments were that several agreements were observed 
between the total SCFA and acetate concentrations after in vitro fermentation of the 
single fibres and a different mixture of NDCs, and those predicted the estimated FC 
using our developed equations. For total SCFA concentration, the fermentation in 
vitro of the mixture of all 4 fibres and the medium FC mixture NDCs had an excellent 
agreement with predicted FC compared with other NDCs. On the other hand, 
psyllium had a stronger agreement with predicted FC values when examined 
against the acetate concentration. This study produced results which corroborate 
the findings of a large number of the previous work on in vitro digestion and 
fermentation of NDCs to predict the amount of fermentation products in vivo. Daniel 
et al. (1997) used a randomized cross-over study for three weeks which fed six 
women meals containing low fibre diet, two high fibre diets high or low in protein, an 
d a barley fibre concentrate. In an in vitro fermentation phase, faecal samples were 
obtained from these women and fibre residues were obtained from the fibre 
containing foods consumed during the trials. They observed that NSP fermentation 
in humans was 83.8 ± 0.9 % (low fibre diet), 61.8 ± 3.6 % (high fibre diet high in 
protein) and 59.2 ± 3.9 % (high fibre diet low in protein). The in vitro fermentation 
was different from fermentation in humans by −4.0 ± 1.6 % (low fibre diet, p < 0.05), 
4.9 ± 3.7 % (high fibre diet high in protein) and 8.8 ± 3.0 % (high fibre diet low in 
protein, p < 0.01). The authors conclude that fermentation of NSP in humans in vivo 
could be predicted with sufficient accuracy by this in vitro fermentation. These 
findings were also confirmed in a study conducted by the same authors, which found 
similar results (Wisker et al., 1998).  
The SCFA profiles depends on the physiochemical properties of FC in the colon; 
the human diet is made up of mixtures of NDCs, which might regulate the role SCFA 
products in the colon (Flint et al., 2012). This current study found that the 
fermentation pattern of total SCFA concentration of the mixture of all 4 fibres had a 
higher total SCFA concentration, followed by the raw potato starch and raftiline, 
which was significantly higher when compared with the culture of wheat barn and 
psyllium at 24 hours. The lowest SCFA producer was wheat bran, which is 
composed of > 80 % insoluble DF, which supports our predicted equation that 50 % 
might be fermented. Chen et al. (1998) reported that 90 % of wheat bran is insoluble 
fibre, which contributed to an increase faecal output and lower colonic transit time. 
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Nordlund et al. (2012) investigated fermentability of rye bran and aleurone, wheat 
bran and aleurone, and oat bran and cell wall concentrate in vitro. Their results 
showed wheat ban produced a lower total SCFA than other fibre (69 mM/ 24 h).  
In our experiments, fermentation of raw potato starch, the mixture of all 4 fibres and 
isolated FC mixture of RS had the highest concentrations of butyrate (16.18 ± 2.3, 
13.03 ± 0.6, and 7.96 ± 0.9 respectively), compared with different NDCs (low, 
medium and high FC) mixtures. This finding supports previous research into this 
area which links RS fermentation with a high butyrate production. Muir et al. (2004) 
in a randomized crossover study showed that a diet combining wheat bran and RS 
increased faecal bulking, reduced transit time, increased butyrate and acetate 
productions, when compared to wheat bran alone. A randomized cross over study 
carried out by McOrist et al. (2011) investigated effectiveness of habitual diets 
supplemented with 25 g of NSP, or 25 g of NSP plus 22 g of RS/day, over 4 weeks 
in 46 healthy adults, on in increasing faecal butyrate excretion. They concluded that 
the habitual intake of a high NSP plus RS diet was associated with a higher faecal 
butyrate concentration than NSP alone, which may result in promoting optimum 
colorectal health (McOrist et al., 2011). Since the different NDCs (low, medium and 
high FC) mixtures were obtained from habitual diets of general population, there are 
several possible explanations for high butyrate and SCFA concentrations when 
combining RS with other FC substrates. The habitually high fibre consumers are 
likely to eat a wide variety of fibre types, not all of which may be readily fermentable, 
for example wheat bran, whereas supplementation studies only added known and 
relatively well controlled amounts of fermentable NDCs. Another possible 
explanation is that a greater overall intake of fermentable substrates for example, 
protein, fibre, and starch combined, which may have overloaded the gut microflora 
and would lower the SCFA production. Also, individuals differ in the capacity of their 
large bowel microflora to ferment NDCs (Cummings et al., 1996). This could affect 
the supply of SCFA products to the large bowel and also an individual’s response 
to dietary change. 
The results of these in vitro fermentation experiments indicate that propionate 
formation was favored by the isolated mixture of oligosaccharide DF rather than the 
isolated mixture of insoluble DF at 24, whereas the high-FC mixture of NDCs had 
an intermediate value between the two. This supports previous in vitro results where 
PHGG increased propionate production compared to the other fibres, and the work 
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by Kedia et al. (2009) which showed higher in vitro propionate production from oat 
bran than from FOS. Karppinen et al. (2000) reported a high propionate formation 
oat bran compared with those from rye and wheat bran. Kim and White (2009) 
observed a significant propionate production capacity of β-glucan from oat 
independent of the molecular weight of β-glucan.  
The investigation of whether the amount of SCFA produced in an in vitro 
fermentation of FC after use of an in vitro enzymatic digestion model could be 
predicted by the developed equations of FC, showed several agreements between 
the total SCFA and acetate concentrations after in vitro fermentation of FC, and 
those predicted FC using our developed equation. The mixture of all 4 fibres and 
the medium-FC mixture NDCs showed an excellent correlation with total SCFA 
concentration produced and with those predicted FC. Additionally, the predicted FC 
and psyllium fibre had a strong correlation with acetate concentration. These 
relationship agreements were supported by the bland Altman plot analysis. 
Moreover, raw potato starch and raftiline fermentation showed a high agreement 
with the predicted FC, when examined against the SCFA concentration, especially 
for total SCFA and acetate concentrations. As > 70 % of raw potato starch is RS 
(McCleary et al., 2002), and raftiline is also composed of 95 % fructan, the results 
were a better fit with more SCFA than expected, possibly this is because nearly pure 
RS was used, which made the RS 100 % in our equation. Therefore, we can 
conclude that the newly developed predicted equations have been deemed a valid 
and practical tool to assess SCFA productions for in vitro fermentation. 
One of the limitations of this study could be the small sample size, but as the results 
showed the validity of these developed predicted equations of FC, they may be 
considered as a preliminary practical tool to assess SCFA productions of in vitro 
fermentation in future studies. Another limitation of this study was that we used 
isolated FC rich diets, and different mixtures of FC obtained from habitual dietary 
records; using NDC from well-designed interventions and comparing these with the 
fermentation in humans in vivo might give more reliable results. This could include 
the use of the stable isotope tracers’ technique to measure colonic FC fermentation 
in the colon. Several studies reported that the tracer technique, using stable isotope-
labelled biomarkers, could be used to investigate the colonic NDC fermentation in 
humans, especially as this technique is easy to perform, non-invasive and 
completely safe (Pouteau et al., 1998, De Preter et al., 2004).    
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In conclusion, our results from these three in vitro digestion and fermentation 
experiments suggested that there are strong correlations between the amounts of 
SCFA produced after actual in vitro fermentation of single fibre and different mixture 
of NDC, with the estimated FC from our developed equations. Therefore, these 
findings support our hypothesis that it is possible to estimate FC using our equations 
for in vitro fermentation of single DF and mixtures of different FC in vitro, after an 
extensive in vitro enzymatic digestion model used to remove digested starch prior 
to the in vitro fermentation of NDC samples. Therefore, these equations may be 
useful in predicting the SCFA produced in the proximal colon in humans, and further 
studies in vivo using stable isotope tracers of SCFA flux are needed for further 
validation. 
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 Chapter Six 
General Discussion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 209 
 
 Introduction 
The last decade has witnessed a significant increase in research into NDCs for the 
prevention of diseases (Jones, 2004). Several studies have reported that long term 
consumption of diets rich in NDCs, such as cereals, fruit and vegetables, may 
protect against several chronic diseases including CVD (Threapleton et al., 2013b), 
colorectal cancer (CRC) (Aune et al., 2011a, Park et al., 2005), diabetes mellitus 
(Carter et al., 2010) and obesity (Lindström et al., 2006). However, in many large 
cohorts use data from FFQ and 24-h dietary recalls that designed to measure a 
person’s usual dietary fibre intake over a defined period of time. Over the years, 
researchers have observed that the reported values from FFQs are subject to 
substantial error of both systematic and random, that can profoundly affect the 
results of epidemiologic studies (Maki et al., 2014). In addition, participants’ dietary 
intake underreporting appears to increase with increasing BMI, which may affect 
estimation of dietary intake. Moreover, changes in the food supply and dietary habits 
over time, incomplete information in food and nutrient databases, and changes in 
commercial food products due to formula optimization that are not rapidly explained 
in nutrient databases may also contribute to inaccurate assessments of dietary 
intakes (Bingham et al., 1995).   
Likewise, the World Cancer Research Fund came to a consensus that NDCs 
‘probably’ provide protective effects against CRC incidence when obtained from a 
high cereal, fruit and vegetable intake (WCRF, 2007). The issue here is that there 
are some conflicting studies and to allocate a level of ‘convincing evidence’ the 
criteria demanded ‘no substantial unexplained heterogeneity’ in the evidence. This 
is difficult to achieve if there are inconsistencies in the estimations of NDC intake 
(what is included as dietary fibre, method of analysis for food tables and definitions) 
and if there are several mechanisms which may interact in different types of diet. It 
is also difficult to see any effect if there is limited variation in intake in the cohort 
which can be a probably in many of the large cohort studies (Jones, 2014a). One of 
the more varied population cohort studies is the European Prospective Investigation 
into Cancer and Nutrition Study (EPIC), which is a multi-centre prospective cohort 
that includes more than 500,000 participants from 10 European countries. This 
study reported that the risk of colorectal cancer was inversely associated with 
intakes of total fruit and vegetables and total fibre (Bradbury et al., 2014). The 
strength of the EPIC study is due to recruiting half a million participants, and to date 
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more than 60,000 incident cases of cancer have been identified. Also, one of the 
major strengths of EPIC is the inclusion of study centres in 10 European countries, 
which provide considerable variation in dietary intakes within the cohort (Ferrari et 
al., 2004). Furthermore, a recent systematic review and meta-analysis of 42 cohort 
studies conducted by Liu et al. (2015) proposed that fibre consumption inversely 
associates with CVD by 23% (HR, 0.77; 95% CI, 0.72-0.81), by 17% (HR, 0.83; 95% 
CI, 0.74-0.91) for cancer, by 23% (HR, 0.77; 95% CI, 0.73-0.81) for all-cause 
mortality. 
Most of the evidence for the benefits of NDCs has been derived from 
epidemiological studies, but for many reasons, it has been problematic to fully 
establish the impact of NDCs on health in epidemiology studies (Jones, 2014a). 
Firstly, there are a wide range of properties of different NDCs, and combining them 
all in one category for statistical comparisons may dilute their impact in correlations 
or multivariate analysis. Secondly, several mechanisms have been suggested to 
explain the protective effects of NDCs (Jones, 2014a), including increased stool bulk 
(Karppinen et al., 2000), dilution of carcinogens in the colonic lumen (Tang et al., 
2011a), reduced transit time (Lampe et al., 1993a), lowering colonic pH, and 
bacterial fermentation to SCFA in the colon (Walker et al., 2005). Not all NDCs have 
the same properties nor exert their effects through the same mechanisms. 
Thirdly, one of the major obstacles to epidemiological studies on diet and the risk of 
chronic disease, is the relative inaccuracy of the methods with which individuals' 
habitual long term intake of food or nutrients can be measured by structured dietary 
questionnaires (Jones, 2014a). These methods could cause estimates of relative 
risk, or other measures of diet disease associations to be weakened (an effect 
usually referred to as attenuation bias), and reduce the statistical power of 
epidemiologic studies (Kaaks, 1997, Westenbrink et al., 2013b). The traditional 
analysis method of epidemiological data depend on food composition databases, 
which might not have been updated to include NDOs and RS, or to have accurate 
data on NDC added to food (Westenbrink et al., 2013a, Hollmann et al., 2013).  
One major route by which NDCs may act is via fermentation including the production 
of SCFA. The potential role of SCFA in promoting health has received much 
attention, and this has included more recently, the role of propionate in satiety (Arora 
et al., 2011), and the role of SCFA in obesity (Cani et al., 2005). However, it is very 
 211 
 
difficult to measure SCFA in vivo in humans with any accuracy, so epidemiological 
studies on the impacts of SCFA are impossible. Most studies use DF or NSP intake 
to measure SCFA, but not all DF or NSP are equally fermentable (Jones, 2014a) 
Moreover, different types of NDCs are fermented to varying extents in the human 
gut, meaning that the actual amount of FC entering the large intestine is very difficult 
at present to predict (Laurentin and Edwards, 2005). To the best of our knowledge, 
currently there is no data in the literature aimed at developing an index which allows 
estimates of NDCs that escape digestion and absorption, and are fermented fully to 
SCFA by the colonic bacteria. Therefore, the work in this thesis has focused on 
developing an index of FC that can be used to estimate, from food diaries, the 
amount of carbohydrate that escapes digestion and absorption and is fermented to 
SCFA. Such an index should allow better analysis of epidemiological data to test 
the hypothesis that NDCs which act via SCFA production have any impact on 
incidence of chronic disease. 
 Summary of findings 
The work of this thesis follows the development of a series of potential equations to 
be used as an index of the amount of FC that reaches the human colon for 
fermentation. These were tested for suitability for estimating FC from dietary records 
by comparing their ability to predict SCFA production in in vitro models and in human 
studies as listed below:  
1. A series of potential equations for the FC index were developed to estimate 
FC that entered the human colon and were fermented to SCFA by the 
bacteria, these were developed by considering in detail the evidence for the 
digestibility of all ingested carbohydrates and also their likely fermentability. 
The amount of such carbohydrates in the diet were considered in detail and 
related to evidence for how much SCFA should be expected from their 
fermentation from published studies. 
2. These equations were then tested using dietary data from a study where 
urinary SCFA had been previously measured. The results of chapter 4 
indicate that there were weak but significant correlation between the 24 h 
urinary excretion of acetate, and the estimated FC using the equations FC-
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DF 4 (based on AOAC DF) and FC-NSP 4. Similarly, the 24 h urinary 
excretion of SCFA was correlated with estimated FC using these equations 
unlike NSC or DF values alone. The results of the in vitro fermentation of 
NDCs experiments (chapter 5), showed several agreements between the 
total SCFA, acetate and propionate concentrations after actual in vitro 
fermentation of NDCs, and those predicted FC using our developed index 
equations. This was tested using a range of fibres, fibre mixes and 
combinations of fibres which aimed to have different doses of fermentable 
carbohydrate to test the robustness of the equations in predicting SCFA 
production. The mixture of four fibres, and the medium-FC mixture NDCs, 
showed an excellent correlation with total SCFA concentration produced and 
with the predicted FC. Furthermore, the predicted FC and psyllium fibre had 
a strong correlation with acetate and propionate concentrations. The Bland 
Altman plot analysis also supports these correlations between NDCs 
fermentation and predicted FC with total SCFA and acetate concentrations. 
 Developing an index of dietary estimation of FC 
Currently there is no validated method to estimate how much of NDCs escapes 
digestion and absorption in the small intestine (as some are potentially digestible) 
and how much is fermented in the colon.  
Our model equations for estimating FC (chapter 3), were based on evidence from 
different studies; soluble DF such as pectin is completely fermented (100 %), 
insoluble DF such as wheat bran is less fermented (10-50 %), NDOs were included 
as 100 % of NDOs are completely fermented, and finally, the amount of RS was 
estimated as 5 - 10 % of total starch, but this is assumed to be totally fermented 
(Table 3.3).  
Different models were used in human in vivo determination of NDC that escape 
digestion and enter the colon for fermentation. Direct intubation of the ileum of 
healthy subjects showed that 3.2 – 9.3% of TS were recovered in the terminal ileum 
(Stephen et al., 1983, Flourie et al., 1988). The ileostomy model showed that on 
average < 1 - 12.2% of TS were appeared in ileal effluent of the ileostomies with 
exception 75% of banana starch was recovered (Chapman et al., 1985, Sandberg 
et al., 1986, O'Donnell et al., 1989, Wolever et al., 1986). This model was considered 
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to be a reliable model for studying small intestine digestion. Breath hydrogen 
measurements suggested that 2.2 - 38% of TS escapes digestion in the small 
intestine as RS (Levitt et al., 1987, Wolever et al., 1986, Scheppach et al., 1988b, 
Stephen et al., 1983). The amount of RS in a starchy food is usually less than 5 
to10% but can be between 0% and 100% (Silvester et al., 1995). Overall,  in the 
Western diet approximately 10 % of TS might be RS (Chapman et al., 1985, Englyst 
et al., 1996). Ileostomy patients showed that the mean excretion of inulin and 
oligofructose at the end of the ileum was approximately 88% and 90% respectively 
of the ingested dose of inulin and oligofructose recovered from the effluent (Ellegård 
et al., 1997, Andersson et al., 1999). In addition, the fermentability of NSP is highly 
influenced by its physiochemical properties. Insoluble fibres (lignin, cellulose, wheat 
bran and some hemicelluloses) are resistant to colonic microflora fermentation. In 
humans in vivo, Chen et al. (1998) reported that 96% of oat bran was fermented, 
compared 56 % of wheat bran. Barry et al (1995) reported that only 6-7% of cellulose 
and maize bran were fermented in in vitro. Stevens et al. (1987) stated that less 
than 50% of wheat bran components were fermented. On the other hand, soluble 
fibres (pectin, gums, mucilage and psyllium) were almost completely fermented. 
Barry et al. (1995) showed that more than 97% of pectin and 91% of soybean fibre 
were fermented. 
A major limitation of this approach is that we have not directly measured the 
absorption of foods ourselves, for example with the use of ileostomy patients, but 
made decisions based on incomplete published data. However, these are 
approximate equations and do not claim to give an exact measure of FC in the diet, 
they are more of an index for epidemiological studies. Further research could be 
performed to provide more detailed validations based on such models. 
In the chapter 4 study, the weak correlation between the 24 h urinary acetate, SCFA 
and the estimated FC intake suggested that using urinary output may not be an 
appropriate index to reflect colonic production of SCFA (Layden et al., 2013). 
Urinary excretion of SCFA was not well validated as it didn’t reflect the colonic 
production of SCFA as hoped. There are a number of possible reasons that might 
elucidate the weak correlation between predicted FC intake and 24 h urinary 
excretion of colonic metabolites. The first reason ( as explored in chapter 4) could 
be that although approximately 95 % of all SCFA (acetate, propionate and butyrate) 
components produced from NDCs fermentation in the gut by microflora are rapidly 
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absorbed by the colonocytes (den Besten et al., 2013) most of the butyrate is used 
by the colonocytes (Roediger, 1980) and 70% - 90% of butyrate is metabolized by 
the colonocytes (Cummings, 1983).  
Second, SCFA are also formed by sources other than NDCs fermentation in the gut 
such as the fermentation of protein (Ouwehand et al., 2005).    
Thirdly acetate is produced by human cells from fatty acid oxidation (but also amino 
acid and glucose metabolism), (Wolever et al., 1997, Freeland et al., 2010). The 
major sources of energy in metabolic states with decreased glucose metabolism are 
ketone bodies which are generated via hepatic acetyl-CoA production during fatty 
acid oxidation (Pouteau et al., 2003). Hepatic acetate levels were also increased 
during fatty acid oxidation, and circulating acetate levels increased with the use of 
acetate as a fuel source in fasting states (Layden et al., 2013).  
In addition, acetate, the main SCFA in the circulation is metabolised by human cell 
as it passes around the body. Nearly 70 % of the acetate formed by colonic bacterial 
fermentation of NDCs, and endogenous acetate formed in the liver during fatty acid 
oxidation, is taken up by the liver (Layden et al., 2013). The liver uses acetate as an 
energy source, but also as a substrate for the synthesis of cholesterol and long-
chain fatty acids and as a co-substrate for glutamine and glutamate synthesis. Other 
tissues including the heart, adipose tissue, kidney, and skeletal muscle metabolize 
the remainder of the acetate  (Bloemen et al., 2009). Moreover, It is suggested that 
around 30% of propionate concentration in portal blood and hepatic venous blood, 
is taken up by the liver (Binder, 2010, Bloemen et al., 2009). Peripheral tissues take 
up the remainder of propionate because peripheral venous blood levels were 23% 
lower compared with hepatic venous blood levels. Reilly and Rombeau (1993) 
reported that humans use 50% of the propionate as a substrate for hepatic 
gluconeogenesis. In general, therefore, it seems that the liver clears a large fraction 
of propionate from the portal circulation, but absolute values are still unknown.  
Therefore, urinary SCFA excretion might provide little information about actual 
levels of intestinal SCFA metabolism (den Besten et al., 2013). This might explain 
why urinary excretion of SCFA is not well validated to reflect colonic production of 
SCFA, and the low level of urinary excretion of acetate in the study participants’ 
urine samples.   
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In addition to the loss of SCFA before they enter the urine, there are also issues 
with the dietary records of habitual intake (chapter 4). Participants are likely to eat 
a wide variety of NDCs, which may not all be readily fermentable, for example wheat 
bran. However, several interventional studies and supplementation/trial studies 
have added known and relatively well controlled amounts of fermentable NDCs, 
which produced a predictable amount SCFA. Muir et al. (2004) observed that diets 
supplemented WBRS produced a higher faecal concentration of acetate compared 
with WB alone. Ahmed et al. (2000) found a higher SCFA production, and in 
particular butyrate production, after consumption of a specific mixture of high RS in 
the diet as compared with a low RS diet. Moreover, Henningsson et al. (2002) 
observed that rats fed with specific amounts of high amylose cornstarch with wheat 
bran produced higher faecal excretion of total SCFA, than rats fed with a single fibre 
source high amylose cornstarch or wheat barn.  
Under-reporting dietary intake could also be one of the reasons that might lead to 
weak correlation of exogenous acetate concentration in the urine. Under-reporting 
of food intake is one of the main obstacles inhibiting the collection of accurate 
habitual dietary intake data to investigate the relationship between diet and health 
(Conway et al., 2003, Goran and Poehlman, 1992). MacDiarmid and Blundell (1998) 
stated that under-reporting ranged between 18 % and 54 % in the large nutritional 
surveys when considering the whole sample, and it could reach up to 70 % in 
particular subgroups. Females are more likely to under-report their daily dietary 
intake than men. In our data from all the 122 healthy volunteers (n = 122), 36 % 
under-reported their dietary intake, and of the 36 % under-reporting their dietary 
intake, 57 % were female. Within the sub-group of valid participants (n = 78) 53.8 % 
were female.  
In accordance with published data, the last study (chapter 5) showed several 
agreements between the total SCFA, acetate and propionate concentrations after 
in vitro fermentation of NDCs, with the predicted FC using our developed equation. 
These might validate the significant relationship between FC and the 24 h urinary 
excretion of acetate and SCFA, which observed in our previous (chapter 4) study. 
The mixture of all 4 fibres and the medium-FC mixture NDCs showed an excellent 
correlation with total SCFA concentration produced, and with the predicted FC. 
Additionally, the predicted FC and psyllium fibre had a strong correlation with 
acetate and propionate concentrations. These relationship agreements were 
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supported by the Bland Altman plot analysis, which showed that the bias between 
NDCs fermentation and predicted FC with total SCFA and acetate concentrations 
was relatively small, with wide limits of agreement. Therefore, we can conclude that 
the newly developed predicted FC index is a valid and practical tool to assess SCFA 
productions for in vitro fermentation. This is in agreement with Daniel et al. (1997) 
who showed that fermentation of NSP in humans in vivo could be predicted with 
sufficient accuracy by this in vitro fermentation. These findings were also confirmed 
in a study conducted by the same authors, which found similar results (Wisker et 
al., 1998).  
Overall there was significant difference in the in vitro faecal fermentation metabolites 
(including total SCFA, acetate, propionate and butyrate concentrations), in the three 
in vitro fermentation experiment mixtures of different isolated NDCs, single dietary 
fibre and mixture of all 4 fibres, and the three different NDCs mixtures. In our study 
the fermentation pattern for the total SCFA concentration of the mixture of all 4 fibres 
had the highest total SCFA concentration, followed by the raw potato starch and 
raftiline, which were significantly higher when compared with the culture of wheat 
bran and psyllium at 24 hours. These findings of the current study are consistent 
with those of Khan and Edwards (2005) who found that mixture of raftilose and guar 
gum produced a significantly higher total SCFA concentration than guar gum alone 
(p < 0.002). Moreover, Kaur et al. (2011) observed that the in vitro fermentation of 
benchmark starch-entrapped microspheres resulted in a significantly higher amount 
of total SCFA, particularly in the 24 to 48 h period, as compared to the fermentation 
of long-chain inulin, psyllium, alkali-soluble corn bran arabinoxylan, and β-glucan. 
In the last study (chapter 5), the results showed that wheat bran produced a lower 
SCFA concentration. The present findings seem to be consistent with that found by 
Nordlund et al. (2012) which observed that wheat bran produced a lower total SCFA 
than rye bran, oat bran and aleurone. Wheat bran is composed of > 80 % insoluble 
DF, which supports our predicted equation that 50 % might be fermented. Chen et 
al. (1998) reported that 90 % of wheat bran is insoluble fibre, which contributed to 
an increase faecal output and lower colonic transit time.  
Furthermore, one of the important findings in this study was the significantly higher 
rate of production of propionate in the isolated mixture of oligosaccharide DF, rather 
than the isolated mixture of NDCs at 24 h. The high-FC mixture of NDCs had an 
intermediate value between the two other mixtures of NDCs, which might show that 
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high-FC mixture of NDCs comprised of more rapidly fermented NDCs. The present 
findings are consistent with other research which found oat bran, rather than FOS, 
produced higher in vitro propionate concentrations (Kedia et al., 2009). Similarly, 
Karppinen et al. (2000) reported a high propionate formation form oat bran when 
compared with rye and wheat bran. Additionally, Kim and White (2009) observed a 
significant propionate production capacity of β-glucan from oat independent of the 
molecular weight of β-glucan.   
Another interesting finding of the last study (chapter 5), was that raw potato starch, 
the mixture of all 4 fibres, and the isolated FC mixture of RS had the highest 
concentrations of butyrate, compared with different NDCs (low, medium and high 
FC) mixtures. These results are consistent with those of other studies and suggests 
that RS is a good source of butyrate (Cummings and Macfarlane, 1991). Le Leu et 
al. (2002) reported that combining RS with wheat bran resulted in much higher levels 
of SCFA, particularly butyrate, observed in the faeces. Moreover, the habitual intake 
of a high NSP plus RS diet was associated with a higher faecal butyrate 
concentration than NSP alone, which may result in promoting optimum colorectal 
health (McOrist et al., 2011). Within this study different NDCs (low, medium and high 
FC) mixtures of substrates were obtained from habitual diets of the general 
population, which might explain the high butyrate and SCFA concentrations when 
combining RS with other FC substrates. The habitually high fibre consumers are 
likely to eat a wide variety of fibre types, not all of which may be readily fermentable, 
for example wheat bran. Also, individuals differ in the capacity of their large bowel 
microflora to ferment RS (Cummings et al., 1996). This could affect the supply of 
SCFA products to the large bowel and also an individual’s response to dietary 
change.  
 Limitations 
There are some limitations to these studies; we were unable to validate the 
equations in our in vivo studies using urinary excretion of SCFA products, as more 
than 95 % of SCFA products are rapidly absorbed by the colonocytes. Also 70 % of 
the acetate production, which is exogenous acetate formed by colonic bacterial 
fermentation of NDCs, and endogenous acetate formed in the liver during fatty acid 
oxidation, is taken up by the liver. This might explain why urinary excretion of SCFA 
is not well validated to reflect colonic production of SCFA. Moreover, one of the 
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limitations of the last study (chapter 5), could be the small sample size of the in vitro 
experiments. Using isolated FC rich diets and different mixtures of FC obtained from 
habitual dietary records could be also another limitation of this study. Using NDCs 
from well-designed interventions and comparing these with the fermentation in 
humans in vivo might give more reliable results. Nevertheless, it will be necessary 
to validate the equations more accurately in humans. One approach could be to use 
stable isotope labelled FC and to monitor the label in breath, plasma and urine. The 
in vitro models were not a perfect match for colonic fermentation as they were batch 
cultures and did not have any modelling of the absorption of the SCFA, so there 
may have been some product inhibition especially at low pH.  However, these types 
of models are widely used and have been related to effects in humans by others 
(Pouteau et al., 2003, Edwards et al., 1992). 
 Implications for public health  
This thesis demonstrated several relationships between estimated dietary FC, using 
our equations, and SCFA products in vivo and in vitro. Interventional studies support 
the relevance of prebiotic fermentation in obesity management in humans (Cani et 
al., 2009, Cani et al., 2005). These studies showed that oligofructose fermentation 
increases satiety and reduced the daily total energy by 5 %. On the other hand, 
most of health assessment evidence is based on randomized controlled trials 
examining the relationship between RS, NDOs and the relevant health/disease 
outcomes. There were no prospective cohort studies examining the relationship 
between RS and NDOs intake and the relevant health/disease outcomes (SACN, 
2015). The traditional analysis method of epidemiological data depends on food 
composition databases, which might not have been updated to include NDOs and 
RS or to have accurate data on NDCs added to food (Westenbrink et al., 2013a, 
Hollmann et al., 2013). These methods could cause estimates of relative risk or 
other measures of diet disease associations to be weakened (an effect usually 
referred to as attenuation bias) and reduce the statistical power of epidemiologic 
studies (Kaaks, 1997). Reanalysis of established data from epidemiological studies 
using our predictive FC equations, might over-come assessments bias, which might 
increase the statistical power of the studies to detect the relationships of FC and 
health, and potentially to show links between SCFA production and health effects.        
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 Further research  
Based on the results of this thesis, using NDCs from well-designed interventions 
and comparing these with fermentation in humans in vivo might give more reliable 
results. The most reliable method that could be used to measure SCFA in humans’ 
in vivo is the isotope dilution method. This involves a labelled SCFA dose, preferably 
delivered to the colon, or by looking at dilution of the labelled SCFA infused into the 
plasma by unlabelled SCFA absorbed from the colon. This would provide 
information on all three major SCFA, and the effects of specific NDC could be related 
to specific SCFA. Using stable isotope-labeled substrates (primarily 13C) allows us 
to identify which SCFA metabolites are produced from NDC fermentation by 
analyzing the presence of 13C-atoms in SCFA metabolites (Breves et al., 1993, 
Pouteau et al., 2003). This might overcome the problem that FC and protein both 
contribute to SCFA production (De Preter et al., 2004). This is also might provide 
reliable information on specific SCFA flux, and a potential explanation of specific 
SCFA biomarker relationships in disease. For example, the butyrate flux could be 
assessed in relation to biomarkers of metabolic syndrome, and propionate as a 
biomarker of satiety. Microorganisms that ferment specific NDC could also be 
identified by measuring the 13C-incorporation in microbial biomass, for example 
16S-rRNA (de Graaf and Venema, 2007). 
However, once better validated the FC equations developed in this thesis will be a 
powerful epidemiological tool for future cohort, case controlled and intervention 
studies that investigate the role of fermentation in a range of chronic conditions, and 
will provide more clear results that using dietary fibre alone. 
 Conclusions  
The data of this thesis demonstrated several relationships between the estimated 
dietary FC using our equations and SCFA products in vivo and in vitro. These need 
to be further validated, possibly by using FC from well-designed interventions and 
comparing these with fermentation in humans in vivo. The most reliable method that 
could be used to measure SCFA in humans’ in vivo is the isotope dilution method. 
Once better validated the FC equations developed in this thesis will be a powerful 
epidemiological tool for future cohort, case controlled and intervention studies 
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investigating the role of fermentation in a range of chronic conditions, and will 
provide more clear results that using DF alone. 
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Xylooligosaccharides: manufacture and applications. Trends in Food 
Science & Technology, 11, 387-393. 
Venema, K. 2010. Role of gut microbiota in the control of energy and carbohydrate 
metabolism. Current Opinion in Clinical Nutrition & Metabolic Care, 13, 432-
438. 
Venter, C., Vorster, H. & Cummings, J. 1990a. Effects of dietary propionate on 
carbohydrate and lipid metabolism in healthy volunteers. American Journal 
of Gastroenterology, 85, 549-553. 
Venter, C. S., Vorster, H. H. & Cummings, J. H. 1990b. Effects of dietary propionate 
on carbohydrate and lipid metabolism in healthy volunteers. American journal 
of Gastroenterology, 85. 
 257 
 
Vernia, P., Annese, V., Bresci, G., D’albasio, G., D’incà, R., Giaccari, S., Ingrosso, 
M., Mansi, C., Riegler, G., Valpiani, D., Caprilli, R. & Gisc 2003. Topical 
butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: 
results of a multicentre trial. European Journal of Clinical Investigation, 33, 
244-248. 
Voragen, A. G. J. 1998. Technological aspects of functional food-related 
carbohydrates. Trends in Food Science & Technology, 9, 328-335. 
Vulevic, J., Juric, A., Tzortzis, G. & Gibson, G. R. 2013. A Mixture of trans-
Galactooligosaccharides Reduces Markers of Metabolic Syndrome and 
Modulates the Fecal Microbiota and Immune Function of Overweight Adults. 
The Journal of Nutrition, 143, 324-331. 
Walker, A. R., Richardson, B. D., Walker, B. F. & Woolford, A. 1973. Appendicitis, 
fibre intake and bowel behaviour in ethnic groups in South Africa. 
Postgraduate medical journal, 49, 243-249. 
Walker, A. W., Duncan, S. H., Leitch, E. C. M., Child, M. W. & Flint, H. J. 2005. pH 
and peptide supply can radically alter bacterial populations and short-chain 
fatty acid ratios within microbial communities from the human colon. Applied 
and Environmental Microbiology, 71, 3692-3700. 
Wallström, P., Sonestedt, E., Hlebowicz, J., Ericson, U., Drake, I., Persson, M., 
Gullberg, B., Hedblad, B. & Wirfält, E. 2012. Dietary fiber and saturated fat 
intake associations with cardiovascular disease differ by sex in the Malmö 
Diet and Cancer Cohort: a prospective study. PloS one, 7, e31637. 
Ward, H., Keogh, R., Lentjes, M., Luben, R., Wareham, N. & Khaw, K. 2012. Fibre 
intake in relation to serum total cholesterol levels and CHD risk: a comparison 
of dietary assessment methods. European Journal of Clinical Nutrition, 66, 
296-304. 
Wcrf 2007. Food, nutrition and the prevention of cancer: a global perspective, 
American Institute for Cancer Research. 
Weaver, L. T., Ewing, G. & Taylor, L. C. 1988. The bowel habit of milk-fed infants. 
Journal of Pediatric Gastroenterology and Nutrition, 7, 568-571. 
Westenbrink, S., Brunt, K. & Van Der Kamp, J.-W. 2013a. Dietary fibre: challenges 
in production and use of food composition data. Food Chemistry, 140, 562-
567. 
Westenbrink, S., Brunt, K. & Van Der Kamp, J. 2013b. Dietary fibre: challenges in 
production and use of food composition data. Food Chem, 140, 562 - 567. 
Williams, R. D., Olmsted, W. H., Hamann, C., Fiorito, J. & Duckles, D. 1936. The 
Effect of Cellulose, Hemicellulose and Lignin on the Weight of the Stool: A 
Contribution to the Study of Laxation in Man Two Figures. The Journal of 
nutrition, 11, 433-449. 
 258 
 
Willis, H. J., Eldridge, A. L., Beiseigel, J., Thomas, W. & Slavin, J. L. 2009. Greater 
satiety response with resistant starch and corn bran in human subjects. 
Nutrition Research, 29, 100-105. 
Wisker, E., Daniel, M., Rave, G. & Feldheim, W. 1998. Fermentation of non-starch 
polysaccharides in mixed diets and single fibre sources: comparative studies 
in human subjects and in vitro. British Journal of Nutrition, 80, 253-261. 
Wolever, T., Brighenti, F., Royall, D., Jenkins, A. & Jenkins, D. 1989. Effect of rectal 
infusion of short chain fatty acids in human subjects. The American journal 
of gastroenterology, 84, 1027. 
Wolever, T., Cohen, Z., Thompson, L., Thorne, M., Jenkins, M., Prokipchuk, E. & 
Jenkins, D. 1986. Ileal loss of available carbohydrate in man: comparison of 
a breath hydrogen method with direct measurement using a human ileostomy 
model. The American journal of gastroenterology, 81, 115. 
Wolever, T., Josse, R. G., Leiter, L. A. & Chiasson, J.-L. 1997. Time of day and 
glucose tolerance status affect serum short-chain fatty concentrations in 
humans. Metabolism, 46, 805-811. 
Wolever, T., Spadafora, P. & Eshuis, H. 1991. Interaction between colonic acetate 
and propionate in humans. The American Journal of Clinical Nutrition, 53, 
681. 
Wolever, T., Spadafora, P. J., Cunnane, S. C. & Pencharz, P. B. 1995. Propionate 
inhibits incorporation of colonic [1, 2-13C] acetate into plasma lipids in 
humans. The American journal of clinical nutrition, 61, 1241-1247. 
Wolin, M. J. 1981. Fermentation in the rumen and human large intestine. Science, 
213, 1463-1468. 
Wolin, M. J. & Miller, T. L. Year. Interactions of microbial populations in cellulose 
fermentation. In:  Fed. Proc, 1983. 109-113. 
Wolk, A., Manson, J. a. E., Stampfer, M. J., Colditz, G. A., Hu, F. B., Speizer, F. E., 
Hennekens, C. H. & Willett, W. C. 1999. Long-term intake of dietary fiber and 
decreased risk of coronary heart disease among women. JAMA: the journal 
of the American Medical Association, 281, 1998. 
Wong, J. M. W., De Souza, R., Kendall, C. W. C., Emam, A. & Jenkins, D. J. A. 
2006. Colonic health: fermentation and short chain fatty acids. Journal of 
clinical gastroenterology, 40, 235. 
Wong, J. M. W. & Jenkins, D. J. A. 2007. Carbohydrate digestibility and metabolic 
effects. The Journal of Nutrition, 137, 2539S-2546S. 
Wood, P. J. 1997. Functional foods for health. Cereals. Springer. 
 259 
 
Wood, P. J. 2007. Cereal β-glucans in diet and health. Journal of Cereal Science, 
46, 230-238. 
Wu, K., Bowman, R., Welch, A. A., Luben, R. N., Wareham, N., Khaw, K. T. & 
Bingham, S. A. 2007. Apolipoprotein E polymorphisms, dietary fat and fibre, 
and serum lipids: the EPIC Norfolk study. European heart journal, 28, 2930. 
Würsch, P. & Pi-Sunyer, F. X. 1997. The role of viscous soluble fiber in the metabolic 
control of diabetes: a review with special emphasis on cereals rich in β-
glucan. Diabetes care, 20, 1774-1780. 
Xu, J. & Gordon, J. I. 2003. Honor thy symbionts. Proceedings of the National 
Academy of Sciences, 100, 10452-10459. 
Younes, H., Levrat, M.-A., Demigné, C. & Rémésy, C. 1995. Resistant starch is 
more effective than cholestyramine as a lipid-lowering agent in the rat. Lipids, 
30, 847-853. 
Young, G. P., Hu, Y., Le Leu, R. K. & Nyskohus, L. 2005. Dietary fibre and colorectal 
cancer: a model for environment–gene interactions. Molecular nutrition & 
food research, 49, 571-584. 
Zhou, J., Martin, R. J., Tulley, R. T., Raggio, A. M., Mccutcheon, K. L., Shen, L., 
Danna, S. C., Tripathy, S., Hegsted, M. & Keenan, M. J. 2008. Dietary 
resistant starch upregulates total GLP-1 and PYY in a sustained day-long 
manner through fermentation in rodents. American Journal of Physiology-
Endocrinology and Metabolism, 295, E1160-E1166. 
Zoetendal, E. G., Akkermans, A. D., Akkermans-Van Vliet, W. M., De Visser, J. a. 
G. & De Vos, W. M. 2001. The host genotype affects the bacterial community 
in the human gastronintestinal tract. Microbial Ecology in Health and Disease, 
13, 129-134. 
 
 
 
260 
 
 Appendices 
 Dietary fibre content (Non-starch polysaccharides) in cereals (adapted 
from Englyst et al., 1989). 
 Dietary fibre content (Non-starch polysaccharides) in cereals (adapted 
from Englyst et al., 1988). 
 Dietary fibre (soluble, insoluble and total DF g/100 g as eaten) contents 
of 70 high consumption foods (adapted from Li et al., 2002). 
 Fructooligosaccharide composition of fruits (adapted from Campbell et 
al., 1997). 
 Fructooligosaccharide Composition of vegetables (adapted from 
Campbell et al., 1997). 
 Fructooligosaccharide Composition of fruits, vegetables and cereals 
(adapted from (Hogarth et al., 2000). 
 Inulin and oligofructose content of foods (adapted from Moshfegh et 
al., 1999 and Van Loo et al., 1995) 
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Dietary fibre content (Non-starch polysaccharides) in cereals (adapted from Englyst et al., 1989). 
 
 
 
 
Flour, grain and starches Total g/100 g 
Fresh Weight 
Flour, grain and starches Total g/100 g 
Fresh Weight 
  
 Soluble NSP 1.6  Soluble NSP 0.1 
Plain White Flour, Homepride Insoluble NSP 1.6 Cornflour Insoluble NSP t 
 Total NSP 3.2  Total NSP 0.1 
 Soluble NSP 1.4  Soluble NSP 0.3 
Plain White Flour, McDougalls Insoluble NSP 1.7 Cornmeal Insoluble NSP 1.4 
 Total NSP 3.1  Total NSP 1.7 
 Soluble NSP 2.2  Soluble NSP 0.8 
Country Cookbook Plain Insoluble NSP 4.7 Maize Meal Insoluble NSP 4.1 
 Total NSP 6.9  Total NSP 4.9 
 Soluble NSP 1.9  Soluble NSP 0.2 
Harvest Gold Brown Flour Insoluble NSP 3.9 Millet Insoluble NSP 1.7 
 Total NSP 5.8  Total NSP 1.9 
 Soluble NSP 1.5  Soluble NSP 4.3 
Wholewheat Flour, Jordans Insoluble NSP 6.8 Oatmeal, course Insoluble NSP 2.7 
 Total NSP 8.3  Total NSP 7.0 
 Soluble NSP 2.5  Soluble NSP 3.7 
Wholewheat Flour, Allinsons Insoluble NSP 7.2 Oatmeal, medium ground Insoluble NSP 2.9 
 Total NSP 9.7  Total NSP 6.6 
 Soluble NSP 0.1  Soluble NSP 7.6 
Arrowroot Insoluble NSP t Oatbran & Oatgerm Insoluble NSP 4.8 
 Total NSP 0.1  Total NSP 12.4 
 Soluble NSP 4.0  Soluble NSP 0.5 
Barley, flake Insoluble NSP 10.8 Popcorn Insoluble NSP 9.3 
 Total NSP 14.8  Total NSP 9.8 
 Soluble NSP 3.4  Soluble NSP t 
Barley, Peart Insoluble NSP 6.8 Rice, brown Insoluble NSP 1.9 
 
 
Total NSP 10.2  Total NSP 1.9 
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Flour, grain and starches Total g/100 g 
Fresh Weight 
Flour, grain and starches Total g/100 g 
Fresh Weight 
  1.0  Soluble NSP 2.1 
Buckwheat Insoluble NSP 1.1 Sunflower Seeds Insoluble NSP 3.0 
 Total NSP 2.1  Total NSP 5.1 
 Soluble NSP -  Soluble NSP 0.1 
Rice, White, Long Grain Insoluble NSP 0.4 Tapioca Insoluble NSP 0.3 
 Total NSP 0.4  Total NSP 0.4 
 Soluble NSP -  Soluble NSP 2.1 
Rice, White, Round Grain Insoluble NSP 0.5 Wheat Grain Insoluble NSP 7.7 
 Total NSP 0.5  Total NSP 9.8 
Rye Flakes Soluble NSP 4.0 Wheat Bran, Arjuna Soluble NSP 3.8 
 Insoluble NSP 7.2  Insoluble NSP 32.2 
 Total NSP 11.2  Total NSP 36.0 
Rye Flour Soluble NSP 3.9 Wheat Bran, Allinsons Soluble NSP 2.9 
 Insoluble NSP 7.8  Insoluble NSP 34.3 
 Total NSP 11.7  Total NSP 37.2 
Rye Grain Soluble NSP 4.0 Bran, Boots' Natural Unprocessed Soluble NSP 4.6 
 Insoluble NSP 7.4  Insoluble NSP 32.7 
 Total NSP 11.4  Total NSP 37.3 
Sago Soluble NSP 0.3 Wheat-flakes Soluble NSP 2.0 
 Insoluble NSP 0.4  Insoluble NSP 7.4 
 Total NSP 0.7  Total NSP 9.4 
Semolina Soluble NSP 1.0 Wheat-germ Soluble NSP 3.2 
 Insoluble NSP 1.1  Insoluble NSP 12.4 
 Total NSP 2.1  Total NSP 15.6 
Sesame Seeds Soluble NSP 1.9    
 Insoluble NSP 5.7    
 Total NSP 7.6    
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Bread Total g/100 g Bread Total g/100 g 
Fresh Weight Fresh Weight 
White Bread, Mothers Pride Soluble NSP 0.9 Rye Bread, Local Soluble NSP 2.2 
 Insoluble NSP 0.7  Insoluble NSP 2.2 
 Total NSP 1.6  Total NSP 4.4 
White Bread, Slimcea Soluble NSP 1.1 Rye Bread, Imported Soluble NSP 3.7 
 Insoluble NSP 0.7  Insoluble NSP 3.6 
 Total NSP 1.8  Total NSP 7.3 
White Bread, Sunblest Soluble NSP 0.9 Pumpernickel, Imported Soluble NSP 3.9 
 Insoluble NSP 0.6  Insoluble NSP 3.6 
 Total NSP 1.5  Total NSP 7.5 
Brown Bread, Sunblest Soluble NSP 1.1 PASTA 
 Insoluble NSP 2.5 White Macaroni, raw Soluble NSP 1.6 
 Total NSP 3.6  Insoluble NSP 1.5 
Brown Bread, Windmill Country Soluble NSP 1.2  Total NSP 3.1 
 Insoluble NSP 2.1 White Macaroni, cooked Soluble NSP 0.5 
 Total NSP 3.3  Insoluble NSP 0.4 
Wholemeal Bread, Allinsons Soluble NSP 1.2  Total NSP 0.9 
 Insoluble NSP 4.0 Whole-wheat Macaroni, raw Soluble NSP 2.1 
 Total NSP 5.2  Insoluble NSP 6.2 
Wholemeal Bread, Sainsburys Soluble NSP 1.6  Total NSP 8.3 
 Insoluble NSP 3.2 Whole-wheat Macaroni, cooked Soluble NSP 0.6 
 Total NSP 4.8  Insoluble NSP 2.2 
Wholemeal Bread, Windmill Soluble NSP 1.2  Total NSP 2.8 
 Insoluble NSP 3.7 White Spaghetti, raw Soluble NSP 1.5 
 Total NSP 4.9  Insoluble NSP 1.4 
Hovis Wheatgerm Soluble NSP 0.8  Total NSP 2.9 
 Insoluble NSP 1.4 White Spaghetti, cooked Soluble NSP 0.6 
 Total NSP 2.2  Insoluble NSP 0.6 
Hovis Wheatgerm, Sainsburys Soluble NSP 1.3  Total NSP 1.2 
 Insoluble NSP 1.7 Whole-wheat Spaghetti, raw Soluble NSP 2.0 
 Total NSP 3.0  Insoluble NSP 6.4 
Hovis Stoneground Soluble NSP 0.9  Total NSP 8.4 
 Insoluble NSP 3.3 Whole-wheat Spaghetti, cooked Soluble NSP 0.8 
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 Total NSP 4.2  Insoluble NSP 2.7 
Granary Loaf, Local Soluble NSP 2.1  Total NSP 3.5 
 Insoluble NSP 2.2    
 Total NSP 4.3    
Breakfast cereals 
Total g/100 g 
Breakfast cereals 
Total g/100 g 
Fresh Weight Fresh Weight 
All Bran, Kelloggs Soluble NSP 4.1 Meusli, Jordans' Special Soluble NSP 1.7 
  Insoluble NSP 20.4   Insoluble NSP 4.5 
  Total NSP 24.5   Total NSP 6.2 
Bran Flakes, Kelloggs Soluble NSP 3.0 Meusli,  Jordans' Fruit and Nut Soluble NSP 1.6 
  Insoluble NSP 8.3   Insoluble NSP 4.2 
  Total NSP 11.3   Total NSP 5.8 
Coco Pops, Kelloggs Soluble NSP 0.2 Original Crunchy, Jordan's Natural  Soluble NSP 2.7 
  Insoluble NSP 0.4   Insoluble NSP 4.6 
  Total NSP 0.6   Total NSP 7.3 
Cornflakes, Kelloggs Soluble NSP 0.4 Original Crunchy, Jordan's Bran  Soluble NSP 1.5 
  Insoluble NSP 0.5    Insoluble NSP 5.6 
  Total NSP 0.9   Total NSP 7.1 
Kelloggs Country Store Soluble NSP 1.8 Original Crunchy, Jordan's Honey,  Soluble NSP 1.6 
  Insoluble NSP 4.4   Insoluble NSP 5.0 
  Total NSP 6.2   Total NSP 6.6 
Crunchy Nut Cornflakes, Kelloggs Soluble NSP 0.3 Original Crunchy, Jordan's Original Soluble NSP 3.3 
  Insoluble NSP 0.5   Insoluble NSP 2.7 
  Total NSP 0.8   Total NSP 6.0 
Frosties, Kellogg’s Soluble NSP 0.2 Quaker Oats Soluble NSP 4.5 
  Insoluble NSP 0.3   Insoluble NSP 3.2 
  Total NSP 0.5   Total NSP 7.7 
Fruit 'n' Fibre, Kelloggs Soluble NSP 2.6 Porridge Oats, Scotts Soluble NSP 3.6 
  Insoluble NSP 4.4   Insoluble NSP 2.8 
  Total NSP 7.0   Total NSP 6.4 
Honey Smacks, Kelloggs Soluble NSP 1.6 Ready Bret, Kelloggs Soluble NSP 3.1 
  Insoluble NSP 3.1   Insoluble NSP 4.1 
  Total NSP 4.7   Total NSP 7.2 
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Breakfast cereals 
Total g/100 g 
CRISPBREADS 
Total g/100 g 
Fresh Weight Fresh Weight 
Rice Krispies, Kelloggs Soluble NSP 0.1 Allinsons Wholemeal Soluble NSP 3.1 
  Insoluble NSP 0.4   Insoluble NSP 6.0 
  Total NSP 0.5   Total NSP 9.1 
Ricicles, Kelloggs Soluble NSP t  Cracottes, Original Wheat Slice Soluble NSP 2.6 
  Insoluble NSP 0.3   Insoluble NSP 1.2 
  Total NSP 0.3   Total NSP 3.8 
Shredded Wheat, Nabisco Soluble NSP 2.0 Cracottes, Brown Wheat Soluble NSP 3.3 
  Insoluble NSP 7.8   Insoluble NSP 5.8 
  Total NSP 9.8   Total NSP 9.1 
Special K Soluble NSP 0.8 Hovis Traditional Wheat Slice Soluble NSP 3.3 
  Insoluble NSP 1.2   Insoluble NSP 4.9 
  Total NSP 2.0   Total NSP 8.2 
Start, Kelloggs Soluble NSP 1.8 Rye King, Brown Soluble NSP 5.4 
  Insoluble NSP 3.9   Insoluble NSP 6.2 
  Total NSP 5.7   Total NSP 11.6 
Sugar Puffs, Kelloggs Soluble NSP 1.6 Ryvita, Original Soluble NSP 3.9 
  Insoluble NSP 1.6   Insoluble NSP 7.8 
  Total NSP 3.2   Total NSP 11.7 
Sultana Bran, Kelloggs Soluble NSP 4.3 Ryvita, Brown Soluble NSP 5.1 
  Insoluble NSP 5.7   Insoluble NSP 8.5 
  Total NSP 10.0   Total NSP 13.6 
Weetabix Soluble NSP 3.1 Ryvita, High Fibre Soluble NSP 4.4 
  Insoluble NSP 6.6   Insoluble NSP 13.5 
  Total NSP 9.7   Total NSP 17.9 
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BISCUITS 
Total g/100 g 
BISCUITS 
Total g/100 g 
Fresh Weight Fresh Weight 
Cheddars, McVities Soluble NSP 1.3 Oat Cakes Soluble NSP 4.0 
  Insoluble NSP 0.7   Insoluble NSP 3.3 
  Total NSP 2.0   Total NSP 7.3 
Chocolate Homewheat, McVities Soluble NSP 1.1 Penguin biscuits Soluble NSP 0.6 
  Insoluble NSP 1.1   Insoluble NSP 0.7 
  Total NSP 2.2   Total NSP 1.3 
Cream Crackers, Jacobs Soluble NSP 1.4 Rich Tea, McVities Soluble NSP 1.1 
  Insoluble NSP 0.8   Insoluble NSP 0.6 
  Total NSP 2.2   Total NSP 1.7 
Custard Creams, Peak Frean Soluble NSP 0.9 Shortcake, Peak Frean Soluble NSP 0.8 
  Insoluble NSP 0.5   Insoluble NSP 0.7 
  Total NSP 1.4   Total NSP 1.5 
Digestive, McVities Soluble NSP 1.1 Wafer Biscuits Soluble NSP 0.8 
  Insoluble NSP 1.1   Insoluble NSP 0.8 
  Total NSP 2.2   Total NSP 1.6 
Farmhouse Wheat Crackers, Jacobs Soluble NSP 1.9 Water Biscuits Soluble NSP 1.8 
  Insoluble NSP 1.9   Insoluble NSP 1.3 
  Total NSP 3.8   Total NSP 3.1 
Fig Rolls Soluble NSP 0.8 Sauces   
  Insoluble NSP 2.0 HP Sauce Soluble NSP 0.3 
  Total NSP 2.8   Insoluble NSP 0.4 
Garibaldi Soluble NSP 1.1   Total NSP 0.7 
  Insoluble NSP 1.0 Tomato Ketchup  Soluble NSP 0.3 
  Total NSP 2.1   Insoluble NSP 0.5 
Ginger Nuts, McVities Soluble NSP 0.9   Total NSP 0.8 
  Insoluble NSP 0.5 Tomato Ketchup, Heinz Soluble NSP 0.5 
  Total NSP 1.4   Insoluble NSP 0.6 
Matzos Soluble NSP 1.6   Total NSP 1.1 
  Insoluble NSP 1.4 Branston Pickle Soluble NSP 0.5 
  Total NSP 3.0   Insoluble NSP 0.7 
Nice, Peak Frean Soluble NSP 1.2   Total NSP 1.2 
  Insoluble NSP 0.9    
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Dietary fibre content (Non-starch polysaccharides) in cereals (adapted from Englyst et al., 1988). 
 
 
 
  Total NSP 2.1    
Vegetables Total g/100 g Vegetables Total g/100 g 
Fresh Weight Fresh Weight 
Asparagus, cooked, bases of stalks Soluble NSP 0.8 Beans, haricot, dried, raw Soluble NSP 7.9 
 Insoluble NSP 0.9  Insoluble NSP 9.1 
 Total NSP 1.7  Total NSP 17.0 
Aubergine, raw Soluble NSP 1.0 Beans, haricot, dried, cooked Soluble NSP 3.7 
 Insoluble NSP 1.0  Insoluble NSP 4.6 
 Total NSP 2.0  Total NSP 8.3 
Bean sprouts, raw as purchased Soluble NSP 0.6 Beans, red kidney, dried, raw Soluble NSP 6.9 
 Insoluble NSP 0.9  Insoluble NSP 8.8 
 Total NSP 1.5  Total NSP 15.7 
Beans, baked, tinned 5 brans in Soluble NSP 2.1 Beans, red kidney, dried, cooked Soluble NSP 3.2 
 Insoluble NSP 1.4  Insoluble NSP 3.5 
 Total NSP 3.5  Total NSP 6.7 
Beans, broad, cooked Soluble NSP 1.2 Beans, mung, dried Soluble NSP 2.8 
 Insoluble NSP 4.2  Insoluble NSP 7.2 
 Total NSP 5.4  Total NSP 10.0 
Beans, butter, dried, raw Soluble NSP 6.3 Beans, mung, dried, cooked Soluble NSP 0.7 
 Insoluble NSP 9.7  Insoluble NSP 2.3 
 Total NSP 16.0  Total NSP 3.0 
Beans, butter, dried, cooked Soluble NSP 2.9 Beans, runner, cooked Soluble NSP 0.9 
 Insoluble NSP 4.0  Insoluble NSP 1.4 
 Total NSP 6.9  Total NSP 2.3 
Beans, french, cooked Soluble NSP 1.3 Beans, soya, dried Soluble NSP 6.8 
 Insoluble NSP 1.8  Insoluble NSP 8.9 
 Total NSP 3.1  Total NSP 15.7 
Beans, frozen sliced, cooked Soluble NSP 1.3 Beans, soya bran Soluble NSP 14.1 
 Insoluble NSP 1.8  Insoluble NSP 54.9 
 Total NSP 3.1  Total NSP 69.0 
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Vegetables  Total g/100 g Vegetables Total g/100 g 
Fresh Weight Fresh Weight 
Beans, soya bran (gluten free) Soluble NSP 9.8 Cabbage, Winter Admiral Hawke, cooked Soluble NSP 0.9 
 Insoluble NSP 41.6  Insoluble NSP 1.1 
 Total NSP 51.4  Total NSP 2.0 
Beans, soya flour Soluble NSP 5.2 Cabbage, Winter January King, raw Soluble NSP 1.4 
 Insoluble NSP 6.0  Insoluble NSP 1.5 
 Total NSP 11.2  Total NSP 2.9 
Beetroot, cooked Soluble NSP 1.2 Cabbage, Winter January King, cooked Soluble NSP 1.2 
 Insoluble NSP 1.3  Insoluble NSP 1.5 
 Total NSP 2.5  Total NSP 2.7 
Broccoli, sprouting, cooked, boiled 10 min Soluble NSP 1.5 Cabbage, Winter Savoy raw Soluble NSP 2.0 
 Insoluble NSP 1.5  Insoluble NSP 1.7 
 Total NSP 3.0  Total NSP 3.7 
Cabbage, summer, early summer, raw Soluble NSP 1.5 Cabbage, Winter Savoy, cooked Soluble NSP 1.6 
 Insoluble NSP 1.6  Insoluble NSP 1.6 
 Total NSP 3.1  Total NSP 3.2 
Cabbage, summer, early summer, cooked Soluble NSP 0.9 Cabbage, Red, raw Soluble NSP 1.8 
 Insoluble NSP 1.1  Insoluble NSP 2.0 
 Total NSP 2.0  Total NSP 3.8 
Cabbage, Summer Golden Acre, cooked Soluble NSP 0.8 Cababge, Red, cooked Soluble NSP 1.5 
 Insoluble NSP 0.8  Insoluble NSP 1.8 
 Total NSP 1.6  Total NSP 3.3 
Cabbage, Summer Greyhound, cooked Soluble NSP 0.7 Calabrese, cooked Soluble NSP 1.2 
 Insoluble NSP 0.7  Insoluble NSP 1.5 
 Total NSP 1.4  Total NSP 2.7 
Cabbage, Summer Emerald Cross, cooked Soluble NSP 0.9 Carrots, raw, Flesh only Soluble NSP 1.4 
 Insoluble NSP 1.1  Insoluble NSP 1.0 
 Total NSP 2.0  Total NSP 2.4 
Vegetables Total g/100 g Vegetables Total g/100 g 
Fresh Weight Fresh Weight 
Carrots, cooked, Flesh only, sliced, Soluble NSP 1.4 Cress, raw Soluble NSP 0.5 
 Insoluble NSP 1.1  Insoluble NSP 0.6 
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 Total NSP 2.5  Total NSP 1.1 
Carrots, tinned, Drained contents Soluble NSP 1.0 Cress, water, raw Soluble NSP 0.8 
 Insoluble NSP 0.9  Insoluble NSP 1.0 
 Total NSP 1.9  Total NSP 1.8 
Cauliflower, raw Soluble NSP 0.9 Cucumber, raw, Soluble NSP 0.2 
 Insoluble NSP 0.9  Insoluble NSP 0.3 
 Total NSP 1.8  Total NSP 0.5 
Cauliflower, cooked Soluble NSP 0.7 Cucumber, raw, Soluble NSP 0.2 
 Insoluble NSP 0.9  Insoluble NSP 0.3 
 Total NSP 1.6  Total NSP 0.5 
Celeriac, raw, Flesh only Soluble NSP 2.4 Endives, raw Soluble NSP 0.9 
 Insoluble NSP 1.3  Insoluble NSP 1.1 
 Total NSP 3.7  Total NSP 2.0 
Celery, raw, Stems only Soluble NSP 0.6 Fennel, raw Soluble NSP 1.1 
 Insoluble NSP 0.7  Insoluble NSP 1.3 
 Total NSP 1.3  Total NSP 2.4 
Chicory, raw Soluble NSP 0.5 Leeks, cooked Soluble NSP 1.2 
 Insoluble NSP 0.7  Insoluble NSP 1.1 
 Total NSP 1.2  Total NSP 2.3 
Courgette, raw Soluble NSP 0.5 Lentils, Red, dried Soluble NSP 1.3 
 Insoluble NSP 0.6  Insoluble NSP 3.6 
 Total NSP 1.1  Total NSP 4.9 
Courgette, cooked, Soluble NSP 0.6 Lentils, Red, dried, cooked Soluble NSP 0.6 
 Insoluble NSP 0.6  Insoluble NSP 1.3 
 Total NSP 1.2  Total NSP 1.9 
Vegetables Total g/100 g Vegetables Total g/100 g 
Fresh Weight Fresh Weight 
Lettuce, round, raw Soluble NSP 0.6 Parsnip, cooked Soluble NSP 2.3 
 Insoluble NSP 0.6  Insoluble NSP 1.7 
 Total NSP 1.2  Total NSP 4.0 
Lettuce, Iceberg, raw Soluble NSP 0.4 Peas, Chick, dried Soluble NSP 3.3 
 Insoluble NSP 0.5  Insoluble NSP 7.4 
 Total NSP 0.9  Total NSP 10.7 
Marrow, cooked Soluble NSP 0.3 Peas, Chick, dried, cooked Soluble NSP 1.6 
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 Insoluble NSP 0.7  Insoluble NSP 3.2 
 Total NSP 1.0  Total NSP 4.8 
Mushrooms, raw Soluble NSP 0.2 Peas, dried Soluble NSP 3.6 
 Insoluble NSP 0.9  Insoluble NSP 9.4 
 Total NSP 1.1  Total NSP 13.0 
Okra, raw Soluble NSP 2.9 Peas, dried, cooked Soluble NSP 1.6 
 Insoluble NSP 1.9  Insoluble NSP 3.9 
 Total NSP 4.8  Total NSP 5.5 
Onion, raw Soluble NSP 1.1 Peas, fresh, cooked Soluble NSP 0.8 
 Insoluble NSP 0.9  Insoluble NSP 2.1 
 Total NSP 2.0  Total NSP 2.9 
Onion, cooked Soluble NSP 1.0 Peas, frozen, cooked Soluble NSP 1.6 
 Insoluble NSP 0.8  Insoluble NSP 3.6 
 Total NSP 1.8  Total NSP 5.2 
Onion, salad, raw Soluble NSP 0.9 Peas, Garden, tinned Soluble NSP 1.1 
 Insoluble NSP 0.6  Insoluble NSP 2.9 
 Total NSP 1.7  Total NSP 4.0 
Parsley, raw Soluble NSP 2.8 Peas, processed, tinned Soluble NSP 1.0 
 Insoluble NSP 2.2  Insoluble NSP 2.4 
 Total NSP 5.0  Total NSP 3.4 
Vegetables 
Total g/100 g 
Vegetables 
Total g/100 g 
Fresh Weight Fresh Weight 
Pea hulls, dried, test sample Soluble NSP 11.8 Radish, raw Soluble NSP 0.4 
  Insoluble NSP 55.8   Insoluble NSP 0.6 
  Total NSP 67.6   Total NSP 1.0 
Peas, split, dried Soluble NSP 2.2 Spinach, cooked leaves Soluble NSP 0.6 
  Insoluble NSP 4.1   Insoluble NSP 1.0 
  Total NSP 6.3   Total NSP 1.6 
Peas, split, dried, cooked Soluble NSP 1.1 Spring greens, cooked leaves Soluble NSP 1.8 
  Insoluble NSP 1.6   Insoluble NSP 1.8 
  Total NSP 2.7   Total NSP 3.6 
Pepper, green, raw Soluble NSP 0.7 Sprouts, brussels, raw Soluble NSP 3.0 
  Insoluble NSP 0.9   Insoluble NSP 2.6 
  Total NSP 1.6   Total NSP 5.6 
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Plantain, cooked Soluble NSP 0.5 Sprouts, brussels Soluble NSP 2.5 
  Insoluble NSP 0.7   Insoluble NSP 2.3 
  Total NSP 1.2   Total NSP 4.8 
Potato, new, cooked Soluble NSP 0.6 Swede, cooked Soluble NSP 1.6 
  Insoluble NSP 0.5   Insoluble NSP 1.8 
  Total NSP 1.1   Total NSP 3.4 
Potato, old, cooked Soluble NSP 0.7 Sweetcorn kernels, cooked Soluble NSP 0.1 
  Insoluble NSP 0.5   Insoluble NSP 1.3 
  Total NSP 1.2   Total NSP 1.4 
Potato, sweet, cooked Soluble NSP 1.1 Sweetcorn on the cob, cooked Soluble NSP 0.5 
  Insoluble NSP 1.3   Insoluble NSP 2.2 
  Total NSP 2.4   Total NSP 2.7 
Potato Crisps Soluble NSP 2.7 Tomato, fresh, raw Soluble NSP 0.4 
  Insoluble NSP 2.2   Insoluble NSP 0.7 
  Total NSP 4.9   Total NSP 1.1 
Vegetables 
Total g/100 g 
Fruits  
Total g/100 g 
Fresh Weight Fresh Weight 
Tomato, tinned Soluble NSP 0.4 Apples, Bramley Soluble NSP 0.6 
  Insoluble NSP 0.6  Insoluble NSP 1.0 
  Total NSP 1.0  Total NSP 1.6 
Turnip, cooked Soluble NSP 2.2 Apples, Bramley Soluble NSP 0.7 
  Insoluble NSP 3.5   Insoluble NSP 0.9 
  Total NSP 5.7   Total NSP 1.6 
Yam, raw Soluble NSP 0.5 Apples, Cox Soluble NSP 0.9 
  Insoluble NSP 0.8  Insoluble NSP 1.1 
  Total NSP 1.3  Total NSP 2.0 
Yam, cooked Soluble NSP 0.5 Apples, Cox  Soluble NSP 0.7 
  Insoluble NSP 0.6   Insoluble NSP 1.0 
  Total NSP 1.1   Total NSP 1.7 
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Fruits  
Total g/100 g Apples, red Soluble NSP 0.9 
Fresh Weight  Insoluble NSP 1.0 
Apples, Golden Delicious Soluble NSP 0.7  Total NSP 1.9 
 Insoluble NSP 1.0 Apples, red Soluble NSP 0.6 
 Total NSP 1.7   Insoluble NSP 1.0 
Apples, Golden Delicious Soluble NSP 0.6   Total NSP 1.6 
  Insoluble NSP 0.9 Apricots, fresh Soluble NSP 1.3 
  Total NSP 1.5  Insoluble NSP 1.0 
Apples, Granny Smith Soluble NSP 0.7  Total NSP 2.3 
 Insoluble NSP 1.0 Apricots, tinned Soluble NSP 0.6 
 Total NSP 1.7   Insoluble NSP 0.7 
Apples, Granny Smith Soluble NSP 0.6   Total NSP 1.3 
  Insoluble NSP 0.9 Apricots, dried Soluble NSP 4.4 
  Total NSP 1.5  Insoluble NSP 2.9 
        Total NSP 7.3 
Fruits Total g/100 g Fruits Total g/100 g 
Fresh Weight Fresh Weight 
Avocado pears, raw Soluble NSP 1.8 Dates, dried Soluble NSP 1.2 
 Insoluble NSP 2.6  Insoluble NSP 2.8 
 Total NSP 4.4  Total NSP 4.0 
Bananas, raw Soluble NSP 0.7 Figs, raw Soluble NSP 1.7 
 Insoluble NSP 0.4  Insoluble NSP 1.1 
 Total NSP 1.1  Total NSP 2.8 
Blackberries, raw Soluble NSP 1.0 Figs, dried, Soluble NSP 4.0 
 Insoluble NSP 2.1  Insoluble NSP 3.5 
 Total NSP 3.1  Total NSP 7.5 
Cherries (Black), raw Soluble NSP 0.7 Fruit pie filling, tinned, Whole can Soluble NSP 0.5 
 Insoluble NSP 0.5  Insoluble NSP 0.5 
 Total NSP 1.2  Total NSP 1.0 
Clementines, raw Soluble NSP 0.8 Fruit cocktail, tinned Soluble NSP 0.6 
 Insoluble NSP 0.5  Insoluble NSP 0.9 
 Total NSP 1.3  Total NSP 1.5 
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Cranberries, raw Soluble NSP 1.1 Gooseberries, raw Soluble NSP 0.9 
 Insoluble NSP 1.9  Insoluble NSP 1.5 
 Total NSP 3.0  Total NSP 2.4 
Currants (red), raw Soluble NSP 0.7 Grapefruit, raw Soluble NSP 0.9 
 Insoluble NSP 2.7  Insoluble NSP 0.4 
 Total NSP 3.4  Total NSP 1.3 
Currants (black), raw Soluble NSP 1.6 Grapefruit, tinned Soluble NSP 0.7 
 Insoluble NSP 2.0  Insoluble NSP 0.4 
 Total NSP 3.6  Total NSP 1.1 
Currants (dried grapes), raw Soluble NSP 1.0 Grapes (white), raw Soluble NSP 0.4 
 Insoluble NSP 0.9  Insoluble NSP 0.3 
 Total NSP 1.9  Total NSP 0.7 
Fruits  
Total g/100 g 
Fruits  
Total g/100 g 
Fresh Weight Fresh Weight 
Grapes (black), raw Soluble NSP 0.3 Mango, tinned Soluble NSP 0.6 
  Insoluble NSP 0.3  Insoluble NSP 0.5 
  Total NSP 0.6  Total NSP 1.1 
Greengages, raw Soluble NSP 1.3 Melon, Canteloupe, raw Soluble NSP 0.2 
 Insoluble NSP 0.8   Insoluble NSP 0.4 
 Total NSP 2.1   Total NSP 0.6 
Guava, tinned Soluble NSP 0.9 Melon, Gallia, raw Soluble NSP 0.2 
  Insoluble NSP 3.9  Insoluble NSP 0.3 
  Total NSP 4.8  Total NSP 0.5 
Kiwi fruit, raw Soluble NSP 0.8 Melon, Honeydew, raw Soluble NSP 0.2 
 Insoluble NSP 0.9   Insoluble NSP 0.3 
 Total NSP 1.7   Total NSP 0.5 
Lemon juice, fresh Soluble NSP t Melon, Water, raw Soluble NSP 0.2 
  Insoluble NSP 0.1  Insoluble NSP 0.1 
  Total NSP 0.1  Total NSP 0.3 
Loganberries, tinned Soluble NSP 0.5 Nectarines, raw Soluble NSP 0.6 
 Insoluble NSP 2.4   Insoluble NSP 0.6 
 Total NSP 2.9   Total NSP 1.2 
Lychees, tinned Soluble NSP 0.7 Olives, tinned Soluble NSP 0.3 
  Insoluble NSP 0.3  Insoluble NSP 2.6 
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  Total NSP 1.0  Total NSP 2.9 
Mandarins, tinned Soluble NSP 0.2 Oranges, raw Soluble NSP 1.4 
 Insoluble NSP 0.2   Insoluble NSP 0.7 
 Total NSP 0.4   Total NSP 2.1 
Mango, raw Soluble NSP 1.6 Orange juice Soluble NSP 0.1 
  Insoluble NSP 1.0  Insoluble NSP t 
  Total NSP 2.6  Total NSP 0.1 
Fruits Total g/100 g Fruits Total g/100 g 
Fresh Weight Fresh Weight 
Passion fruit, raw Soluble NSP 0.5 Pears, tinned Soluble NSP 0.5 
 Insoluble NSP 0.1  Insoluble NSP 1.3 
 Total NSP 0.6  Total NSP 1.8 
Paw paw, tinned Soluble NSP 0.5 Pineapples, raw Soluble NSP 0.1 
 Insoluble NSP 0.7  Insoluble NSP 1.1 
 Total NSP 1.2  Total NSP 1.2 
Peaches, raw Soluble NSP 0.8 Pineapples, tinned Soluble NSP 0.1 
 Insoluble NSP 0.7  Insoluble NSP 1.0 
 Total NSP 1.5  Total NSP 1.1 
Peaches, tinned Soluble NSP 0.5 Plums, Sicoval Soluble NSP 1.0 
 Insoluble NSP 0.5  Insoluble NSP 0.6 
 Total NSP 1.0  Total NSP 1.6 
Peaces, dried Soluble NSP 3.8 Plums, Victoria Soluble NSP 1.2 
 Insoluble NSP 3.5  Insoluble NSP 0.6 
 Total NSP 7.3  Total NSP 1.8 
Pears, Comice, Soluble NSP 0.6 Pomengranate, raw Soluble NSP 0.7 
 Insoluble NSP 1.4  Insoluble NSP 2.7 
 Total NSP 2.0  Total NSP 3.4 
Pears, Comice, Soluble NSP 0.6 Prunes, dried Soluble NSP 4.7 
 Insoluble NSP 0.9  Insoluble NSP 2.2 
 Total NSP 1.5  Total NSP 6.9 
Pears, Conference Soluble NSP 0.8 Prunes, cooked, stewed (no sugar), no juice Soluble NSP 1.7 
 Insoluble NSP 1.6  Insoluble NSP 0.9 
 Total NSP 2.4  Total NSP 2.6 
Pears, Conference Soluble NSP 0.6 Pumpkin, raw Soluble NSP 0.4 
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 Insoluble NSP 1.2  Insoluble NSP 0.6 
 Total NSP 1.8  Total NSP 1.0 
Fruits  
Total g/100 g 
Fresh Weight 
Raisins, dried Soluble NSP 1.1 
 Insoluble NSP 1.0 
 Total NSP 2.1 
Raspberries, raw Soluble NSP 0.7 
  Insoluble NSP 1.8 
  Total NSP 2.5 
Raspberries, tinned Soluble NSP 0.5 
 Insoluble NSP 2.3 
 Total NSP 2.8 
Rhubarb, raw Soluble NSP 0.6 
  Insoluble NSP 1.0 
  Total NSP 1.6 
Satsumas, raw Soluble NSP 1.1 
 Insoluble NSP 0.5 
 Total NSP 1.6 
Strawberries, raw Soluble NSP 0.6 
  Insoluble NSP 0.8 
  Total NSP 1.4 
Strawberries, tinned Soluble NSP 0.5 
 Insoluble NSP 0.8 
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Dietary fibre (soluble, insoluble and total DF g/100 g as eaten) contents of 70 high consumption foods (adapted from Li et al., 2002). 
 
Baked products Soluble DF Insoluble DF Total DF 
Bagel, plain, frozen 1.17 1.29 2.46 
Bread, white, reduced calorie, soft 0.01 8.46 9.47 
Bread, white, reduced calorie, firm 1.03 8.64 9.67 
Bread, rye, w/ caraway seeds 1.09 1.98 3.07 
Bread, rye, seedless 1.62 2.84 4.46 
Bread, wheat, soft 1.26 2.13 3.38 
Bread, wheat, firm 1.56 4.63 6.19 
Bread, white, soft 1.02 0.53 1.54 
Bread, white, firm 1.30 1.36 2.66 
Bread, whole wheat, soft 1.26 4.76 6.01 
Bread, whole wheat, firm 1.51 5.21 6.71 
Hamburger/hotdog rolls 0.56 1.44 1.99 
Tortilla, corn 1.11 4.39 5.50 
Tortilla, flour (wheat) 1.51 0.85 2.37 
Cereal grains and pasta Soluble DF Insoluble DF Total DF 
Corn meal, yellow, degermed 0.62 3.32 3.94 
Cornstarch, wholesale 1.00 0.08 1.08 
Brown rice, long grain, cooked 0.44 2.89 3.33 
Flour, all purpose, bleached 1.54 1.50 3.04 
Grits, quick, cooked 0.12 1.14 1.26 
  Total NSP 1.3 
Sultanas, dried Soluble NSP 1.0 
 Insoluble NSP 1.2 
  Total NSP 2.2 
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Grits, instant, cooked 0.07 1.48 1.55 
Oatmeal, instant, cooked 1.45 1.14 2.58 
Oatmeal, regular, cooked 0.42 1.23 1.65 
Spaghetti, cooked 0.54 1.33 2.06 
White rice, long grain, cooked - 0.34 0.34 
Fruits Soluble DF Insoluble DF Total DF 
Apple (Red delicious), raw, ripe w/ skin 0.67 1.54 2.21 
Avocado (California, Haas), raw, ripe 2.03 3.51 5.53 
Avocado (Florida, Fuertes), raw, ripe 1.25 5.48 6.72 
Bananas, raw, ripe 0.58 1.21 1.79 
Grapefruit, raw, white, ripe 0.58 0.32 0.89 
Grapes (Thompson seedless), raw, ripe 0.24 0.36 0.60 
Guava, raw, ripe 1.54 11.81 12.72 
Mango, raw, ripe 0.69 1.08 1.76 
Nectarine, raw, ripe, w/ skin 0.98 1.06 2.04 
Oranges (Navel), raw, ripe 1.37 0.99 2.35 
Orange juice, retail, from concentrate 0.28 0.03 0.31 
Peaches, raw, ripe, w/ skin 1.31 1.54 2.85 
Peaches, raw, ripe, w/o skin 0.84 1.16 2.00 
Pears, raw, ripe, w/ skin 0.92 2.25 3.16 
Pineapple (smooth Cayenne), raw, ripe 0.04 1.42 1.46 
Plum, raw, ripe, w/ skin 1.12 1.76 2.87 
Prunes, pitted 4.50 3.63 8.13 
Raisins, seedless 0.90 2.17 3.07 
Watermelon, raw, ripe 0.13 0.27 0.40 
Legumes Soluble DF Insoluble DF Total DF 
Beans, canned, w/ pork and tomato sauce 1.38 4.02 5.40 
Chick peas, canned, drained 0.41 5.79 6.19 
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Cowpeas, canned, drained 0.43 4.11 4.53 
Lentils, dry, cooked, drained 0.44 5.42 5.86 
Pinto beans, canned, drained 0.99 5.66 6.65 
Red kidney beans, can, drained 1.36 5.77 7.13 
Split peas, dry, cooked, drained 0.09 10.56 10.65 
Vegetables, cooked Soluble DF Insoluble DF Total DF 
Beans, green, fresh, microwaved 1.38 2.93 4.31 
Broccoli, fresh microwaved 1.85 2.81 4.66 
Carrots, fresh, microwaved 1.58 2.29 3.87 
Corn, yellow, from cob, grocery store 0.13 4.12 4.25 
Corn, yellow, from cob, farm market 0.25 2.63 2.87 
Lima beans, immature, froz., microwaved 1.02 4.21 5.23 
Peas, green, froz., microwaved 0.94 2.61 3.54 
Potato, french fries, fast food 0.67 3.44 4.11 
Potato, white, baked, w/ skin 0.61 1.70 2.31 
Potato, white, boiled, w/o skin 0.99 1.06 2.05 
Vegetables, raw Soluble DF Insoluble DF Total DF 
Broccoli, raw 0.44 3.06 3.50 
Cabbage, green, raw 0.46 1.79 2.24 
Carrots, raw 0.49 2.39 2.88 
Cauliflower, raw 0.47 2.15 2.62 
Cucumber, raw, with peel 0.20 0.94 1.14 
Lettuce, iceberg, raw 0.10 0.88 0.98 
Onion, mature, raw 0.71 1.22 1.93 
Pepper, sweet, green, raw 0.53 0.99 1.52 
Tomatoes, red, ripe, raw 0.15 1.19 1.34 
Spinach, raw 0.77 2.43 3.20 
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Fructooligosaccharide composition of fruits (adapted from Campbell et al., 1997). 
 
 
Fructooligosaccharide Composition of vegetables (adapted from Campbell et al., 1997). 
 
Fruits TOTAL (mg/g as is) 
apple, Red Delicious 0.1 
apple, Golden Delicious 0.0 
apple, Granny Smith 0.1 
apple, Jonagold 0.1 
apple, Rome 0.0 
banana 1.4 
banana, green 0.7 
banana, red 0.5 
banana, ripe 2.0 
blackberry 0.2 
blueberry 0.0 
cantaloupe 0.0 
gooseberry 0.1 
grapes, black 0.2 
grapes, Thompson 0.0 
muskmelon 0.1 
orange, navel 0.3 
peach 0.4 
pear, bosc 0.1 
pear, d'Anjou 0.2 
plantain 0.4 
plum, red 0.2 
raspberry, red 0.2 
rhubarb 0.0 
strawberry tr  
watermelon 0.2 
Vegetables TOTAL (mg/g as is) INGREDIENT TOTAL (mg/g as is) 
acorn squash 0.4 grains   
artichoke, globe 2.4 barley 1.7 
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asparagus 0.0 corn 0.0 
bean, green 0.0 hominy tr 
bean, kidney 0.1 milo 0.0 
beet, red 0.0 oats 0.3 
carrot, Bunny Luv 0.3 rice, brown 0.0 
carrot, Dole  0.2 rice, white 0.0 
celery 0.0 rye 3.8 
chicory root, raw 3.9 soybean tr 
chicory root, roasted 4.2 wheat 1.3 
Chinese chive 0.0 forages   
daikon 0.0 alfalfa 0.0 
eggplant 0.0 Brome-grass tr 
endive 0.0 clover hay 0.4 
garlic 3.9 oat straw 0.7 
garlic powder 1.6 Orchard-grass 0.2 
ginger root 0.0 timothy hay 1.0 
Jerusalem artichoke 58.4 wheat straw 0.0 
kiwi 0.0 other   
leek 0.9 alfalfa meal 2.1 
lettuce 0.5 beet pulp 0.1 
onion, red 1.4 brewer's rice 0.0 
onion, Welch 1.1 canola meal 0.0 
onion, white 3.1 corn distiller’s solution tr 
onion, yellow 2.6 corn gluten feed 0.1 
onion powder 45.0 corn gluten meal 0.3 
peas 0.1 oat groats 0.1 
peas, snap 1.1 peanut hulls 2.2 
peas, snow 0.6 rice bran 0.1 
potato, Idaho 0.0 rice hulls 0.0 
potato, sweet 0.2 seaweed 0.0 
radish, red 0.1 soybean hulls 0.1 
shallot 8.5 soybean meal 0.0 
taro root 0.0 wheat bran 3.5 
tomato 0.0 wheat germ 4.2 
tomato, cherry 0.0 wheat middling’s 4.6 
tomato, Roma  0.0    
yam 0.2    
 
 
281 
 
 
Fructooligosaccharide Composition of fruits, vegetables and cereals (adapted from (Hogarth et al., 2000). 
 
 
 
 
zucchini 0.0    
PRODUCT Total  PRODUCT Total 
A. Fruit Products     C. Sugars, Grains, and Flours 
apples <0.02 barley flour 0.43 
apple juice 0.05 barley, quick cook 0.19 
apple juice 0.04 brown sugar, dark 0.36 
apple juice <0.02 brown sugar, dark 0.12 
applesauce <0.02 honey 0.06 
applesauce, stage 1 <0.02 honey <0.02 
bananas, stage 1 0.13 molasses, blackstrap 0.43 
bananas, stage 1 0.04 oatmeal <0.02 
bananas, stage 1 0.04 oat bran <0.02 
banana chips <0.02 oat bran cereal <0.02 
grapes, seedless <0.02 rice cereal   
grapes, seedless, liquid <0.02 rye flour 0.96 
Concord grape juice, can <0.02 rye flour, dark 1.17 
Concord grape juice, jar <0.02 wheat bran 0.53 
Concord grape juice, juice-makers <0.02 wheat flour 0.15 
white grape juice <0.02 D. Miscellaneous Products   
tomato juice <0.02 formula, infant 1.78 
tomato paste 0.25 Garlic Plus FOS, tablets 25.70 
tomato puree <0.02 Garliphants 0.88 
tomato sauce <0.02 Sportalyte <0.02 
  Sweetener, Japanese 99.90 
PRODUCT Total 
Vegetable Products  
artichoke hearts 0.13 
artichoke hearts, liquid 15.10 
artichoke hearts 0.13 
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Inulin and oligofructose content of foods (adapted from Moshfegh et al., 1999 and Van Loo et al., 1995) 
 
artichoke hearts, liquid 14.90 
artichoke hearts, marinade 7.00 
artichoke hearts <0.02 
asparagus spears <0.02 
asparagus spears, liquid <0.02 
asparagus spears <0.02 
asparagus spears, liquid <0.02 
garlic powder 0.22 
onions, liquid 6.13 
onions, whole 0.04 
onions, dry, minced 4.40 
onions, dry, minced 3.94 
pumpkin <0.02 
squash, stage 1 <0.02 
squash, stage 3 <0.02 
sweet potatoes 0.03 
sweet potatoes, syrup 1.70 
sweet potatoes, stage 1 <0.02 
yams <0.02 
yams, candied, syrup 0.59 
yams candied <0.02 
 Food item  Inulin Oligofructose  
  g/100g 
  Range Midpoint Range Midpoint 
Banana     
 Raw 0.3-0.7 0.5 0.3-0.7 0.5 
 Raw-dried 0.9-2.0 1.4 0.9-2.0 1.4 
 Canned 0.1-0.3 0.2 0.1-0.3 0.2 
Asparagus     
 Raw 2.0-3.0 2.5 2.0-3.0 2.5 
 Boiled 1.4-2.0 1.7 1.4-2.0 1.7 
Chicory root 35.7-47.6 41.6 19.6-26.2 22.9 
Dandelion greens     
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 Raw 12.0-15.0 13.5 9.6-12.0 10.8 
 Cooked 8.1-10.1 9.1 6.5-8.1 7.3 
Garlic     
 Raw 9.0-16.0 12.5 3.6-6.4 5.0 
 Dried 20.3-36.1 28.2 8.1-14.5 11.3 
Globe artichoke 2.0-6.8 4.4 0.2-0.7 0.4 
Jerusalem artichoke 16.0-20.0 18.0 12.0-15.0 13.5 
Leeks     
 Raw 3.0-10.0 6.5 2.4-8.0 5.2 
Onions     
 Raw 1.1-7.5 4.3 1.1-7.5 4.3 
 Raw-dried 4.7-31.9 18.3 4.7-31.9 18.3 
 Cooked 0.8-5.3 3.0 0.8-5.3 3.0 
Wheat     
 Bran-raw 1.0-4.0 2.5 1.0-4.0 2.5 
 Flour-baked 1.0-3.8 2.4 1.0-3.8 2.4 
 Flour-boiled 0.2-.06 0.4 0.2-.06 0.4 
Barley     
 Raw 0.5-1.0 0.8 0.5-1.0 0.8 
 Cooked 0.1-0.2 0.2 0.1-0.2 0.2 
Rye      
 Baked 0.5-0.9 0.7 0.5-0.9 0.7 
